Compounds > prednisolone
Page last updated: 2024-11-06

prednisolone and Libman-Sacks Disease

prednisolone has been researched along with Libman-Sacks Disease in 1017 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"We evaluated the efficacy and safety of low-dose cyclosporine A (CsA) in patients with refractory lupus nephritis."9.12Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. ( Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tsuzaka, K, 2007)
"We report a patient with protein-losing gastropathy probably associated with autoimmune disease, in whom prednisolone treatment was highly effective."8.81Protein-losing gastropathy associated with autoimmune disease: successful treatment with prednisolone. ( Aoki, T; Asada, Y; Eto, T; Inatsu, H; Ishikawa, N; Noma, N; Otsuka, M; Sakata, J; Takajo, I; Yamaga, J; Yuchi, H, 2002)
"8%) pregnancies, and these patients had a significantly higher dose of prednisolone, hypocomplementemia, lower estimated glomerular filtration rate, past history of lupus nephritis, and complication with antiphospholipid syndrome."7.88The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus. ( Fujikawa, K; Fukui, S; Horai, Y; Ichinose, K; Iwamoto, N; Kawakami, A; Kawashiri, SY; Kitajima, Y; Koga, T; Masuzaki, H; Nakamura, H; Nishino, A; Origuchi, T; Sato, S; Tamai, M; Umeda, M; Yasuhi, I, 2018)
"This observational, retrospective, single-center cohort study aimed to assess pregnancy outcome in women with antiphospholipid antibodies who were treated with hydroxychloroquine in addition to conventional treatment during pregnancy."7.83The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. ( Cuadrado, MJ; Hunt, BJ; Khamashta, MA; Lliso, G; Sciascia, S; Talavera-Garcia, E, 2016)
"A patient with Stevens-Johnson syndrome related to danazol is presented."7.81Danazol-induced Stevens-Johnson syndrome in a patient with systemic lupus erythematosus. ( Koh, MJ; Koh, WL; Tay, YK, 2015)
"The efficacy of isoniazid (INAH) prophylaxis against tuberculosis (TB) in patients taking corticosteroid remains controversial."7.73Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. ( Chan, TM; Lau, CS; Lo, Y; Mok, MY; Wong, WS, 2005)
"Following an acute episode of undifferentiated collagenosis/autoimmune disease with joint pain, a 50-year-old female patient with known long-standing chronic hepatitis B was treated orally with corticosteroids (30 mg prednisolone in decreasing doses over a period of six months)."7.72[Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma]. ( Chrissafidou, A; Malek, M; Musch, E, 2003)
"Ten patients with rapidly progressive glomerulonephritis and acute renal failure were treated with extracorporeal immunoadsorption, prednisolone, and cyclophosphamide."7.68Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. ( Cairns, T; Dische, F; Gjorstrup, P; Gluck, G; Palmer, A; Parsons, V; Taube, D; Welsh, K, 1991)
"A 10-year-old boy with systemic lupus erythematosus exhibiting prominent features of dermatomyositis has been treated with 600 mg prednisolone intravenously per day on 3 consecutive days."7.67Prednisolone pulse therapy for childhood systemic lupus erythematosus with prominent dermatomyositis. A case report. ( Schreiber, G; Wollina, U, 1985)
"Intensive immunosuppression (IIS) was compared with prednisolone alone over a 2-year period in the treatment of severe connective tissue diseases."7.66Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. ( Ansell, BM; de Vere Tyndall, A; Denman, AM; Gumpel, JM; Hollingworth, P; Mertin, J; Platts-Mills, T; Smith, DS, 1982)
"The effects of long-term treatment with azathioprine and prednisolone on T- and B-lymphocytes were studied in 52 patients with lupus nephritis (LN) and chronic glomerulonephritis (GN)."7.66The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis. ( Gordovskaya, NB; Shilov, EM; Tareyeva, IE, 1980)
"Sirolimus is an effective and safe treatment option for refractory CTD-TP patients."7.01Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial. ( Li, M; Wang, Q; Wu, C; Xu, D; Zeng, X, 2021)
"Tacrolimus was continued as maintenance therapy."6.87Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. ( Amano, K; Chino, K; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Okada, Y; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2018)
"Tacrolimus was discontinued."6.48Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature. ( Imai, H; Komatsu, N; Nakamura, N; Noguchi, M; Sawada, T; Sekiguchi, Y; Shimada, A; Sugimoto, K; Wakabayashi, M, 2012)
"Prednisolone was gradually tapered and stopped after 3 years, although tacrolimus 3 mg/day was continued."5.72Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review. ( Kurihara, I; Sugawara, H; Terai, C; Yabe, H, 2022)
" Seventy adults with severe SLE including lupus nephritis will be randomized 1:1 to receive either standard of care consisting of prednisolone and mycophenolate as induction and maintenance treatment, or belimumab and rituximab combined with standard of care as induction treatment, followed by prednisolone and belimumab as maintenance treatment."5.51Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial. ( Arends, EJ; de Leeuw, K; Huizinga, TWJ; Limper, M; Rabelink, TJ; Rotmans, JI; Soonawala, D; Teng, YKO; Toes, REM; van Kooten, C; van Ommen, E; van Paassen, P; van Schaik, M, 2022)
"Patients with systemic lupus erythematosus (SLE) are at high risk of tuberculosis (TB) because of their immunocompromised status and the use of immunosuppressive drugs."5.51Prednisolone dose during treatment of tuberculosis might be a risk factor for mortality in patients with systemic lupus erythematosus: a hospital-based cohort study. ( Cheng, CF; Hsieh, SC; Huang, YM; Li, KJ; Lu, CH, 2019)
" Pregnancy with SLE is associated with an increase risk of adverse maternal and fetal outcomes."5.40Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. ( Izumi, Y; Migita, K; Miyashita, T, 2014)
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."5.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)
"Thrombocytopenia is one of the common manifestations of systemic lupus erythematosus (SLE)."5.33Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. ( Bae, YD; Choi, HJ; Lee, EB; Lee, JC; Shin, KC; Song, YW, 2005)
"Procainamide was discontinued."5.30[Procainamide-induced lupus in a patient with bilateral pleural effusion]. ( Hisauchi, K; Mitunaga, K; Miyake, S; Ohtani, Y; Sawada, M; Sumi, Y; Yamashita, Y; Yoshizawa, Y, 1998)
"Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described."5.29Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. ( Abe, K; Mizuki, T; Ohji, T; Terao, T, 1994)
"A case of full blown systemic lupus erythematosus (SLE) was treated with steroid."5.29Danazol for thrombocytopenia in pregnancy with underlying systemic lupus erythematosus. ( Bumpenboon, T; Chanchairujira, T; Insiripong, S, 1996)
"A diagnosis of systemic lupus erythematosus (SLE) was made, and she received 40 mg of prednisolone daily."5.29[A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment]. ( Arakawa, M; Maruyama, Y; Sato, T; Ueno, M; Wakasugi, M, 1996)
" Long term administration of amphotericin B (cumulative dose 5 g) combined with 5-flucytosine eradicated this fungal infection."5.28[A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B]. ( Chida, Y; Hiruma, M; Ida, T; Makiguchi, K; Malumo, F; Matsuda, O; Tsutsui, H, 1990)
"We evaluated the efficacy and safety of low-dose cyclosporine A (CsA) in patients with refractory lupus nephritis."5.12Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. ( Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tsuzaka, K, 2007)
"We report on three patients who developed four episodes of acute pancreatitis while their systemic lupus erythematosus was active and being treated with prednisolone."4.89Systemic lupus erythematosus-related pancreatitis in children. ( Dendumrongsup, T; Dissaneewate, P; Kritsaneepaiboon, S; Limwattana, S; Vachvanichsanong, P, 2013)
"We report a patient with protein-losing gastropathy probably associated with autoimmune disease, in whom prednisolone treatment was highly effective."4.81Protein-losing gastropathy associated with autoimmune disease: successful treatment with prednisolone. ( Aoki, T; Asada, Y; Eto, T; Inatsu, H; Ishikawa, N; Noma, N; Otsuka, M; Sakata, J; Takajo, I; Yamaga, J; Yuchi, H, 2002)
" A diagnosis of lupus cystitis was made and administration of 40mg of prednisolone was started."4.79Lupus cystitis. report of a case. ( Nakano, K; Ohtake, N; Takezawa, Y; Yamanaka, H, 1994)
"A 14-year-old female developed systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA) two weeks after administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy."4.78Carbamazepine-induced systemic lupus erythematosus-like disease. ( Kanno, T; Kasukawa, R; Kazuta, Y; Miyata, M; Nishimaki, T; Sato, Y, 1992)
" The SLE Disease Activity Index score and prednisolone dose were significantly reduced after switching, with few disease exacerbations over 12 months."4.31Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study. ( Akahoshi, M; Akashi, K; Arinobu, Y; Ayano, M; Horiuchi, T; Kimoto, Y; Mitoma, H; Niiro, H; Ono, N, 2023)
" History of lupus nephritis and a higher average dose of prednisolone used since diagnosis were associated with cIMT progression in patients."3.96Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol ( Ajeganova, S; Frostegård, J; Gustafsson, T; Hafström, I; Lindberg, L, 2020)
" We analyzed 14 patients with lupus nephritis (LN) who were given MMF, and 13 patients who received monthly intravenous cyclophosphamide (IVCY) as induction therapy, and a further 19 patients without LN who were treated with MMF, and 13 patients who took tacrolimus (TAC) to reduce glucocorticoid dosages."3.91Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus. ( Kaburaki, M; Kaneko, K; Kawai, S; Kawazoe, M; Masuoka, S; Mizutani, S; Muraoka, S; Nanki, T; Sato, H; Shikano, K; Yamada, S; Yamada, Z, 2019)
" A total of 91 patients with systemic autoimmune diseases who received initial glucocorticoid therapy with prednisolone (30-60 mg daily) were prospectively enrolled."3.88Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases. ( Kaneko, K; Kawai, S; Kawazoe, M; Kusunoki, N; Nanki, T; Shikano, K, 2018)
"8%) pregnancies, and these patients had a significantly higher dose of prednisolone, hypocomplementemia, lower estimated glomerular filtration rate, past history of lupus nephritis, and complication with antiphospholipid syndrome."3.88The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus. ( Fujikawa, K; Fukui, S; Horai, Y; Ichinose, K; Iwamoto, N; Kawakami, A; Kawashiri, SY; Kitajima, Y; Koga, T; Masuzaki, H; Nakamura, H; Nishino, A; Origuchi, T; Sato, S; Tamai, M; Umeda, M; Yasuhi, I, 2018)
"This observational, retrospective, single-center cohort study aimed to assess pregnancy outcome in women with antiphospholipid antibodies who were treated with hydroxychloroquine in addition to conventional treatment during pregnancy."3.83The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. ( Cuadrado, MJ; Hunt, BJ; Khamashta, MA; Lliso, G; Sciascia, S; Talavera-Garcia, E, 2016)
" Univariate and multivariate analysis showed that higher numbers of system or organ involvement in SLE, abdominal obesity, hypertriglyceridemia and daily prednisolone of ≥ 1 mg/kg/day were the important associated factors of SDM (P ≤ 0."3.81Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort. ( Gafor, AH; Kong, NC; Said, MS; Shaharir, SS, 2015)
"A patient with Stevens-Johnson syndrome related to danazol is presented."3.81Danazol-induced Stevens-Johnson syndrome in a patient with systemic lupus erythematosus. ( Koh, MJ; Koh, WL; Tay, YK, 2015)
"9 g 24-h proteinuria while still in remission of the protein-losing enteropathy, receiving 5 mg prednisone and 100 mg azathioprine daily."3.78Protein-losing enteropathy as initial manifestation of systemic lupus erythematosus. ( Braga, LL; Brandão, LA; Carneiro, FO; Rocha, FA; Sampaio, LR, 2012)
" Intravenous boluses of cyclophosphamide (IVCY) with oral prednisolone and cyclosporin A induced remission of SLE, and a subsequent disappearance of anti-insulin receptor autoantibodies, followed by a recovery of glucose intolerance."3.76Type B insulin resistance complicated with systemic lupus erythematosus. ( Aramaki, T; Eguchi, K; Fujikawa, K; Ida, H; Iwamoto, N; Kawakami, A; Kawashiri, SY; Nakamura, H; Origuchi, T; Tamai, M, 2010)
"We recruited 18 consecutive SLE patients (tacrolimus group) with recently confirmed biopsy-proven class V lupus nephritis."3.74Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. ( Chow, KM; Gang, W; Kwan, BC; Lai, FM; Li, EK; Li, PK; Szeto, CC; Tam, LS, 2008)
" Non-Afro-Caribbean race and exposure to prednisolone >10 mg daily were significantly associated with reduced BMD, while age and menopause were associated with osteoporosis."3.73Prevalence and predictors of fragility fractures in systemic lupus erythematosus. ( Amft, N; Bowman, S; Crabtree, N; Gordon, C; Situnayake, D; Skan, J; Yee, CS, 2005)
"The efficacy of isoniazid (INAH) prophylaxis against tuberculosis (TB) in patients taking corticosteroid remains controversial."3.73Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. ( Chan, TM; Lau, CS; Lo, Y; Mok, MY; Wong, WS, 2005)
"The objective of this study was to define prospectively the early development of corticosteroid-induced osteonecrosis of femoral head (ONF) in patients with systemic lupus erythematosus (SLE) and to identify the association of initial steroid treatment with the development of early (silent) ONE Forty-five patients who were newly diagnosed as having SLE and required 40 mg/day or more prednisolone were enrolled."3.73Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. ( Horiuchi, T; Koarada, S; Murai, K; Nagasawa, K; Ohta, A; Tada, Y; Tsukamoto, H; Ueda, A; Yoshizawa, S, 2005)
"Intravenous cyclophosphamide therapy associated with oral prednisolone proved effective in inducing complete remission of nephrotic syndrome."3.73Systemic lupus erythematosus (SLE) presenting with nephrotic syndrome and membranous glomerulopathy in a 10-year-old girl. ( Afonso, C; Brito, I; Machado, V; Pontes, T, 2005)
"Following an acute episode of undifferentiated collagenosis/autoimmune disease with joint pain, a 50-year-old female patient with known long-standing chronic hepatitis B was treated orally with corticosteroids (30 mg prednisolone in decreasing doses over a period of six months)."3.72[Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma]. ( Chrissafidou, A; Malek, M; Musch, E, 2003)
" Patients with TB were more likely to have organic brain syndrome, vasculitis, and nephritis: and they were also more likely to have received intravenous 'pulse' methylprednisolone or high cumulative dose of prednisolone."3.71Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. ( Li, EK; Szeto, CC; Tam, LS; Wong, SM, 2002)
" In addition to treatment with prednisolone, they were administered anticoagulants(warfarin, or aspirin, or heparin) for APSN and an angiotensin II receptor blocker, candesartan, for the hypertension."3.71[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis]. ( Kawakami, K; Komiya, T; Negoro, N; Okada, S; Okamura, M; Okazaki, M; Sumi, T; Tsukamoto, J; Yoshikawa, J, 2002)
"We report a case with typical clinical features of drug-induced lupus erythematosus, together with verrucous endocarditis and pleuropericardial effusion, due to amiodarone treatment."3.71Drug-induced lupus erythematosus by amiodarone. ( Schäfer, U; Schnabel, A; Sheikhzadeh, A, 2002)
" She was treated with prednisolone, and < 1 year later she presented with marked hyperglycemia."3.70Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report. ( Bremell, T; Eliasson, B; Eriksson, JW; Fowelin, J; Fredriksson, L; Yu, ZW, 1998)
" During pregnancy she was treated with a daily dosage of prednisolone 15 mg."3.70Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A. ( Kodama, N; Maeshima, E; Mune, M; Yamada, Y; Yukawa, S, 1999)
"This prospective study is an attempt to address the issues of whether or not antiphospholipid antibodies (aPL) constitute a significant risk factor for pregnancy in individuals with systemic lupus erythematosus (SLE) and whether or not combination therapy of high-dose prednisolone (PSL) and low-dose acetylsalicylic acid (ASA) offers efficient control."3.69A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus. ( Aoki, K; Hayashi, Y; Ogasawara, M, 1995)
" Then, we have introduced Mizoribine in addition to prednisolone (PSL) therapy for more than 18 months in three SLE children with lupus nephritis."3.69[Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis]. ( Aihara, Y; Ibe, M; Kuriyama, T; Mitsuda, T; Mori, M; Shimizu, C; Takahashi, Y; Yokota, S, 1994)
" Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone."3.68Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. ( Hashimoto, H; Hirose, S; Kobayashi, S; Mokuno, C; Tamura, N; Tsuda, H, 1992)
"This is a case report of fatal cryptococcal meningitis in a child with systemic lupus erythematosus being treated with prednisolone and azathioprine."3.68Cryptococcal meningitis in a child with systemic lupus erythematosus. ( al-Fawaz, IM; al-Rasheed, SA, 1990)
"Ten patients with rapidly progressive glomerulonephritis and acute renal failure were treated with extracorporeal immunoadsorption, prednisolone, and cyclophosphamide."3.68Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. ( Cairns, T; Dische, F; Gjorstrup, P; Gluck, G; Palmer, A; Parsons, V; Taube, D; Welsh, K, 1991)
"A homozygous C2 deficient patient with a lupus-like syndrome developed hypogammaglobulinemia soon after treatment with prednisolone together with phenytoin, replaced subsequently by carbamazepine."3.67Persistent immunoglobulin deficiency after prednisolone and antiepileptic therapy in a C2 deficient patient with lupus-like syndrome. ( Lever, AM; Pereira, RS; Woo, P, 1984)
"We studied the pharmacokinetics of prednisolone (PSL) in eight patients (two each with subacute thyroiditis, systemic lupus erythematosus, and nephrotic syndrome: and one each of Crohn's disease and aortitis syndrome) before and during the daily treatment with PSL(duration of 0."3.67[Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment]. ( Adachi, K; Fuwa, Y; Goshima, E; Minamori, Y; Miura, K; Murase, H; Murayama, M; Yamakita, N; Yasuda, K, 1986)
"A 10-year-old boy with systemic lupus erythematosus exhibiting prominent features of dermatomyositis has been treated with 600 mg prednisolone intravenously per day on 3 consecutive days."3.67Prednisolone pulse therapy for childhood systemic lupus erythematosus with prominent dermatomyositis. A case report. ( Schreiber, G; Wollina, U, 1985)
"Intensive immunosuppression (IIS) was compared with prednisolone alone over a 2-year period in the treatment of severe connective tissue diseases."3.66Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. ( Ansell, BM; de Vere Tyndall, A; Denman, AM; Gumpel, JM; Hollingworth, P; Mertin, J; Platts-Mills, T; Smith, DS, 1982)
"The effects of long-term treatment with azathioprine and prednisolone on T- and B-lymphocytes were studied in 52 patients with lupus nephritis (LN) and chronic glomerulonephritis (GN)."3.66The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis. ( Gordovskaya, NB; Shilov, EM; Tareyeva, IE, 1980)
"Two patients with systemic lupus erythematosus complicated with lupus nephritis were treated with levamisole, an immunomodulator."3.66Levamisole in systemic lupus erythematosus. ( Hisano, G; Ogawa, K; Sano, T; Tsubura, E, 1979)
" The chemotactic indices in three patients with severe connective tissue disease (seropositive rheumatoid arthritis, systemic lupus erythematosus, and polymyositis) returned to normal after 5 days' treatment with 60 mg of prednisolone per day."3.65Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis. ( Baum, J; Mowat, AG, 1971)
"Patients with systemic lupus erythematosus (SLE) are at increased risk of tuberculosis (TB) infection due to immune dysfunction and immunosuppressive therapy."3.01Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review. ( Bilukha, A; Komorovsky, R; Koshak, B; Slaba, U; Smiyan, S, 2023)
"Sirolimus is an effective and safe treatment option for refractory CTD-TP patients."3.01Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial. ( Li, M; Wang, Q; Wu, C; Xu, D; Zeng, X, 2021)
"Tacrolimus was continued as maintenance therapy."2.87Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. ( Amano, K; Chino, K; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Okada, Y; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2018)
"5 mg/d and standard immunosuppressant dosage tolerance) was assessed."2.87Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: ( Berglind, A; Illei, GG; Morand, EF; Trasieva, T; Tummala, R, 2018)
"The prednisolone dose was increased to 15 mg/day, and hydroxychloroquine (200 mg/day) was administered."2.82Congenital cytomegalovirus infection after maternal primary infection in a patient with systemic lupus erythematosus: A case report and literature review. ( Fujiki, Y; Fujita, D; Hiramatsu, Y; Isoda, K; Kotani, T; Nakamura, E; Takeuchi, T; Wada, Y, 2022)
"Pseudotumor cerebri is a disease that involves an idiopathic rise in intracranial pressure in association with papilledema."2.82Lupus Anticoagulant-Hypoprothrombinemia Syndrome and Pseudotumor Cerebri as an Initial Presentation of Systemic Lupus Erythematosus in a 16-Year-Old Male Patient: A Case Report and Literature Review. ( Alghaythi, AM; Alharbi, AA; AlJohani, G; Omer, MH; Salama, H, 2022)
"Thirty-one patients with SLE receiving a fixed dosage regimen of MMF (median and interquartile range, 1500 and 1000-2000mg/day) for at least 1month and who had not experienced any adverse drug reactions for more than 3months were enrolled."2.77Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase. ( Kawakami, J; Mino, Y; Naito, T; Ogawa, N; Shimoyama, K, 2012)
"Paquinimod treatment resulted in disease inhibition in MRL-lpr/lpr mice, comparable to that obtained with prednisolone and mycophenolate mofetil; prominent effects on disease manifestations and serologic markers and a steroid-sparing effect were observed."2.77Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in ( Axelsson, B; Bengtsson, AA; Leanderson, T; Lood, C; Ohman, MW; Rönnblom, L; Sparre, B; Sturfelt, G; Tuvesson, H; van Vollenhoven, RF, 2012)
"The purpose of this study was to characterize the pharmacokinetic (PK) properties of prednisolone, the metabolite of the prodrug prednisone, in cSLE patients and explore the relationship between PK properties and cSLE disease activity."2.76Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study. ( Brunner, HI; Rieder, MJ; Sagcal-Gironella, AC; Sherwin, CM; Tirona, RG; Vinks, AA, 2011)
" Retreatment with an augmented dosage of prednisolone, +/- another immunosuppressive agent, resulted in CR and PR in 15 (79%) and 4 (21%) of these flare episodes, respectively."2.74Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. ( Mok, CC; Ng, WL; Wong, WS; Yim, CW; Ying, KY, 2009)
"Pregnancy was successfully carried out in 12/12 (100%) SLE-RSA patients with a mean Apgar score of 8."2.73Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. ( Cipriani, P; De Carolis, C; Fontana, L; Giacomelli, R; Greco, E; Kröegler, B; Perricone, C; Perricone, R, 2008)
"Hydroxychloroquine and steroid treatments were started after the operation."2.72Systemic lupus erythematosus complicated with Castleman disease: a case-based review. ( Aktay Ayaz, N; Demirkan, FG; Doğan, S; Kalyoncu Uçar, A; Sönmez, HE, 2021)
"Acute acalculous cholecystitis (AAC) is an extremely rare manifestation of systemic lupus erythematous (SLE)."2.72Acute acalculous cholecystitis as the initial manifestation of systemic lupus erythematous: A case report. ( Kim, Y; Lee, J; Lee, YJ, 2021)
"Active systemic lupus erythematosus (SLE) can cause fever."2.71Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. ( Aziz, A; Birmingham, DJ; Gray, L; Hackshaw, KV; Hebert, LA; Nagaraja, HN; Rice, R; Rovin, BH; Spetie, DN; Sun, J; Tang, Y; Yu, CY, 2005)
"To evaluate whether treatment with prasterone (dehydroepiandrosterone [DHEA]) would allow the dosage of prednisone (or an equivalent corticosteroid) to be reduced to < or = 7."2.70Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. ( Ginzler, EM; Gorelick, KJ; Kunz, A; Lahita, RG; Merrill, JT; Petri, MA; Schiff, M; Schwartz, KE; Strand, V; Van Vollenhoven, RF, 2002)
"The prednisolone dose was reduced from a mean (SD) of 17."2.68Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). ( Breitbart, A; Gansauge, S; Rinaldi, N; Schwarz-Eywill, M, 1997)
" In April 1995, the microemulsion-based formulation of cyclosporin (Neoral) was introduced based on its increased bioavailability at 'no extra cost'."2.68Neoral--new cyclosporin for old? ( Scott, DG; Somerville, MF, 1997)
"Lupus enteritis is one of the manifestations of gastrointestinal involvement in SLE patients."2.61Lupus enteritis as the sole presenting feature of systemic lupus erythematosus: case report and review of the literature. ( Aanpreung, P; Charuvanij, S; Chowichian, M; Pongpaibul, A, 2019)
"Although the symptoms of systemic lupus erythematosus (SLE) worsen during pregnancy, few previous studies have reported lupus enteritis in pregnant women with SLE."2.55Lupus enteritis during pregnancy: A case-based review. ( Arata, N; Kaneshige, T; Kitami, M; Mito, A; Murashima, A; Nagakawa, A; Sago, H, 2017)
" The aim of this study was to establish the optimal dosage and administration of immunosuppressants and antifungal agents."2.52[Optimization of Immunosuppression and the Prevention of Fungal Infection in Autoimmune Diseases]. ( Mino, Y, 2015)
"Juvenile systemic lupus erythematosus (JSLE) is a chronic autoimmune disease characterized by multisystem involvement and diverse clinical and serological manifestations."2.50Hepatic manifestations in juvenile systemic lupus erythematosus. ( El-Shabrawi, MH; Farrag, MI, 2014)
"We herein describe a case of acute spinal subdural hematoma (SSDH) during the administration of high-dose corticosteroids and intravenous heparin for the treatment of active lupus nephritis."2.50Acute spinal subdural hematoma in a patient with active systemic lupus erythematosus: a case report and literature review. ( Adachi, T; Akita, K; Horii, S; Itoh, K; Kimura, F; Matsumoto, M; Wada, T, 2014)
" Here we report a similar case of SLE combined with CD in a 23-year-old girl who displayed systemic symptoms, including systemic lymphadenopathy and abnormal laboratory findings indicating the active phase of SLE."2.48A case report of systemic lupus erythematosus combined with Castleman's disease and literature review. ( Chen, XY; Wang, HY; Xia, JY; Xu, F; Xue, J; Yang, Y, 2012)
" Rituximab's adverse effects generally could be controlled with an effective dosing regimen."2.48Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis. ( Chen, JH; Han, F; Lan, L, 2012)
"Tacrolimus was discontinued."2.48Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature. ( Imai, H; Komatsu, N; Nakamura, N; Noguchi, M; Sawada, T; Sekiguchi, Y; Shimada, A; Sugimoto, K; Wakabayashi, M, 2012)
"In addition, diffuse proliferative lupus nephritis was consistently confirmed by a renal biopsy."2.45[Case of lupus nephritis and enteritis associated with bilateral hydronephrosis]. ( Akimoto, T; Inoue, M; Kanashiki, E; Kato, M; Kusano, E; Meguro, D; Muto, S; Nakazawa, E; Tozawa, R; Yumura, W, 2009)
"Most patients were on corticosteroid treatment."2.43Necrotizing fasciitis in rheumatic diseases. ( Chan, TM; Lau, CS; Mok, MY; Tang, WM; Wong, SY; Wong, WS, 2006)
"We described a young Chinese lady with systemic lupus erythematosus and normal tension glaucoma, who had sudden headache, nausea and vomiting coupled with rapid neurological deterioration leading to comatose status."2.43Cerebellum vasculopathy and normal tension glaucoma in systemic lupus erythematosus: report of a case and review of the literature. ( Chan, AY; Li, EK; Liu, DT; Wong, GL, 2006)
"In patients with systemic lupus erythematosus(SLE), interstitial cystitis(lupus cystitis) is an uncommon, but important manifestation."2.42[Two cases of lupus cystitis complicated by lupus nephritis treated successfully with steroid therapy]. ( Harada, T; Obayashi, M; Takahara, K; Uzu, T; Yamato, M; Yamauchi, A, 2003)
"The authors reported a case of systemic lupus erythematosus (SLE) with an unusual presentation."2.42Acute lupus hemophagocytic syndrome: report of a case and review of the literature. ( Chansung, K; Mootsikapun, P; Nanagara, R; Sirijerachai, C, 2004)
"Computed tomography demonstrated aortic dissection extending from the ascending aorta to the abdominal aorta."2.41Acute type A aortic dissection in a patient with systemic lupus erythematosus. ( Akashi, H; Aoyagi, S; Okazaki, T; Otsuka, H; Sakashita, H; Tayama, aK, 2002)
"We report on a case of juvenile parkinsonism as a manifestation of SLE and review the literature."2.41Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. ( Chacón, J; García-Moreno, JM, 2002)
"A 39-year-old woman had been treated for systemic lupus erythematosus from 1982 to 1993."2.41Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission. ( Fujita, K; Goto, H; Imai, H; Komatsuda, A; Miura, AB; Wakui, H, 2000)
"Optic neuropathy is a well-known ocular manifestation occurring in patients with systemic lupus erythematosus (SLE), and it remains one of the major causes of blindness in these patients."2.40Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. ( Balacco Gabrieli, C; Giorgi, D, 1999)
"A 46-year old woman with systemic lupus erythematosus (SLE) who had been treated with oral administration of prednisolone (7."2.39[Optic neuropathy in systemic lupus erythematosus (SLE)--analysis of 54 cases including our case]. ( Igarashi, T; Ishigatsubo, Y; Motoji, K; Ohno, S; Ohta, S; Okubo, T; Shirai, A; Soga, T; Sumino, K; Takeshita, F, 1995)
"A case of systemic lupus erythematosus (SLE) with benign intracranial hypertension (BIH) is reported."2.38[Systemic lupus erythematosus associated with benign intracranial hypertension: a case report]. ( Amasaki, Y; Atsumi, T; Fujisaku, A; Jodo, S; Mukai, M; Nakabayashi, T; Nakagawa, S; Ogura, N; Sagawa, A; Watanabe, I, 1992)
"Two cases of nocardiosis with underlying SLE are presented."2.38Nocardiosis: report of 2 cases with review of literature in Thailand. ( Pupaibul, K; Shuangshoti, S; Yenrudi, S, 1991)
"A sixteen year old girl with systemic lupus erythematosus developed acute transverse myelopathy."2.38Acute transverse myelopathy complicating systemic lupus erythematosus. ( Bucknall, RC; Propper, DJ, 1989)
"The prednisolone dose was increased to 40 mg/day, and cyclosporine A was introduced."1.91Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis. ( Hasegawa, E; Hoshino, J; Ikuma, D; Kinowaki, K; Kono, K; Mizuno, H; Oba, Y; Ohashi, K; Sawa, N; Sawamura, M; Sekine, A; Suwabe, T; Ubara, Y; Yamanouchi, M, 2023)
"Reduction of the hydroxychloroquine (HCQ) dosage is recommended in systemic lupus erythematosus (SLE) patients with renal impairment, but a pharmacokinetics (PK) study of patients with renal impairment has not yet been performed."1.91Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment. ( Furudate, S; Hashiguchi, M; Nagai, Y; Ohshima, M; Setoguchi, K; Shimada, K; Shimizu, M; Yokogawa, N, 2023)
"In trials of systemic lupus erythematosus (SLE), the SLE Responder Index (SRI) is the most commonly used primary efficacy end point but has limited validation against long-term outcomes."1.91Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study. ( An, Y; Bae, SC; Basnayake, B; Chan, M; Chen, YH; Cho, J; Connelly, K; Gibson, KA; Goldblatt, F; Golder, V; Hamijoyo, L; Hao, Y; Harigai, M; Hoi, A; Kandane-Rathnayake, R; Karyekar, CS; Katsumata, Y; Kikuchi, J; Kumar, S; Lateef, A; Lau, CS; Law, A; Li, Z; Louthrenoo, W; Luo, SF; Morand, EF; Navarra, S; Ng, KPL; Nikpour, M; O'Neill, S; Ohkubo, N; Oon, S; Sockalingam, S; Takeuchi, T; Tan, JY; Tanaka, Y; Tee, C; Tee, M; Tugnet, N; Wu, YJ; Zamora, L; Zhang, Z, 2023)
" Any adverse events that required dose reduction or cessation of hydroxychloroquine, indicating intolerance to the drug, were recorded for up to 26 weeks after initiation of hydroxychloroquine."1.91Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus. ( Araki, K; Hirata, S; Ishitoku, M; Kohno, H; Masuda, S; Mokuda, S; Oka, N; Sugimoto, T; Watanabe, H; Yorishima, A; Yoshida, Y, 2023)
"An 18-year-old Japanese woman with systemic lupus erythematosus experienced dyspnoea, headache, tinnitus, and purpura for 2 weeks and was admitted to our hospital."1.91A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura. ( Fujisaki, M; Harigai, M; Higuchi, T; Hirahara, S; Katsumata, Y; Kawaguchi, Y; Konda, N; Motoyama, R; Watanabe, K; Yamada, R; Yamaguchi, R, 2023)
"Clinical features regarding systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K), immunosuppressant use, and laboratory results were obtained from the electronic medical database."1.91Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids. ( Choi, SR; Kim, MH; Lee, EB; Lee, EY; Park, JK; Park, JW, 2023)
"Visceral disseminated varicella zoster virus (VZV) infection is a rare but life-threatening complication in immunosuppressed patients."1.91A survival case of visceral disseminated varicella zoster virus infection in a patient with systemic lupus erythematosus. ( Fukasawa, H; Furuya, R; Ishino, Y; Kaneko, M; Kitamoto, S; Nakagami, D; Yasuda, H, 2023)
"Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP)."1.72New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination. ( Ebata, K; Fujii, F; Hidaka, D; Imamura, M; Kobayashi, N; Kojima, K; Nagai, J; Ogasawara, M; Ogasawara, R; Okada, K; Ota, S; Sugimura, S, 2022)
"Oral prednisolone was used in more than 97% of cSLE patients during the study period, and the median of the maximum daily dose in each patient decreased over time."1.72Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18. ( Harigai, M; Katsumata, Y; Kishi, T; Miyamae, T; Nagata, S; Sakai, R; Tani, Y, 2022)
"We assessed Demographic data, the Systemic Lupus Erythematosus Activity Index, the Systemic Lupus International Collaborating Clinics Damage Index, Numeric Rating Scale, Fatigue Severity Scale, Body Image Scale, and the ENRICHD Social Support Instrument."1.72Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand. ( Narupan, N; Pumpuang, W; Seeherunwong, A, 2022)
"001), mean daily prednisolone dosage 7."1.72Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study. ( Chang, JW; Liu, CS; Lu, JH; Tsai, HL, 2022)
"Prednisolone was gradually tapered and stopped after 3 years, although tacrolimus 3 mg/day was continued."1.72Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review. ( Kurihara, I; Sugawara, H; Terai, C; Yabe, H, 2022)
"001), and average oral dosage of >7."1.72Pneumocystis Jirovecii Pneumonia in Systemic Lupus Erythematosus: A Nationwide Cohort Study in Taiwan. ( Chang, YS; Chen, WS; Huang, YF; Lai, CC; Li, TH; Tsao, YP; Wang, WH, 2022)
"The patient later developed cervical lymphadenopathy, arthritis and livedo reticularis, then systemic lupus erythematosus was diagnosed with positive double-stranded DNA and low complement."1.62Systemic lupus erythematosus presenting with lymphoid interstitial pneumonia as an initial manifestation. ( Kinjo, K; Kinjo, M; Kishaba, T; Maeda, A, 2021)
"While survival of systemic lupus erythematosus (SLE) patients has improved substantially, problems remain in the management of their emotional health."1.62Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. ( Asano, Y; Fujiwara, M; Fukuhara, S; Hayashi, K; Hiramatsu-Asano, S; Ichinose, K; Kajiyama, H; Katayama, Y; Matsumoto, Y; Miyawaki, Y; Morishita, M; Ogawa, Y; Ohashi, K; Ohno, S; Sada, KE; Sato, S; Shimizu, S; Shimojima, Y; Takano-Narazaki, M; Wada, J; Watanabe, H; Yajima, N; Yamamoto, Y; Yamamura, Y; Yamazaki, H; Yoshimi, R, 2021)
"Systemic lupus erythematosus is a rare autoimmune disorder, with the prevalence in Asia ranging from 30 to 50/100,000."1.62A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report. ( Dissanayaka, P; Jayawickreme, KP; Perera, L; Subasinghe, S; Weerasinghe, S, 2021)
"The patient was diagnosed to have systemic lupus erythematosus and immune-mediated intravascular haemolysis and was treated with prednisolone and hydroxychloroquine."1.62Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE). ( Bammigatti, C; Jose, A; Kolar Vishwanath, V; Magendiran, B, 2021)
"Predominant conditions included juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM)."1.56Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania. ( Furia, FF; Godfrey, E; Mwamanenge, N; Swai, P, 2020)
"We report a case of a new diagnosis of systemic lupus erythematosus (SLE) in a patient with HIV who presented to the outpatient department with a fever, headache and lymphadenopathy."1.56HIV and systemic lupus erythematosus: where immunodeficiency meets autoimmunity. ( Durcan, L; McConkey, S; McNally, C; O'Kelly, B, 2020)
"Rowell's syndrome is a rare disorder characterised by an association of lupus erythematosus with erythema multiforme (EM)-like skin lesions."1.56Rowell's syndrome: a rare but distinct entity in rheumatology. ( Chandra, A; Karmakar, P; Ray, AK; Saha, SK, 2020)
"Childhood-onset systemic lupus erythematosus (SLE) is associated with greater disease activity, more aggressive course, and high rates of organ damage."1.56Epidemiology and risk factors for avascular necrosis in childhood systemic lupus erythematosus in a Taiwanese population. ( Chang, JW; Liu, CS; Lu, JH; Tsai, HL, 2020)
"When she was 20 years old, she developed lupus nephritis."1.56A case of systemic lupus erythematosus complicated by subclinical Cushing's syndrome: case report. ( Inagaki, N; Kuramoto, N; Mimori, T; Nakayama, Y; Shibue, K; Taura, D, 2020)
"Patients with systemic lupus erythematosus (SLE) are at high risk of tuberculosis (TB) because of their immunocompromised status and the use of immunosuppressive drugs."1.51Prednisolone dose during treatment of tuberculosis might be a risk factor for mortality in patients with systemic lupus erythematosus: a hospital-based cohort study. ( Cheng, CF; Hsieh, SC; Huang, YM; Li, KJ; Lu, CH, 2019)
"Data on flares in Asian patients with systemic lupus erythematosus (SLE) are scarce."1.51Predicting flares in patients with stable systemic lupus erythematosus. ( Cheung, PP; Cho, J; Dhanasekaran, P; Lahiri, M; Lateef, A; Teoh, LK, 2019)
"Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis."1.51Risk of severe herpes simplex virus infection in systemic lupus erythematosus: analysis of epidemiology and risk factors analysis in Taiwan. ( Chang, YS; Chen, WS; Lai, CC; Li, TH; Tsai, CY; Tsao, YP; Wang, WH, 2019)
"A young woman with systemic lupus erythematosus (SLE) developed recurrent enterovirus meningoencephalitis while taking prednisolone, azathioprine and rituximab."1.51Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE. ( Bunting, E; Cheema, S; Good, C; Hajela, V; Ridha, BH; Saha, RA, 2019)
"To report a case of systemic lupus erythematosus-induced choroidal vasculitis."1.48Role of Angiography in Systemic Lupus Erythematosus-Induced Choroiditis. ( Iqbal, TB; Lee, KR; Peng, LY; Subrayan, V, 2018)
"To develop an objective, readily measurable pharmacodynamic biomarker of glucocorticoid (GC) activity."1.48Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids. ( Bandyopadhyay, S; Carman, JA; Connolly, S; Fan, L; Furie, R; Goldstine, C; Holloway, D; Hu, Y; Johnsen, A; Kansal, S; Latek, R; Lee, D; Nadler, SG; Shadick, N; Somerville, JE; Townsend, R; Weinblatt, ME, 2018)
"Tacrolimus therapy was stopped due to the possibility of immunodeficiency-related lymphoproliferative disease; however, the lesion did not improve."1.48A case of duodenal malignant lymphoma presenting as acute pancreatitis: systemic lupus erythematosus and immunosuppressive therapy as risk factors. ( Hamada, Y; Horiki, N; Inoue, H; Katsurahara, M; Miura, H; Nakamura, M; Okuse, H; Sakuno, T; Shiono, Y; Takei, Y; Takeuchi, T; Tanaka, K; Yamada, R, 2018)
"Further workup lead to a diagnosis of systemic lupus erythematosus with neuropsychiatric involvement."1.48Angioedema as the presenting feature of systemic lupus erythematosus. ( Bammigatti, C; Kumar, N; Surendran, D, 2018)
"We report here a case of systemic lupus erythematosus (SLE) with pulmonary hemorrhage and anti-glomerular basement membrane (anti-GBM) antibodies."1.48A Case of Anti-Glomerular Basement Membrane Antibody-Positive Systemic Lupus Erythematosus with Pulmonary Hemorrhage Successfully Treated at an Early Stage of the Disease. ( Endo, Y; Higo, S; Itagaki, F; Kashiwagi, T; Mugishima, K; Shimizu, A; Tsuruoka, S; Yamada, T; Yoshida, Y; Yui, S, 2018)
"Methods Forty-seven systemic lupus erythematosus patients and 21 healthy controls were immunized with a single dose of 13-valent conjugated pneumococcal vaccine."1.46Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine. ( Bengtsson, AA; Geborek, P; Jacobsen, S; Jönsen, A; Kapetanovic, MC; Nagel, J; Nilsson, JÅ; Saxne, T; Skattum, L; Svaerke Joergensen, C, 2017)
"Corticosteroid therapy remains the main treatment for systemic lupus erythematosus."1.46[Severe Interstitial Lung Disease and Manic Symptoms Secondary to Corticosteroids in a Patient with Systemic Lupus Erythematosus and Secondary Sjögren's Syndrome]. ( Branco, JC; Falcão, S; Pedrosa, T; Serra, SS, 2017)
"SLE patients with lupus nephritis were also associated with higher levels of circulating CD16- monocytes and total monocytes, in comparison with that of controls (both p < 0."1.46Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients. ( Fei, Y; Li, J; Li, Y; Wang, L; Wen, X; Wu, Z; Zeng, X; Zhang, F; Zhang, S; Zhao, L, 2017)
"Lenalidomide was well tolerated."1.46Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus. ( Rabinovich, CE; Schanberg, LE; Wershba, EC; Wu, EY, 2017)
" The current dosage of prednisolone correlated inversely with the levels of bioactive testosterone (r = -0."1.46Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis. ( Arnaud, L; Gunnarsson, I; Hellbacher, E; Lundholm, H; Nordin, A; Svenungsson, E; Wikner, J; Zickert, A, 2017)
"Treatment with prednisolone resulted in an amelioration of the symptoms."1.43A case of systemic lupus erythematosus (SLE) following Human papillomavirus (HPV) vaccination. ( Furuya, K; Hirai, K; Ito, H; Kurosaka, D; Noda, K; Ukichi, T, 2016)
"Retrospective review of AILD [autoimmune hepatitis type 1 and 2 (AIH1, AIH2), primary sclerosing cholangitis (PSC) and autoimmune sclerosing cholangitis (ASC)] seen at two pediatric liver units in Malaysia."1.42Characteristics and outcome of autoimmune liver disease in Asian children. ( Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM, 2015)
"Azathioprine was discontinued due to hematological toxicity and failure to control SLE."1.42First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient. ( Dierberg, KL; Dorjee, K; Reingold, AL; Sadutshang, TD, 2015)
"Juvenile systemic lupus erythematosus (JSLE) is a rare multisystem autoimmune disease with broad heterogeneity of clinical manifestations."1.42[Juvenile systemic lupus erythematosus with unusual manifestation of lupus-associated panniculitis]. ( Hashemie, H; Hoff, NP; Homey, B; Klossowski, N; Meller, S; Neubert, J; Oommen, PT; Reifenberger, J, 2015)
"Rare cases of association between lupus nephritis (LN) and minimal changes nephrotic syndrome (MCNS) were described."1.40Lupus nephritis emerging during remission of minimal change disease. ( Alayoud, A; Benyahia, M; El Kabbaj, D; Hamzi, AM, 2014)
"He had been diagnosed as mixed connective tissue disease in 1997 and lupus nephritis ISN III (A/C) + V in 2003."1.40[Rare case of systemic lupus erythematosus with encapsulating peritoneal sclerosis during hemodialysis]. ( Ichinose, K; Kawakami, A; Ohtsubo, T, 2014)
"There are reports on patients with systemic lupus erythematosus (SLE) with aspergillosis; however, aspergillosis-related pneumothorax has not been reported in SLE."1.40The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case. ( Barutcu, E; Celik, AD; Pamuk, GE; Pamuk, ON, 2014)
" Pregnancy with SLE is associated with an increase risk of adverse maternal and fetal outcomes."1.40Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. ( Izumi, Y; Migita, K; Miyashita, T, 2014)
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."1.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)
"Prednisolone was given in dosages ranging from 5 to 60 mg/day, adjusted according to laboratory data and clinical symptoms."1.39Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus. ( Igarashi, T; Itoh, Y; Shimizu, A, 2013)
"She also had developed anasarca two years prior to presentation."1.39Systemic lupus erythematosus and granulomatous lymphadenopathy. ( Dhakal, AK; Shah, SC; Shakya, A; Shakya, H; Shiva, RK; Shrestha, D, 2013)
"Lymphedema is a very uncommon entity and has not been previously documented in SLE."1.39Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus. ( Gumdal, N; Habibi, S; Rajasekhar, L; Sudhakar, P, 2013)
"A 36-year-old woman was diagnosed with systemic lupus erythematosus (SLE)."1.39Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. ( Ito, S; Kuroda, T; Murakami, S; Murasawa, A; Nagai, S; Nakano, M; Narita, I; Sato, H; Wada, Y, 2013)
"The outcome of systemic lupus erythematosus (SLE) is largely influenced by the existence of lupus nephritis (LN), and its histologic classification guides the treatment and prognosis of SLE."1.38Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study. ( Ahn, JK; Cha, HS; Huh, WS; Hwang, J; Kim, HJ; Kim, YG; Koh, EM; Lee, J; Lee, YS; Oh, JM; Seo, J, 2012)
"We report a rare case of diffuse systemic sclerosis (SSc) evolving into diffuse SSc/systemic lupus erythematosus (SLE) overlap syndrome."1.38Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome--a case report. ( Fu, LS; Lin, HK; Wang, JD, 2012)
"The aim of our study was to investigate systemic lupus erythematosus (SLE) related protein-losing enteropathy (PLE) in the following areas: clinical features, laboratory, endoscopic and imaging characteristics, treatment and outcome."1.38The clinical characteristics of lupus related protein-losing enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital. ( Law, ST; Li, KK; Ma, KM, 2012)
"Bullous systemic lupus erythematosus is extremely rare in children."1.38Bullous systemic lupus erythematosus with lupus nephritis: a rare case of a subepidermal bullous disorder in a child. ( Poojary, S; Rais, S, 2012)
"Bullous systemic lupus erythematosus (SLE) is a kind of LE-non-specific bullous skin disease that is rarely induced by a medication."1.38Methimazole-induced bullous systemic lupus erythematosus: a case report. ( Byun, HJ; Cho, KH; Lee, EB; Seo, JY, 2012)
"Although the mechanism underlying limbic encephalitis associated with SLE remains unclear, at least in some cases, the anti-glutamate antibodies may play an important role in the pathogenesis of limbic encephalitis with SLE."1.38[Case of acute limbic encephalitis associated with SLE accompanied with anti-glutamate receptor antibodies]. ( Kato, T; Kurita, K; Takahashi, Y; Wada, M; Yamaguchi, Y, 2012)
"A 16-year-old female with systemic lupus erythematosus was diagnosed with choledochal cyst."1.37Choledochal cyst and systemic lupus erythematosus. ( Arakawa, A; Hayashi, T; Kato, Y; Lane, GJ; Miyano, G; Nawata, M; Okazaki, T; Takasaki, Y; Tanaka, N; Yamataka, A, 2011)
"Bilateral optic neuritis is an extremely uncommon complication of pediatric systemic lupus erythematosus and sporadic cases are reported in the literature."1.37Bilateral optic neuritis in pediatric systemic lupus erythematosus with antiphospholipid antibody syndrome. ( Aneja, S; Beri, S; Krishnamurthy, S; Patra, S; Seth, A, 2011)
"The outcome of systemic lupus erythematosus (SLE) has dramatically improved since the introduction of corticosteroids; however, although many regimens of treatment have been supplemented, the mortality has not improved further."1.37Twenty-two years' experience with childhood-onset SLE in a developing country: are outcomes similar to developed countries? ( Dissaneewate, P; McNeil, E; Vachvanichsanong, P, 2011)
"Psychiatric disorders were classified according to ACR criteria for neuropsychiatric systemic lupus erythematosus (NPSLE)."1.37Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. ( Bogaczewicz, J; Hawro, T; Krupińska-Kun, M; Rabe-Jabłońska, J; Robak, E; Sysa-Jędrzejowska, A; Woźniacka, A, 2011)
"Treatment with prednisolone and azathioprine led to fast and durable resolution of symptoms."1.37[Protein-losing enteropathy: a cause of hypoalbuminaemia in patients with systemic lupus erythematosus]. ( Briem, S; Fiehn, C; Mühleisen, H; Weis, D; Xanthouli, P, 2011)
"Pancreatitis is a relatively rare complication in systemic lupus erythematosus (SLE)."1.37A case of lupus-associated pancreatitis with ruptured pseudoaneurysms. ( Fujioka, H; Fujiwara, S; Izumi, Y; Koga, M; Koga, T; Migita, K; Miyashita, T; Nakamichi, C; Nakashima, K; Onizuka, S, 2011)
"Intestinal vasculitis is a serious and often underrecognized complication of systemic lupus erythematosus (SLE) usually managed with high-dose corticosteroids."1.37Colitis associated with active systemic lupus erythematosus successfully treated with rituximab. ( Chiu, YH; George, E; Mane, S; Tayal, V, 2011)
"He had a history of systemic lupus erythematosus and had received oral prednisolone for 7 months."1.37Disseminated Nocardia farcinica infection in a patient with systemic lupus erythematosus. ( Hara, H; Ochiai, T; Wakui, F, 2011)
"Her other medical conditions include systemic lupus erythematosus on daily prednisolone 15 mg during 19 years."1.37Vesicovaginal fistula following large-loop excision of the transformation zone in a chronic systemic glucocorticoid user. ( Choi, YM; Kim, HS; Kim, JG; Kim, SH; Ku, SY; Kwak, C; Moon, SY; Park, KE, 2011)
"The risk for amenorrhea following treatment of systemic lupus erythematosus (SLE) patients with low-dose intravenous cyclophosphamide (IVCY) has not been fully explored."1.37Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study. ( Baba, S; Gono, T; Hara, M; Kanno, T; Katsumata, Y; Kawaguchi, Y; Sugiura, T; Yamanaka, H, 2011)
"Acute cerebellar ataxia in patients with lupus is rare and occurs early in the course of disease."1.37Acute cerebellar ataxia in lupus. ( Chattopadhyay, P; Dhua, D; Philips, CA; Saha, S, 2011)
"Here we report a 37-year-old woman with autoimmune hepatitis who developed SLE and acquired haemophilia caused by factor VIII (fVIII) inhibitors."1.37Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus: review of literature. ( Hashemzadeh, K; Mansouritorghabeh, H; Rezaieyazdi, Z; Sharifi-Doloui, D; Shirdel, A, 2011)
"Patient was started on NIH protocol for lupus nephritis on which he was doing well."1.37Young male with systemic lupus erythematosus presenting with sensorineural deafness with immune suppression induced miliary tuberculosis. ( Chatterjee, S; Ghosh, A; Kundu, S; Mitra, R, 2011)
"Bone infarcts were also associated with these factors."1.36A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur. ( Karimifar, M; Karimzadeh, H; Mottaghi, P; Salesi, M; Sayedbonakdar, Z, 2010)
"Membranous nephropathy is uncommon in Chinese children and could be a possible early presentation of SLE."1.36An unusual case of loin pain and nephritis. ( Chiu, MC; Lai, WM; Ma, AL, 2010)
"Colchicine and aspirin were administered, together with prednisolone, after which no further relapses occurred."1.36Influenza virus B-associated hemophagocytic syndrome and recurrent pericarditis in a patient with systemic lupus erythematosus. ( Ando, H; Horai, Y; Minami, R; Miyamura, T; Nakamura, M; Sonomoto, K; Suematsu, E; Takahama, S; Yamamoto, M, 2010)
" Linear regression analysis showed that serum sST2 level was an independent predictive factor for modified SLEDAI, excluding anti-dsDNA and complement score after controlling for age, sex, glomerular filtration rate and prednisolone dosage (regression coefficient: 8."1.36Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. ( Chan, EY; Huang, FP; Ip, WK; Lam, KF; Lo, Y; Mok, MY; Wong, FY; Xu, D, 2010)
"Prednisolone dosage was increased from 10 to 60 mg/day."1.36Type B insulin resistance syndrome with systemic lupus erythematosus. ( Gohda, T; Horikoshi, S; Ohsawa, I; Sato, N; Shirato, I; Takagi, M; Tomino, Y; Yamaguchi, Y, 2010)
"The prednisolone dose was then reduced from 30 mg/day to 5 mg/day and maintained at that level until she was admitted to our hospital."1.36[Case of lupus peritonitis with thrombus in the right atrium]. ( Amamiya, H; Ishizuka, S; Kubota, K; Nakayama, K; Yagawa, K, 2010)
" There was an increased risk of IFI in the lupus patients receiving high daily dosage of prednisolone therapy."1.36A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. ( Chang, HY; Chang, TW; Lee, NY; Lin, TS; Liu, MF; Wang, CR; Wang, JY; Weng, CT; Weng, MY; Wu, AB, 2010)
"Systemic lupus erythematosus was confirmed by hematological investigations."1.36Transient myopic shift as the presenting symptom of systemic lupus erythematosus: a UBM study. ( Cardia, G; Ciracì, L; Guerriero, S; Vetrugno, M, 2010)
"Prednisolone dose was weaned in both groups, p<0."1.36Mycophenolate mofetil treatment in children and adolescents with lupus. ( Kazyra, I; Marks, SD; Pilkington, C; Tullus, K, 2010)
"A 36-year-old man with underlying systemic lupus erythematosus complicated by autoimmune hemolytic anemia underwent immunosuppressive treatment."1.36Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation. ( Fujisaki, T; Kubo, T; Muta, T; Nakanishi, H; Yokota, E; Yoshitomi, R, 2010)
"We report a patient with systemic lupus erythematosus (SLE) who developed progressive emaciation and postprandial abdominal pain with a 27-year history of corticosteroid treatment."1.36Intestinal angina due to atherosclerosis in a 45-year-old systemic lupus erythematosus patient. ( Fukui, D; Ikeda, S; Kurozumi, M; Matsuda, M; Miyazaki, D; Sano, K; Shimojima, Y; Tazawa, K; Tojo, K, 2010)
"Prednisolone was found to improve the rate of live births, although it was also a predictor of prematurity."1.36Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. ( Al Arfaj, AS; Khalil, N, 2010)
"A 42-year-old woman with systemic lupus erythematosus was admitted to our hospital because of severe anemia."1.35Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies. ( Furuichi, K; Hara, A; Higuchi, M; Iwata, Y; Kaneko, S; Kitagawa, K; Kitajima, S; Okumura, T; Sakai, N; Toyama, T; Wada, T, 2008)
"Lupus cystitis is a rare manifestation in systemic lupus erythematosus (SLE); it usually occurs in association with gastrointestinal manifestations."1.35Two cases of lupus cystitis with no bladder irritation symptoms. ( Funauchi, M; Ikoma, S; Kinoshita, K; Kishimoto, K; Nozaki, Y; Shimazu, H; Sugiyama, M, 2008)
"Although PCP infected systemic lupus erythematosus (SLE) patient carries poor outcome, no standard guideline for prevention has been established."1.35Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. ( Janwityanujit, S; Lertnawapan, R; Nantiruj, K; Totemchokchyakarn, K, 2009)
" The mean maximum daily dosage of prednisolone was 32."1.35Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus. ( Ma, KM; Mok, CC; To, CH, 2008)
"Prednisolone was shown to alter the qualitative composition of microflora and the structure of symbiotic interactions between different organisms."1.35[Intestinal microbial biocenosis in patients with systemic lupus erythematosus treated with prednisolone]. ( Gul'neva, MIu; Shilkina, NP, 2009)
"Tacrolimus was administered at doses of 1-3 mg daily, and efficacy was assessed from the SLE Disease Activity Index (SLEDAI) after 1 year."1.35Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study. ( Endo, H; Kaneko, K; Kawai, S; Kusunoki, Y; Tanaka, N; Yamamoto, T, 2009)
" Additionally, a positive relationship was seen between the level of apoptotic lymphocytes'and the dosage of prednisolone used for treatment of SLE (r = 0."1.35The role of apoptotic proteins in patients with systemic lupus erythematosis. ( Alenzi, FQ, 2009)
"Leg ulcerations can occur in systemic lupus erythematosus (SLE) patients with antiphospholipid (aPL) antibodies and/or vasculitis, and it has been suggested that aPL antibodies may play a pathogenetic role in skin manifestations of SLE."1.34Lupus and leg ulcers--a diagnostic quandary. ( Boyce, S; Dziadzio, M; Hamdulay, S; Keat, A; Prasad, N; Reddy, V, 2007)
"She had systemic lupus erythematosus and interstitial pneumonia for 17 years, treated with prednisolone and azathioprine."1.34Mycobacterial spindle cell pseudotumor of the skin. ( Manabe, T; Shiomi, T; Yamamoto, T, 2007)
"Involvement of the kidneys, lupus nephritis (LN), affects up to 50% of SLE patients during the course of their disease, and is characterized by periods of active disease (flares) and remission."1.34The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis. ( Dellow, E; Fordham, RJ; Jayne, DR; Wilson, EC, 2007)
"Vasculitis is often seen with SLE, but is usually limited to small vessels alone."1.34Extensive medium-vessel vasculitis with SLE: an unusual association. ( Agarwal, G; Ahlawat, R; Choudhary, N; Kaul, B; Kumar, N; Rizvi, Y, 2007)
" A young patient presenting with toxic maculopathy after 57 g of hydroxychloroquine and a daily dosage of 2 mg/kg body weight prompted us to retrospectively look at our patients examined in this respect over about 1 year."1.34[Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses]. ( Berndt, S; Foerster, J; Rüther, K; Schroeter, J, 2007)
"Pulmonary nocardiosis was clinically suspected because we detected nocardia from Gram staining of sputum."1.34[A case of pulmonary nocardiosis cured by early sulfamethoxazole-trimethoprim therapy]. ( Katakura, H; Kojima, M; Matsui, Y; Sakai, N; Wada, H; Yamanaka, A, 2007)
"Systemic lupus erythematosus is a multisystem organ inflammation due to damage of cells and tissues by pathogenic auto-antibodies and immune complexes."1.34Familial childhood systemic lupus erythematosus: report of 2 cases. ( Das, S; Kar, C; Maiti, A; Pal, D; Roy, AK, 2007)
"Systemic lupus erythematosus is a multisystem autoimmune disorder."1.34Laryngeal involvement in systemic lupus erythematosus: report of two cases. ( Bahar, S; Dere, H; Karaaslan, Y; Ozcan, I; Ozcan, KM; Pasaoglu, L; Sennaroglu, E, 2007)
"In 2001, she was diagnosed with systemic lupus erythematosus (SLE) and treated with prednisolone and ciclosporin."1.34[Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis]. ( Hagiharai, K; Hirano, T; Kawai, M; Kawase, I; Kuwahara, Y; Ogata, A; Shima, Y; Tanaka, T; Yamadori, T; Yoshizaki, K, 2007)
"We describe a middle-aged Chinese systemic lupus erythematosus (SLE) patient developing steroid refractory and transfusion dependent red cell aplasia."1.33Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid. ( Chan, AY; Cheng, G; Choi, PC; Li, EK; Tam, LS, 2005)
"A diagnosis of systemic lupus erythematosus was made and oral administration of 60 mg/day prednisolon was started on May 10."1.33[A case of systemic lupus erythematosus presenting with jaundice and lupus pneumonia]. ( Fujino, MA; Katoh, K; Kawai, T; Kudo, M; Okouchi, A; Shoda, M; Tominaga, S, 2005)
"A 51 year old woman with systemic lupus erythematosus (SLE) serially developed thrombocytopenia, arthritis, lupus nephritis, pleuritis, mesenteric vasculitis and refractory hemolytic anemia during the past 19 years prior to presentation."1.33Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report. ( Cheng, TT; Wang, SW, 2005)
"Patients with systemic lupus erythematosus are prone to various infections, often associated with high mortality."1.33CAPD-related peritonitis due to Salmonella enteritidis in a patient with SLE. ( Chiu, YL; Chu, TS; Hsueh, PR; Huang, JW; Wu, KD, 2005)
" Most of the patients who had infection received prednisolone at a dosage of more than 0."1.33Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. ( Chartapisak, W; Opastirakul, S, 2005)
"Thrombocytopenia is one of the common manifestations of systemic lupus erythematosus (SLE)."1.33Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. ( Bae, YD; Choi, HJ; Lee, EB; Lee, JC; Shin, KC; Song, YW, 2005)
"Bilateral internuclear ophthalmoplegia was also followed by TM."1.33A catastrophic-onset longitudinal myelitis accompanied by bilateral internuclear ophthalmoplegia in a patient with systemic lupus erythematosus. ( Lee, SI; Rheu, CW; Yoo, WH, 2005)
"Respiratory manifestations of systemic lupus erythematosus (SLE) are frequent."1.33The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. ( Bresser, P; Jonkers, RE; Oud, KT; ten Berge, RJ, 2005)
"However, there are rare cases of catatonia being described in SLE."1.33Benzodiazepines in catatonia associated with systemic lupus erythematosus. ( Huang, TL; Wang, HY, 2006)
"Pregnancy is relatively safe in women with SLE in remission but should be considered as a high-risk pregnancy."1.33Outcome of pregnancy in patients with systemic lupus erythematosus. ( Chen, CP; Chen, TL; Lee, CS; Lin, CJ; Wong, CH, 2006)
"She was diagnosed as having systemic lupus erythematosus at the age of 21 years and had been receiving systemic steroid treatment (5 mg prednisolone/day)."1.32A case of nodular cutaneous lupus mucinosis. ( Furue, M; Koga, T; Moroi, Y; Terao, H; Urabe, K, 2003)
"We report a woman with lupus nephritis complicated with lupus peritonitis and cytomegalovirus (CMV) colitis."1.32Cytomegalovirus colitis following immunosuppressive therapy for lupus peritonitis and lupus nephritis. ( Hishida, A; Ikegaya, N; Isozaki, T; Ohashi, N; Shirakawa, K; Yamamoto, T, 2003)
"A 42-year-old woman with systemic lupus erythematosus (SLE) had an episode of fever, arthralgia and anemia."1.32Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. ( Fujii, H; Harigae, H; Hirabayashi, Y; Ishii, T; Kodera, T; Munakata, Y; Saito, S; Sasaki, T; Suzuki, T, 2003)
"International autoimmune hepatitis (AIH) score showed definite AIH before treatment, but autoantibodies could not make a differential diagnosis of AIH and SLE-associated hepatitis."1.32Autoimmune hepatitis in a patient with systemic lupus erythematosus. ( Harada, Y; Hirohata, S; Ishii, M; Iwai, M; Mori, T; Muramatsu, A; Nakashima, T; Okanoue, T; Tanaka, S, 2003)
"She was diagnosed with systemic lupus erythematosus in September, 1996 and had been on a regular glucocorticoid therapy since then."1.32[Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report]. ( Hirata, D; Isoda, N; Kamata, Y; Kamimura, T; Kanai, N; Masuyama, J; Minota, S; Yoshio, T, 2003)
"Patients with systemic lupus erythematosus (SLE) are usually exposed to high doses of corticosteroids and eventually develop defective cellular immunity that increases the risk for active tuberculosis."1.32An overwhelming pulmonary fungus ball in a systemic lupus erythematosus patient. ( Boztosun, Y; Kiris, A; Kocakoc, E; Ozcakar, L; Ozgocmen, S; Yildirim, N, 2003)
"She had suffered from lupus nephritis in early childhood."1.32Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus. ( Beer, R; Lhotta, K; Mayer, G; Neumair, F; Rosenkranz, AR; Rudisch, A; Würzner, R, 2004)
"Esophageal varices were disappeared, and splenomegaly had improved after 6 months."1.32[Beneficial effect of glucocorticosteroids for esophageal varices due to idiopathic portal hypertension following systemic lupus erythematosus]. ( Imai, K; Naishiro, Y; Ohara, M; Ozeki, I; Suzuki, C; Takahashi, H; Taniguchi, H; Yamamoto, H; Yamamoto, M, 2004)
"Treatment with prednisolone (2 mg/kg/day) for 14 days resulted in dramatic improvement of the thrombocytopenia."1.32Neonatal lupus erythematosus with cholestatic hepatitis. ( Chuo, HT; Huang, LH; Lee, HC; Lin, SC; Shyur, SD; Wu, JY, 2004)
"Systemic lupus erythematosus is an autoimmune disease primarily affecting women."1.32Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays. ( Jusko, WJ; Kamal, MA, 2004)
"Diagnosis of systemic lupus erythematosus (SLE) was made."1.31Bilateral optic neuritis as first manifestation of systemic lupus erythematosus. ( Im, CY; Kim, HK; Kim, SS, 2002)
" After the primary care doctor had increased the dosage of prednisolone from 7."1.31[Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus]. ( Gromnica-Ihle, E; Natusch, A, 2002)
" Of the 12 patients followed up for >1 year after HSCT, 10 have discontinued immunosuppressive medications, and the prednisone dosage has been tapered to 15 mg/day in 1."1.31Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. ( Baker, S; Barr, WG; Brush, M; Burt, RK; Oyama, Y; Rodriguez, J; Rosa, RM; Traynor, AE, 2002)
" There was no significant difference between the two genotypes in age, gender, body mass index (BMI), disease duration, disease types, time of glucocorticoid administration and cumulative dosage (P > 0."1.31Relationship between glucocorticoid-induced osteoporosis and vitamin D receptor genotypes. ( Chen, L; Li, Y; Shen, L; Xu, L; Yu, L, 2002)
"We described a 28-year-old woman with systemic lupus erythematosus (SLE) presented with digestive tract, skin and renal symptoms and afterwards developed acute cerebellar ataxia, a paresis of the right inferior rectus muscle, left abducens paralysis and left facial palsy which seemed to be consistent with a brainstem lesion visible on magnetic resonance imaging (MRI)."1.31Acute cerebellar ataxia of a patient with SLE. ( Sakamoto, M; Shiono, Y; Suenaga, M; Yaginuma, M, 2000)
"Psychiatric manifestations of systemic lupus erythematosus (SLE) are well recognized but usually occur in the later stages of the illness, with organic syndromes being the most common."1.31Systemic lupus erythematosus presenting as mania. ( Haddad, P; Khan, S; Montague, L; Summerton, C, 2000)
" We conclude that the treatment with CPM combined with PSL may be useful, when neurological manifestations of MCTD are serious and resistant to conventional therapy."1.31[A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone]. ( Iga, M; Kai, Y; Kuroki, M; Kuwata, G; Matsuyama, M; Murai, K; Okamoto, M; Okayama, A; Tanaka, G; Tsubouchi, H, 2000)
" Although initiation of high-dose prednisolone therapy resulted in a gradual improvement in clinical symptoms, reducing the dosage of prednisolone caused a relapse."1.31Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus. ( Ito, T; Kakizaki, Y; Nakahata, T; Sugimoto, K; Tanaka, H; Tateyama, T; Tomimoto, K; Waga, S; Yokoyama, M, 2000)
"A 26-year-old woman suffered from acute myelitis at Th 6 level associated with systemic lupus erythematosus."1.31Development of severe longitudinal atrophy of thoracic spinal cord following lupus-related myelitis. ( Kawagoe, J; Kawasaki, S; Matsukura, S; Ohi, T; Shiomi, K; Sugimoto, S; Yazawa, S, 2001)
"Sixty days after the treatment, thrombocytopenia was observed with positive lupus anticoagulant and anticardiolipin antibody."1.31[A case of SLE presenting the features of antiphospholipid antibody syndrome during a treatment for complicated cryptococcal meningitis]. ( Izumi, Y; Kameyama, M; Sakoda, H; Udaka, F, 2001)
"They are normal in SLE, systemic sclerosis, and vasculitides as well as in non-rheumatic inflammatory controls, but are significantly increased by steroids."1.31Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. ( Damas, P; Franchimont, N; Houssiau, FA; Jaspar, JM; Kaiser, MJ; Malaise, MG; Martin y Porras, M; Ribbens, C, 2002)
"We report on a patient with systemic lupus erythematosus (SLE) who showed elevated titers of IgM antibodies to cytomegalovirus (CMV), suggesting CMV infection at the onset of SLE."1.31Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. ( Hashimoto, H; Lida, N; Nawata, M; Sekigawa, I; Seta, N; Yamada, M, 2001)
"Here, we report a case of systemic lupus erythematosus (SLE) complicated by cytomegalovirus (CMV)-induced hemophagocytic syndrome (HPS) and colitis."1.31Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis. ( Ando, M; Kohrogi, H; Sakamoto, O; Suga, M; Yoshimatsu, S, 2002)
"A 25-year-old Japanese woman with systemic lupus erythematosus (SLE) was admitted because of numbness of the face and left upper extremity, headache, and intermittent fever."1.31Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord. ( Amano, H; Aramaki, T; Hirayama, Y; Kimura, KY; Seino, Y; Takano, T; Yamaguchi, H, 2002)
"A case of systemic lupus erythematosus (SLE) associated with serositis presenting with disseminated intravascular coagulation (DIC) is reported."1.31Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation. ( Kageyama, Y; Miyairi, M; Yagi, T, 2002)
"Treatment with prednisolone (40 mg/day) started and the bleeding tendency gradually improved."1.31Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus. ( Hasegawa, H; Hayashi, Y; Kushiro, M; Niiya, K; Niiya, M; Takazawa, Y; Tanimizu, M; Tanimoto, M; Tanio, Y, 2002)
"Seventeen of 21 patients had systemic lupus erythematosus, and all patients had a history of corticosteroid use."1.30Total knee arthroplasty for corticosteroid associated avascular necrosis of the knee. ( Hungerford, DS; Krackow, KA; Mont, MA; Myers, TH, 1997)
"A 21-year-old man with systemic lupus erythematosus (SLE) who developed acute lupus peritonitis is described."1.30Acute lupus peritonitis successfully treated with steroid pulse therapy. ( Andoh, A; Bamba, T; Fujiyama, Y; Hodohara, K; Ihara, T; Inoue, H; Kitamura, S; Miyagawa, A; Ueda, K, 1997)
"She was eventually diagnosed as MCTD when she was found to have polymyositis by EMG and serum CK."1.30[Two cases with SLE and MCTD developed after a long period of chronic arthritis that was initially diagnosed as JRA]. ( Hokonohara, M; Imanaka, H; Maeno, N; Miyata, K; Mori, H; Nakae, Y; Nerome, Y; Shigemori, M; Takei, S, 1997)
"The bone metabolism in patients with systemic lupus erythematosus (SLE) has previously been examined, but the results are conflicting."1.30Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. ( Halberg, P; Hansen, M; Hyldstrup, L; Hørslev-Petersen, K; Kollerup, G; Lorenzen, I; Pedersen-Zbinden, B, 1998)
"Procainamide was discontinued."1.30[Procainamide-induced lupus in a patient with bilateral pleural effusion]. ( Hisauchi, K; Mitunaga, K; Miyake, S; Ohtani, Y; Sawada, M; Sumi, Y; Yamashita, Y; Yoshizawa, Y, 1998)
"Prednisolone was infused intravenously to prevent the acute deterioration of SLE after the operation."1.30[Successful surgical treatment of atrial septal defect with systemic lupus erythematosis in a 47-year-old female]. ( Koh, E; Okamura, T; Yokoyama, S, 1998)
"At admission, she had symmetrical tetraplegia, which was peripherally predominant and severer in the lower extremities, and hypoesthesia accompanied by numbness."1.30[A case developing tetraplegia due to systemic lupus erythematosus which was remitted by a steroid]. ( Katagiri, T, 1998)
"We report two patients with systemic lupus erythematosus (SLE) in whom cytomegalovirus (CMV) infection may have played a significant role in the exacerbation or onset of symptoms."1.30Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. ( Hashimoto, H; Hayashi, T; Hirose, S; Iida, N; Lee, S; Ogasawara, H; Sekigawa, I; Tomino, Y, 1998)
"A 17-year-old girl with systemic lupus erythematosus presented with painful edematous abdominal striae."1.30A case of edematous striae distensae in lupus nephritis. ( Kim, CW; Kim, TY; Lee, EK; Lee, JH, 1999)
"The rate of the intrauterine growth retardation was significantly higher than that observed in pregnancies with normal complement activity."1.30Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus. ( Ebina, Y; Fujimoto, S; Kato, EH; Kishida, T; Kobashi, G; Kobayashi, N; Sakuragi, N; Tsutsumi, A; Yamada, H, 1999)
"Patients with systemic lupus erythematosus (SLE) have an extremely variable prognosis and mortality."1.29Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus. ( Duraisamy, G; Lajin, I; Lim, CB; Pasangna, J, 1994)
" The initial heavy proteinuria promptly decreased after the prednisolone dosage was increased and disappeared 4 weeks later."1.29Minimal-change nephrotic syndrome associated with systemic lupus erythematosus. ( Haramoto, T; Makino, H; Ogura, T; Ota, Z; Shikata, K, 1995)
"Acute pancreatitis is thought to be quite uncommon in patients with systemic lupus erythematosus (SLE), especially if it is the initial manifestation of the disease."1.29Acute pancreatitis: an early manifestation of systemic lupus erythematosus. ( Chen, CY; Huang, CC; Huang, JL; Hung, IJ, 1994)
"These were attributed to systemic lupus erythematosus (SLE)."1.29Systemic lupus erythematosus--not to be forgotten in the elderly. ( Chan, KM, 1995)
" These patients were receiving prednisolone at a mean dosage of 9."1.29[Outcome of patients with chronic systemic lupus erythematosus]. ( Arakawa, M; Honma, T; Ito, S; Kikuchi, M; Nakano, M; Ozawa, T; Saeki, T; Sato, T; Watanabe, T, 1995)
"In the treatment of systemic lupus erythematosus (SLE) with acute CNS affections good results may be obtained with intravenous cyclophosphamide (CP) + methylprednisolone followed with long-term parenteral CP administration."1.29[The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement]. ( Bliziuk, OI; Ivanova, MM; Travkina, IV, 1995)
"Cases 1 and 2 were bilateral sensorineural hearing loss which responded to steroid therapy."1.29Sensorineural hearing loss of suspected autoimmune etiology: a report of three cases. ( Kataoka, H; Nakatani, H; Saito, H; Takeda, T, 1995)
"The case of a 40-year-old woman with Werner's syndrome associated with systemic lupus erythematosus (SLE) is reported."1.29A case of Werner's syndrome associated with systemic lupus erythematosus. ( Kasukawa, R; Kogure, A; Miyata, M; Nishimaki, T; Ohara, M; Ohba, T; Ohshima, Y; Watanabe, N, 1995)
"In a multi-centre prospective study of systemic lupus erythematosus and pregnancy in France, 117 cases were identified from 1987 to 1992."1.29Pregnancy and its outcome in systemic lupus erythematosus. ( Bletry, O; Godeau, P; Le Thi Huong, D; Piette, JC; Wechsler, B, 1994)
"We report a case of bullous systemic lupus erythematosus (SLE)."1.29A case of bullous systemic lupus erythematosus. ( Furukawa, F; Shirahama, S; Takigawa, M; Yagi, H, 1994)
"Prednisolone was effective in improving the anemia and the serum immunoglobulin, immune complex, and antinuclear antibody levels."1.29Post-infantile giant cell hepatitis in an elderly female patient with systemic lupus erythematosus. ( Arase, K; Asayama, R; Dohmen, K; Ishibashi, H; Kuroiwa, S; Nakamura, H; Ohtsuka, S; Yokogawa, Y, 1994)
"Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described."1.29Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. ( Abe, K; Mizuki, T; Ohji, T; Terao, T, 1994)
"Survival of patients with systemic lupus erythematosus has increased with corticosteroid therapy."1.29Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus. ( Hoffman, R; Lethen, H; Maurin, N; Schöndube, FA; Sieberth, HG; Zunker, U, 1994)
"Fatty liver was also demonstrated in this patient on ultrasonography, and was thought to be resulted from long-term steroid hormone administration."1.29[Two cases of systemic lupus erythematosus associated with fatty liver and Basedow's disease]. ( Arase, K; Asayama, R; Dohmen, K; Ishibashi, H; Itateyama, E; Nakamura, H; Nishizaka, H; Shibuya, T; Yokogawa, Y, 1994)
"These findings suggested fibrosing alveolitis."1.29[A case of systemic lupus erythematosus who developed nodular shadows in the lung in parallel with the disease activity]. ( Nagasawa, K; Niho, Y; Otsuka, T; Takenaka, K; Tsukamoto, H; Yoshimatsu, H, 1993)
"Prednisolone was increased from 30 mg/every other day to 30 mg/day, and oral azathioprine, 50 mg/day, was started for the treatment of lupus nephritis."1.29[Renal and cerebral infarctions in a patient with systemic lupus erythematosus without antiphospholipid antibodies]. ( Arimori, S; Hoshina, Y; Ichikawa, Y; Iwata, Y; Moriuchi, J; Suwabe, H, 1993)
" Serial IV pharmacokinetic studies of prednisolone (1 mg/kg) in groups of 3 patients over a 1 month period of rifampin co-treatment or after its withdrawal, revealed significant changes in the area under the curve, the total clearance, the non-renal clearance and the half-life."1.29Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin. ( Chong, WS; Jang, IJ; Kim, S; Lee, JS; Lee, KH; Shin, JG; Shin, SG, 1993)
"Pulmonary hypertension was diagnosed in a patient with SLE after her 5th delivery."1.29Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. ( Bootsma, H; Groen, H; Kallenberg, CG; Postma, DS, 1993)
"A 47-year-old woman affected by systemic lupus erythematosus (SLE) presented with headache, fever, splenomegaly and edema of the lower extremities."1.29Unusual neuroradiological findings in systemic lupus erythematosus. ( Hinoshita, H; Ono, K; Shiigai, T; Shintani, S; Tsuruoka, S, 1993)
"An optic neuritis in systemic lupus erythematosus was diagnosed, which is called atopic, because of its association to a systemic disease and the old age of the patient."1.29[Atypical optic neuritis in systemic lupus erythematosus (SLE)]. ( Eckstein, A; Kötter, I; Wilhelm, H, 1995)
"She was diagnosed to have systemic lupus erythematosus (SLE) because of malar rash, serositis (pleuritis), positive antinuclear antibody and positive anti-DNA antibody."1.29[A case of SLE with the onset of pleuritis showing eosinophilia and elevation of serum IgE]. ( Kojima, T; Nagasawa, K; Takaki, K; Takeda, T; Tanaka, M; Umeno, M, 1996)
"Pathologic investigations disclosed chronic interstitial cystitis (IC) with evidence of focal immune complex deposition in blood vessel walls of the bladder."1.29Obstructive uropathy due to interstitial cystitis in a patient with systemic lupus erythematosus. ( Kim, HJ; Park, MH, 1996)
"A case of full blown systemic lupus erythematosus (SLE) was treated with steroid."1.29Danazol for thrombocytopenia in pregnancy with underlying systemic lupus erythematosus. ( Bumpenboon, T; Chanchairujira, T; Insiripong, S, 1996)
"We describe the case of a patient with systemic lupus erythematosus, treated by corticosteroids, who presented during two successive pregnancies with serological reactivation of toxoplasmosis associated with fetal lesions."1.29Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. ( Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M, 1995)
"A 51-year-old woman complained of hoarseness of two years duration."1.29Hoarseness as the initial manifestation of systemic lupus erythematosus. ( Soda, Y; Tsunoda, K, 1996)
"A 23-year-old female with systemic lupus erythematosus is reported."1.29False positive pleural biopsy and high CA125 levels in serum and pleural effusion in systemic lupus erythematosus. ( Calguneri, M; Ruacan, S; Yucel, AE, 1996)
"A diagnosis of systemic lupus erythematosus (SLE) was made, and she received 40 mg of prednisolone daily."1.29[A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment]. ( Arakawa, M; Maruyama, Y; Sato, T; Ueno, M; Wakasugi, M, 1996)
"The association of systemic lupus erythematosus (SLE) and solid tumors is infrequent."1.29[A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus]. ( Akama, T; Iijima, T; Kashiwagi, H; Nakahara, A; Suzuki, H; Takemura, H; Yamane, K; Yuhara, T, 1996)
"She developed hypoxemia after intensive immunosuppressive therapy with prednisolone and cyclophosphamide."1.29Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus. ( Asayama, R; Shibuya, T; Takenaka, K; Tokunaga, Y, 1996)
"A 9-year-old Chinese girl with systemic lupus erythematosus presented initially with persistent cervical lymphadenopathy without any constitutional symptoms."1.29Systemic lupus erythematosus with erythema multiforme-like lesions and histiocytic necrotizing lymphadenitis--a case report. ( Chua, SH; Giam, YC; Sim, CS, 1996)
"To identify the risk factors for infection and to develop a model for the prediction of infection in hospitalized patients with active systemic lupus erythematosus (SLE), we carried out a retrospective cohort study with clinical data collected from 121 consecutive patients with active SLE."1.29Predicting infection in hospitalized patients with systemic lupus erythematosus. ( Akama, T; Kashiwagi, H; Suzuki, H; Takemura, H; Yamane, K; Yuhara, T, 1996)
" We found three predictors of flares: renal disease, persistence of dsDNA antibodies for at least 1 year after the beginning of treatment and reduction in azathioprine dosage to below 2 mg/kg/d."1.29Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone. ( Abendroth, K; Hein, G; Oelzner, P; Stein, G, 1996)
"12 patients with rapidly progressive systemic lupus erythematosus (SLE) combined with renal failure were treated for 6 months according to the following scheme: 3 consecutive procedures of plasmapheresis (60 ml/kg x 3), 3 consecutive pulse doses of cyclophosphamide (400 mg/m2 x 3), 3 prednisolone infusions (2 mg/kg x 3), oral cyclophosphamide (100-250 mg/day) and prednisolone (0."1.29[Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement]. ( Demin, AA; Demina, LM; Mamin, IV; Sentiakova, TN; Smirnov, VV, 1996)
"We studied 75 cases of canine systemic lupus erythematosus (SLE) presenting with at least four criteria of the American Rheumatism Association (ARA), including antinuclear antibodies (ANAb)."1.28Canine systemic lupus erythematosus. I: A study of 75 cases. ( Caux, C; Chabanne, L; Faure, JR; Fournel, C; Magnol, JP; Monier, JC; Rigal, D, 1992)
"The prednisolone test was made in 15 SSD patients and 27 donors."1.28[An analysis of the hormonal response during the performance of stress tests in patients with systemic lupus erythematosus and systemic scleroderma]. ( Apanasovich, VG; Bolotina, NG; Dosin, IuM; Grigorchuk, IP; Iagur, VE; Kurchenkova, VI; Lazareva, VI, 1992)
"Two flares of acute myelitis were observed in a 31-year-old woman with previously known mild SLE."1.28Two UV-induced episodes of myelitis in a patient with systemic lupus erythematosus. ( Nived, O; Ryberg, B; Sturfelt, G, 1992)
"Two patients presented with a subacute confusional state, two with dementia, and one with depression."1.28Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. ( Bendall, P; Byrne, EJ; Dennis, MS; Hopkinson, N, 1992)
"A prospective study of systemic lupus erythematosus (SLE) patients under high doses of corticosteroid therapy (greater than 30 mg/day prednisolone) for a five-year period elucidated some risk factors of avascular necrosis of the femoral head (ANFH)."1.28Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. ( Komazawa, T; Ono, K; Tohjima, T, 1992)
"Transverse myelitis is a rare but serious complication of systemic lupus erythematosus (SLE)."1.28Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide. ( Barile, L; Lavalle, C, 1992)
" Measurement of plasma peak PE or AUC could be valuable for individualizing steroid dosing in children with RD."1.28Use of a radioreceptor assay in the assessment of cushingoid features in patients with juvenile rheumatic diseases. ( Getson, PR; Lipnick, RN; Morales, A; Soldin, SJ; White, PH, 1992)
"Eight patients, 3 with systemic lupus erythematosus (SLE) or "SLE-like" disease, 1 with sarcoidosis, and 4 with no connective tissue disease had transient ischemic attacks (TIA) or cerebral infarctions associated with high levels of anticardiolipin antibodies (ACA)."1.28Cerebral ischemia associated with anticardiolipin antibodies. ( Ernerudh, J; Lindström, F; Olsson, JE; Vrethem, M, 1992)
"It was increased in the active cases of systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD)."1.28Serum level of interferon-gamma in autoimmune diseases. ( Funauchi, M; Horiuchi, A; Minoda, M; Sugishima, H, 1991)
"A 49 year old white woman with systemic lupus erythematosus and bronchiolitis obliterans was treated with prednisone (1 mg/kg daily), which led to a transitory improvement in pulmonary status."1.28Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. ( Cormier, C; Godeau, B; Menkes, CJ, 1991)
"Two patients with systemic lupus erythematosus (SLE) and T-zone lymphoma are described."1.28T-zone lymphoma in association with systemic lupus erythematosus. ( Andoh, K; Inose, K; Kaji, T; Murakami, H; Naruse, T; Ohkubo, Y; Omine, M; Ono, K; Tsuchida, A; Yano, S, 1991)
"In 1986, she was diagnosed as systemic lupus erythematosus (SLE)."1.28[A case of systemic lupus erythematosus complicated with pulmonary hypertension and massive pericardial effusion]. ( Akizuki, S; Irimajiri, S; Matsuoka, Y; Tsuji, S, 1991)
"To determine the pharmacokinetic changes of prednisolone associated with an alternate-day regimen, 12 patients with various diseases were studied longitudinally."1.28The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen. ( Adachi, K; Fuwa, Y; Goshima, E; Miura, K; Yamakita, N; Yasuda, K, 1991)
"Prednisolone therapy was accompanied by a drastic reduction in circulating HLA-DR+, CD4+ T-cell subsets, serum anti-DNA titre, normalization of the serum immunoglobulin profile, and CD4+ T-cell responses to phytohaemagglutinin and concanavalin A."1.28Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. ( al-Wabel, AA; Nur, MA; Raziuddin, S, 1990)
"We describe a fatal case of systemic lupus erythematosus (SLE) developing cerebral and systemic necrotizing vasculitis during pregnancy."1.28Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus. ( Fukuda, J; Kitagawa, Y; Matsuoka, Y; Mizushima, Y; Suzuki, Y, 1990)
" Long term administration of amphotericin B (cumulative dose 5 g) combined with 5-flucytosine eradicated this fungal infection."1.28[A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B]. ( Chida, Y; Hiruma, M; Ida, T; Makiguchi, K; Malumo, F; Matsuda, O; Tsutsui, H, 1990)
"Twenty five cases with systemic lupus erythematosus admitted to a referral service hospital over a period of 6 years have been studied to analyse the pattern of multisystem involvement."1.28Systemic manifestations of systemic lupus erythematosus. ( Bhalla, IP; Bhangui, GR; Chopra, A; Dham, SK; Gupta, MM; Jagadish, TK; Kasthuri, AS; Kumaravelu, S; Uberoi, HS, 1990)
"Prednisolone 20 mg/day was used because the signs of SLE, such as fever and decreased serum C3, levels, became aggravated on the fifth hospital day of acute myocardial infarction."1.28Cardiac rupture following acute myocardial infarction in systemic lupus erythematosus: case report. ( Kishimoto, M; Nakamura, Y; Ouami, H; Shibata, S; Takayanagi, K, 1990)
"A rare case of systemic lupus erythematosus (SLE) associated with lateral medullary syndrome and unilateral internuclear ophthalmoplegia was reported."1.28[A case of systemic lupus erythematosus associated with lateral medullary syndrome and unilateral internuclear ophthalmoplegia]. ( Fujishima, M; Ishitsuka, T; Okada, Y; Sadoshima, S; Sugie, Y, 1989)
"In 53 patients with systemic lupus erythematosus sequential blood samples obtained during a four year period (range 6-47 months) were screened for anticardiolipin antibodies (ACAs)."1.28Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. ( dan Vliet, M; de Groot, PG; Derksen, RH; Hasselaar, P; Out, HJ, 1989)
"A patient with systemic lupus erythematosus who subsequently developed attacks of acute intermittent porphyria is described."1.28Systemic lupus erythematosus and acute intermittent porphyria. ( Allard, SA; Scott, JT, 1989)
"When the diagnosis of systemic lupus erythematosus (SLE) was established at the Department of Internal Medicine in our hospital, he was referred to our clinic for examination of pollakisuria on November 22."1.28[A case of lupus cystitis]. ( Hisazumi, H; Kunimi, K; Misaki, T; Nagano, K, 1989)
"Optic neuritis is an exceedingly rare complication in SLE."1.28[A case of systemic lupus erythematosus associated with meningitis, myelitis, and bilateral optic neuritis]. ( Hayashida, K; Ichiki, S; Ishii, T; Niimi, K; Oda, T; Ohfu, M, 1989)
"A case of steroid induced exophthalmos in a patient with systemic lupus erythematosus with renal involvement is described."1.28Steroid induced exophthalmos. A case report. ( Fan, CJ; Goh, KL; Wang, F, 1989)
"Thirty-one patients with systemic lupus erythematosus had membranous lupus nephropathy (MLN)."1.27Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients. ( Looi, LM; Wang, F, 1984)
"We describe a patient with systemic lupus erythematosus who developed an unusual form of anaplastic myeloma."1.27Anaplastic myeloma in systemic lupus erythematosus. ( Butler, RC; Keat, AC; Thomas, SM; Thompson, JM, 1984)
"A patient with systemic lupus erythematosus (SLE) developed amegakaryocytic thrombocytopenic purpura."1.27Amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus successfully treated by a high-dose prednisolone therapy. ( Kabashima, T; Kashiwagi, H; Kono, I; Nagasawa, T; Sakurai, T; Yamane, K, 1984)
"Thirteen children with systemic lupus erythematosus (SLE) and 5 with juvenile dermatomyositis (JDM) were studied for natural cytotoxicity (NK) and antibody-dependent cellular cytotoxicity (ADCC)."1.27Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis. ( Lantner, R; Miller, ML; Pachman, LM, 1983)
"Neurological complications of systemic lupus erythematosus (SLE) are relatively common, but isolated chorea as the initial manifestation of SLE is very rare."1.27Chorea as an initial manifestation of systemic lupus erythematosus. A case report of a 10-year-old girl. ( Arisaka, M; Arisaka, O; Kaneko, K; Obinata, K; Sasaki, H, 1984)
"Treatment with prednisolone alone or with a prednisolone/azathioprine combination resulted in an equal five-year survival (82%) and a similar overall preservation of renal function."1.27Renal involvement in systemic lupus erythematosus. ( Atkins, RC; Boyce, NW; Holdsworth, SR; Thomson, NM, 1984)
"Two paediatric patients with systemic lupus erythematosus were treated with immunoglobulin G (IgG)."1.27IgG therapy in systemic lupus erythematosus--two case reports. ( Dopfer, R; Gaedicke, G; Kohne, E; Niethammer, D; Teller, WM, 1984)
"The main group comprised patients with thromboangitis obliterans (23), nonspecific aortoarteritis was recognized in 6 cases, systemic scleroderma and systemic lupus erythematosus in 4, nodular periarteritis in 2."1.27[Hemosorption in the complex treatment of rheumatic diseases]. ( Alekseev, VI; Lileeva, MA; Pukhov, AG; Verkhovskii, SIu; Vilianskiĭ, MP, 1985)
"Two patients had a diagnosis of systemic lupus erythematosus and mixed connective tissue disease respectively; the other patient had no signs of underlying auto-immune disease."1.27Arterial thrombotic manifestations in young women associated with the lupus anticoagulant. ( De Wolf, JT; Kallenberg, CG; Ter Borg, EJ; Van der Meer, J; Van Leeuwen, MH, 1988)
"Three patients presented with cerebellar ataxia among 350 cases of systemic lupus erythematosus (SLE) seen over the last 14 years."1.27Cerebellar ataxia in systemic lupus erythematosus: three case reports. ( Kumar, A; Malaviya, AN; Misra, A; Padmakumar, K; Prasad, K; Singh, RR, 1988)
"The coexistence of myelofibrosis and pancytopenia in patients with systemic lupus erythematosus has been reported, but their possible causal relationship remains unresolved."1.27Myelofibrosis and pancytopenia in systemic lupus erythematosus. ( Ahmad, MA; al Fadel Saleh, M; al Gindan, YM; al Sohaibani, MO; el Mouzan, MI, 1988)
"We describe a patient with systemic lupus erythematosus (SLE) who presented with both steroid induced psychosis and central nervous system (CNS) SLE at different times."1.27A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis. ( Hirohata, S; Inokuma, S; Iwamoto, S; Miyamoto, T; Nakano, K; Sugiyama, H, 1988)
"Two patients with severe systemic lupus erythematosus, who had not responded to conventional therapy, were treated with plasmapheresis and subsequent pulse cyclophosphamide."1.27Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. ( Euler, HH; Löffler, H; Schroeder, JO, 1987)
"A 5 year old girl with systemic lupus erythematosus developed extensive thromboses at multiple sites."1.27Multiple thromboses in systemic lupus erythematosus. ( Appan, S; Boey, ML; Lim, KW, 1987)
"A 19-year old female with catatonia associated with multi-system involvement with systemic lupus erythematosus is described."1.27Lupus catatonia: a case report. ( Daradkeh, TK; Nasrallah, NS, 1987)
" There were negative correlations between the receptor numbers (both whole cell and nucleus) of patients and daily dosage of prednisolone."1.27[Studies on the glucocorticoid receptor in human peripheral lymphocytes. II. Regulation by glucocorticoid]. ( Oshima, H, 1986)
" The relative receptor number was expressed as a percentage of the receptor number to the mean of the receptor number in the group of patients stratified by every 10mg/day of the dosage of prednisolone."1.27[Studies on the glucocorticoid receptor in human peripheral lymphocytes. III. Correlation between receptor number and clinical response to glucocorticoid]. ( Oshima, H, 1986)
"Systemic lupus erythematosus was subsequently diagnosed, when malar rash, arthritis, leucopenia, anti-native DNA and anti-Sm antibodies appeared."1.27[Ascites disclosing systemic lupus erythematosus]. ( Andréani, T; Darnis, F; Poupon, R, 1986)
"Myelopathy is a rare complication of systemic lupus erythematosus (SLE)."1.27Myelopathy as the main presenting feature of systemic lupus erythematosus. ( Al-Husaini, A; Jamal, GA, 1985)
" These results suggested that prednisolone treatment with a smaller dosage as well as with the higher dosage resulted in a carbohydrate intolerance, the main cause of which is located in a postreceptor step (or steps) of insulin action."1.27Erythrocyte insulin receptor and glucose tolerance test in children treated with prednisolone. ( Fujimoto, S; Kan, H; Matsuda, I, 1985)
"Fulminant lupus pneumonitis, acute renal failure, and RBC hypoplasia occurred in a 14-year-old girl."1.26Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression. ( Hayes, JM; Isbister, JP; Ralston, M; Wright, R, 1981)
"Examination of 27 patients with systemic lupus erythematosus (SLE) before treatment showed an elevation of the serum level of lactic dehydrogenase (LDH) in 15 patients."1.26Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus. ( Horiguchi, T; Inoue, T; Kanayama, Y; Kato, N; Ohe, A; Shiota, K, 1981)
"When six untreated female patients with systemic lupus erythematosus were compared with fifteen age-matched, corticosteroid-treated female patients, NK activity in the latter was significantly suppressed."1.26Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. ( Gonda, N; Kano, S; Oshimi, K; Sumiya, M, 1980)
"In a 25-year old woman with ulcerative colitis a lupus erythematosus syndrome occurred during treatment with salazosulfapyridine."1.26[Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)]. ( Jaup, BH, 1978)
"Of these dogs, 29 had systemic lupus erythematosus, 15 had arthritis in association with some chronic infectious disease process, and 19 had a similar type of arthritis, but without serologic evidence of systemic lupus erythematosus or any chronic infectious disease process."1.26Noninfectious canine arthritis: the inflammatory, nonerosive arthritides. ( Castles, JJ; Ling, GV; Pedersen, NC; Weiser, G; Weisner, K, 1976)
"Subcutaneous abscesses and exophthalmos disappeared after one week of therapy and she made an uneventful recovery."1.26Disseminated nocardiosis after pulmonary collapse: a case report. ( Aswapokee, N; Aswapokee, P; Jaroonvesma, N; Leelarasamee, A; Nilvarangkur, S; Vanichakarn, S, 1977)
" Monitoring prednisolone levels may be of value in identifying those children who accumulate excessively high levels on moderate dosage regimens."1.26Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. ( Green, OC; Hart, RL; Kawahara, FS; Lewy, PR; Pachman, LM; Phillips, LS; Winter, RJ, 1978)
"A 3-year-old boy with systemic lupus erythematosus (SLE) with no skin rash whatever throughout the course of the disease is described, and the possibility of occurrence without skin rash is stressed."1.26Systemic lupus erythematosus in a boy with a review of the Japanese literature. ( Fujii, H; Fujii, Y; Hara, H; Higaki, T; Kobayashi, Y, 1977)
"Differences between the human and canine diseases are listed."1.26Canine systemic lupus erythematosus. The disease, clinical manifestations and treatment. ( Moore, DJ, 1976)
"Four patients with systemic lupus erythematosus (SLE) are described in whom there were major psychiatric complications."1.26Psychiatric problems in systemic lupus erythematosus. ( Dick, WC; Grennan, DM; MacNeill, A; Ward, D, 1976)
"Features of both systemic lupus erythematosus and scleroderma developed in a young Chinese girl while on multiple anticonvulsant therapy."1.25Lupus-scleroderma syndrome induced by ethosuximide. ( Chan, HL; Teoh, PC, 1975)
"An 18-year-old girl with systemic lupus erythematosus developed progressive electrocardiographic abnormalities over a period of 16 years, culminating in complete heart block with Adams-Stokes attacks."1.25Complete heart block and systemic lupus erythematosus. ( Iveson, M; Wray, R, 1975)
"The authors studied 200 cases of systemic lupus erythematosus."1.25[Psychopathologic manifestations in systemic lupus erythematosus]. ( Guseva, LL; Luninskaia, IR, 1975)
"Twenty-nine patients with systemic lupus erythematosus were treated with a new synthetic unsaturated prednisolone derivative, triamcinolone, for as long as 11 months."1.24Systemic lupus erythematosus; results of treatment with triamcinolone. ( DUBOIS, EL, 1958)

Research

Studies (1,017)

TimeframeStudies, this research(%)All Research%
pre-1990324 (31.86)18.7374
1990's215 (21.14)18.2507
2000's224 (22.03)29.6817
2010's196 (19.27)24.3611
2020's58 (5.70)2.80

Authors

AuthorsStudies
Hidaka, D1
Ogasawara, R1
Sugimura, S1
Fujii, F1
Kojima, K1
Nagai, J1
Ebata, K2
Okada, K1
Kobayashi, N2
Ogasawara, M2
Imamura, M1
Ota, S1
Ali, MA1
Stratton, R1
Prata, AR1
Luís, M1
Assunção, H1
da Silva, JAP1
Inês, LS1
van Vollenhoven, RF4
Bertsias, G1
Doria, A1
Isenberg, D2
Morand, E3
Petri, MA3
Pons-Estel, BA1
Rahman, A3
Ugarte-Gil, MF1
Voskuyl, A1
Arnaud, L2
Bruce, IN1
Cervera, R3
Costedoat-Chalumeau, N1
Gordon, C4
Houssiau, FA4
Mosca, M2
Schneider, M2
Ward, MM1
Alarcon, G1
Aringer, M1
Askenase, A1
Bae, SC3
Bootsma, H2
Boumpas, DT2
Brunner, H1
Clarke, AE2
Coney, C1
Czirják, L1
Dörner, T1
Faria, R1
Fischer, R2
Fritsch-Stork, R1
Inanc, M3
Jacobsen, S2
Jayne, D2
Kuhn, A1
van Leeuw, B1
Limper, M2
Mariette, X1
Navarra, S2
Nikpour, M2
Olesinska, MH1
Pons-Estel, G1
Romero-Diaz, J1
Rubio, B1
Schoenfeld, Y1
Bonfá, E1
Smolen, J1
Teng, YKO2
Tincani, A1
Tsang-A-Sjoe, M1
Vasconcelos, C1
Voss, A1
Werth, VP1
Zakharhova, E1
Aranow, C1
Kishi, T1
Sakai, R3
Tani, Y1
Nagata, S1
Katsumata, Y4
Miyamae, T3
Harigai, M3
Maeda, A1
Kinjo, M1
Kinjo, K1
Kishaba, T1
Kikuchi, J2
Hanaoka, H4
Saito, S3
Oshige, T1
Hiramoto, K1
Kaneko, Y2
Takeuchi, T10
Nakamura, E2
Isoda, K1
Kotani, T2
Hiramatsu, Y1
Wada, Y3
Fujiki, Y2
Fujita, D1
Hirooka, Y1
Okuda, S1
Sugiyama, M2
Shiga, T1
Nozaki, Y2
Kinoshita, K2
Funauchi, M5
Matsumura, I1
Narupan, N1
Seeherunwong, A1
Pumpuang, W1
Tsai, HL2
Chang, JW2
Lu, JH2
Liu, CS2
Abe, K7
Ishikawa, Y1
Kita, Y3
Yajima, N4
Inoue, E1
Sada, KE5
Miyawaki, Y3
Yoshimi, R4
Shimojima, Y5
Ohno, S5
Kajiyama, H3
Ichinose, K8
Sato, S6
Fujiwara, M3
Ayano, M1
Kimoto, Y1
Mitoma, H1
Akahoshi, M1
Ono, N1
Arinobu, Y1
Akashi, K1
Horiuchi, T3
Niiro, H1
Sawamura, M1
Sawa, N1
Ikuma, D1
Oba, Y1
Yamanouchi, M1
Sekine, A1
Mizuno, H1
Hasegawa, E1
Suwabe, T1
Hoshino, J1
Kono, K2
Kinowaki, K1
Ohashi, K3
Ubara, Y1
Mok, CC13
Chan, KL5
Tse, SM6
Shimizu, M1
Furudate, S1
Nagai, Y1
Shimada, K2
Ohshima, M1
Setoguchi, K1
Hashiguchi, M1
Yokogawa, N2
Connelly, K1
Kandane-Rathnayake, R1
Hoi, A1
Louthrenoo, W1
Hamijoyo, L1
Luo, SF1
Wu, YJ1
Cho, J2
Lateef, A2
Lau, CS4
Chen, YH1
Zamora, L1
Li, Z1
An, Y1
Sockalingam, S2
Hao, Y1
Zhang, Z1
Chan, M1
Oon, S1
O'Neill, S1
Gibson, KA1
Basnayake, B1
Ng, KPL1
Tugnet, N1
Kumar, S1
Goldblatt, F2
Law, A3
Tee, M1
Tee, C1
Tanaka, Y4
Ohkubo, N1
Tan, JY1
Karyekar, CS1
Golder, V1
Morand, EF3
Katayama, Y2
Asano, Y3
Hayashi, K2
Katsuyama, E1
Katsuyama, T1
Takano-Narazaki, M2
Matsumoto, Y4
Omer, MH1
Salama, H1
Alghaythi, AM1
Alharbi, AA1
AlJohani, G1
Kurihara, I1
Terai, C1
Yabe, H1
Sugawara, H1
van Schaik, M1
Arends, EJ1
Soonawala, D1
van Ommen, E1
de Leeuw, K1
van Paassen, P1
Huizinga, TWJ1
Toes, REM1
van Kooten, C1
Rotmans, JI1
Rabelink, TJ1
Yoshida, Y4
Oka, N3
Yorishima, A3
Masuda, S3
Ishitoku, M3
Araki, K3
Kohno, H3
Watanabe, H7
Sugimoto, T3
Mokuda, S3
Hirata, S3
Ho, LY4
To, CH6
Ma, M2
Santosa, A2
Fong, W2
Chew, LC2
Low, AH2
Poh, YJ2
Yeo, SI2
Leung, YY2
Ng, VW2
Koh, JZ2
Tay, SH3
Mak, A5
Teng, GG2
Xu, C2
Tang, JG2
Kong, KO3
Angkodjojo, S2
Goh, WR2
Chuah, TY2
Roslan, NE2
Arkachaisri, T3
Teh, KL2
Sriranganathan, M2
Tan, TC2
Phang, KF2
Yap, QV2
Chan, YH2
Cheung, PP3
Lahiri, M3
Sah, BK1
Chaudhary, S1
Pahari, A1
Ghimire, A1
Sah, RK1
Sah, AK1
Kumari, N1
Jaiswal, YK1
Sah, VK1
Motoyama, R1
Higuchi, T1
Hirahara, S1
Konda, N1
Yamada, R2
Watanabe, K4
Fujisaki, M1
Yamaguchi, R1
Kawaguchi, Y2
Kim, MH1
Choi, SR1
Park, JK1
Lee, EY1
Lee, EB3
Park, JW1
Smith, EMD1
Aggarwal, A2
Ainsworth, J1
Al-Abadi, E1
Avcin, T1
Bortey, L1
Burnham, J1
Ciurtin, C1
Hedrich, CM1
Kamphuis, S1
Lambert, L1
Levy, DM1
Lewandowski, L1
Maxwell, N1
Ozen, S1
Pain, CE1
Ravelli, A1
Saad Magalhaes, C1
Pilkington, C2
Schonenberg-Meinema, D1
Scott, C1
Tullus, K2
Beresford, MW1
Ishino, Y1
Fukasawa, H1
Kitamoto, S1
Nakagami, D1
Kaneko, M1
Yasuda, H1
Furuya, R1
Basu, S1
Sil, A1
Jindal, AK1
Tyagi, R1
Arafath, MY1
Vyas, S1
Rawat, A1
Smiyan, S1
Koshak, B1
Komorovsky, R1
Slaba, U1
Bilukha, A1
Mifune-Morioka, T1
Uchida, HA1
Fukushima, K1
Watanabe, M1
Ouchi, C1
Mise, K1
Kawakita, C1
Kano, Y1
Onishi, A1
Toma, K1
Eguchi, J1
Wada, N1
Ikeda, F1
Sasaki, E1
Suganami, Y1
Kishida, M1
Sugiyama, H3
Okada, H3
Wada, J2
Takamasu, E1
Sugii, S1
Cheng, CF1
Huang, YM1
Lu, CH1
Hsieh, SC1
Li, KJ1
Hayashi, Y4
Fukutomi, T1
Ohmatsu, H1
Eguchi, T1
Inoue, K5
Horino, T3
Matsumoto, T2
Kamioka, S1
Nishida, Y1
Morimoto, M1
Morimoto, N1
Ichii, O2
Terada, Y2
Gutta, S1
Das, S2
Kodiatte, TA1
Vimala, LR1
Maeshima, K1
Shibata, H1
Lee, I1
Marshall, B1
Ranganathan, P1
Eisen, S1
Rajagopal, R1
Kim, AHJ1
Li, T1
Teo, R1
Dhanasekaran, P2
Ajeganova, S1
Gustafsson, T1
Lindberg, L1
Hafström, I1
Frostegård, J1
Okamoto, M2
Imadome, KI1
Furukawa, K2
Kawakami, A5
Furia, FF1
Godfrey, E1
Mwamanenge, N1
Swai, P1
Iwai, Y1
Hama, N1
Abe, R1
Shah, K1
Porter, A1
Takhar, G1
Reddy, V2
Imai, M1
Yamamoto, H3
Hashimoto, T2
Koyama, H1
Kihara, S1
O'Kelly, B1
McNally, C1
McConkey, S1
Durcan, L1
Cavallasca, JA1
Cousillas, JE1
Demirkan, FG1
Doğan, S1
Kalyoncu Uçar, A1
Sönmez, HE1
Aktay Ayaz, N1
Chandra, A1
Saha, SK1
Ray, AK1
Karmakar, P1
Björk, A1
Da Silva Rodrigues, R1
Richardsdotter Andersson, E1
Ramírez Sepúlveda, JI1
Mofors, J1
Kvarnström, M1
Oke, V1
Svenungsson, E2
Gunnarsson, I2
Wahren-Herlenius, M1
Miyagawa, I1
Nakano, K4
Nakayamada, S2
Mori, H2
Okada, Y4
Saito, K4
Nakayama, Y2
Taura, D1
Shibue, K1
Kuramoto, N1
Mimori, T3
Inagaki, N1
Wu, C1
Wang, Q2
Xu, D2
Li, M3
Zeng, X3
Wang, WH2
Lai, CC3
Huang, YF1
Li, TH2
Tsao, YP2
Chen, WS3
Chang, YS3
Shimizu, S1
Ogawa, Y1
Yamamura, Y1
Hiramatsu-Asano, S1
Morishita, M1
Yamazaki, H1
Yamamoto, Y2
Fukuhara, S1
Saito, M3
Yanai, R1
Tsubokura, Y1
Nomura, S1
Yoshizawa, E1
Kondo, Y1
Kishida, D1
Sekijima, Y1
Long, Y1
Zhang, S2
Zhao, J1
You, H1
Zhang, L1
Li, J2
Leng, X1
Tian, X1
Lee, J2
Lee, YJ1
Kim, Y1
Jayawickreme, KP1
Subasinghe, S1
Weerasinghe, S1
Perera, L1
Dissanayaka, P1
Magendiran, B1
Jose, A1
Kolar Vishwanath, V1
Bammigatti, C2
Lee, KR1
Peng, LY1
Iqbal, TB1
Subrayan, V1
Nagel, J1
Saxne, T1
Geborek, P1
Bengtsson, AA2
Svaerke Joergensen, C1
Nilsson, JÅ1
Skattum, L1
Jönsen, A1
Kapetanovic, MC1
Vinay, K1
Sawatkar, G1
Dogra, S1
Saikia, UN1
Serra, SS1
Pedrosa, T1
Falcão, S1
Branco, JC1
Kawazoe, M2
Kaneko, K4
Shikano, K2
Kusunoki, N1
Nanki, T3
Kawai, S5
Kurasawa, T2
Nishi, E2
Kondo, T2
Shibata, A2
Nishimura, K2
Chino, K2
Okuyama, A2
Takei, H3
Nagasawa, H3
Amano, K6
Wu, Z1
Zhao, L1
Fei, Y1
Wang, L1
Wen, X1
Zhang, F1
Li, Y2
Tomimatsu, T1
Hazama, Y1
Takeuchi, M2
Kimura, T1
Shimoya, K1
Maethasith, I1
Sathirapanya, P1
Wei, J1
Gao, J1
Ding, X1
Dholaria, B1
Patel, RJ1
Sluzevich, JC1
Ailawadhi, S1
Roy, V1
Tulbă, D1
Balea, M1
Băicuş, C1
Thomas, J1
Babu, AK1
Aoyama-Maeda, N1
Matsuda, S2
Yoshida, S3
Makino, S3
Piga, M1
Floris, A1
Cappellazzo, G1
Chessa, E1
Congia, M1
Mathieu, A1
Cauli, A1
Gravito-Soares, E1
Gravito-Soares, M1
Cipriano, MA1
Amaro, P1
Deguchi, M1
Maesawa, Y1
Kubota, S1
Morizane, M1
Tanimura, K1
Ebina, Y2
Yamada, H4
Trasieva, T1
Berglind, A1
Illei, GG1
Tummala, R1
Hu, Y1
Carman, JA2
Holloway, D1
Kansal, S1
Fan, L2
Goldstine, C1
Lee, D1
Somerville, JE1
Latek, R1
Townsend, R1
Johnsen, A1
Connolly, S1
Bandyopadhyay, S1
Shadick, N1
Weinblatt, ME1
Furie, R1
Nadler, SG1
Sakuno, T1
Inoue, H4
Miura, H1
Shiono, Y2
Okuse, H1
Nakamura, M3
Katsurahara, M1
Hamada, Y1
Tanaka, K1
Horiki, N1
Takei, Y1
Kumar, N2
Surendran, D1
Kitajima, Y3
Horai, Y2
Fujikawa, K3
Umeda, M1
Fukui, S1
Nishino, A1
Koga, T3
Kawashiri, SY3
Iwamoto, N3
Tamai, M3
Nakamura, H8
Origuchi, T3
Yasuhi, I1
Masuzaki, H1
Yamada, T1
Mugishima, K1
Higo, S1
Itagaki, F1
Yui, S1
Kashiwagi, T1
Endo, Y1
Shimizu, A2
Tsuruoka, S2
Shi, W1
Duan, M1
Jie, L1
Sun, W1
Tsukita, K1
Miyake, H1
Kageyama, T1
Suenaga, T1
Ishida, T1
Kimura, Y2
Arawaka, S1
Choi, YJ1
Yoo, WH2
Abe, N2
Fujieda, Y1
Nagaoka, K1
Ohkusu, M1
Yasuda, S1
Kamei, K1
Atsumi, T2
Chowichian, M1
Aanpreung, P1
Pongpaibul, A1
Charuvanij, S1
Ghazali, WSW1
Daud, SMM1
Mohammad, N1
Wong, KK1
Magro, R1
Borg, AA1
Iida, H3
Kiyokawa, T3
Takakuwa, Y3
Kawahata, K3
Ichiyama, S1
Hoashi, T1
Kanda, N1
Hashimoto, H13
Matsushita, M1
Nozawa, K2
Ueno, T1
Saeki, H1
Teoh, LK1
Yamada, Z1
Masuoka, S2
Mizutani, S1
Yamada, S2
Sato, H5
Kaburaki, M1
Muraoka, S1
Giménez, AR1
Pastrana, DB1
Huaranga, MAR1
Izquierdo, JR1
Cabrera, B1
García, AN1
Rodríguez, CCR1
Tsai, CY1
Li, GM1
Liu, HM1
Guan, WZ1
Xu, H1
Wu, BB1
Feng, JY1
Sun, L1
Vithoosan, S1
Karunarathna, T1
Shanjeeban, P1
Piranavan, P1
Matthias, T1
Gamlaksha, D1
Liyadipita, A1
Kulatunga, A1
Cheema, S1
Bunting, E1
Good, C1
Hajela, V1
Ridha, BH1
Saha, RA1
Kawai, J1
Kakimoto, K1
Miyazaki, H1
Hirata, Y1
Kawakami, K2
Higuchi, K1
Chen, D1
Lao, M1
Cai, X1
Li, H2
Zhan, Y1
Wang, X1
Zhan, Z1
Christodoulou, C1
Economides, C1
D'Cruz, D1
Kasatkar, P1
Ghosh, K1
Shetty, S1
Limwattana, S1
Dissaneewate, P2
Kritsaneepaiboon, S1
Dendumrongsup, T1
Vachvanichsanong, P2
Ogawa, H2
Ito, T2
Kato, H1
Buyon, J1
Levy, RA1
Navarra, SV1
Zhong, ZJ1
Freimuth, WW1
Liyanage, A1
Lekamwasam, S1
Dissanayake, SP1
Munidasa, D1
Noh, JJ1
Park, CH1
Jo, MH1
Kwon, JY1
Ong, CS1
Cheah, TE1
Jasmin, R1
Yahya, F1
Ng, CT1
Matsumoto, M3
Kaieda, S1
Honda, S1
Ida, H3
Hoshino, T2
Fukuda, T1
Grover, S1
Aarya, KR1
Sharma, A1
Ying, SK1
Ma, KM4
Wong, CK2
Igarashi, T3
Itoh, Y1
Shrestha, D1
Dhakal, AK1
Shiva, RK1
Shakya, A1
Shah, SC1
Shakya, H1
Jung, SY1
Fallahi, S1
Akbarian, M1
Dabiri, S1
El-Shabrawi, MH1
Farrag, MI1
Ueda, Y2
Takahashi, Y6
Yamashita, H3
Kano, T2
Mimori, A3
Miyagi, R1
Ideguchi, H1
Soga, T2
Sakamoto, K1
Niino, H1
Shiina, T1
Ueda, A4
Ishigatsubo, Y2
Fegan, D1
Glennon, MJ1
Hamzi, AM1
Alayoud, A1
El Kabbaj, D1
Benyahia, M1
Ohtsubo, T1
Akita, K1
Wada, T4
Horii, S1
Adachi, T1
Kimura, F1
Itoh, K1
Sasaki, H2
Ito, K1
Furusaki, A1
Amasaki, Y2
Abe, T5
Pamuk, ON1
Pamuk, GE1
Barutcu, E1
Celik, AD1
Wang, Y3
Da, G1
Yu, Y1
Han, J1
Izumi, Y3
Miyashita, T3
Migita, K3
Shaharir, SS1
Gafor, AH1
Said, MS1
Kong, NC1
Wei, X1
Tu, L1
Wan, H1
Chen, Q1
Koh, WL1
Tay, YK1
Koh, MJ1
Sharma, S1
Lerman, MA1
Fitzgerald, MP1
Ruebner, RL1
Christenson, ES1
Ligon, C1
Hsu, S1
Ogawa, M1
Muro, Y2
Sugiura, K1
Sakakibara, A1
Akiyama, M1
Lee, WS1
Lum, SH1
Lim, CB2
Chong, SY1
Khoh, KM1
Ng, RT1
Teo, KM1
Boey, CC1
Pailoor, J1
Ramcharan, K1
Abdool, K1
Persad, N1
Dyaanand, H1
Nagakawa, A1
Arata, N1
Mito, A1
Kaneshige, T1
Kitami, M1
Sago, H1
Murashima, A1
Nause, SL1
Spiegler, J1
Weichert, J1
Hartge, DR1
Dorjee, K1
Dierberg, KL1
Sadutshang, TD1
Reingold, AL1
Hashemie, H1
Klossowski, N1
Oommen, PT1
Neubert, J1
Homey, B2
Hoff, NP1
Reifenberger, J1
Meller, S2
Cheah, CK1
Ramanujam, S1
Mohd Noor, N1
Gandhi, C1
D Souza, BA1
Gun, SC1
Kuroda, T2
Tanabe, N1
Wakamatsu, A1
Takai, C1
Nakatsue, T1
Nakano, M5
Narita, I2
Kansal, A1
Tripathi, D1
Rai, MK1
Agarwal, V1
Mino, Y2
Sciascia, S1
Hunt, BJ1
Talavera-Garcia, E1
Lliso, G1
Khamashta, MA2
Cuadrado, MJ1
Khan, WA1
Qureshi, JA1
Yamamoto, T7
Ohtsuka, M1
Mylona, E1
Vadala, C1
Galanidi, E1
Skliros, N1
Loverdos, D1
Skoutelis, A1
Basaran, O1
Aydın, F1
Celikel, BA1
Uncu, N1
Cakar, N1
Noviani, M1
Wasserman, S1
Clowse, ME1
Ohashi, T1
Ito, H3
Noda, K1
Hirai, K2
Ukichi, T1
Furuya, K1
Kurosaka, D2
Wu, EY1
Schanberg, LE1
Wershba, EC1
Rabinovich, CE1
Andrews, JS1
Trupin, L1
Hough, CL1
Daikh, DI1
Yelin, EH1
Katz, PP1
Dudhgaonkar, S1
Ranade, S1
Nagar, J1
Subramani, S1
Prasad, DS1
Karunanithi, P1
Srivastava, R1
Venkatesh, K1
Selvam, S1
Krishnamurthy, P1
Mariappan, TT1
Saxena, A1
Stetsko, DK1
Holloway, DA1
Li, X1
Zhu, J1
Yang, WP1
Ruepp, S1
Nair, S1
Santella, J1
Duncia, J1
Hynes, J1
McIntyre, KW1
Thornhill, SI1
Lee, B1
Lee, HY1
Poidinger, M1
Connolly, JE1
Fairhurst, AM1
Nordin, A1
Lundholm, H1
Hellbacher, E1
Wikner, J1
Zickert, A1
Ying, SKY1
Hara, A1
Kitajima, S1
Toyama, T1
Okumura, T1
Kitagawa, K1
Iwata, Y2
Sakai, N2
Furuichi, K2
Higuchi, M1
Kaneko, S1
Blaise, S1
Salameire, D1
Carpentier, PH1
Sasaki, N1
Baba, S2
Takahashi, S1
Itou, H1
Kowada, K1
Shikanai, T1
Nakamura, Y4
Yamauchi, K1
Sawai, T1
Kishimoto, K2
Shimazu, H1
Ikoma, S1
Szeto, CC2
Kwan, BC1
Lai, FM1
Tam, LS5
Li, EK8
Chow, KM1
Gang, W1
Li, PK1
Lertnawapan, R1
Totemchokchyakarn, K2
Nantiruj, K1
Janwityanujit, S2
Huang, CS1
Wu, WF1
Masatlioğlu, SP1
Göktay, F1
Mansur, AT1
Akkaya, AD1
Güneş, P1
MacIver, H1
Hordon, L1
Reynolds, JA1
Toescu, V1
Yee, CS2
Prabu, A1
Situnayake, D3
Mardjuadi, A1
Soedirman, M1
Utoyo, B1
Rasker, JJ1
Korkmaz, C2
Woo, SI1
Hwang, GS1
Kang, SJ1
Park, JS1
Park, SJ1
Lee, YS2
Lee, YH1
Tahk, SJ1
Taki, H1
Shinoda, K1
Hounoki, H1
Ogawa, R1
Hayashi, R1
Sugiyama, E1
Tobe, K1
Kusumoto, N1
Kai, Y3
Kubo, K3
Miyauchi, S2
Umekita, K2
Ueno, S2
Takajo, I2
Nagatomo, Y2
Okayama, A3
Kameda, T1
Shimoda, K1
Sahin, G1
Işiksoy, S1
Yalçin, AU1
Salesi, M1
Karimifar, M1
Mottaghi, P1
Sayedbonakdar, Z1
Karimzadeh, H1
Chambers, S1
Isenberg, DA7
Altaie, R1
Patel, D1
McGhee, C1
Owada, T1
Takahashi, K2
Gul'neva, MIu1
Shilkina, NP1
Kusunoki, Y1
Tanaka, N2
Endo, H2
Kato, M2
Nakazawa, E1
Akimoto, T1
Inoue, M1
Kanashiki, E1
Meguro, D1
Tozawa, R1
Muto, S1
Yumura, W1
Kusano, E1
Suzuki, D1
Ogawa, N4
Sawada, J1
Kimoto, O1
Shimoyama, K2
Hayashi, H1
Rajasekhar, L1
Habibi, S1
Sudhakar, P1
Gumdal, N1
Ying, KY2
Yim, CW1
Ng, WL1
Wong, WS3
Ma, AL1
Lai, WM1
Chiu, MC1
Sekiya, F1
Yamaji, K2
Yang, K1
Tsuda, H4
Takasaki, Y8
Ambrose, NL1
Kearns, G1
Mohammad, A1
Yamaya, M1
Yoshida, M3
Yamasaki, M1
Kubo, H1
Arai, H1
Miyamura, T1
Takahama, S1
Sonomoto, K1
Ando, H1
Minami, R1
Yamamoto, M3
Suematsu, E1
Yoshikawa, N1
Hattori, S1
Sasaki, S3
Ando, T1
Ikeda, M2
Honda, M1
Mok, MY3
Huang, FP1
Ip, WK1
Lo, Y2
Wong, FY1
Chan, EY2
Lam, KF1
Griffiths, B1
Emery, P1
Ryan, V1
Akil, M1
Thompson, R1
Maddison, P1
Griffiths, ID2
Lorenzi, A1
Miles, S1
Teh, LS1
Plant, M1
Hallengren, C1
Nived, O3
Sturfelt, G6
Chakravarty, K1
Tait, T1
Sato, N1
Ohsawa, I1
Takagi, M1
Gohda, T1
Horikoshi, S1
Shirato, I1
Yamaguchi, Y2
Tomino, Y2
Aramaki, T3
Eguchi, K4
Möller, J1
Girschick, HJ1
Hahn, G1
Pessler, F1
Sarkar, RN1
Banerjee, S1
Dey, S1
Saha, A1
Bhattacharjee, P1
Banerjee, TK1
Sinha, PK1
Chakraborty, A1
Xia, JY1
Chen, XY1
Xu, F1
Yang, Y1
Wang, HY2
Xue, J1
Chia, FL1
Thong, BY2
Lau, TC1
Feng, PH5
Lui, NL1
Thumboo, J1
Fong, KY1
Eguchi, E1
Shimazu, K1
Takaori, K1
Nishiguchi, K1
Mori, K2
Yorifuji, S1
Murakami, T1
Koshikawa, M1
Tanaka, A1
Kuwahara, T1
Ishizuka, S1
Nakayama, K1
Yagawa, K1
Kubota, K1
Amamiya, H1
Weng, CT1
Lee, NY1
Liu, MF1
Weng, MY1
Wu, AB1
Chang, TW1
Lin, TS1
Wang, JY1
Chang, HY1
Wang, CR1
Caltik, A1
Demircin, G1
Bülbül, M1
Erdogan, O1
Akyüz, SG1
Arda, N1
Lee, CK1
Lee, TH1
Lee, SH1
Chung, IK1
Park, SH2
Kim, HS2
Kim, SJ1
Akazawa, S1
Kamachi, M1
Arima, K1
Seishima, M2
Shibuya, Y1
Kato, G1
Phillips, PJ1
Burnet, S1
Takajou, I1
Sayarlioglu, M2
Yuzbasioglu, N1
Kamali, S2
Cefle, A2
Karaman, O2
Onat, AM1
Avan, R1
Cetin, GY1
Gul, A2
Ocal, L2
Aral, O2
Alenzi, FQ1
Guerriero, S1
Ciracì, L1
Cardia, G1
Vetrugno, M1
Kazyra, I1
Marks, SD1
Al-Shibli, A1
Al-Salam, S1
Bernieh, B1
Matta, H1
Al Attrach, I1
Nakanishi, H1
Muta, T1
Fujisaki, T1
Yoshitomi, R1
Kubo, T1
Yokota, E1
Miyano, G1
Hayashi, T2
Arakawa, A2
Nawata, M3
Lane, GJ1
Kato, Y2
Yamataka, A1
Okazaki, T2
Patra, S1
Krishnamurthy, S1
Seth, A1
Beri, S1
Aneja, S1
McNeil, E1
Matsuda, M2
Miyazaki, D1
Tojo, K1
Tazawa, K1
Kurozumi, M1
Fukui, D1
Sano, K1
Ikeda, S1
Jhanji, V1
Agarwal, T1
Sharma, N1
Vajpayee, RB1
Al Arfaj, AS1
Khalil, N1
Zhu, TY2
Hung, VY1
Kwok, AW2
Lee, VW1
Lee, KK1
Griffith, JF2
Wong, KC1
Leung, PC2
Qin, L2
Hawro, T1
Krupińska-Kun, M1
Rabe-Jabłońska, J1
Sysa-Jędrzejowska, A1
Robak, E1
Bogaczewicz, J1
Woźniacka, A1
Dang Do, AN1
Umoren, RA1
Tarvin, SE1
Heilbrunn, BR1
Mahajerin, A1
Bowyer, SL1
Efthimiou, P1
Kukar, M1
Hersh, A1
Xanthouli, P1
Mühleisen, H1
Briem, S1
Weis, D1
Fiehn, C1
Koga, M1
Onizuka, S1
Fujioka, H2
Fujiwara, S1
Nakamichi, C1
Nakashima, K2
Tayal, V1
Chiu, YH1
George, E1
Mane, S1
Katayama, A1
Otsuka, F2
Tanabe, K1
Tsukamoto, N2
Yamanaka, R2
Nasu, Y1
Makino, H4
Efe, C1
Purnak, T1
Ozaslan, E1
Ozbalkan, Z1
Karaaslan, Y2
Altiparmak, E1
Muratori, P1
Wahlin, S1
Hara, H2
Wakui, F1
Ochiai, T1
Turner-Stokes, T1
Lu, TY1
Ehrenstein, MR2
Giles, I1
Watanabe, S3
Tsuruga, K1
Aizawa-Yashiro, T1
Oki, E3
Ito, E3
Tanaka, H5
Hwang, J1
Kim, HJ2
Oh, JM1
Ahn, JK1
Kim, YG1
Huh, WS1
Seo, J1
Koh, EM1
Cha, HS1
Londhey, VA1
Buche, AS1
Kini, SH1
Rajadhyaksha, GC1
Naito, T1
Kawakami, J1
Rasalkar, DD1
Paunipagar, BK1
Lin, HK1
Wang, JD1
Fu, LS1
Park, KE1
Ku, SY1
Kwak, C1
Kim, SH1
Choi, YM1
Kim, JG1
Moon, SY1
Kaneko, H2
Ha, Y1
Lee, KH2
Jung, S1
Lee, SW2
Lee, SK3
Park, YB3
Gono, T1
Sugiura, T1
Kanno, T2
Hara, M1
Yamanaka, H2
Chattopadhyay, P1
Dhua, D1
Philips, CA1
Saha, S1
Hirase, N1
Goda, H1
Nishikawa, H1
Ikuyama, S1
Kikuchi, H1
Asako, K1
Takayama, M1
Shirasaki, R1
Ono, Y1
Ravindran, V1
Rezaieyazdi, Z1
Sharifi-Doloui, D1
Hashemzadeh, K1
Shirdel, A1
Mansouritorghabeh, H1
Baumann, P1
Völkl, A1
Bäuerle, M1
Schmidmaier, R1
Oduncu, FS1
Sagcal-Gironella, AC1
Sherwin, CM1
Tirona, RG1
Rieder, MJ1
Brunner, HI1
Vinks, AA1
Carneiro, FO1
Sampaio, LR1
Brandão, LA1
Braga, LL1
Rocha, FA1
Awazawa, R1
Mine, Y1
Nakamura, I1
Kinjyo, F1
Hagiwara, K1
Fujita, J1
Uezato, H1
Lorcy, S1
Hacia, J1
Roche, C1
de Biasi, C1
Lightburne, E1
Morand, JJ1
Ezeonyeji, AN1
Misago, N1
Narisawa, Y1
Tada, Y6
Nagasawa, K10
Lood, C1
Rönnblom, L2
Axelsson, B1
Sparre, B1
Tuvesson, H1
Ohman, MW1
Leanderson, T1
Shu, E1
Ichiki, Y2
Moriya, C1
Iwata, H1
Handa, H1
Yokohama, A1
Mitsui, T1
Saitoh, T1
Koiso, H1
Uchiumi, H1
Karasawa, M1
Murakami, H2
Kojima, M2
Nojima, Y1
Law, ST1
Li, KK1
Dhir, V1
Singh, YP1
Misra, R1
Poojary, S1
Rais, S1
Ito, S4
Nagai, S1
Murasawa, A1
Murakami, S1
Chen, GL1
Chen, Y1
Zhu, CQ1
Yang, CD2
Ye, S2
Kundu, S1
Mitra, R1
Chatterjee, S1
Ghosh, A1
Kagawa, H1
Hiromasa, T1
Hara, T2
Takaki, A1
Seo, JY1
Byun, HJ1
Cho, KH1
Hong, JY1
Hsiao, KH1
Chou, CT1
Noh, TK1
Haw, S1
Soung, JH1
Won, CH1
Chang, S1
Choi, JH1
Moon, KC1
Park, YS1
Lee, MW1
Lan, L1
Han, F1
Chen, JH1
Li, R1
Chen, Z1
Wada, M1
Kurita, K1
Kato, T2
Tang, XL1
Kun, EW1
Hung, VW1
Su, GX1
Wu, FQ1
Wang, F3
Zhou, ZX1
Huang, XL1
Lu, J1
Sekiguchi, Y1
Shimada, A1
Imai, H2
Wakabayashi, M1
Sugimoto, K3
Nakamura, N1
Sawada, T1
Komatsu, N1
Noguchi, M1
Kamata, Y2
Minota, S2
Queiro, R1
Weruaga, A1
Riestra, JL1
Komura, K1
Ishida, W1
Fujii, H3
Takehara, K1
Maeshima, E3
Kobayashi, T2
Mune, M2
Yukawa, S3
Lahita, RG1
Merrill, JT1
Schiff, M1
Ginzler, EM1
Strand, V1
Kunz, A1
Gorelick, KJ1
Schwartz, KE1
Im, CY1
Kim, SS1
Kim, HK2
Hashimoto, N1
Asagoe, K1
Hara, K1
Yamasaki, O1
Yamasaki, Y1
Seta, N3
Shimizu, T1
Wada, R1
Sekigawa, I4
Iida, N4
Maeda, M1
Natusch, A1
Gromnica-Ihle, E1
Takano, H2
Katada, K1
Yoshikawa, T2
Leandro, MJ1
Edwards, JC1
Cambridge, G1
Suzuki, K4
Nakahata, T2
Tateyama, T2
Waga, S2
Traynor, AE1
Barr, WG1
Rosa, RM1
Rodriguez, J1
Oyama, Y1
Baker, S1
Brush, M1
Burt, RK1
Madge, SN1
Donegan, C1
Aoyagi, S1
Akashi, H1
Otsuka, H1
Sakashita, H1
Tayama, aK1
Wong, SM1
García-Moreno, JM1
Chacón, J1
Falcini, F1
Bindi, G1
Simonini, G1
Stagi, S1
Galluzzi, F1
Masi, L1
Cimaz, R1
Aviña-Zubieta, JA1
Galindo-Rodrìguez, G1
Robledo, I1
Vela-Ojeda, J1
Vadillo-Buenfil, M1
Rosas-Cabral, A1
Salazar-Exaire, D1
Komiya, T1
Okamura, M2
Okazaki, M1
Tsukamoto, J1
Okada, S1
Sumi, T1
Negoro, N1
Yoshikawa, J1
Hashimoto, K4
Asaba, K1
Tamura, K1
Takao, T2
Nakamura, T4
Xu, L1
Shen, L1
Yu, L1
Chen, L1
Terao, H1
Moroi, Y2
Urabe, K1
Furue, M2
Ohashi, N1
Isozaki, T1
Shirakawa, K1
Ikegaya, N1
Hishida, A1
Musch, E1
Malek, M1
Chrissafidou, A1
Martínez-Berriotxoa, A1
Ruiz-Irastorza, G2
Egurbide Arberas, MV1
Rueda Gutiérrez, M1
Aguirre Errasti, C1
Hill, VA1
Chow, J1
Cowley, N1
Marsden, RA1
Taniguchi, Y1
Kumagi, M1
Haranaka, M1
Tatsukawa, H1
Hino, I1
Ishii, K1
Yoshimatsu, H2
Etou, T1
Chan, WM1
Chan, AY3
Lam, DS1
Suzuki, T1
Hirabayashi, Y1
Harigae, H1
Ishii, T2
Kodera, T1
Munakata, Y1
Sasaki, T1
Yasuda, J1
Yoshida, K1
Yokoyama, T1
Ozawa, Y1
Obayashi, Y1
Kingetsu, I1
Yamada, A2
Kobayashi, H2
Seino, T1
Suzuki, S2
Sato, Y5
BOLLET, AJ1
SEGAL, S1
BUNIM, JJ1
DUBOIS, EL5
HARNECKER, J2
JALIL, J2
GONZALEZ, F1
DYK, T2
SOFFER, LJ1
WOLF, R2
MOSES, A1
SILBERSWEIG, M1
GABRILOVE, JL1
McMAHON, FG1
GORDON, ES1
BENEDETTI, A1
FUSARO, A1
POLI, D1
RUGGIERO, HA1
HAUSER, TE1
BERGOEND, H1
BEST, MM1
DUNCAN, CH1
HOLT, KS1
FORSSMAN, O1
KORSGREN, M1
NORDH, B1
PAULSEN, F1
COLLORIDI, V1
PRESTI, A1
NATHAN, DB1
ANDREWS, JT1
MACKAY, IR11
MASEL, M1
BURNET, FM1
WEIDEN, S1
UNGAR, B1
MAGUIRE, A1
PETRANYI, G4
LENOCH, F1
DOSTAL, C1
ZVERV, ME1
SIEGENTHALER, W1
SIEGENTHALER, G1
BONER, A1
GRAYZEL, EF1
LONGSON, D1
HARTMAN, MM1
RADO, J1
TAKO, J1
GEDER, L1
JENEY, E1
FUELOEP, E1
NIETH, H1
GAYER, J1
SEN, AK1
MCDUFFIE, FC1
GUERRERO, R1
OLIVO, MA1
Iwai, M1
Harada, Y1
Ishii, M2
Tanaka, S3
Muramatsu, A1
Mori, T1
Nakashima, T1
Okanoue, T1
Hirohata, S7
Tsunoda, S2
Kurosawa, R1
Umezawa, R1
Kobayashi, Y4
Nakajima, S1
Imagawa, T2
Katakura, S1
Mori, M4
Aihara, Y3
Yokota, S4
Kamimura, T1
Yoshio, T1
Hirata, D1
Masuyama, J1
Isoda, N1
Kanai, N1
Uaratanawong, S2
Deesomchoke, U1
Lertmaharit, S1
Kocakoc, E1
Ozgocmen, S1
Kiris, A1
Ozcakar, L1
Boztosun, Y1
Yildirim, N1
Obayashi, M1
Uzu, T1
Harada, T1
Yamato, M1
Takahara, K1
Yamauchi, A1
Hepburn, AL1
Mason, JC1
Davies, KA1
Bang, S1
Kang, BS1
Park, MC1
Hwang, MH1
Lhotta, K1
Würzner, R1
Rosenkranz, AR1
Beer, R1
Rudisch, A1
Neumair, F1
Mayer, G1
Taniguchi, H1
Ohara, M2
Suzuki, C2
Naishiro, Y1
Ozeki, I1
Takahashi, H3
Imai, K1
Tsuzake, K1
Kameda, H3
Yamashita, M1
Funayama, H1
Anami, Y1
Morikawa, N1
Inokuma, S3
Tojo, J1
Ohira, H2
Yokokawa, J1
Takiguchi, J2
Rai, T1
Shishido, S1
Kasukawa, R6
Mootsikapun, P1
Sirijerachai, C1
Chansung, K1
Nanagara, R1
Konice, M1
Lin, SC1
Shyur, SD1
Huang, LH1
Wu, JY1
Chuo, HT1
Lee, HC1
Badsha, H1
Teh, CL1
Lian, TY1
Chng, HH2
Lee, PH1
Joo, US1
Bang, OY1
Seo, CH1
Hirakata, M2
Suwa, A1
Satoh, S1
Nojima, T1
Ikeda, Y1
Kamal, MA1
Jusko, WJ1
Cheng, G1
Choi, PC1
Crabtree, N1
Skan, J1
Amft, N1
Bowman, S1
Hod, N1
Hendler, A1
Dotan, E1
Horne, T1
Tikhonova, TL1
Mach, ES1
Shirokova, IE1
Reshetniak, TM2
Tomita, Y1
Chan, TM2
Kawai, T1
Tominaga, S1
Okouchi, A1
Kudo, M1
Katoh, K2
Shoda, M1
Fujino, MA1
Arbel, O1
Pizov, G1
Ben-Yehuda, A1
Rubinow, A1
Naparstek, Y1
Amital, H1
Takada, H1
Saito, Y3
Nomura, A1
Ohga, S1
Kuwano, K1
Nakashima, N1
Aishima, S1
Tsuru, N1
Ece, A1
Bosnak, M1
Gurkan, F1
Davutoglu, M1
Haspolat, K1
Coll, AP1
Morganstein, D1
Soos, MA1
O'Rahilly, S1
Burke, J1
Hussey, SM1
Gander, R1
Southern, P1
Hoang, MP1
Koarada, S2
Tsukamoto, H4
Murai, K3
Yoshizawa, S3
Ohta, A2
Hou, TY1
Chang, DM2
Gao, HW1
Chen, CH1
Chen, HC1
Lai, JH1
Udono, M1
Kinoshita, A1
Osumi, M1
Ito, M2
Hamada, H1
Ezaki, H1
Mukobara, S1
Härle, P1
Straub, RH3
Wiest, R1
Mayer, A1
Schölmerich, J3
Atzeni, F1
Carrabba, M1
Cutolo, M1
Sarzi-Puttini, P1
Hrycek, A1
Cieślik, P1
Szkróbka, W1
Pajak, J1
Li, SL1
Liou, LB2
Fang, JT1
Tsai, WP2
Rovin, BH1
Tang, Y1
Sun, J1
Nagaraja, HN1
Hackshaw, KV1
Gray, L1
Rice, R1
Birmingham, DJ1
Yu, CY1
Spetie, DN1
Aziz, A1
Hebert, LA1
Wang, SW1
Cheng, TT1
Chiu, YL1
Huang, JW1
Hsueh, PR1
Wu, KD1
Chu, TS1
Bassingthwaighte, C1
Lim, LT1
Joshua, F1
Opastirakul, S1
Chartapisak, W1
Emori, A1
Matsushima, E1
Aihara, O1
Ohta, K1
Koike, R2
Miyasaka, N2
Morita, T2
Armstrong, DJ1
McCarron, MT1
Wright, GD1
Szeto, ML1
Akamatsu, S1
Tsukazaki, H1
Nishio, Y1
Machado, V1
Pontes, T1
Brito, I1
Afonso, C1
Man, BL1
Pasangna, J1
Duraisamy, G1
Lajin, I1
Shin, KC1
Choi, HJ1
Bae, YD1
Lee, JC1
Song, YW1
Rheu, CW1
Lee, SI1
Nordmark, G1
Bengtsson, C1
Larsson, A1
Karlsson, FA1
Hirose, I1
Ymamaguchi, H1
Inaguma, D1
Ono, K6
Shimada, S1
Kawada, J1
Shiraki, K1
Kimura, H1
Hosseinzadeh, M1
Kumar, PV1
Rahemi, M1
Oud, KT1
Bresser, P1
ten Berge, RJ1
Jonkers, RE1
Yoshida, H2
Ishikawa, A1
Kondo, H1
Toubi, E1
Kessel, A1
Rosner, I1
Rozenbaum, M1
Paran, D1
Shoenfeld, Y1
Dziadzio, M1
Hamdulay, S1
Boyce, S1
Prasad, N1
Keat, A1
Iwadate, H1
Shio, K1
Noguchi, E1
Sasajima, T2
Sekine, H1
Obara, K1
Moosig, F1
Fähndrich, E1
Knorr-Spahr, A1
Böttcher, S1
Ritgen, M1
Zeuner, R1
Kneba, M1
Schröder, JO1
Bird, S1
Hayakawa, S1
Nakabayashi, K2
Karube, M1
Arimura, Y3
Soejima, A1
Fujioka, Y1
Haruta, Y1
Wong, SY1
Tang, WM1
Wong, GL1
Liu, DT1
Bernatsky, S1
Ramsey-Goldman, R1
Lachance, S1
Pineau, CA1
Wang, XD1
Gu, YY1
Bao, CD1
Chen, SL1
Chen, HS1
Leu, HS1
Ho, HH1
Huang, TL1
Wong, CH1
Chen, TL1
Lee, CS1
Lin, CJ1
Chen, CP1
Muramoto, Y1
Kosaka, H1
Ohshima, S1
Mima, T1
Katada, Y1
Saeki, Y1
Hengge, U1
Marini, A1
Ruzicka, T1
Bruch-Gerharz, D1
Koh, ET2
Chow, WC1
Shiomi, T1
Manabe, T1
Wilson, EC1
Jayne, DR1
Dellow, E1
Fordham, RJ1
Sekiguchi, N1
Tsuzaka, K2
Tsugawa, K2
Yamasaki, S1
Abe, H2
Kon, K1
Kobayashi, S4
Matsuo, S1
Uchida, E1
Shimajiri, S1
Nishihara, G2
Choudhary, N1
Agarwal, G1
Rizvi, Y1
Kaul, B1
Ahlawat, R1
Rüther, K1
Foerster, J1
Berndt, S1
Schroeter, J1
Kuramochi, Y1
Sudou, M1
Sugano, H1
Takagi, H1
Olowu, W1
Akimoto, M1
Matsushita, K1
Suruga, Y1
Aoki, N2
Ozaki, A1
Uozumi, K1
Tei, C1
Arima, N1
Yonemoto, H1
Itoh, S1
Takeda, S2
Wada, H1
Matsui, Y2
Katakura, H1
Yamanaka, A1
Roy, AK1
Pal, D1
Kar, C1
Maiti, A1
Górska, A1
Gardziejczyk, M1
Urban, M1
Kwok, SK1
Seo, SH1
Ju, JH1
Park, KS1
Yoon, CH1
Kim, WU1
Min, JK1
Cho, CS1
Kim, HY1
Ozcan, KM1
Bahar, S1
Ozcan, I1
Pasaoglu, L1
Sennaroglu, E1
Dere, H1
Yasuda, M3
Yang, KS1
Kanai, Y1
Yamaji, C1
Kawanishi, T1
Toumyo, M1
Funabiki, K1
Hou, CL1
Tsai, YC1
Chen, LC1
Huang, JL3
Vass, G1
Antal, Z1
Katona, M1
Kárpáti, S1
Balogh, L1
Spalding, SJ1
Hennon, T1
Dohar, J1
Hirano, T1
Hagiharai, K1
Kawai, M1
Kuwahara, Y1
Yamadori, T1
Shima, Y1
Ogata, A1
Tanaka, T1
Yoshizaki, K1
Kawase, I1
Iyoda, M1
Suzuki, H7
Ashikaga, E1
Nagai, H1
Kuroki, A1
Shibata, T1
Kitazawa, K1
Akizawa, T1
Trakakis, E1
Loghis, C1
Laggas, D1
Simeonides, G1
Vaggopoulos, V1
Chrelias, C1
Lambos, G1
Kassanos, D1
Narita, Y1
Naoki, K1
Hida, N1
Okamoto, H1
Kunikane, H1
Omori, T1
Kase, M1
Perricone, R1
De Carolis, C1
Kröegler, B1
Greco, E1
Giacomelli, R1
Cipriani, P1
Fontana, L1
Perricone, C1
Ozçakar, ZB1
Yalçinkaya, F1
Odek, C1
Ekim, M1
Hatamochi, A1
Kamada, N1
Matsue, H1
Shinkai, H1
Zhang, B1
Zhang, X1
Tang, F1
Zhu, L1
Liu, Y1
Glavinskaia, TA3
Matsumoto, J1
Shirasu, H1
Mikami, R1
Simpson, JR1
Goldie, I1
Tibblin, G1
Scheller, S1
Boros, G1
Halda, T1
Leövey, A2
Whittingham, S1
Balazs, ND1
Furuyama, T1
Saito, H4
Hollingworth, P1
de Vere Tyndall, A1
Ansell, BM1
Platts-Mills, T1
Gumpel, JM1
Mertin, J1
Smith, DS1
Denman, AM3
Hughes, RA1
Cameron, JS4
Hall, SM1
Heaton, J1
Payan, J1
Teoh, R1
Siegert, E1
Häntzschel, HJ1
Dietel, K1
Voigt, W1
Barratt, TM1
Geary, DF1
Miyawaki, S2
Ofuji, T1
Ishimoto, F1
Shibasaki, T1
Murai, S1
Kodama, K2
Ohno, I2
Looi, LM1
Sueishi, M1
Tomioka, H1
Yanagisawa, T2
Nawata, Y2
Kagami, M1
Koike, T2
Takabayashi, K3
Kumagai, A1
Tsuchida, H1
Butler, RC1
Thomas, SM1
Thompson, JM1
Keat, AC1
Kato, A1
Nagao, K1
Kikuchi, N1
Takizawa, H1
Shimura, A1
Woo, P1
Pereira, RS1
Lever, AM1
Marga, OIa1
Kuplaĭs, VP1
Guberman, SL1
Lipkin, DP1
Mowbray, JF1
Fisher, C1
Davies, R1
Sakurai, T3
Kono, I3
Kabashima, T2
Yamane, K6
Nagasawa, T2
Kashiwagi, H7
McDonald, CF1
Barter, CE1
Fraser, KJ1
Hanan, JA1
Nishikai, M1
Okano, Y1
Mukohda, Y1
Sato, A1
Sugimoto, M3
Wakabayashi, Y3
Shiokawa, Y3
Miller, ML1
Lantner, R1
Pachman, LM2
Nazarenko, PV1
Riabova, TV2
Fedorov, AA2
Arisaka, O1
Obinata, K1
Arisaka, M1
Boyce, NW1
Holdsworth, SR1
Thomson, NM1
Atkins, RC1
Gaedicke, G1
Teller, WM1
Kohne, E1
Dopfer, R1
Niethammer, D1
Itoh, H2
Fujihira, T1
Harada, S1
Kido, M1
Kajiki, A1
Nakashima, Y1
Kuroiwa, A1
Pepys, MB1
Lanham, JG1
De Beer, FC1
Wahn, V1
Göbel, U1
Ebell, W1
Jürgens, H1
Jimi, S1
Hayashida, I1
Ota, A1
Kameda, S1
Kusaba, T4
Takagi, S1
Oshimi, K2
Sumiya, M3
Gonda, N2
Kano, S4
Takaku, F3
Chew, SK1
Tan, BY1
Novikov, AI1
Pavlova, LT2
Linder, C1
Sjöholm, AG1
Svensson, B1
Taubert, M1
Döring, E1
Finkelstein, R1
Carter, A1
Markel, A1
Brook, JG1
Goto, M2
Tanimoto, K1
Horiuchi, Y1
Tareyeva, IE1
Shilov, EM3
Gordovskaya, NB1
Fujita, T1
Tamura, N2
Kobayashi, K2
Negishi, M1
Ide, H1
Takahashi, T1
Hasegawa, S1
Baba, T1
Koitabashi, Y1
Shimizu, Y1
Sonozaki, H1
Hori, Y1
Nishiyama, S1
Nahon, E1
Delfraissy, JF1
Kahn, MF1
Jeusset, J1
Galanaud, P1
Lacour, F1
Komeji, S1
Kitamura, M1
Kashiwazaki, S1
Belovezhdov, N1
Tsekova, D1
Dzherasi, R1
Gruev, I1
Kiperova, B1
Matuszkiewicz, J1
Wardyn, K1
Imiela, J1
Siciński, A1
Isbister, JP1
Ralston, M1
Hayes, JM1
Wright, R1
Kanayama, Y2
Shiota, K1
Horiguchi, T2
Kato, N2
Ohe, A2
Inoue, T2
Mulshine, J1
Lucas, FV1
Clough, JD1
Oku, H1
Amatsu, K1
Nasonova, VA2
Ivanova, MM3
Speranskiĭ, AI3
Solov'ev, SK1
Shumakov, VI1
Glöckner, WM1
Dienst, C1
Kindler, J1
Sieberth, HG2
Kutti, J1
Bergström, AL1
Vyas, CK1
Talwar, KK1
Bhatnagar, V1
Sharma, BK1
Kartasheva, VI3
Ağabeyoğlu, IT1
Wagner, JG1
Kay, DR1
Bahemuka, M1
Bhatt, KM1
Tareeva, IE8
Hartikainen-Sorri, AL1
Kaila, J1
Al-Habet, S1
Kinsella, HC1
Rogers, HJ1
Trounce, JR1
Haramoto, T1
Shikata, K1
Ogura, T1
Ota, Z1
Huang, CC1
Chen, CY1
Hung, IJ1
Chan, KM1
Watanabe, T1
Saeki, T1
Honma, T1
Ozawa, T1
Kikuchi, M2
Sato, T5
Arakawa, M3
Ishiga, K1
Morita, S1
Sakaguchi, K1
Hasegawa, H2
Yokono, K1
Kasuga, M1
Bliziuk, OI1
Travkina, IV1
Sibanda, E1
Stanczuk, G1
Taylor, G1
Goodfield, MJ1
Jackson, N1
Hashim, ZA1
Zainal, NA1
Jamaluddin, N1
Kataoka, H1
Takeda, T2
Nakatani, H1
de Vries, TW1
van der Veer, E1
Heijmans, HS1
Motoji, K1
Takeshita, F1
Ohta, S1
Sumino, K1
Shirai, A1
Okubo, T2
Nakamura, K1
Fujii, T1
Yoshida, T2
Mukai, M3
Akizuki, M1
Ohdama, S1
Yoshizawa, Y2
Kubota, T1
Shaskey, DJ1
Mijer, JF1
Williams, HJ1
Sawitzke, AD1
Aoki, K1
Kogure, A1
Ohshima, Y1
Watanabe, N1
Ohba, T1
Miyata, M3
Nishimaki, T4
Onishi, R1
Namiuchi, S1
Tatara, I1
Arakawa, K1
Govindan, R1
Das, AK1
Filimonova, RG2
Ianushkevich, TN2
Le Thi Huong, D1
Wechsler, B1
Piette, JC1
Bletry, O1
Godeau, P1
Ohno, M1
Minoda, M3
Horiuchi, A4
Takezawa, Y1
Ohtake, N1
Ahmadieh, H1
Roodpeyma, S1
Azarmina, M1
Soheilian, M1
Sajjadi, SH1
Tai, S1
Yamaguchi, A1
Shibatoge, M1
Akatai, S1
Hishigawa, R1
Matsuo, T1
Leong, KH1
Boey, ML2
Rönnelid, J1
Huang, YH1
Norrlander, T1
Rogberg, S1
Nilsson, B1
Gustafsson, R1
Klareskog, L1
Shirahama, S1
Yagi, H1
Furukawa, F1
Takigawa, M1
Sugano, N1
Ohzono, K1
Masuhara, K1
Takaoka, K1
Dohmen, K2
Ohtsuka, S1
Arase, K2
Yokogawa, Y2
Asayama, R3
Kuroiwa, S1
Ishibashi, H2
Miyagawa, S1
Shiomi, Y1
Fukumoto, T1
Nishikawa, K1
Ako, H1
Shirai, T1
Hashimoto, M1
Nonaka, S1
Furuta, E1
Suenaga, Y1
Shingu, M1
Nobunaga, M3
Yell, JA1
Wojnarowska, F1
Allen, J1
Burge, SM1
Terao, T1
Mizuki, T1
Ohji, T1
Ibe, M2
Mitsuda, T2
Shimizu, C1
Kuriyama, T1
Zanker, B1
Schirmacher, P1
Köhler, H1
Hoffman, R1
Lethen, H1
Zunker, U1
Schöndube, FA1
Maurin, N1
Itateyama, E1
Nishizaka, H1
Shibuya, T2
Takenaka, K2
Otsuka, T1
Niho, Y4
Suwabe, H1
Moriuchi, J1
Hoshina, Y1
Ichikawa, Y6
Arimori, S1
TambyRaja, RL1
Shin, JG1
Chong, WS1
Kim, S1
Lee, JS1
Jang, IJ1
Shin, SG1
Fujita, Y1
Yuasa, S1
Yura, T1
Sumikura, T1
Takahashi, N1
Shoji, T1
Uchida, K1
Aono, M1
Matsuo, H2
Tsuji, K1
Hirohara, J1
Fukui, Y1
Fujinami, S1
Shiozaki, Y1
Uoi, M1
Hosokawa, H1
Asada, Y2
Toyazaki, N1
Erlendsson, K1
Steinsson, K1
Jóhannsson, JH1
Geirsson, RT1
Yamanishi, Y2
Taooka, Y1
Mukuzono, H1
Aoi, K1
Ishibe, Y1
Yamana, S1
Stuart, RA1
Quinn, MJ1
McHugh, NJ1
Manto, M1
Badot, V1
Koulischer, D1
Henriet, M1
Guillaume, B1
Jacquy, J1
Groen, H1
Postma, DS1
Kallenberg, CG4
Yasuda, D1
Tomooka, K1
Venables, PJ1
Shintani, S1
Hinoshita, H1
Shiigai, T1
Matsukawa, Y1
Nishinarita, S1
Hayama, T1
Sawada, S2
Horie, T1
Lin, WS1
Yang, WS1
Lin, HY2
Noguchi, A1
Sakurai, Y1
Kurihara, R1
Suga, S1
Owada, K1
Yoneshima, H1
Osono, E1
Matsunobu, S1
Hayama, S1
Akiba, T1
Eckstein, A1
Kötter, I1
Wilhelm, H1
Lima, F1
Alves, J1
Simpson, J1
Hughes, GR4
Buchanan, NM1
Lefebvre, C3
Depresseux, G2
Lambert, M2
Devogelaer, JP2
Nagant de Deuxchaisnes, C1
Iijima, S1
Takita, T1
Moro, H1
Hayashi, J1
Okazaki, H1
Eguchi, S1
Yazawa, M1
Togashi, K1
Segawa, C1
Takasawa, K1
Yokoyama, H1
Kojima, T1
Umeno, M1
Takaki, K1
Tanaka, M1
Watanabe, A1
Kawachi, Y1
Nishihara, T1
Miyake, T1
Uchida, T2
Park, MH1
Koyama, K1
Takeda, A1
Yoshida, A1
Morozumi, K1
Fujinami, T1
Sumida, A1
Insiripong, S1
Chanchairujira, T1
Bumpenboon, T1
Kashiwabara, K1
Syouda, S1
Narushima, K1
Yagyu, H1
Kiguchi, T1
Kusama, H1
Matsuoka, K1
Zeuner, M1
Antoniou, E1
Lang, B1
Usui, M1
Yukihiro, S1
D'Ercole, C1
Boubli, L1
Franck, J1
Casta, M1
Harle, JR1
Chagnon, C1
Cravello, L1
Leclaire, M1
Blanc, B1
Tsunoda, K1
Soda, Y1
Nasonov, EL1
Karpov, IuA1
Alekberova, ZS1
Vil'chinskaia, MIu1
Fomicheva, OA1
Aleksandrova, EN1
Kliukvina, NG1
Andreev, AIa1
Agarwal, BR1
Bhalla, K1
Dalvi, R1
Currimbhoy, ZE1
Mehta, KP1
Yucel, AE1
Calguneri, M1
Ruacan, S1
Wakasugi, M1
Maruyama, Y1
Ueno, M1
Iijima, T1
Nakahara, A1
Takemura, H2
Yuhara, T2
Akama, T3
Tokunaga, Y1
Loo, CS1
Boulton-Jones, M2
Simpson, K1
Goupille, P1
Jeannou, J1
Valat, JP1
Tokano, Y4
Miyake, S2
Kayagaki, N1
Morimoto, S2
Azuma, M1
Yagita, H2
Okumura, K2
Chua, SH1
Giam, YC1
Sim, CS1
Sathapatayavongs, B1
Puavilai, S1
Oelzner, P1
Abendroth, K1
Hein, G1
Stein, G1
Toda, R3
Saigenji, H1
Nishida, T2
Moriyama, Y2
Masuda, H1
Taira, A2
Mathelier-Fusade, P1
Marinho, E1
Aissaoui, M1
Mounedji, N1
Chabane, MH1
Leynadier, F1
Lawson, TM1
Borysiewicz, LK1
Camilleri, JP1
Jessop, JD1
Pritchard, MH1
Williams, BD1
Teuber, G1
Schwarting, A1
Mildenberger, P1
Schmidt-Brücken, G1
Moll, R1
Bornemann, A1
Wandel, E1
Wanitschke, R1
Meyer zum Büschenfelde, KH1
Demin, AA3
Sentiakova, TN3
Smirnov, VV1
Demina, LM1
Mamin, IV1
Yasaka, N1
Otake, N1
Tamaki, K1
Lee, HJ1
Yi, JY1
Kim, TY3
Kim, CW2
Mont, MA1
Myers, TH1
Krackow, KA1
Hungerford, DS1
Yuda, T1
Matsumoto, H1
Pang, M2
Koide, J1
Gansauge, S1
Breitbart, A1
Rinaldi, N1
Schwarz-Eywill, M1
Thomas, N1
Jesudason, M1
Mukundan, U1
John, TJ1
Seshadri, MS1
Cherian, AM1
Feng, Y1
Dessoukey, MW1
Omar, MF1
Abdel-Dayem, H1
Yeh, KW1
You, DL1
Hsieh, KH2
Dawn, G1
Handa, S1
Kumar, B1
Nair, K1
Pavithran, K1
Philip, J1
Thomas, M1
Geetha, V1
Andoh, A1
Fujiyama, Y1
Kitamura, S1
Ihara, T1
Ueda, K1
Miyagawa, A1
Hodohara, K1
Bamba, T1
Somerville, MF1
Scott, DG1
Kohro-Kawata, J1
Fukuta, S1
Matsuzaki, M1
Takei, S1
Maeno, N1
Shigemori, M1
Nakae, Y1
Nerome, Y1
Imanaka, H1
Hokonohara, M1
Miyata, K1
Nakamoto, M1
Yasunaga, C1
Takeda, K1
Matsuo, K1
Urabe, M1
Goya, T1
Sakemi, T1
Ri, S1
Kaneko, R1
Hishikawa, T1
Sekikawa, I1
Tokano, K1
Ota, H1
Yoshizumi, M1
Yamaguchi, H3
Otte, A1
Weiner, SM1
Hoegerle, S1
Juengling, FD1
Peter, HH1
Nitzsche, EU1
Wong, RW1
Seki, M1
Ushiyama, C1
Fukazawa, T1
Asakawa, J1
Nishitsuji, M1
Fujimura, M1
Matsuda, T1
Inoue, Y1
Kanzaki, J1
Ogawa, K2
Hashiguchi, K1
Masuda, M1
Hansen, M1
Halberg, P1
Kollerup, G1
Pedersen-Zbinden, B1
Hørslev-Petersen, K1
Hyldstrup, L1
Lorenzen, I1
Hayakawa, K1
Shiohara, T1
Eriksson, JW1
Bremell, T1
Eliasson, B1
Fowelin, J1
Fredriksson, L1
Yu, ZW1
Kuchabal, DS1
Kuchabal, SD1
Pandit, AM1
Nashi, HK1
Uchida, H1
Oishi, Y1
Inaba, M1
Kurasawa, K1
Iwamoto, I1
Matsumura, R1
Ohtani, Y1
Sumi, Y1
Hisauchi, K1
Sawada, M1
Yamashita, Y1
Mitunaga, K1
Masago, R1
Fukuma, H1
Okamura, T1
Yokoyama, S1
Koh, E1
Kawamoto, S1
Kuroda, H1
Azuma, Y1
Yano, H1
Kobayashi, M1
Katagiri, T1
Lee, S1
Ogasawara, H1
Hirose, S7
Jacobson, SH1
Ringertz, B1
Kipen, Y2
Briganti, E1
Strauss, B1
Will, R1
Littlejohn, G1
Tsushima, K1
Lee, JH1
Lee, EK1
Yamada, Y2
Kodama, N1
Briganti, EM1
Strauss, BJ1
Littlejohn, GO1
Koch, CA1
Takahira, S1
Sugahara, S1
Nakamoto, H1
Giorgi, D1
Balacco Gabrieli, C1
Maeda, N1
Tahara, K1
Nishiya, K1
Nishioka, T1
Matsubara, Y1
Zorbas, P1
Kontochristopoulos, G1
Detsi, I1
Apostolakis, E1
Kouris, N1
Katsambas, A1
Kim, DS2
Lee, WK1
Suh, CH1
Chung, MS1
Driebe, WT1
Kishida, T1
Kato, EH1
Sakuragi, N1
Kobashi, G1
Tsutsumi, A1
Fujimoto, S2
Wano, Y1
Masaki, Y1
Takeshita, S1
Kim, CG1
Okada, J1
Hirose, Y1
Tohyama, T1
Sugai, S1
Amano, H2
Bohgaki, T1
Notoya, A1
Kohno, M1
Tateno, M1
Yaginuma, M1
Suenaga, M1
Sakamoto, M1
Kawano, M1
Koni, I1
Kasahara, Y1
Yachie, A1
Miyawaki, T1
Seki, H1
Glück, T1
Oertel, M1
Reber, T1
Zietz, B1
Ooiwa, H1
Miyazawa, T1
Hiyama, K1
Ishioka, S1
Yamakido, M1
Jardinet, D1
Khan, S1
Haddad, P1
Montague, L1
Summerton, C1
Kuroki, M1
Kuwata, G1
Tanaka, G1
Iga, M1
Matsuyama, M1
Tsubouchi, H1
Ozaki, D1
Shirai, Y1
Yoshihara, K1
Huzita, T1
Kakizaki, Y1
Tomimoto, K1
Yokoyama, M1
Dai, YS1
Chiu, HC1
Saigal, R1
Kumar, R1
Vottery, R1
Jakobsen, LP1
Knudsen, TB1
Bloch, T1
Ho, CY1
Lam, CW1
Dammacco, F1
Della Casa Alberighi, O1
Ferraccioli, G1
Racanelli, V1
Casatta, L1
Bartoli, E1
Yung, A1
Oakley, A1
Shih, YL1
Mitsunaka, H1
Tokuda, M1
Takahara, J1
Matoba, K1
Swaak, AJ1
van de Brink , H1
Smeenk, RJ1
Manger, K1
Kalden, JR1
Tosi, S1
Marchesoni, A1
Domljan, Z1
Rozman, B1
Logar, D1
Pokorny, G1
Kovacs, L1
Kovacs, A1
Vlachoyiannopoulos, PG1
Moutsopoulos, HM1
Chwalinska-Sadowska, H1
Dratwianka, B1
Kiss, E1
Cikes, N1
Anic, B1
Bombardieri, S1
Graninger, W1
Smolen, JS1
Bijl, M1
Horst, G2
Limburg, PC2
Goto, H1
Wakui, H1
Komatsuda, A1
Miura, AB1
Fujita, K1
Tani, K1
Sone, S1
Yazawa, S1
Kawasaki, S1
Ohi, T1
Shiomi, K1
Sugimoto, S1
Kawagoe, J1
Matsukura, S1
Saka, M1
Shishido, H1
Saito, A1
Kokubun, M1
Formiga, F1
Meco, JF1
Pinto, X1
Jacob, J1
Moga, I1
Pujol, R1
Ogata, T1
Ishikawa, S1
Sakata, K1
Muraoka, M1
Igarashi, K1
Morishita, Y1
Bae, YS1
Yoo, DH1
Kim, SY1
Masuo, T1
Onozato, Y1
Ishihara, H1
Ishikawa, T1
Tanahashi, Y1
Ikeya, T1
Oshimoto, H1
Okamura, S1
Sakoda, H1
Udaka, F1
Kameyama, M1
Ushida, H1
Koizumi, S1
Onizuka, T1
Tsuji, H1
Nomiyama, K1
Fujishima, M2
Iida, M1
Shetty, VB1
Rao, S1
Krishnamurthy, PN1
Shenoy, VU1
Barthel, HR1
Lee, SC1
Kim, DH1
Won, YH1
Ribbens, C1
Martin y Porras, M1
Franchimont, N1
Kaiser, MJ1
Jaspar, JM1
Damas, P1
Malaise, MG1
Yamada, M1
Lida, N1
Kawamura, N1
Tsutsui, H2
Fukuyama, K1
Hayashidani, S1
Koike, G1
Egashira, K1
Abe, Y3
Tsuneyoshi, M1
Takeshita, A1
Sakamoto, O1
Ando, M2
Yoshimatsu, S1
Kohrogi, H1
Suga, M1
Kimura, KY1
Seino, Y1
Hirayama, Y1
Takano, T1
Kageyama, Y1
Yagi, T1
Miyairi, M1
Koh, MS1
Sunil, K1
Howe, HS1
Sheikhzadeh, A1
Schäfer, U1
Schnabel, A1
Aoki, T1
Noma, N1
Yamaga, J1
Otsuka, M1
Yuchi, H1
Ishikawa, N1
Inatsu, H1
Sakata, J1
Eto, T1
Williams, FM1
Chinn, S1
Leach, RM1
López-Medrano, F1
Trejo, O1
Font, J1
Ingelmo, M1
Niiya, M1
Niiya, K1
Takazawa, Y1
Tanio, Y1
Kushiro, M1
Tanimizu, M1
Tanimoto, M1
White, RP1
Abraham, S1
Singhal, S1
Manji, H1
Clarke, CR1
Setoyama, Y1
Yoshimoto, K2
Alexander, M1
Kampf, D1
Jaup, BH1
Wutke, K1
Müller, E1
Dittrich, P1
Pedersen, NC1
Weisner, K1
Castles, JJ1
Ling, GV1
Weiser, G1
Saito, E3
Arikawa, K1
Suzuki, Y3
Hayes, K1
Symington, G1
Guseva, LL2
Bernstein, BH2
Stobie, D1
Singsen, BH2
Koster-King, K1
Kornreich, HK2
Hanson, V3
King, KK1
Tan, EM1
Gordovskaia, NB1
Nakamoto, Y2
Sano, T1
Hisano, G1
Tsubura, E1
Betourne, C1
Cassan, P1
Franc, B1
Bacri, JL1
Levy, R1
Attman, PO1
Westberg, G1
Niwa, Y2
Kanoh, T2
Honma, M1
Koide, K1
Toyama, J1
Uwadoko, S1
Nagase, M1
Semenkova, EN1
McKenzie, PE1
Taylor, AE1
Woodroffe, AJ1
Seymour, AE1
Chan, YL1
Clarkson, AR1
Maini, RN1
Scott, JT2
Kawagoe, M1
Aswapokee, P2
Aswapokee, N2
Chirawong, P1
Leelarasamee, A2
Vanichakarn, S1
Nilvarangkur, S1
Jaroonvesma, N1
Futrakul, P1
Poshyachinda, M1
Mitrakul, C1
McShane, DJ1
Porta, J1
Fries, JF1
Green, OC1
Winter, RJ1
Kawahara, FS1
Phillips, LS1
Lewy, PR1
Hart, RL1
Miyahara, H1
Yokohari, R3
Fukui, H1
Teoh, PC1
Chan, HL1
Fujii, Y1
Higaki, T1
Rass, IT1
Borisov, IA2
Nikishova, TA1
Sura, VV2
Folomeeva, OM1
Kozlova, VN1
Belov, VA1
Berliner, GB1
Zernov, VP1
Ostroumova, TN1
Archibald, GC1
Moore, DJ1
Menon, ND1
Sharma, NN1
Suri, ML1
Hoon, RS1
Ueda, M1
Fujii, N1
Akamatsu, K1
Tsunashima, T1
Wray, R1
Iveson, M1
Tsuchiya, M1
Okazaki, I1
Asakura, H1
Luninskaia, IR1
MacNeill, A1
Grennan, DM1
Ward, D1
Dick, WC1
Bolz, M1
Schmitt, E1
Schneidwind, JM1
Kazuta, Y1
Fournel, C1
Chabanne, L1
Caux, C1
Faure, JR1
Rigal, D1
Magnol, JP1
Monier, JC1
Dosin, IuM1
Apanasovich, VG1
Bolotina, NG1
Kurchenkova, VI1
Grigorchuk, IP1
Lazareva, VI1
Iagur, VE1
Bansal, A1
Roberts, T1
Hay, EM1
Kay, R1
Pumphrey, RS1
Wilson, PB1
De Leeuw, P1
Tomasi, JP1
Rahier, J1
Geubel, A1
Nishizaka, Y1
Oda, Y1
Nagasato, K1
Tsujihata, M1
Nagataki, S1
Ryberg, B1
Furuya, H1
Nakagawa, Y1
Dennis, MS1
Byrne, EJ1
Hopkinson, N1
Bendall, P1
MacGregor, AJ1
Dhillon, VB2
Binder, A1
Forte, CA1
Knight, BC1
Betteridge, DJ1
Tohjima, T1
Komazawa, T1
Out, HJ2
van Vliet, M1
de Groot, PG2
Derksen, RH2
Mokuno, C1
Barile, L1
Lavalle, C1
Lipnick, RN1
Morales, A1
Getson, PR1
White, PH1
Soldin, SJ1
Tsunematsu, T2
Kabasawa, K1
Ogura, N1
Sagawa, A1
Jodo, S1
Nakabayashi, T1
Watanabe, I1
Fujisaku, A1
Nakagawa, S1
Waldmann, KD1
García Jiménez, E1
Cortés Rubio, JA1
Oliart Delgado de Torres, S1
Reig del Moral, C1
Herrera Martín, M1
García Velázquez, J1
Cuadrado Bello, P1
Johansson, I1
Itoh, M1
Goto, Y1
Vrethem, M1
Ernerudh, J1
Lindström, F1
Olsson, JE1
Yamauchi, Y3
Mayumi, T2
al-Rasheed, SA1
al-Fawaz, IM1
Sugishima, H2
Chayakul, P1
Thammakumpee, G1
Mitarnun, W1
Godeau, B1
Cormier, C1
Menkes, CJ1
Shome, GP1
Kaji, T1
Inose, K1
Tsuchida, A2
Andoh, K1
Ohkubo, Y1
Yano, S2
Omine, M1
Naruse, T2
Volkova, ZI1
Patronas, NJ1
Scott, D1
Klippel, JH1
Balow, JE1
Koehler, PJ1
Tsuji, S1
Akizuki, S1
Matsuoka, Y2
Irimajiri, S1
Memon, S1
Rab, SM1
Palmer, A1
Cairns, T1
Dische, F1
Gluck, G1
Gjorstrup, P1
Parsons, V1
Welsh, K1
Taube, D1
Iio, A1
Niwa, G1
Sakane, T1
Fuwa, Y3
Yasuda, K2
Adachi, K2
Goshima, E2
Yamakita, N2
Miura, K4
ter Borg, EJ2
Hummel, E1
Yenrudi, S1
Shuangshoti, S1
Pupaibul, K1
Witt, C1
Neuhaus, K1
Winsel, K1
Brenke, A1
Hiepe, F1
Volk, HD2
Shimatsu, Y1
Raziuddin, S1
Nur, MA1
al-Wabel, AA1
Yoshikawa, H1
Kitagawa, Y1
Fukuda, J1
Mizushima, Y1
Torikai, K1
Nyberg, G2
Karlberg, I1
Svalander, C2
Hedman, L1
Blohmé, I2
Fox, R2
Lumb, MR1
Hawkins, DF3
Stevens, WM1
Burdon, JG1
Clemens, LE1
Webb, J1
Zaĭrat'iants, OV1
Tarasova, LR1
Trishkina, NV1
Khavinson, VKh1
Yamada, F1
Irie, Y1
Nishida, K1
Sakamoto, Y1
Shimojo, N1
Hoshioka, A1
Kohno, Y1
Niimi, H1
Nakajima, H1
Tanabe, E1
Koyama, A1
Matsuda, O1
Hiruma, M1
Makiguchi, K1
Chida, Y1
Ida, T1
Malumo, F1
Jagadish, TK1
Kasthuri, AS1
Uberoi, HS1
Chopra, A1
Gupta, MM1
Dham, SK1
Bhalla, IP1
Kumaravelu, S1
Bhangui, GR1
Takayanagi, K1
Kishimoto, M1
Ouami, H1
Shibata, S2
Davies, MC1
Hall, ML1
Round, JM1
Ell, PJ1
Jacobs, HS1
Snaith, ML1
Vilianskiĭ, MP1
Alekseev, VI1
Pukhov, AG1
Lileeva, MA1
Verkhovskii, SIu1
Becker, H1
Loers, E1
Helmke, K1
Federlin, K1
Kurosawa, M1
Terashima, K2
Morito, T1
Sakata, S2
Takuno, H1
Chimori, K1
Sugie, Y1
Ishitsuka, T1
Sadoshima, S1
Ishii, Y1
Kanai, H1
Goulding, NJ1
Podgorski, MR1
Hall, ND1
Flower, RJ1
Browning, JL1
Pepinsky, RB1
Maddison, PJ1
Herrmann, F1
Hambsch, K1
Sorger, D1
Häntzschel, H1
Müller, P1
Nagel, I1
Köstler, E1
Heinicke, HJ1
Schneider, F1
Riedel, H1
Hensel, J1
Oura, T1
Nakasone, Y1
Mimura, G1
Knopf, HL1
Hasselaar, P1
dan Vliet, M1
Mukherji, N1
Pal, S1
Sen, R1
Mukherji, P1
Biswas, TK1
Dey, SC1
Saima, S1
Ishikawa, H2
Kinoshita, M2
Hasegawa, J1
Kameda, Y1
Kawaguchi, I1
Nakaya, M1
Propper, DJ1
Bucknall, RC2
Sharipov, AM1
Donov, GI1
Klimov, IuV1
Allard, SA1
Kunimi, K1
Nagano, K1
Misaki, T1
Hisazumi, H1
Kimura, K1
Maeta, T1
Shitomi, K1
Takata, K1
Sudo, K1
Yamauchi, T1
Okada, T1
Kaneta, H1
Ichiki, S1
Ohfu, M1
Niimi, K1
Hayashida, K1
Oda, T1
Fan, CJ1
Goh, KL1
Gold, SI1
Imai, Y2
Minami, N2
Munakata, M2
Nihei, M2
Sekino, H2
Yoshinaga, K1
Miyamoto, T4
Davies, SM1
Dunger, DB1
Van der Meer, J1
De Wolf, JT1
Van Leeuwen, MH1
Matsumura, T1
Singh, RR1
Prasad, K1
Kumar, A1
Misra, A1
Padmakumar, K1
Malaviya, AN1
el Mouzan, MI1
Ahmad, MA1
al Fadel Saleh, M1
al Sohaibani, MO1
al Gindan, YM1
Englert, HJ1
Derue, GM1
Loizou, S1
Elder, MG1
De Swiet, M1
Walport, MJ1
Gilleece, MH1
Evans, CC1
Solakov, P1
Atanasov, K1
Ushiroda, S1
Konno, M1
Komatsu, M1
Kariyone, S1
Koyama, T1
Kakishita, E1
Nagai, K2
Sekiya, S1
Iwasaki, H1
Takeda, B1
Takamizawa, H1
Tsuchiya, N1
Mitamura, T1
Persson, H1
Brynger, H1
Fisher, BW1
Murakami, O1
Matsue, K1
Miura, Y1
Iwamoto, S1
Bunker, CB1
Dowd, PM1
Palmer, RG1
Dore, CJ1
Henderson, L1
Jahn, S1
Krohm, P1
Kiessig, S1
Grunow, R1
von Baehr, R1
Lin, YZ1
Matsuura, T1
Nakabayashi, H1
Yamazaki, K1
Watanabe, R1
Sakata, A1
Tsurui, H1
Miwa, A1
Kreuzfelder, E1
Rodeck, U1
Brittinger, G1
Kirch, W1
Scheiermann, N1
Ogino, S1
Nagao, M1
Schroeder, JO1
Euler, HH1
Löffler, H1
Tamura, G1
Kaizuka, H1
Iwasaki, T1
Satodate, R1
Ishida, M1
Mori, S1
Appan, S1
Lim, KW1
Daradkeh, TK1
Nasrallah, NS1
Petrova, GN1
Baranova, FS1
Popova, LK1
Dmitriev, AA1
Popovic, S1
Bartlett, RR1
Nakamura, S1
Komaki, T1
Kawade, M1
Niwa, T1
Leaker, BR1
Becker, GJ1
Dowling, JP1
Kincaid-Smith, PS1
Minamori, Y1
Murase, H1
Murayama, M1
Yanase, T1
Nawata, H1
Kato, K1
Ibayashi, H1
Borges, NE1
Tanna, DD1
Sequeira, RD1
Mangat, GK1
Gokhale, AS1
Joshi, VR1
Oshima, H2
Andréani, T1
Poupon, R1
Darnis, F1
Al-Husaini, A1
Jamal, GA1
Amaki, S1
Takei, M1
Karasaki, M1
Amaki, I1
Ho, CH1
Chiang, YM1
Chong, LL1
Hwang, TS1
Kan, H1
Matsuda, I1
Dodd, HJ1
Sarkany, I1
O'Shaughnessy, D1
Thomson, BJ1
Watson, ML1
Liston, WA1
Lambie, AT1
Wollina, U1
Schreiber, G1
Kutyrina, IM1
Klepikov, PV1
Domingo-Pedrol, P1
Rodriguez de la Serna, A1
Mancebo-Cortes, J1
Sanchez-Segura, JM1
Tomiyaya, Y1
Ohki, A1
Kashihara, T1
Tako, H1
Kawakami, F1
Okuno, G1
Kawano, K1
Dormidontov, EN1
Korshunov, NI1
Baranova, EIa1
Zheltkevich, SN1
Razumova, EB1
Riazantseva, TA1
Poliachenko, EA1
Robinson, R1
Ogg, C1
Sperryn, PN1
Mace, BE1
Fabius, AJ1
Gaulhofer, WK1
Epstein, MT1
Deicher, H3
Raftery, EB1
Gutman, LT1
Schaller, J1
Wedgwood, RJ1
Pyörälä, K1
Suhonen, O1
Pentikäinan, P1
Robson, GS1
Fung, WP1
Chew, BK1
Tan, KK2
Brandt, L1
Hedberg, H1
Robson, G1
Chan, D1
Vick, RM1
Ogg, CS1
Seymour, WM1
Chantler, C1
Turner, DR1
Abdusametov, RKh1
Abdusametova, ShR1
Riemenschneider, TA1
Wilson, JF1
Vernier, RL1
Berry, CZ1
Goldberg, LC1
Shepard, WL1
Swannell, AJ1
Coomes, EN1
Myles, AB1
Bacon, PA1
Daly, JR1
Cosh, JA1
Akaishi, K1
Nishio, T1
Akatsuka, N1
Yamaguchi, T1
Timpatanapong, P1
Tasanapradit, P1
Indulak, S1
Sundaravej, P1
Choi, IN1
Cho, SH1
Marmont, AM1
Rossi, FA1
Cheah, JS1
Mathews, JD2
Toh, BH1
Baker, HW1
Walker, I1
Buckley, JD1
Gledhill, VX1
Komarov, FI1
Savel'ev, AI1
Frumina, EI1
Pukhal'skiĭ, AL1
Gutorova, NM1
Skinner, MD1
Schwartz, RS1
Moiseev, VS1
Altmeyer, P1
Kornreich, H1
Koster, K1
Ziff, M1
Hurd, ER1
Stastny, P1
Sigidin, IaA1
Sherlock, S1
Gandzha, IM1
Shub, NI1
Holland, NH1
de Bracco, MM1
Christian, CL1
Carey, RM1
Coleman, M1
Feder, A1
Jayaratnam, FJ1
Tock, EP1
Seah, CS1
Wenger, ME1
Bole, GG1
Goebel, KM1
Gassel, WD1
Goebel, FD1
Cheah, PS1
Lee, YK1
Meinel, H1
Miagka, IP1
Kligerman, MM1
Bochman, NL1
Tavonius, KE1
Striker, GE1
Kelly, MR1
Quadracci, LJ1
Scribner, BH1
Nanra, RS1
Kincaid-Smith, P1
Mukherjee, AP1
Randow, U1
Sönnichsen, N1
Schulz, H1
Fricke, R2
Krull, P2
Roberts, CI1
Johan, A1
Cudworth, AG1
Ellis, A1
Sehgal, VN1
Rege, VL1
Vadiraj, SN1
Szegedi, G2
Kakuk, G1
Bobory, J1
Matveev, MP1
Gamburg, RL1
Solomatina, OG1
Ignatova, MS1
Gavriushova, LP1
Mowat, AG1
Baum, J1
Smalley, M1
Volkov, VE1
Ageev, AF1
Okuda, M1
Goerz, G1
Kida, H1
Kibe, Y1
Takada, A1
Tsuda, I1
Zheltakov, MM1
Sharapova, GIa1
Khamaganova, AV1
Berezhnoĭ, IuZ1
Borisova, IuF1
Madan, MS1
Nesterov, AI1
Dobronyi, I1
Karászi, B1
Minovich, AI1
Komissarova, IA1
Martynova, MA1
Poliantseva, LR1
Androsova, SO1
Kargashin, IA1
Aleksandrovskaia, TN1
Hadidi, T1
Nagy, G1
Igaki, Y1
Nagy, E1
Mészáros, C1
Daróczy, P1
Hashimoto, S1
Oishi, M1
Daijima, Y1
Bihari, M1
Grossman, BJ1
Saito, Z1
Umeda, T1
Kitamura, K1
Kumagai, T1
Doishita, K1
Lagrue, G1
Bariéty, J1
Milliez, P1
RuDusky, BM1
Gött, E1
Hare, WS1
Günther, R1
Boros, A1
Hanson, GC1
Ghosh, S1
Leckie, WJ1
Tothill, P1
Bayliss, RI1
Miller, WT1
Restifo, RA1
Vinogradova, OM1
Potekseva, MA1

Clinical Trials (20)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Trial to Investigate the Reset of Humoral Autoimmunity by Combining Belimumab With Rituximab in Severe Systemic Lupus Erythematosus[NCT03747159]Phase 370 participants (Anticipated)Interventional2018-10-01Recruiting
Sirolimus in Patients With Connective Tissue Disease Related Thrombocytopenia (CTD-TP): a Single-arm, Open-label Clinical Trial in China[NCT03688191]Phase 420 participants (Anticipated)Interventional2017-09-21Active, not recruiting
An Experimental Medicine Study to Assess the Pharmacodynamics Following Administration of Multiple Doses of Prednisolone to Healthy Male Subjects[NCT03196557]Phase 124 participants (Actual)Interventional2008-03-31Completed
A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the P[NCT00119678]Phase 2183 participants (Actual)Interventional2005-09-30Completed
Placebo-Controlled, Double-Blind, Ascending Single and Multiple Oral Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-791826 and to Assess Its Marker Specific Pharmacodynamics in Relation to Prednisolone in Healthy Males[NCT03198013]Phase 1120 participants (Actual)Interventional2008-11-11Completed
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus[NCT02455089]143 participants (Actual)Interventional2015-06-30Completed
The BAFF-var Polymorphism as a Biomarker of Response to B-depletive Treatment in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis: a Prospective Study[NCT05659407]60 participants (Anticipated)Observational2020-07-24Recruiting
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)[NCT00424476]Phase 3865 participants (Actual)Interventional2007-05-31Completed
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 76-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE[NCT00410384]Phase 3819 participants (Actual)Interventional2006-12-31Completed
A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome[NCT04624269]Phase 4384 participants (Anticipated)Interventional2020-12-01Not yet recruiting
A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174]420 participants (Anticipated)Interventional2019-08-02Recruiting
The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies[NCT03746028]100 participants (Anticipated)Observational [Patient Registry]2018-06-06Recruiting
Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus-Prevalence,Risk Factors and Treatment[NCT00668330]Phase 440 participants (Actual)Interventional2007-04-30Completed
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone[NCT03187743]72 participants (Actual)Interventional2018-04-17Completed
Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis[NCT00261118]Phase 2/Phase 324 participants (Actual)Interventional2004-04-30Completed
"Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - RUSTY)"[NCT00216762]Phase 1/Phase 215 participants (Anticipated)Interventional2006-01-31Terminated (stopped due to Full Clinical Hold)
A Randomized, Open Label, Phase II Multicenter Study of Non-Myeloablative Autologous Transplantation With Auto-CD34+HPC Versus Currently Available Immunosuppressive/Immunomodulatory Therapy for Treatment of Systemic Lupus Erythematosus[NCT00230035]Phase 20 participants (Actual)Interventional2005-09-30Withdrawn (stopped due to Recommended by DSMB due to lack of accrual)
The Efficacy of Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE): a Randomized Control Trial[NCT04305418]26 participants (Actual)Interventional2017-01-23Completed
The Efficacy of Mindfulness- Based Intervention for Fibromyalgia Patients: a Randomized Control Trial[NCT04304664]95 participants (Actual)Interventional2017-01-23Completed
Impact of Probiotic Use on Immune Cell Function in Children[NCT02687503]23 participants (Actual)Interventional2017-05-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

DB; Median Number of Days to the First Occurrence of a New SLE Flare

Elapsed days between start of corticosteroid taper & first day of flare.Scored using BILAG:A:presence of =>1 serious;B:more moderate;C:mild symptomatic;D:prior activity,no current symptoms;E:organ that has never been involved.Calculated based on change during previous 4 weeks (1=improving,2=staying same,3=worsening,4=new).New SLE flare:first BILAG 'A' or 'B' event adjudicated to be flare following resolution of entry flare and/or start of corticosteroid taper.Inception treatment failure included (entry flare did not subside by Day 57/participant discontinued double-blind period before Day 29). (NCT00119678)
Timeframe: From start of corticosteroid taper to confirmation of disease flare or the end of double-blind period

InterventionDays (Median)
Abatacept107.0
Placebo92.0

DB; Number of Participants With a New SLE Flare During the Initial 6 Months

SLE flares scored using BILAG:A:presence of =>1 serious;B:more moderate;C:mild symptomatic;D:prior activity,no current symptoms;E:organ that has never been involved.Calculated based on change during previous 4 weeks (1=improving,2=staying same,3=worsening,4=new).New SLE flare:first BILAG 'A' or 'B' event adjudicated to be flare following resolution of entry flare and/or start of prednisone/prednisone-equivalent taper.Inception treatment failure included (entry flare did not subside by Day 57/participant discontinued double-blind period before Day 29). (NCT00119678)
Timeframe: From start of corticosteroid taper to 6 months.

InterventionParticipants (Number)
Abatacept75
Placebo36

DB; Number of Participants With Antibodies Specific for CTLA4-T and Abatacept, Following Abatacept Treatment

Electrochemiluminescence (ECL) immunoassay based on Meso Scale Discovery (MSD) technology was used to detect antibodies specific for CTLA4-T and for abatacept. (NCT00119678)
Timeframe: From Day 1 to Day 365

Interventionparticipants (Number)
Abatacept2

Double Blind Period (DB); Number of Participants Experiencing a New SLE Flare

SLE flares scored using BILAG:A:presence of =>1 serious;B:more moderate;C:mild symptomatic;D:prior activity,no current symptoms;E:organ that has never been involved. Calculated based on change during previous 4 weeks (1=improving,2=staying same,3=worsening,4=new).New SLE flare:first BILAG 'A' or 'B' event adjudicated to be flare following resolution of entry flare and start of prednisone/prednisone-equivalent taper.Inception treatment failure included (entry flare did not subside by Day 57/participant discontinued double-blind period before Day 29). (NCT00119678)
Timeframe: From start of corticosteroid taper to Day 365

InterventionParticipants (Number)
Abatacept94
Placebo47

OL; Number of Participants With Antibodies Specific for CTLA4-T and Abatacept, Following Abatacept Treatment

MSD technology was used to detect antibodies specific for CTLA4-T and for abatacept. (NCT00119678)
Timeframe: After the first dose of open-label period

Interventionparticipants (Number)
Abatacept30

DB; Number of Participants Who Died, Experienced AEs, Other SAEs or Discontinuations Due to AEs, Drug Related AEs

AEs: any new untoward medical occurrences/worsening of pre-existing medical condition, whether or not related to study drug. SAE: any AE that resulted in death; was life threatening; resulted in persistent/significant disability/incapacity; resulted in/prolonged an existing in-patient hospitalization; was a congenital anomaly/birth defect; or was an overdose. Drug-related AEs: events with a certain; probable; possible; or missing relationship to the study therapy. Participants who discontinued the study due to an AE were recorded. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
DeathsAEsSAEsAll AEs Leading to DiscontinuationDrug related AEs
Abatacept0110241059
Placebo0544328

DB; Number of Participants With a Change in the SLICC/ACR Damage Index at 1 Year Compared to Baseline

SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. (NCT00119678)
Timeframe: From start of study drug treatment to Day 365

,
Interventionparticipants (Number)
No changeIncreased 1Increased >1
Abatacept10133
Placebo4421

DB; Number of Participants With MAs in Hematology: Hemoglobin, Hematocrit, Erythrocytes and Platelet Count

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following hematology MA definitions specify the criteria for the data presented. Hemoglobin: >3 g/dL decrease from pre-treatment (pre-Rx) value; hematocrit: <0.75* pre-Rx value; erythrocyte count: <0.75* pre-Rx value; platelet count: <0.67* LLN or >1.5* ULN (or, if pre-Rx value NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
Hemoglobin (n = 120, 58)Hematocrit (n=120, 58)Erythrocytes (n=120, 58)Platelet count (n= 118, 58)
Abatacept1113
Placebo1110

DB; Number of Participants With MAs in Hematology: Leukocytes, Neutrophils + Bands (Absolute), Lymphocytes (Absolute), Monocytes (Absolute), Basophils (Absolute) and Eosinophils (Absolute)

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following hematology MA definitions specify the criteria for the data presented. Leukocytes: <0.75* LLN or >1.25* ULN (or, if pre-Rx value ULN. If pre-Rx value >ULN, then >1.2* pre-Rx or 7.50* 10^3 c/uL; Monocytes (absolute): >2000/mm^3; Basophils (absolute): >0.40* 10^3 c/uL; Eosinophils (absolute): >0.75* 10^3 c/uL. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
Leukocytes (n = 120, 58)Neutrophils+bands (absolute) (n = 120, 59)Lymphocytes (absolute) (n = 120, 59)Monocytes (absolute) (n = 120, 59)Basophils (absolute) (n = 120, 59)Eosinophils (absolute) (n = 120, 59)
Abatacept26846106
Placebo11230002

DB; Number of Participants With MAs in Serum Chemistry: Glucose (Serum), Glucose (Fasting Serum), Albumin, Cholesterol (Total), Triglycerides, Fasting Triglycerides

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria, Glucose: <65 mg/dl or >220 mg/dl; Glucose (fasting serum): <0.8* LLN or >1.5 ULN (if pre-Rx ULN. If pre-Rx >ULN, then >2.0* pre-Rx or 2* pre-Rx; triglycerides: >=2.5* ULN, or if pre Rx>ULN then use >2.5* pre Rx; fasting triglycerides: >=2.0* ULN, or if pre Rx>ULN then use >2.0* pre Rx. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
Glucose (serum) (n = 120, 59)Glucose, fasting (n = 77, 37)Albumin (n = 120, 59)Cholesterol (total) (n = 118, 58)Triglycerides (n = 75, 36)Triglycerides (fasting) (n = 64, 34)
Abatacept2754000
Placebo1011000

DB; Number of Participants With MAs in Serum Chemistry: Sodium (Serum), Potassium (Serum), Chloride (Serum), Calcium (Total),Protein (Total)

MAs are laboratory measurements marked as abnormal as per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria, Sodium (serum): <0.95* LLN or >1.05* ULN (if pre-Rx ULN. If pre-Rx >ULN, then >1.05* pre-Rx or 1.1* ULN (if pre-Rx ULN. If pre-Rx >ULN, then >1.1* pre-Rx or 1.2* ULN (if pre-Rx ULN. If pre-Rx >ULN, then >1.25* pre-Rx or NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
Sodium (serum) (n = 120, 59)Potassium (serum) (n = 120, 59)Chloride (serum) (n = 120, 59)Calcium (total) (n= 120, 59)Protein (total) (n = 120, 59)
Abatacept11001
Placebo01000

DB; Number of Participants With MAs in Urinalysis

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following definitions specify the criteria for MAs in urinalysis, Protein, glucose, blood, Leukocyte esterase, RBC, WBC: >=2+ (or, if value >=4, or if pre-Rx value = 0 or 0.5, then >= 2* pre-Rx, or if pre-Rx value =1, then >=3, or if pre-Rx = 2 or 3, then >=4); protein (24 hour urine): >1000 mg/24 hrs and >=2* pre-Rx; GFR: <=60 mL/min/1.73m^2 or > 15% change from baseline; Protein/creatinine ratio: > 100 mg/mmol. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
Protein (n = 120, 58)Glucose (n = 120, 58)Blood (n = 120, 58)Leukocyte esterase (n = 107, 51)RBC (n = 107, 55)WBC (n = 115, 54)Protein, 24 hours (n = 89, 40)GFR (n = 120, 59)Protein/creatinine ratio (n = 119, 58)
Abatacept151392338614711
Placebo921881626144

DB; Number of Participants With Significant AEs of Special Interest

An AE was defined as any new untoward medical occurrence or worsening of a pre-existing medical condition (even if not caused by the study drug). For this study, AEs of special interest were associated with the use of immunomodulatory agents. Number of participants with infections, malignant neoplasms, pre-specified autoimmune disorders, acute infusional AEs and peri-infusional AEs were recorded. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
InfectionsMalignant neoplasmsPre-specified autoimmune disordersAcute-infusional AEsPeri-infusional AEs
Abatacept7114527
Placebo3802513

DB; Total Number of New SLE Flares Each Participant Experienced

SLE flares scored using BILAG:A:presence of =>1 serious;B:more moderate;C:mild symptomatic;D:prior activity,no current symptoms;E:organ that has never been involved.Calculated based on change during previous 4 weeks (1=improving,2=staying same,3=worsening,4=new).New SLE flare:BILAG 'A' or 'B' event adjudicated to be flare following resolution of entry flare and/or start of prednisone/prednisone-equivalent taper.Inception treatment failure included (entry flare did not subside by Day 57/participant discontinued double-blind period before Day 29). (NCT00119678)
Timeframe: From start of corticosteroid taper to Day 365

,
InterventionParticipants (Number)
None12>=3Inception treatment failure
Abatacept244721179
Placebo102110115

DB: Number of Participants With MAs in Serum Chemistry: ALP, AST, ALT, GGT, Bilirubin (Total), BUN and Creatinine

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria. ALP, GGT: >2* ULN (if pre-Rx >ULN, then >3* pre-Rx); AST, ALT: >3* ULN (if pre-Rx >ULN, then >4* pre-Rx). Bilirubin (total): >2* ULN (if pre-Rx >ULN, then >4* pre-Rx), BUN:>2* pre-Rx; Creatinine:>1.5* pre-Rx. (NCT00119678)
Timeframe: Events recorded at each participant encounter, from start of study drug therapy up to Day 337, including up to 56 days after the last dose or up to the first dose of open-label, whichever occurred earlier

,
Interventionparticipants (Number)
ALP (n = 120, 59)AST (n = 120, 59)ALT (n = 120, 59)GGT (n = 120, 59)Bilirubin (total) (n = 120, 59)BUN (n = 120, 59)Creatinine (n = 120, 59)
Abatacept2323046
Placebo0003034

OL; Number of Participants With Marked Abnormalities (MAs) in Hematology: Hemoglobin, Hematocrit, Erythrocytes and Platelet Count

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following hematology MA definitions specify the criteria for the data presented. Hemoglobin: >3 g/dL decrease from pre-treatment (pre-Rx) value; hematocrit: <0.75* pre-Rx value; erythrocyte count: <0.75* pre-Rx value; platelet count: <0.67* lower limit of normal (LLN) or >1.5* upper limit of normal (ULN) (or, if pre-Rx value NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
Hemoglobin (n = 110)Hematocrit (n = 110)Erythrocytes (n = 110)Platelet count (n = 108)
Abatacept2323

OL; Number of Participants With MAs in Hematology: Leukocytes, Neutrophils + Bands (Absolute), Lymphocytes (Absolute), Monocytes (Absolute), Basophils (Absolute) and Eosinophils (Absolute)

MMAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following hematology MA definitions specify the criteria for the data presented. Leukocytes: <0.75* LLN or >1.25* ULN (or, if pre-Rx value ULN. If pre-Rx value >ULN, then >1.2* pre-Rx or 7.50* 10^3 c/uL; Monocytes (absolute): >2000/mm^3; Basophils (absolute): >0.40* 10^3 c/uL; Eosinophils (absolute): >0.75* 10^3 c/uL. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
LeukocytesNeutrophils+bands (absolute)Lymphocytes (absolute)Monocytes (absolute)Basophils (absolute)Eosinophils (absolute)
Abatacept18632003

OL; Number of Participants With MAs in Serum Chemistry: Alkaline Phosphatase (ALP), Aspartate-aminotransferase (AST), Alanine-aminotransferase (ALT), Gamma-glutamyl Transferase (GGT), Bilirubin(Total), Blood Urea Nitrogen (BUN), Creatinine

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria. ALP, GGT: >2* ULN (if pre-Rx >ULN, then >3* pre-Rx); AST, ALT: >3* ULN (if pre-Rx >ULN, then >4* pre-Rx). Bilirubin (total): >2* ULN (if pre-Rx >ULN, then >4* pre-Rx), BUN:>2* pre-Rx; Creatinine:>1.5* pre-Rx. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
ALPASTALTGGTBilirubin (total)BUNCreatinine
Abatacept0346037

OL; Number of Participants With MAs in Serum Chemistry: Glucose (Serum), Glucose (Fasting Serum), Albumin, Cholesterol (Total), Triglycerides, Fasting Triglycerides

MAs are laboratory measurements marked as abnormal, as per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria, Glucose: <65 mg/dL or >220 mg/dL; Glucose (fasting serum): <0.8* LLN or >1.5 ULN (if pre-Rx ULN. If pre-Rx >ULN, then >2.0* pre-Rx or 2* pre-Rx; triglycerides: >=2.5* ULN, or if pre Rx>ULN then use >2.5* pre Rx; fasting triglycerides: >=2.0* ULN, or if pre Rx>ULN then use >2.0* pre Rx. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
Glucose (serum) (n = 110)Glucose (fasting serum) (n = 55)Albumin (n = 110)Cholesterol (total) (n = 15)Triglycerides (n = 10)Triglycerides (fasting) (n = 9)
Abatacept2166000

OL; Number of Participants With MAs in Serum Chemistry: Sodium (Serum), Potassium (Serum), Chloride (Serum), Calcium (Total), Protein (Total)

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following serum chemistry MA definitions specify MA criteria, Sodium (serum): <0.95x LLN or >1.05x ULN (if pre-RxULN. If pre-Rx >ULN, then >1.05x pre-Rx or 1.1xULN (if pre-Rx ULN. If pre-Rx >ULN, then >1.1xpre-Rx or 1.2xULN (if pre-Rx ULN. If pre-Rx >ULN, then >1.25x pre-Rx or NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
Sodium (serum)Potassium (serum)Chloride (serum)Calcium (total)Protein (total)
Abatacept07014

OL; Number of Participants With MAs in Urinalysis

MAs are laboratory measurements marked as abnormal, per pre-defined study criteria, at any study time point. The following definitions specify the criteria for MAs in urinalysis, Protein, glucose, blood, Leukocyte esterase, red blood cells (RBC), white blood cells (WBC): >=2+ (or, if value >=4, or if pre-Rx value = 0 or 0.5, then >= 2* or if pre-Rx value =1, then >=3, or if pre-Rx = 2 or 3, then >=4); protein (24 hour urine): >1000 mg/24 hrs and >=2* pre-Rx; Glomerular filtration rate (GFR): <=60 mL/min/1.73m^2 or > 15% change from baseline; Protein/creatinine ratio: > 100 mg/mmol. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
Protein (n = 110)Glucose (n= 110)Blood (n = 110)Leukocyte esterase (n = 104)WBC (n = 105)RBC (n = 101)GFR (n = 110)Protein/creatinine ratio (n = 109)
Abatacept12041285735910

OL; Number of Participants With Significant AEs of Special Interest

An AE was defined as any new untoward medical occurrence or worsening of a pre-existing medical condition (even if not caused by the study drug). For this study, it was decided that AEs of particular importance were associated with the use of immunomodulatory agents. Number of participants with infections, malignant Neoplasms, pre-specified autoimmune disorders, acute-infusional AEs and peri-infusional AEs were recorded. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
InfectionsMalignant neoplasmsPre-specified autoimmune disordersAcute-infusional AEsPeri-infusional AEs
Abatacept8214315

Open Label Period (OL); Number of Participants Who Died, Experienced Adverse Events (AEs), Serious AEs, Drug Related AEs or SAEs and Discontinued Due to AEs

AEs: any new untoward medical occurrences/worsening of pre-existing medical condition, whether or not related to study drug. SAE: any AE that resulted in death; was life threatening; resulted in persistent/significant disability/incapacity; resulted in/prolonged an existing in-patient hospitalization; was a congenital anomaly/birth defect; or was an overdose. Participants who discontinued the study due to an AE were recorded. Drug-related AEs or SAEs: events with a relationship to the study therapy of certain; probable; possible; or missing. (NCT00119678)
Timeframe: From start of study drug therapy in open-label period (Day 365) up to 56 days after the last dose of open-label period

Interventionparticipants (Number)
DeathsAEsSAEsAll AEs Leading to DiscontinuationDrug related AEsDrug related SAEs
Abatacept1972134911

Mean Change From Baseline in Medical Outcomes 36-Item Short Form Health Survey (SF-36) Physical Component Summary Score (PCS) at Wk 24.

The SF-36 is a generic health related quality of life (HRQOL) measurement. The survey includes 36 questions grouped to 8 domains and 2 summary measures (physical and mental health component, PCS and MCS, respectively) assessing HRQOL. Responses are scored according to the SF-36v2™ manual. A score is calculated for each SF-36 domain based on the patient's response to each question within it. This is then transformed to a scale ranging from 0 (worst) to 100 (best) points. The PCS is norm-based where the mean=50 and standard deviation (SD)=10. Higher scores represent better physical health. (NCT00424476)
Timeframe: Baseline, 24 weeks

InterventionScores on a scale (Mean)
Placebo3.64
Belimumab 1 mg/kg3.65
Belimumab 10 mg/kg3.58

Mean Change in Physician's Global Assessment (PGA) at Wk 24.

The PGA is a visual analog scale scored from 0 to 3. A score of 1 corresponds to mild lupus disease activity. A score of 2 correlates with moderate disease activity and a score of 3 with severe disease activity. (NCT00424476)
Timeframe: Baseline, 24 weeks

InterventionScores on a 3-point scale (Mean)
Placebo-0.39
Belimumab 1 mg/kg-0.44
Belimumab 10 mg/kg-0.54

Percent of Subjects Whose Average Prednisone Dose Has Been Reduced by ≥ 25% From Baseline to ≤ 7.5 mg/Day During Weeks 40 Through 52

(NCT00424476)
Timeframe: Baseline, Weeks 40 through 52

InterventionPercentage of participants (Number)
Placebo12.0
Belimumab 1 mg/kg20.6
Belimumab 10 mg/kg18.6

Percent of Subjects With a ≥ 4 Point Reduction From Baseline in SELENA SLEDAI Score at Wk 52.

(NCT00424476)
Timeframe: Baseline, 52 weeks

InterventionPercentage of participants (Number)
Placebo46.0
Belimumab 1 mg/kg53.1
Belimumab 10 mg/kg58.3

SLE Responder Index (SRI) Response Rate at Week 52

"Percentage of subjects with a ≥ 4 point reduction from baseline in SELENA SLEDAI score, and no worsening (increase of < 0.30 points from baseline) in PGA, and no new BILAG A organ domain score or 2 new BILAG B organ domain scores compared with baseline.~SELENA SLEDAI is calculated from 24 individual descriptors; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare. PGA is a visual analog scale scored from 0 to 3 (1=mild, 2=moderate, 3=severe). BILAG uses a single score for each of the 8 organ domains; range is from severe to no disease (A to E)." (NCT00424476)
Timeframe: Baseline, 52 weeks

InterventionPercentage of participants (Number)
Placebo43.6
Belimumab 1 mg/kg51.4
Belimumab 10 mg/kg57.6

Adverse Events (AE) Overview

SEE ALSO ADVERSE EVENTS RESULTS SECTION (NCT00424476)
Timeframe: Up to 56 Weeks

,,
InterventionPercentage of participants (Number)
Percent of patients with at least 1 AEPercent of patients with at least 1 Serious AEPercent of patients with an AE resulting in death
Belimumab 1 mg/kg91.716.30.7
Belimumab 10 mg/kg91.714.11.4
Placebo91.612.51.0

Mean Change From Baseline in Medical Outcomes 36-Item Short Form Health Survey (SF-36) Physical Component Summary Score (PCS) at Week 24.

The SF-36 is a generic health related quality of life (HRQOL) measurement. The survey includes 36 questions grouped to 8 domains and 2 summary measures (physical and mental health component, PCS and MCS, respectively) assessing HRQOL. Responses are scored according to the SF-36v2™ manual. A score is calculated for each SF-36 domain based on the patient's response to each question within it. This is then transformed to a scale ranging from 0 (worst) to 100 (best) points. The PCS is norm-based where the mean=50 and standard deviation (SD)=10. Higher scores represent better physical health. (NCT00410384)
Timeframe: Baseline, 24 Weeks

InterventionScores on a scale (Mean)
Placebo3.35
Belimumab 1 mg/kg3.78
Belimumab 10 mg/kg3.21

Mean Change in Physician's Global Assessment (PGA) at Week 24.

The PGA is a visual analog scale scored from 0 to 3. A score of 1 corresponds to mild lupus disease activity. A score of 2 correlates with moderate disease activity and a score of 3 with severe disease activity. (NCT00410384)
Timeframe: Baseline, 24 Weeks

InterventionScores on a 3-point scale (Mean)
Placebo-0.49
Belimumab 1 mg/kg-0.47
Belimumab 10 mg/kg-0.44

Percent of Subjects Whose Average Prednisone Dose Has Been Reduced by ≥ 25% From Baseline to ≤ 7.5 mg/Day During Weeks 40 Through 52

(NCT00410384)
Timeframe: Baseline, Weeks 40-52

InterventionPercentage of participants (Number)
Placebo12.7
Belimumab 1 mg/kg19.2
Belimumab 10 mg/kg17.5

Percent of Subjects With a ≥ 4 Point Reduction From Baseline in SELENA SLEDAI Score at Week 52.

(NCT00410384)
Timeframe: Baseline, 52 Weeks

InterventionPercentage of participants (Number)
Placebo35.3
Belimumab 1 mg/kg42.8
Belimumab 10 mg/kg46.5

SLE Responder Index (SRI) Response Rate at Week 52

"Percentage of subjects with a ≥ 4 point reduction from baseline in SELENA SLEDAI score, and no worsening (increase of < 0.30 points from baseline) in PGA, and no new BILAG A organ domain score or 2 new BILAG B organ domain scores compared with baseline.~SELENA SLEDAI is calculated from 24 individual descriptors; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare. PGA is a visual analog scale scored from 0 to 3 (1=mild, 2=moderate, 3=severe). BILAG uses a single score for each of the 8 organ domains; range is from severe to no disease (A to E)." (NCT00410384)
Timeframe: Baseline, 52 Weeks

InterventionPercentage of participants (Number)
Placebo33.5
Belimumab 1 mg/kg40.6
Belimumab 10 mg/kg43.2

SRI Response Rate at Week 76

"Percentage of subjects with a ≥ 4 point reduction from baseline in SELENA SLEDAI score, and no worsening (increase of < 0.30 points from baseline) in PGA, and no new BILAG A organ domain score or 2 new BILAG B organ domain scores compared with baseline.~SELENA SLEDAI is calculated from 24 individual descriptors; 0 indicates inactive disease and the maximum theoretical score is 105; scores > 20 are rare. PGA is a visual analog scale scored from 0 to 3 (1=mild, 2=moderate, 3=severe). BILAG uses a single score for each of the 8 organ domains; range is from severe to no disease (A to E)." (NCT00410384)
Timeframe: Baseline, 76 Weeks

InterventionPercentage of participants (Number)
Placebo32.4
Belimumab 1 mg/kg39.1
Belimumab 10 mg/kg38.5

Adverse Event (AE) Overview

SEE ALSO ADVERSE EVENT RESULTS SECTION (NCT00410384)
Timeframe: Up to 80 Weeks

,,
InterventionPercentage of participants (Number)
Percent of patients with at least 1 AEPercent of patients with at least 1 Serious AEPercent of patients with an AE resulting in death
Belimumab 1 mg/kg93.423.20.7
Belimumab 10 mg/kg92.722.30.4
Placebo92.019.60.0

Reviews

68 reviews available for prednisolone and Libman-Sacks Disease

ArticleYear
Congenital cytomegalovirus infection after maternal primary infection in a patient with systemic lupus erythematosus: A case report and literature review.
    Lupus, 2022, Volume: 31, Issue:2

    Topics: Antibodies, Viral; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunoglobulin G; Lu

2022
Lupus Anticoagulant-Hypoprothrombinemia Syndrome and Pseudotumor Cerebri as an Initial Presentation of Systemic Lupus Erythematosus in a 16-Year-Old Male Patient: A Case Report and Literature Review.
    The American journal of case reports, 2022, Oct-08, Volume: 23

    Topics: Adolescent; Adrenal Cortex Hormones; Antiphospholipid Syndrome; Hemorrhage; Humans; Hydroxychloroqui

2022
Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review.
    Rheumatology international, 2023, Volume: 43, Issue:11

    Topics: Adult; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mycobacterium tuberculosis; P

2023
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5

    Topics: Adult; Alopecia; Azetidines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Janus Kin

2020
Systemic lupus erythematosus complicated with Castleman disease: a case-based review.
    Rheumatology international, 2021, Volume: 41, Issue:2

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Castleman Disease; Diagnosis, Differential; Female;

2021
Acute acalculous cholecystitis as the initial manifestation of systemic lupus erythematous: A case report.
    Medicine, 2021, Jun-04, Volume: 100, Issue:22

    Topics: Acalculous Cholecystitis; Acute Disease; Adult; Aged; Antibodies, Antinuclear; Antirheumatic Agents;

2021
Lupus enteritis as the sole presenting feature of systemic lupus erythematosus: case report and review of the literature.
    Paediatrics and international child health, 2019, Volume: 39, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Balloon Enteroscopy; Child; Enteritis; Female; Histocytochemis

2019
Systemic lupus erythematosus-related pancreatitis in children.
    Clinical rheumatology, 2013, Volume: 32, Issue:6

    Topics: Abdominal Pain; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Female; Humans; I

2013
Pure red cell aplasia as a presenting feature in systemic lupus erythematosus and association with thymoma, hypothyroidism and hypoparathyroidism: a case report and literature review.
    Iranian journal of allergy, asthma, and immunology, 2014, Volume: 13, Issue:2

    Topics: Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Hypoparathyroidism; Hypot

2014
Hepatic manifestations in juvenile systemic lupus erythematosus.
    Recent patents on inflammation & allergy drug discovery, 2014, Volume: 8, Issue:1

    Topics: Adolescent; Antibodies, Antinuclear; B-Lymphocytes; Child; Clinical Trials as Topic; Disease-Free Su

2014
Acute spinal subdural hematoma in a patient with active systemic lupus erythematosus: a case report and literature review.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:8

    Topics: Acute Disease; Adult; Female; Hematoma, Subdural, Spinal; Heparin; Humans; Lupus Erythematosus, Syst

2014
Lupus enteritis during pregnancy: A case-based review.
    Modern rheumatology, 2017, Volume: 27, Issue:6

    Topics: Abdomen, Acute; Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Enteritis; Female; Humans;

2017
[Optimization of Immunosuppression and the Prevention of Fungal Infection in Autoimmune Diseases].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015, Volume: 135, Issue:10

    Topics: Complement C3; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Glucuronides; Humans;

2015
Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: two case reports and a review of the literature.
    Modern rheumatology, 2009, Volume: 19, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Brain; Cerebral Angiography; Disease Progression; Female; Humans; J

2009
[Case of lupus nephritis and enteritis associated with bilateral hydronephrosis].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:5

    Topics: Adult; Enteritis; Female; Humans; Hydronephrosis; Lupus Erythematosus, Systemic; Lupus Nephritis; Me

2009
Male lupus: a diagnosis often delayed--a case series and review of the literature.
    Irish journal of medical science, 2011, Volume: 180, Issue:1

    Topics: Adult; Aged; Fatal Outcome; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Age

2011
A case report of systemic lupus erythematosus combined with Castleman's disease and literature review.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Biopsy; Castleman Disease; Chest Pain; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemi

2012
Systemic lupus erythematosus complicated with protein-losing enteropathy: a case report and review of the published works.
    The Journal of dermatology, 2012, Volume: 39, Issue:5

    Topics: alpha 1-Antitrypsin; Asian People; Humans; Japan; Lupus Erythematosus, Systemic; Male; Middle Aged;

2012
Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis.
    Journal of Zhejiang University. Science. B, 2012, Volume: 13, Issue:9

    Topics: Antibodies, Monoclonal, Murine-Derived; Female; Humans; Immunosuppressive Agents; Lupus Erythematosu

2012
Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.
    Journal of clinical and experimental hematopathology : JCEH, 2012, Volume: 52, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; CD5 An

2012
Acute type A aortic dissection in a patient with systemic lupus erythematosus.
    Japanese heart journal, 2002, Volume: 43, Issue:5

    Topics: Adult; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Valve Insufficiency; Cardiopulmonary Byp

2002
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Lupus Erythematosus, Sy

2002
[TREATMENT OF KIDNEY DISEASES, CARDIAC AND VASCULAR DISORDERS AS WELL AS COLLAGENOSES WITH CORTISONES].
    Die Therapiewoche, 1964, Volume: 14

    Topics: Adams-Stokes Syndrome; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Rheumatoid;

1964
[Two cases of lupus cystitis complicated by lupus nephritis treated successfully with steroid therapy].
    Nihon Jinzo Gakkai shi, 2003, Volume: 45, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Cystitis, Interstitial; Female; Humans; Lupus Erythematosus, System

2003
[Systemic lupus erythematosus].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl

    Topics: Anticonvulsants; Autoantibodies; Biomarkers; Cyclophosphamide; Humans; Immunoglobulins; Immunosuppre

2004
[Collagen diseases and rheumatic diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Mar-10, Volume: 93, Issue:3

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Drug Therapy, Com

2004
Acute lupus hemophagocytic syndrome: report of a case and review of the literature.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2004, Volume: 87, Issue:3

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bone Marrow; Diagnosis, Differential; Humans; Lupus

2004
[Nephropathies in patients with collagen diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

    Topics: Combined Modality Therapy; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythema

2004
Sweet's syndrome as an initial presentation in systemic lupus erythematosus: a case report and review of the literature.
    Lupus, 2005, Volume: 14, Issue:5

    Topics: Adult; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Prednisolone; Sweet Syndrome

2005
Resolution of complete heart block after prednisolone in a patient with systemic lupus erythematosus.
    Lupus, 2005, Volume: 14, Issue:7

    Topics: Female; Glucocorticoids; Heart Block; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolo

2005
Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus.
    Modern rheumatology, 2006, Volume: 16, Issue:1

    Topics: Animals; Antiparasitic Agents; Female; Glucocorticoids; Humans; Immunocompromised Host; Intestinal P

2006
Necrotizing fasciitis in rheumatic diseases.
    Lupus, 2006, Volume: 15, Issue:6

    Topics: Adult; Aeromonas; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Arth

2006
Cerebellum vasculopathy and normal tension glaucoma in systemic lupus erythematosus: report of a case and review of the literature.
    Rheumatology international, 2006, Volume: 27, Issue:1

    Topics: Cerebrovascular Disorders; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Glaucoma; Hum

2006
Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:3

    Topics: Adult; Cryptococcosis; Cryptococcus neoformans; Drug Administration Schedule; Epidemiologic Methods;

2007
[Neonatal lupus erythematosus: case report and review of the literature].
    Orvosi hetilap, 2007, Oct-28, Volume: 148, Issue:43

    Topics: Autoantibodies; Glucocorticoids; Humans; Infant, Newborn; Liver Function Tests; Lupus Erythematosus,

2007
[Recent topics on rheumatism and collagen diseases in childhood].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Oct-10, Volume: 96, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis, Juvenile; Child; Child,

2007
[Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:2

    Topics: Adult; Chylothorax; Drainage; Drug Resistance; Female; Humans; Immunosuppressive Agents; Ligation; L

2008
[Efficacy and problems of the pulse therapy and alternate-day schedule].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:11

    Topics: Acute Disease; Drug Administration Schedule; Glomerulonephritis; Humans; Infusions, Parenteral; Lupu

1984
[Steroid pulse therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 1981, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Female; Glomerulonephritis; Humans; Immunoglobulin G; Infusions, Parenteral; Lupu

1981
C-reactive protein in SLE.
    Clinics in rheumatic diseases, 1982, Volume: 8, Issue:1

    Topics: Acute Disease; Adult; Animals; Bacterial Infections; Blood Sedimentation; C-Reactive Protein; Child;

1982
[Optic neuropathy in systemic lupus erythematosus (SLE)--analysis of 54 cases including our case].
    Ryumachi. [Rheumatism], 1995, Volume: 35, Issue:1

    Topics: Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Optic Nerve Diseases

1995
Lupus cystitis. report of a case.
    Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:8

    Topics: Adult; Cystitis; Female; Humans; Hydronephrosis; Lupus Erythematosus, Systemic; Prednisolone; Radiog

1994
[Diagnosis and therapy of systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Mar-10, Volume: 82, Issue:3

    Topics: Diagnosis, Differential; Humans; Immunosorbent Techniques; Kidney; Lupus Erythematosus, Systemic; Lu

1993
Diagnosis and treatment of systemic lupus erythematosus.
    BMJ (Clinical research ed.), 1993, Sep-11, Volume: 307, Issue:6905

    Topics: Autoantibodies; Azathioprine; Cyclophosphamide; Humans; Lupus Erythematosus, Systemic; Prednisolone

1993
[Emergency therapy of collagen diseases and their complications].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Nov-10, Volume: 84, Issue:11

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Collagen Diseases; Drug Administration Schedule; Em

1995
[A case of SLE-like syndrome and severe hemolytic anemia caused by methyldopa].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Dec-10, Volume: 84, Issue:12

    Topics: Anemia, Hemolytic, Autoimmune; Humans; Immunosorbent Techniques; Lupus Erythematosus, Systemic; Male

1995
[Recent topics on collagen diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1996, Mar-10, Volume: 85, Issue:3

    Topics: Anti-Inflammatory Agents; Collagen Diseases; Humans; Immunosuppressive Agents; Lupus Erythematosus,

1996
Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
    Clinical nephrology, 1997, Volume: 48, Issue:5

    Topics: Adolescent; Biopsy; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Nephrosis, Lipoid; Predni

1997
Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis.
    Clinical rheumatology, 1999, Volume: 18, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprin

1999
[Systemic lupus erythematosus].
    Ryoikibetsu shokogun shirizu, 2000, Issue:29 Pt 4

    Topics: Central Nervous System Diseases; Cyclophosphamide; Diagnosis, Differential; Humans; Lupus Erythemato

2000
Bullous systemic lupus erythematosus.
    The Australasian journal of dermatology, 2000, Volume: 41, Issue:4

    Topics: Adult; Biopsy, Needle; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-U

2000
Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: Adult; Amylases; Antibody Specificity; Antigen-Antibody Complex; Autoantibodies; Autoantigens; Autoi

2000
[Immunologic pleuritis].
    Ryoikibetsu shokogun shirizu, 2000, Issue:31

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Diagnosis, Differential; Humans; Lupus Erythematosus, Sy

2000
[A case of lupoid hepatitis satisfying criteria for systemic lupus erythematosus associated with psychosis].
    Fukuoka igaku zasshi = Hukuoka acta medica, 2001, Volume: 92, Issue:7

    Topics: Adult; Antibodies, Antinuclear; Biomarkers; Female; Hepatitis, Autoimmune; Humans; Lupus Erythematos

2001
Protein-losing gastropathy associated with autoimmune disease: successful treatment with prednisolone.
    Journal of gastroenterology, 2002, Volume: 37, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Edema

2002
[Indications and limits of glucocorticoid therapy in collagen disease (author's transl)].
    Horumon to rinsho. Clinical endocrinology, 1979, Volume: 27, Issue:10

    Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Female; gamma-Globulins; Humans; Lupus Erythematosus

1979
[Treatment of SLE-nephritis: literature review].
    Lakartidningen, 1978, May-31, Volume: 75, Issue:22

    Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis; Humans; Kidney Glomer

1978
Carbamazepine-induced systemic lupus erythematosus-like disease.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:11

    Topics: Adolescent; Carbamazepine; Epilepsy; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone

1992
[Transverse myelopathy in a patient with systemic lupus erythematosus associated with positive anticardiolipin antibody--a case report].
    Rinsho shinkeigaku = Clinical neurology, 1992, Volume: 32, Issue:6

    Topics: Antibodies, Anticardiolipin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Myelitis, T

1992
[Systemic lupus erythematosus associated with benign intracranial hypertension: a case report].
    Ryumachi. [Rheumatism], 1992, Volume: 32, Issue:1

    Topics: Adult; Antibodies, Antinuclear; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Pre

1992
Nocardiosis: report of 2 cases with review of literature in Thailand.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1991, Volume: 74, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Kidney; Lung; Lupus Erythematosus, Systemic; Nocardi

1991
Acute transverse myelopathy complicating systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1989, Volume: 48, Issue:6

    Topics: Acute Disease; Adolescent; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Myelitis

1989
Immunosuppressive therapy. 1.
    The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5

    Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid

1972
[Pathologic changes in the cardiovascular system during treatment with glucocorticoid hormones].
    Kardiologiia, 1972, Volume: 12, Issue:10

    Topics: Animals; Arteriosclerosis; Arthritis, Rheumatoid; Asparagine; Biological Transport, Active; Calcium;

1972
The rheumatic diseases in adolescence.
    Pediatric clinics of North America, 1973, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Antimalarials; Arthritis, Rheumatoid; Child; Child, Preschool; Dermatomyositis; D

1973
[Corticosteroid therapy in modern medicine (on the 25th anniversary of the first application of cortisone)].
    Sovetskaia meditsina, 1974, Volume: 0, Issue:7

    Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Asthma; Collagen Diseases; Cortisone; Glucocorticoid

1974
Chronic hepatitis.
    Gut, 1974, Volume: 15, Issue:7

    Topics: Adult; Animals; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Ch

1974
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs.
    Journal of the Royal College of Physicians of London, 1971, Volume: 5, Issue:4

    Topics: Adult; Anti-Glomerular Basement Membrane Disease; Antilymphocyte Serum; Antineoplastic Agents; Azath

1971

Trials

37 trials available for prednisolone and Libman-Sacks Disease

ArticleYear
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
    Trials, 2022, Nov-12, Volume: 23, Issue:1

    Topics: Adult; Clinical Trials, Phase III as Topic; Humans; Immunosuppressive Agents; Lupus Erythematosus, S

2022
Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
    Rheumatology (Oxford, England), 2021, 06-18, Volume: 60, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Connective Tissue Diseases; Female; Glucocorticoids; Humans

2021
Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Lupus, 2018, Volume: 27, Issue:2

    Topics: Administration, Intravenous; Adult; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Enzyme

2018
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial:
    Annals of the rheumatic diseases, 2018, Volume: 77, Issue:5

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Humans; Immunosuppressive

2018
Characterisation of Patients with Systemic Lupus Erythematosus in Malta: A Population Based Cohort Cross-Sectional Study.
    BioMed research international, 2018, Volume: 2018

    Topics: Adult; Age of Onset; Aged; Cross-Sectional Studies; Fatigue; Female; Humans; Incidence; Lupus Erythe

2018
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; B-Cell Activating Factor; Complem

2013
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Lupus, 2013, Volume: 22, Issue:14

    Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Double-Blind Method;

2013
Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus.
    Clinical rheumatology, 2016, Volume: 35, Issue:2

    Topics: Adult; Antirheumatic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistanc

2016
Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus.
    Cytokine, 2017, Volume: 90

    Topics: Adult; Biomarkers; C-Reactive Protein; Female; Humans; Inflammation Mediators; Interleukin-6; Lupus

2017
Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
    Lupus, 2009, Volume: 18, Issue:12

    Topics: Adult; Azathioprine; Creatinine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Im

2009
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:5

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Surviva

2010
The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Female

2010
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
    Arthritis research & therapy, 2010, Volume: 12, Issue:5

    Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Doubl

2010
Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Glucocorticoids; Glucuronides; Humans; Immunosuppre

2012
Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study.
    Clinical therapeutics, 2011, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Child; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fe

2011
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in
    Arthritis and rheumatism, 2012, Volume: 64, Issue:5

    Topics: Adult; Aged; Animals; Disease Models, Animal; Double-Blind Method; Female; Humans; Immunosuppressive

2012
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:7

    Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Dehydroepiandrosterone; Double-Bli

2002
An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:10

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-

2002
An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:10

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-

2002
An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:10

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-

2002
An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:10

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-

2002
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study.
    The Journal of rheumatology, 2003, Volume: 30, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents;

2003
Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.
    Kidney international, 2005, Volume: 68, Issue:2

    Topics: Adult; Diagnosis, Differential; Female; Fever; Glucocorticoids; Humans; Longitudinal Studies; Lupus

2005
Cognitive dysfunction in systemic lupus erythematosus.
    Psychiatry and clinical neurosciences, 2005, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema

2005
Cognitive dysfunction in systemic lupus erythematosus.
    Psychiatry and clinical neurosciences, 2005, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema

2005
Cognitive dysfunction in systemic lupus erythematosus.
    Psychiatry and clinical neurosciences, 2005, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema

2005
Cognitive dysfunction in systemic lupus erythematosus.
    Psychiatry and clinical neurosciences, 2005, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema

2005
Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Autoimmunity, 2005, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Adrenocorticotropic Hormone; Adult; Aged; Androgens; Dehydroepiandrosterone;

2005
The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Scandinavian journal of immunology, 2006, Volume: 63, Issue:4

    Topics: Adult; Antibodies, Anticardiolipin; Antirheumatic Agents; Azathioprine; B-Cell Activating Factor; Ca

2006
Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.
    Lupus, 2006, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Anticoagulants; Female; Femur Head Necrosis; Humans; Immunosuppressive Agents; Lu

2006
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
    Modern rheumatology, 2007, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Antirheumatic Agents; Cyclosporine; Dose-Response Relationship, Drug; Female; Glu

2007
Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; CD28 Antigens; CD40 Ligand; Cell Proliferation; C

2007
Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Clinical rheumatology, 2008, Volume: 27, Issue:1

    Topics: Adolescent; Biopsy; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Huma

2008
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:5

    Topics: Abortion, Habitual; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antibodies

2008
Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
    The Journal of rheumatology, 1996, Volume: 23, Issue:5

    Topics: Adult; Cell Adhesion Molecules; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; E-Selectin;

1996
Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease).
    Annals of the rheumatic diseases, 1997, Volume: 56, Issue:6

    Topics: Adult; Aged; Antibodies, Antinuclear; Blood Sedimentation; Complement C3c; Complement C4; Drug Admin

1997
Neoral--new cyclosporin for old?
    British journal of rheumatology, 1997, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, P

1997
Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. I. The hypothalamus-autonomic nervous system axis.
    The Journal of rheumatology, 2000, Volume: 27, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Blood Pressure; Corticotropin-Releasin

2000
The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus.
    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 2000, Volume: 4, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Blood Component Removal; Cellulose; Combin

2000
Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.
    International journal of clinical & laboratory research, 2000, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female;

2000
[Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].
    Klinicheskaia meditsina, 1978, Volume: 56, Issue:7

    Topics: B-Lymphocytes; Clinical Trials as Topic; Drug Evaluation; Glomerulonephritis; Heparin; Humans; Leuko

1978
Comparison of therapy in severe systemic lupus erythematosus employing stratification techniques.
    The Journal of rheumatology, 1978,Spring, Volume: 5, Issue:1

    Topics: Azathioprine; Creatinine; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Lupus Eryt

1978
Immunosuppressive therapy. 1.
    The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5

    Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid

1972

Other Studies

913 other studies available for prednisolone and Libman-Sacks Disease

ArticleYear
New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    International journal of hematology, 2022, Volume: 115, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; BNT162 Vaccine; Female; Hematologic Tests; Hemoglobins; Humans; Lupus

2022
A Woman With Fatigue and Orthostatic Hypotension Who Had Run Out of Steroids.
    Annals of emergency medicine, 2021, Volume: 78, Issue:5

    Topics: Adrenal Insufficiency; Adult; Diagnosis, Differential; Fatigue; Female; Glucocorticoids; Humans; Hyp

2021
Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study.
    Clinical rheumatology, 2022, Volume: 41, Issue:4

    Topics: Antimalarials; Cohort Studies; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Prospect

2022
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
    Lupus science & medicine, 2021, Volume: 8, Issue:1

    Topics: Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Prednisolone; Remission Induction;

2021
Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18.
    Modern rheumatology, 2022, Apr-18, Volume: 32, Issue:3

    Topics: Adolescent; Age of Onset; Female; Humans; Insurance, Health; Japan; Lupus Erythematosus, Systemic; M

2022
Systemic lupus erythematosus presenting with lymphoid interstitial pneumonia as an initial manifestation.
    BMJ case reports, 2021, Dec-30, Volume: 14, Issue:12

    Topics: Adult; Female; Humans; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lymphadenopathy;

2021
Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2022, 08-30, Volume: 61, Issue:9

    Topics: Humans; Lupus Erythematosus, Systemic; Prednisolone; Risk Factors; Severity of Illness Index

2022
Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Biomarkers; Female; Humans; Interleukin-18; Lu

2022
Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand.
    BMC psychiatry, 2022, 02-09, Volume: 22, Issue:1

    Topics: Cross-Sectional Studies; Depression; Fatigue; Humans; Lupus Erythematosus, Systemic; Pain; Prednisol

2022
Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study.
    The Korean journal of internal medicine, 2022, Volume: 37, Issue:4

    Topics: Adrenal Cortex Hormones; Alcoholism; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male

2022
Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study.
    Arthritis research & therapy, 2022, 07-28, Volume: 24, Issue:1

    Topics: Adult; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mal

2022
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study.
    Modern rheumatology, 2023, Aug-25, Volume: 33, Issue:5

    Topics: Adult; Disease Progression; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic;

2023
Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis.
    Internal medicine (Tokyo, Japan), 2023, Apr-01, Volume: 62, Issue:7

    Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents

2023
Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
    Vaccine, 2022, 09-29, Volume: 40, Issue:41

    Topics: Adult; Arthritis; COVID-19; COVID-19 Vaccines; Female; Humans; Lupus Erythematosus, Systemic; Male;

2022
Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment.
    Modern rheumatology, 2023, Aug-25, Volume: 33, Issue:5

    Topics: Antirheumatic Agents; East Asian People; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic;

2023
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study.
    Arthritis & rheumatology (Hoboken, N.J.), 2023, Volume: 75, Issue:3

    Topics: Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Odds Ratio; Prednisolone; Prospective Studie

2023
Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study.
    Lupus science & medicine, 2022, Volume: 9, Issue:1

    Topics: Cross-Sectional Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupu

2022
Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review.
    The American journal of case reports, 2022, Nov-07, Volume: 23

    Topics: Adult; Female; Humans; Induction Chemotherapy; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephr

2022
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Lupus Erythematosus, Sy

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Herpes Zoster; Herp

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Journal of autoimmunity, 2023, Volume: 134

    Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Child; Coronavirus; COVID-19; COVID-19 Vaccines; Female;

2023
Dysentery and leg ulcer as an atypical presentation of systemic lupus erythematosus: A case report.
    Medicine, 2022, Dec-16, Volume: 101, Issue:50

    Topics: Adolescent; Antibodies, Antinuclear; Child; Dysentery; Female; Fever; Humans; Leg Ulcer; Leukopenia;

2022
A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura.
    Modern rheumatology case reports, 2023, 06-19, Volume: 7, Issue:2

    Topics: ADAMTS13 Protein; Adolescent; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Purpura,

2023
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids.
    Lupus, 2023, Volume: 32, Issue:5

    Topics: Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Prednisolone; Seps

2023
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
    Clinical immunology (Orlando, Fla.), 2023, Volume: 250

    Topics: Adult; Child; Consensus; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Prednisolo

2023
A survival case of visceral disseminated varicella zoster virus infection in a patient with systemic lupus erythematosus.
    BMC nephrology, 2023, 06-08, Volume: 24, Issue:1

    Topics: Acyclovir; Adult; Chickenpox; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Lupus Erythematos

2023
A young boy with rash, arthritis, and developmental delay: Monogenic lupus due to DNASE2 gene defect.
    International journal of rheumatic diseases, 2023, Volume: 26, Issue:12

    Topics: Arthritis; Child; Exanthema; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Male; Mycoph

2023
A Patient with Type 3 Autoimmune Polyglandular Syndrome who Developed Systemic Lupus Erythematosus 8 years after the Diagnosis of Autoimmune Hepatitis.
    Acta medica Okayama, 2019, Volume: 73, Issue:4

    Topics: Anti-Inflammatory Agents; Cyclophosphamide; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive

2019
Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Lupus, 2019, Volume: 28, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clinical Protocols; Cyclophosphamide; Dose-Respo

2019
Prednisolone dose during treatment of tuberculosis might be a risk factor for mortality in patients with systemic lupus erythematosus: a hospital-based cohort study.
    Lupus, 2019, Volume: 28, Issue:14

    Topics: Adult; Aged; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppre

2019
Cellulitis with Pseudomonas putida bacteremia in a patient with systemic lupus erythematosus: A case report.
    The Journal of dermatology, 2020, Volume: 47, Issue:1

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Blood Culture; Cellulitis; Female; Glucocorticoi

2020
Intestinal Spirochetosis Caused by Brachyspira pilosicoli in a Systemic Lupus Erythematosus Patient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2019, Volume: 25, Issue:8

    Topics: Aftercare; Anti-Infective Agents; Biopsy; Brachyspira; Colonoscopy; Diagnosis, Differential; Female;

2019
Organising pneumonia in Rhupus syndrome.
    BMJ case reports, 2019, Dec-19, Volume: 12, Issue:12

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Cough; Diagnosis, Differential; Drug Ther

2019
Choroidal thickness in lupus nephritis.
    Lupus, 2020, Volume: 29, Issue:2

    Topics: Adult; Choroid; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle

2020
Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2020, 09-01, Volume: 59, Issue:9

    Topics: Adult; Cognitive Dysfunction; Correlation of Data; Dose-Response Relationship, Drug; Female; Glucoco

2020
Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol
    Lupus science & medicine, 2020, Volume: 7, Issue:1

    Topics: Adult; Aged; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-

2020
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Antibodies, Viral; Chronic Disease; Cyclosporine; Diverticulitis; DNA, Viral; Drainage; Epstein-Barr

2020
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Pediatric rheumatology online journal, 2020, Apr-03, Volume: 18, Issue:1

    Topics: Adolescent; Anemia; Antibodies, Antinuclear; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile;

2020
sQuiz your knowledge! Cord-like erythematous plaques on the lower limbs of a patient with systemic lupus erythematosus.
    European journal of dermatology : EJD, 2020, Feb-01, Volume: 30, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Dermatitis; Erythema; Female; Granuloma; Humans; Lower Extremity; L

2020
Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
    BMJ case reports, 2020, Apr-07, Volume: 13, Issue:4

    Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glucocorticoid

2020
Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies.
    Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Diet, Fat-Restricted; Female; Fenofibrate; Hum

2020
HIV and systemic lupus erythematosus: where immunodeficiency meets autoimmunity.
    Lupus, 2020, Volume: 29, Issue:9

    Topics: Adult; Antibodies, Antinuclear; Brain; DNA; Female; Fever; Headache; HIV Infections; Humans; Lupus E

2020
Numbness and Weakness in a Patient With Systemic Lupus Erythematosus.
    The American journal of medicine, 2021, Volume: 134, Issue:1

    Topics: Electromyography; Female; Glucocorticoids; Humans; Hypesthesia; Lupus Erythematosus, Systemic; Methy

2021
Rowell's syndrome: a rare but distinct entity in rheumatology.
    BMJ case reports, 2020, Sep-23, Volume: 13, Issue:9

    Topics: Adolescent; Antibodies, Antinuclear; Antipyretics; Arthralgia; Drug Therapy, Combination; Erythema M

2020
Epidemiology and risk factors for avascular necrosis in childhood systemic lupus erythematosus in a Taiwanese population.
    Scientific reports, 2020, 09-23, Volume: 10, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Asian People; Female; Humans; Lupus Erythematosus, Syste

2020
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.
    Rheumatology (Oxford, England), 2021, 03-02, Volume: 60, Issue:3

    Topics: Anti-Inflammatory Agents; Antibodies, Viral; Antibody Formation; Antigens, Viral; Autoantibodies; Bl

2021
A case of systemic lupus erythematosus in which Cushing's syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
    Modern rheumatology case reports, 2020, Volume: 4, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenocortical Adenoma; Adult; Cushing Syndrome; Diagnosis, Differential; F

2020
A case of systemic lupus erythematosus complicated by subclinical Cushing's syndrome: case report.
    Modern rheumatology case reports, 2020, Volume: 4, Issue:1

    Topics: Adolescent; Adrenocortical Adenoma; Clinical Decision-Making; Cushing Syndrome; Disease Management;

2020
Pneumocystis Jirovecii Pneumonia in Systemic Lupus Erythematosus: A Nationwide Cohort Study in Taiwan.
    Arthritis care & research, 2022, Volume: 74, Issue:9

    Topics: Cohort Studies; Cyclophosphamide; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Lupus Erythem

2022
Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.
    Arthritis research & therapy, 2021, 03-10, Volume: 23, Issue:1

    Topics: Adult; Cross-Sectional Studies; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Midd

2021
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
    Lupus, 2021, Volume: 30, Issue:7

    Topics: Adult; Atherosclerosis; Cohort Studies; Cross-Sectional Studies; Dyslipidemias; Female; Glucocortico

2021
Mesenteric panniculitis in systemic lupus erythematosus showing characteristic computed tomography findings.
    Lupus, 2021, Volume: 30, Issue:8

    Topics: Abdominal Pain; Aged; Fatigue; Female; Humans; Lupus Erythematosus, Systemic; Pancytopenia; Pannicul

2021
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
    Lupus, 2021, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Antibodies, Antiphospholipid; Antirheumatic Agents; China; Cohort Studies; Female

2021
A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report.
    Journal of medical case reports, 2021, Jun-28, Volume: 15, Issue:1

    Topics: Adult; Child, Preschool; Female; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus,

2021
Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE).
    BMJ case reports, 2021, Aug-20, Volume: 14, Issue:8

    Topics: Adult; Coombs Test; Female; Hemolysis; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pr

2021
Role of Angiography in Systemic Lupus Erythematosus-Induced Choroiditis.
    Ocular immunology and inflammation, 2018, Volume: 26, Issue:8

    Topics: Administration, Oral; Adult; Choroiditis; Coloring Agents; Female; Fluorescein Angiography; Glucocor

2018
Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
    Lupus, 2017, Volume: 26, Issue:10

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antibody Formation;

2017
Prevalence of remission and its effect on damage and quality of life in Chinese patients with systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2017, Volume: 76, Issue:8

    Topics: Adult; Antirheumatic Agents; Asian People; China; Databases, Factual; Female; Glucocorticoids; Human

2017
Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis.
    International journal of dermatology, 2017, Volume: 56, Issue:7

    Topics: Adolescent; Aspirin; Biopsy, Needle; Dermoscopy; Drug Therapy, Combination; Female; Humans; Hydroxyc

2017
[Severe Interstitial Lung Disease and Manic Symptoms Secondary to Corticosteroids in a Patient with Systemic Lupus Erythematosus and Secondary Sjögren's Syndrome].
    Acta medica portuguesa, 2017, Mar-31, Volume: 30, Issue:3

    Topics: Bipolar Disorder; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lupus Erythematosus,

2017
Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
    Clinical rheumatology, 2018, Volume: 37, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Adult; Autoimmune Diseases; Biomarkers; Bone Density; Bone Den

2018
Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
    Clinical rheumatology, 2017, Volume: 36, Issue:10

    Topics: Adult; Case-Control Studies; Female; Flow Cytometry; GPI-Linked Proteins; Granulocytes; Humans; Leuk

2017
Unresponsiveness to oxytocin due to an extremely thin uterine wall in a pregnant woman with systemic lupus erythematosus and Sjögren's syndrome.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018, Volume: 38, Issue:2

    Topics: Adult; Cesarean Section; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Hyster

2018
Cerebral lupus presented with late postpartum eclampsia and atypical reversible leucoencephalopathy.
    Neuroradiology, 2017, Volume: 59, Issue:11

    Topics: Adrenal Cortex Hormones; Biomarkers; Diagnosis, Differential; Eclampsia; Female; Humans; Leukoenceph

2017
Exploring the mechanism of Jieduquyuziyin prescription on systemic lupus erythematosus by GC-MS-based urine metabolomics.
    Biomedical chromatography : BMC, 2018, Volume: 32, Issue:2

    Topics: Animals; Disease Models, Animal; Drugs, Chinese Herbal; Female; Gas Chromatography-Mass Spectrometry

2018
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
    Annals of hematology, 2017, Volume: 96, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclo

2017
Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2018, Mar-01, Volume: 56, Issue:1

    Topics: Adult; Diagnosis, Differential; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents;

2018
Bilateral Lupus Mastitis During Pregnancy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic; Mastitis; Prednisolo

2017
Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2018, Jun-01, Volume: 56, Issue:2

    Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobu

2018
Refractory chronic lupus peritonitis resolved by multitargeted therapy.
    Lupus, 2018, Volume: 27, Issue:5

    Topics: Adult; Ascites; Chronic Disease; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; My

2018
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
    Arthritis research & therapy, 2017, Nov-10, Volume: 19, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Cohort Studies; Disease Progression; Human

2017
Fatal colitis associated with active systemic lupus erythematosus complicated by cytomegalovirus superinfection.
    BMJ case reports, 2017, Nov-28, Volume: 2017

    Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; H

2017
Factors associated with adverse pregnancy outcomes in women with systematic lupus erythematosus.
    Journal of reproductive immunology, 2018, Volume: 125

    Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Complement Syste

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:8

    Topics: Administration, Oral; Arthritis, Rheumatoid; Biomarkers; Dose-Response Relationship, Drug; Down-Regu

2018
A case of duodenal malignant lymphoma presenting as acute pancreatitis: systemic lupus erythematosus and immunosuppressive therapy as risk factors.
    Clinical journal of gastroenterology, 2018, Volume: 11, Issue:4

    Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb

2018
Angioedema as the presenting feature of systemic lupus erythematosus.
    BMJ case reports, 2018, Mar-28, Volume: 2018

    Topics: Adult; Angioedema; Anti-Inflammatory Agents; Cyclophosphamide; Diagnosis, Differential; Female; Huma

2018
The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus.
    Lupus, 2018, Volume: 27, Issue:8

    Topics: Adolescent; Adult; Antiphospholipid Syndrome; Female; Humans; Immunosuppressive Agents; Japan; Lupus

2018
A Case of Anti-Glomerular Basement Membrane Antibody-Positive Systemic Lupus Erythematosus with Pulmonary Hemorrhage Successfully Treated at an Early Stage of the Disease.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2018, Volume: 85, Issue:2

    Topics: Adult; Autoantibodies; Biomarkers; Biopsy; Combined Modality Therapy; Early Diagnosis; Female; Glome

2018
A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
    Medicine, 2018, Volume: 97, Issue:19

    Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Blood Cell Count; Bone Marrow Examination; Cilas

2018
[Contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging was useful in detecting inflammation of the meninges in neuropsychiatric systemic lupus erythematosus: a case report].
    Rinsho shinkeigaku = Clinical neurology, 2018, Jun-27, Volume: 58, Issue:6

    Topics: Contrast Media; Female; Humans; Image Enhancement; Lupus Erythematosus, Systemic; Magnetic Resonance

2018
Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
    Lupus, 2018, Volume: 27, Issue:10

    Topics: Adult; Biomarkers; Bone Density; Bone Density Conservation Agents; Drug Administration Schedule; Fem

2018
Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus.
    Lupus, 2018, Volume: 27, Issue:13

    Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Lupus Erythem

2018
Disseminated Cryptococcosis with Bronchiolitis and Cellulitis.
    American journal of respiratory and critical care medicine, 2019, 01-15, Volume: 199, Issue:2

    Topics: Antifungal Agents; Bronchiolitis; Cellulitis; Cryptococcosis; Female; Humans; Immunocompromised Host

2019
Slicc damage index score in systemic lupus erythematosus patients and its associated factors.
    Medicine, 2018, Volume: 97, Issue:42

    Topics: Adult; Antirheumatic Agents; Cyclophosphamide; Female; Glucocorticoids; Humans; Hypertension; Lupus

2018
Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.
    International journal of rheumatic diseases, 2019, Volume: 22, Issue:3

    Topics: Adult; Calcineurin Inhibitors; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoi

2019
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast.
    The Journal of dermatology, 2019, Volume: 46, Issue:6

    Topics: Administration, Oral; Adult; Antibodies, Antinuclear; Drug Therapy, Combination; Female; Humans; Lup

2019
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2019, May-01, Volume: 58, Issue:9

    Topics: Adult; Antirheumatic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucoc

2019
Predicting flares in patients with stable systemic lupus erythematosus.
    Seminars in arthritis and rheumatism, 2019, Volume: 49, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Humans; Lupus Erythematosus, Systemic; Middle Aged; Predictive Valu

2019
Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Clinical rheumatology, 2019, Volume: 38, Issue:6

    Topics: Administration, Intravenous; Adult; Antibodies, Antinuclear; Cyclophosphamide; Drug Therapy, Combina

2019
Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report.
    Lupus, 2019, Volume: 28, Issue:4

    Topics: Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Azathioprine; Bronchiolitis Obliterans;

2019
Risk of severe herpes simplex virus infection in systemic lupus erythematosus: analysis of epidemiology and risk factors analysis in Taiwan.
    Annals of the rheumatic diseases, 2019, Volume: 78, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Female; Herpes Simplex; Humans; Incidence; Lupus Erythematosus, Sys

2019
A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
    Medicine, 2019, Volume: 98, Issue:18

    Topics: Adolescent; Antibodies, Antinuclear; Asian People; Class I Phosphatidylinositol 3-Kinases; Complemen

2019
Kikuchi-Fujimoto disease associated with systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report.
    Journal of medical case reports, 2019, Jun-06, Volume: 13, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Bone Marrow; Glucocortico

2019
Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.
    Practical neurology, 2019, Volume: 19, Issue:6

    Topics: Azathioprine; Encephalitis, Viral; Enterovirus Infections; Female; Humans; Immunocompromised Host; I

2019
Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations.
    Clinical rheumatology, 2019, Volume: 38, Issue:10

    Topics: Adult; Aged; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppre

2019
Systemic Lupus Erythematosus from Lupus Enteritis.
    Journal of gastrointestinal and liver diseases : JGLD, 2019, Jun-01, Volume: 28

    Topics: Capsule Endoscopy; Drug Therapy, Combination; Enteritis; Female; Glucocorticoids; Humans; Immunosupp

2019
Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.
    Clinical rheumatology, 2019, Volume: 38, Issue:12

    Topics: Adolescent; Adult; China; Female; Glucocorticoids; Humans; Hypertension, Pregnancy-Induced; Lupus Er

2019
Critical reversible bilateral internal carotid artery stenosis associated with SLE.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:7

    Topics: Adult; Antirheumatic Agents; Aspirin; Carotid Stenosis; Drug Therapy, Combination; Female; Glucocort

2013
An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Antibody Specificity; Autoantibodies; Diagnosis, Differential; Factor VIII; Female; Humans; Immunosu

2014
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

    Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therap

2013
Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry.
    Lupus, 2013, Volume: 22, Issue:9

    Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Asian People; Body Composition; Body Mass Index; Bone

2013
Rupture of an unscarred uterus in a woman with long-term steroid treatment for systemic lupus erythematosus.
    Obstetrics and gynecology, 2013, Volume: 122, Issue:2 Pt 2

    Topics: Adult; Cesarean Section; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Prednisolon

2013
Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy.
    Lupus, 2013, Volume: 22, Issue:11

    Topics: Ascites; Azathioprine; CA-125 Antigen; Cyclophosphamide; Female; Humans; Lupus Erythematosus, System

2013
A case of late-onset systemic lupus erythematosus with severe anemia.
    The Kurume medical journal, 2013, Volume: 60, Issue:1

    Topics: Administration, Oral; Age of Onset; Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Arthralg

2013
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
    The journal of ECT, 2013, Volume: 29, Issue:3

    Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; A

2013
Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:5

    Topics: Administration, Intravenous; Adolescent; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Fe

2013
Systemic lupus erythematosus and granulomatous lymphadenopathy.
    BMC pediatrics, 2013, Nov-05, Volume: 13

    Topics: Antibodies, Antinuclear; Child; Connective Tissue Diseases; Diagnosis, Differential; Disease Progres

2013
Hemophagocytic syndrome diagnosed by liver biopsy in a female patient with systemic lupus erythematosus.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:8

    Topics: Anti-Inflammatory Agents; Cyclosporine; Disease Progression; Female; Humans; Liver; Lupus Erythemato

2013
Chorea in systematic lupus erythematosus; a case report.
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2013, Volume: 36, Issue:6

    Topics: Adult; Antibodies, Anticardiolipin; Autoantibodies; Biomarkers; Chorea; DNA; Dopamine Antagonists; F

2013
Interstitial pneumonia as an initial manifestation in a patient with late-onset SLE.
    International journal of rheumatic diseases, 2014, Volume: 17, Issue:7

    Topics: Age of Onset; Aged; Biomarkers; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lupus Erythema

2014
SLE and dental erosion: a lethal cocktail.
    Tropical doctor, 2014, Volume: 44, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Chloroquine; Female; Fever; Fruit; Human

2014
Lupus nephritis emerging during remission of minimal change disease.
    Arab journal of nephrology and transplantation, 2014, Volume: 7, Issue:1

    Topics: Antibodies, Antinuclear; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenoli

2014
[Rare case of systemic lupus erythematosus with encapsulating peritoneal sclerosis during hemodialysis].
    Nihon Jinzo Gakkai shi, 2014, Volume: 56, Issue:2

    Topics: Ascites; Chronic Disease; Digestive System Surgical Procedures; Humans; Ileus; Immunosuppressive Age

2014
[Case report; Chorea as the first manifestation of systemic lupus erythematosus associated with anti-phospholipid syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3

    Topics: Adult; Antiphospholipid Syndrome; Chorea; Drug Administration Schedule; Female; Humans; Lupus Erythe

2014
The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case.
    BMJ case reports, 2014, May-21, Volume: 2014

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Drainage; Female; Humans; Lupus

2014
Coincident systemic lupus erythematosus and psoriasis vulgaris: a case report.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:6

    Topics: Adult; Autoantibodies; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Phys

2015
Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients.
    The Tohoku journal of experimental medicine, 2014, Volume: 234, Issue:1

    Topics: Adult; Female; Humans; Immunosuppressive Agents; Japan; Lactation; Lupus Erythematosus, Systemic; Pr

2014
Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort.
    International journal of rheumatic diseases, 2015, Volume: 18, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; China; Cohort Studies; Cross-Sectional Studies

2015
Acute kidney injury associated with minimal change disease in systemic lupus erythematosus: a case report.
    Journal of medical case reports, 2014, Dec-13, Volume: 8

    Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic;

2014
Danazol-induced Stevens-Johnson syndrome in a patient with systemic lupus erythematosus.
    Dermatology online journal, 2015, Jan-15, Volume: 21, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Danazol; Epidermis; Estrogen Antagonists; F

2015
Acute psychosis presenting in a patient with systemic lupus erythematosus: Questions and Answers.
    Pediatric nephrology (Berlin, Germany), 2016, Volume: 31, Issue:2

    Topics: Adolescent; Diagnosis, Differential; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic;

2016
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
    The American journal of medicine, 2015, Volume: 128, Issue:7

    Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enteroc

2015
Magnetic resonance imaging findings are useful for evaluating the three-dimensional development and follow-up of linear lupus erythematosus profundus.
    Lupus, 2015, Volume: 24, Issue:11

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Biopsy; Female; Follow-Up Studies; Humans;

2015
Characteristics and outcome of autoimmune liver disease in Asian children.
    Hepatology international, 2015, Volume: 9, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangit

2015
Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.
    BMJ case reports, 2015, May-07, Volume: 2015

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Humans; Imm

2015
Therapeutic management of evans syndrome in a pregnancy with maternal systemic lupus erythematosus.
    Zeitschrift fur Geburtshilfe und Neonatologie, 2015, Volume: 219, Issue:4

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Cesarean Section; Female; Humans; Li

2015
First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient.
    BMC research notes, 2015, Aug-06, Volume: 8

    Topics: Adrenal Cortex Hormones; Antitubercular Agents; Azathioprine; Female; Femur Head Necrosis; Humans; I

2015
[Juvenile systemic lupus erythematosus with unusual manifestation of lupus-associated panniculitis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2015, Volume: 66, Issue:10

    Topics: Adolescent; Anti-Inflammatory Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Hy

2015
A case of mixed connective tissue disease with pseudo-pseudo Meigs' syndrome (PPMS)-like features.
    Lupus, 2016, Volume: 25, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Syste

2016
High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
    Clinical rheumatology, 2015, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Aged; Asymptomatic Diseases; Body Mass Index; Body Surface Area; Female; Femur He

2015
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome;

2016
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome;

2016
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome;

2016
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome;

2016
Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2015, Volume: 123, Issue:12

    Topics: Antibody Affinity; Autoantibodies; Azathioprine; Cloning, Molecular; Enzyme-Linked Immunosorbent Ass

2015
Periorbital edema as an initial sign of systemic lupus erythematosus in an adolescent girl.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:11

    Topics: Administration, Oral; Adolescent; Biopsy; Edema; Eyelid Diseases; Female; Glucocorticoids; Humans; L

2017
First Diagnosis of Systemic Lupus Erythematosus in a Patient on Hemodialysis for Hereditary Polycystic Renal Disease.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:8

    Topics: Aged; Female; Glucocorticoids; Humans; Kidney Failure, Chronic; Late Onset Disorders; Lupus Erythema

2015
Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient.
    Lupus, 2016, Volume: 25, Issue:9

    Topics: Adolescent; Colchicine; Cyclophosphamide; Familial Mediterranean Fever; Female; Humans; Hydroxychlor

2016
Breastfeeding in mothers with systemic lupus erythematosus.
    Lupus, 2016, Volume: 25, Issue:9

    Topics: Adult; Azathioprine; Breast Feeding; Databases, Factual; Decision Making; Female; Humans; Hydroxychl

2016
Acquired reactive perforating collagenosis associated with systemic lupus erythematosus.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Back; Collagen Diseases; Epidermis; Etanercept;

2016
A case of systemic lupus erythematosus (SLE) following Human papillomavirus (HPV) vaccination.
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2016, Volume: 39, Issue:2

    Topics: Adolescent; Autoantibodies; Autoimmune Diseases; Biomarkers; DNA; Female; Humans; Immunization, Seco

2016
Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
    Lupus, 2017, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Age Factors; Cholesterol, LDL; Cohort Studies; Dose-Response Relationship, Drug;

2017
Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus.
    Lupus, 2017, Volume: 26, Issue:6

    Topics: Adolescent; Female; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Lupus

2017
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity.
    Journal of immunology (Baltimore, Md. : 1950), 2017, 02-01, Volume: 198, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Humans; Interleukin-1 Receptor-Associated Kinases; Lupus Er

2017
Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.
    Rheumatology (Oxford, England), 2017, 06-01, Volume: 56, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Case-Control Studies; Female; Genotype; Heterozygote; Humans; Lecti

2017
Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.
    Arthritis & rheumatology (Hoboken, N.J.), 2017, Volume: 69, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Case-Control Studies; Cluster Analysis; Cross-Sectional Studie

2017
Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study.
    Bone, 2008, Volume: 43, Issue:2

    Topics: Adult; Autoantibodies; Body Composition; Body Weight; Bone Density; Case-Control Studies; Hip; Human

2008
Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies.
    American journal of hematology, 2008, Volume: 83, Issue:9

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Autoantibodies; Bone Marrow; Cell Divisi

2008
Interstitial granulomatous dermatitis: a misdiagnosed cutaneous form of systemic lupus erythematosus?
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:6

    Topics: Adult; Azathioprine; Dermatitis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lupus E

2008
[Case of systemic lupus erythematosus occurring after induced abortion and drug eruption].
    Arerugi = [Allergy], 2008, Volume: 57, Issue:7

    Topics: Abortion, Induced; Adult; Anticonvulsants; Diagnosis, Differential; Drug Eruptions; Female; Humans;

2008
Two cases of lupus cystitis with no bladder irritation symptoms.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:16

    Topics: Adrenal Cortex Hormones; Adult; Biopsy; Cystitis; Female; Humans; Lupus Erythematosus, Systemic; Met

2008
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:11

    Topics: Adult; Case-Control Studies; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Co

2008
Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus.
    Rheumatology international, 2009, Volume: 29, Issue:5

    Topics: Adult; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; Humans; Immun

2009
Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Lupus, 2008, Volume: 17, Issue:11

    Topics: Adult; Body Composition; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Predn

2008
Systemic lupus erythematosus associated with extreme hypertriglyceridemia.
    Pediatrics and neonatology, 2008, Volume: 49, Issue:2

    Topics: Adolescent; Chylomicrons; Female; Humans; Hypertriglyceridemia; Lipoprotein Lipase; Lupus Erythemato

2008
Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases.
    Rheumatology international, 2009, Volume: 29, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antiphospholipi

2009
An unusual case of testicular pain.
    Clinical rheumatology, 2009, Volume: 28, Issue:3

    Topics: Administration, Oral; Adult; Azathioprine; Diagnosis, Differential; Diuretics; Drug Therapy, Combina

2009
Effects of rituximab on resistant SLE disease including lung involvement.
    Lupus, 2009, Volume: 18, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; B-Lymph

2009
Prompt remission of severe SLE with only three doses of rituximab infusion and low dose steroid: the first case report from Indonesia.
    Clinical rheumatology, 2009, Volume: 28 Suppl 1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Glucocorticoids; Huma

2009
Do immunosuppressives upregulate antiphospholid antibodies?
    The Journal of rheumatology, 2009, Volume: 36, Issue:2

    Topics: Antiphospholipid Syndrome; Autoantibodies; Autoimmune Diseases; Azathioprine; Biomarkers; Cardiolipi

2009
Lupus myocarditis presenting as acute congestive heart failure: a case report.
    Journal of Korean medical science, 2009, Volume: 24, Issue:1

    Topics: Acute Disease; Administration, Oral; Adult; Echocardiography; Female; Glucocorticoids; Heart Failure

2009
Presenting manifestations of hemophagocytic syndrome in a male patient with systemic lupus erythematosus.
    Rheumatology international, 2010, Volume: 30, Issue:3

    Topics: Biopsy; Bone Marrow; Coma; Fever; Humans; Immunosuppressive Agents; Japan; Leukopenia; Lupus Erythem

2010
[Successful treatment with corticosteroid to the complete atrioventricular block associated with an adult systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Apr-10, Volume: 98, Issue:4

    Topics: Adult; Atrioventricular Block; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Pr

2009
Autoimmune hypothyroidism and lupus-like syndrome.
    Rheumatology international, 2010, Volume: 30, Issue:4

    Topics: Adult; Arthritis; Azathioprine; Biphenyl Compounds; Complement C3; Complement C4; Complement System

2010
A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur.
    Rheumatology international, 2010, Volume: 30, Issue:4

    Topics: Antirheumatic Agents; Drug Therapy, Combination; Female; Femur; Femur Head Necrosis; Humans; Hydroxy

2010
Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.
    Lupus, 2009, Volume: 18, Issue:8

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Female; Hospitalization; Humans; Immunosuppressive Ag

2009
Potentially blinding herbal eye remedies: Cestrum nocturnum or lady of the night.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:5

    Topics: Adult; Blindness; Cestrum; Conjunctival Diseases; Corneal Diseases; Eyelid Diseases; Female; Glucoco

2009
[Intestinal microbial biocenosis in patients with systemic lupus erythematosus treated with prednisolone].
    Klinicheskaia meditsina, 2009, Volume: 87, Issue:6

    Topics: Bacteria; Bacterial Infections; Colon; Colonic Diseases; Colony Count, Microbial; Dose-Response Rela

2009
Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study.
    Modern rheumatology, 2009, Volume: 19, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Cohort Studies; Complement C3; Drug Administration Schedule; Drug T

2009
[The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2009, Volume: 32, Issue:4

    Topics: Adult; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; M

2009
Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus.
    Clinical rheumatology, 2013, Volume: 32 Suppl 1

    Topics: Adolescent; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lymphedema; Prednisolone

2013
An unusual case of loin pain and nephritis.
    Clinical and experimental nephrology, 2010, Volume: 14, Issue:1

    Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosup

2010
Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.
    Rheumatology international, 2010, Volume: 30, Issue:12

    Topics: Adult; Dose-Response Relationship, Drug; Female; Femur Head Necrosis; Glucocorticoids; Humans; Lipid

2010
Seizure and pneumonia in an elderly patient with systemic lupus erythematosus.
    Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Antinuclear; Brain; Consciousness

2009
Influenza virus B-associated hemophagocytic syndrome and recurrent pericarditis in a patient with systemic lupus erythematosus.
    Modern rheumatology, 2010, Volume: 20, Issue:2

    Topics: Anti-Inflammatory Agents; Aspirin; Colchicine; Drug Therapy, Combination; Humans; Influenza B virus;

2010
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:3

    Topics: Adult; Antibodies, Antinuclear; Biomarkers; Dose-Response Relationship, Drug; Epidemiologic Methods;

2010
Type B insulin resistance syndrome with systemic lupus erythematosus.
    Clinical nephrology, 2010, Volume: 73, Issue:2

    Topics: Biopsy; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Insulin; Insul

2010
Type B insulin resistance complicated with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:5

    Topics: Autoantibodies; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucose Intolerance; Huma

2010
[Steroid-induced spinal epidural lipomatosis in pediatric patients].
    Zeitschrift fur Rheumatologie, 2010, Volume: 69, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Child; Drug Therapy, Combination; Epidura

2010
Haematological presentation of systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 2009, Volume: 57

    Topics: Anemia, Hemolytic; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pancyt

2009
Recurrent fractures in an elderly patient with systemic lupus erythematosus.
    International journal of rheumatic diseases, 2009, Volume: 12, Issue:3

    Topics: Aged; Bone Density; Female; Fractures, Bone; Glucocorticoids; Humans; Lupus Erythematosus, Systemic;

2009
A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
    International journal of rheumatic diseases, 2009, Volume: 12, Issue:4

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Fe

2009
[Case of lupus vasculopathy associated with lupus nephritis class IV-G (A)].
    Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:2

    Topics: Adult; Arterioles; Complement System Proteins; Cyclophosphamide; Female; Humans; Immunoglobulins; In

2010
[Case of lupus peritonitis with thrombus in the right atrium].
    Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:2

    Topics: Anticoagulants; Catheterization, Central Venous; Female; Heart Diseases; Humans; Lupus Erythematosus

2010
A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan.
    Lupus, 2010, Volume: 19, Issue:10

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Lupus Erythema

2010
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
    Rheumatology international, 2013, Volume: 33, Issue:1

    Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam

2013
GI vasculitis associated with systemic lupus erythematosus.
    Gastrointestinal endoscopy, 2010, Volume: 72, Issue:3

    Topics: Administration, Oral; Anti-Inflammatory Agents; Colon; Colonic Diseases; Colonoscopy; Diagnosis, Dif

2010
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine.
    Modern rheumatology, 2010, Volume: 20, Issue:6

    Topics: Adult; Female; Glucocorticoids; Heart Failure; Humans; Immunosuppressive Agents; Lupus Erythematosus

2010
Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.
    Modern rheumatology, 2010, Volume: 20, Issue:6

    Topics: Adult; Antibodies, Viral; DNA, Viral; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic

2010
Belinda's back pain.
    Australian family physician, 2010, Volume: 39, Issue:7

    Topics: Absorptiometry, Photon; Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Diphosphon

2010
[A case of intubation granuloma treated with steroid inhalation].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:7

    Topics: Administration, Inhalation; Adult; Androstadienes; Female; Fluticasone; Granuloma; Humans; Intubatio

2010
Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.
    Rheumatology international, 2012, Volume: 32, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Case-Control Studies; Dose-Response Relatio

2012
The role of apoptotic proteins in patients with systemic lupus erythematosis.
    The Egyptian journal of immunology, 2009, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Apoptosis; Autoantibodies; DNA Damage; Fas Ligand Prote

2009
Transient myopic shift as the presenting symptom of systemic lupus erythematosus: a UBM study.
    Ocular immunology and inflammation, 2010, Volume: 18, Issue:5

    Topics: Adolescent; Choroid; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Microscopy, Aco

2010
Mycophenolate mofetil treatment in children and adolescents with lupus.
    Archives of disease in childhood, 2010, Volume: 95, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Complement C3; Complement C4; Drug Administration Schedule; Dru

2010
Lupus cystitis in an Omani girl.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:5

    Topics: Administration, Oral; Adolescent; Biopsy; Cystitis; Cystoscopy; Drug Therapy, Combination; Female; H

2010
Pandemic (H1N1) 2009-associated ARDS rescued by neuraminidase inhibitors with emergency use of extracorporeal membrane oxygenation.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:17

    Topics: Acids, Carbocyclic; Adult; Anemia, Hemolytic, Autoimmune; Antiviral Agents; Combined Modality Therap

2010
Choledochal cyst and systemic lupus erythematosus.
    Pediatric surgery international, 2011, Volume: 27, Issue:1

    Topics: Abdominal Pain; Adolescent; Cholangiopancreatography, Magnetic Resonance; Choledochal Cyst; Common B

2011
Bilateral optic neuritis in pediatric systemic lupus erythematosus with antiphospholipid antibody syndrome.
    Indian journal of pediatrics, 2011, Volume: 78, Issue:2

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome;

2011
Twenty-two years' experience with childhood-onset SLE in a developing country: are outcomes similar to developed countries?
    Archives of disease in childhood, 2011, Volume: 96, Issue:1

    Topics: Adolescent; Age Distribution; Child; Developed Countries; Developing Countries; Epidemiologic Method

2011
Intestinal angina due to atherosclerosis in a 45-year-old systemic lupus erythematosus patient.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:19

    Topics: Abdominal Pain; Aorta, Abdominal; Atherosclerosis; Humans; Intestines; Ischemia; Lupus Erythematosus

2010
Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
    Eye & contact lens, 2010, Volume: 36, Issue:6

    Topics: Adolescent; Aza Compounds; Cornea; Corneal Edema; Corneal Stroma; Corneal Transplantation; Drug Admi

2010
Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Lupus, 2010, Volume: 19, Issue:14

    Topics: Abortion, Spontaneous; Adolescent; Adult; Antibodies, Antiphospholipid; Female; Glucocorticoids; Hum

2010
Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration.
    Rheumatology international, 2011, Volume: 31, Issue:10

    Topics: Adult; Aged; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Humans; Lupus Eryt

2011
Systemic lupus erythematosus in a 3-month old male presenting as thrombocytopenia.
    Lupus, 2011, Volume: 20, Issue:5

    Topics: Aspirin; Fibrinolytic Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Lupus Eryth

2011
Rituximab and lupus interstitial lung disease: friend or foe?
    International journal of rheumatic diseases, 2011, Volume: 14, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Drug Therapy, Combination; Dysp

2011
[Protein-losing enteropathy: a cause of hypoalbuminaemia in patients with systemic lupus erythematosus].
    Zeitschrift fur Rheumatologie, 2011, Volume: 70, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Female; Humans; Hypoalbuminemia; Lup

2011
A case of lupus-associated pancreatitis with ruptured pseudoaneurysms.
    Modern rheumatology, 2011, Volume: 21, Issue:4

    Topics: Aneurysm, False; Aneurysm, Ruptured; Angiography; Anti-Bacterial Agents; Embolization, Therapeutic;

2011
Colitis associated with active systemic lupus erythematosus successfully treated with rituximab.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:2

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Colitis; Colo

2011
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten

2011
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
    Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6

    Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hep

2011
Disseminated Nocardia farcinica infection in a patient with systemic lupus erythematosus.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 6

    Topics: Anti-Bacterial Agents; Debridement; Drainage; Humans; Imipenem; Immunocompromised Host; Immunosuppre

2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation.
    Rheumatology (Oxford, England), 2011, Volume: 50, Issue:8

    Topics: Adult; Antibodies, Monoclonal; B-Lymphocytes; Cyclophosphamide; Drug Therapy, Combination; Female; H

2011
Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare.
    Rheumatology international, 2012, Volume: 32, Issue:4

    Topics: Child; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Sys

2012
Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Adult; Cyclophosphamide; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Inter

2012
Kikuchi fujimoto disease and systemic lupus erythematosus--a rare association.
    The Journal of the Association of Physicians of India, 2010, Volume: 58

    Topics: Adult; Female; Folic Acid; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Lupus

2010
Mesenteric vasculitis with genitourinary tract involvement in systemic lupus erythematosus.
    Postgraduate medical journal, 2011, Volume: 87, Issue:1029

    Topics: Cyclophosphamide; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Male Urogenital Dise

2011
Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome--a case report.
    Rheumatology international, 2012, Volume: 32, Issue:6

    Topics: Adolescent; Antihypertensive Agents; Arthritis; Autoantibodies; Biomarkers; Deglutition Disorders; D

2012
Vesicovaginal fistula following large-loop excision of the transformation zone in a chronic systemic glucocorticoid user.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:10

    Topics: Adult; Cervix Uteri; Female; Glucocorticoids; Gynecologic Surgical Procedures; Humans; Lupus Erythem

2011
[Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2011, Volume: 34, Issue:2

    Topics: Adult; Antihypertensive Agents; Bosentan; Cyclophosphamide; Drug Administration Schedule; Drug Thera

2011
Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy.
    Lupus, 2011, Volume: 20, Issue:10

    Topics: Adult; Aged; Diabetes Mellitus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Ery

2011
Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.
    BMC women's health, 2011, Jun-10, Volume: 11

    Topics: Adolescent; Adult; Age Factors; Amenorrhea; Case-Control Studies; Cyclophosphamide; Dose-Response Re

2011
Acute cerebellar ataxia in lupus.
    Lupus, 2011, Volume: 20, Issue:12

    Topics: Acute Disease; Atrophy; Cerebellar Ataxia; Cerebellum; Female; Humans; Lupus Erythematosus, Systemic

2011
Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus.
    Modern rheumatology, 2012, Volume: 22, Issue:2

    Topics: Bone Marrow; Dose-Response Relationship, Drug; Female; Fever; Humans; Immunosuppressive Agents; Lupu

2012
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.
    Modern rheumatology, 2012, Volume: 22, Issue:2

    Topics: Adult; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunog

2012
Lamotrigine-induced lupus: a case report.
    International journal of rheumatic diseases, 2011, Volume: 14, Issue:3

    Topics: Adolescent; Anticonvulsants; Antirheumatic Agents; Arthralgia; Epilepsy; Female; Humans; Hydroxychlo

2011
Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus: review of literature.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:8

    Topics: Adult; Autoantibodies; Cyclophosphamide; Ecchymosis; Factor VIII; Female; Hematuria; Hemophilia A; H

2011
Aplastic crisis as primary manifestation of systemic lupus erythematosus.
    Onkologie, 2011, Volume: 34, Issue:8-9

    Topics: Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Autoantibodies; Bone Marrow; Bone Marrow Examinatio

2011
Protein-losing enteropathy as initial manifestation of systemic lupus erythematosus.
    Lupus, 2012, Volume: 21, Issue:4

    Topics: Adolescent; Antibodies, Antinuclear; Azathioprine; Biomarkers; Complement C3; Diarrhea; Drug Therapy

2012
[A case of bullous lupus in black skin].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:11

    Topics: Comoros; Complement C3; Dermis; Epidermis; Fluorescent Antibody Technique; Humans; Hydroxychloroquin

2011
Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Rheumatology (Oxford, England), 2012, Volume: 51, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Murine-Derived;

2012
Palisaded neutrophilic granulomatous dermatitis caused by cellulitis in a patient with systemic lupus erythematosus.
    International journal of dermatology, 2011, Volume: 50, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Cefazolin; Cellulitis; D

2011
Three siblings with systemic lupus erythematosus.
    The Journal of dermatology, 2012, Volume: 39, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Azathioprine; Dermatologic Agents; Exanthema; Female; HLA Antigens;

2012
Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus.
    Medical molecular morphology, 2011, Volume: 44, Issue:4

    Topics: Adult; Aging; Epstein-Barr Virus Infections; Female; Glucocorticoids; Herpesvirus 4, Human; Humans;

2011
The clinical characteristics of lupus related protein-losing enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital.
    Lupus, 2012, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Blood Sedimen

2012
Central nervous system tuberculosis: mimicking neuropsychiatric systemic lupus erythematosus.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:2

    Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Diagnostic Errors; Humans; Lupus Erythematosu

2012
Bullous systemic lupus erythematosus with lupus nephritis: a rare case of a subepidermal bullous disorder in a child.
    Cutis, 2012, Volume: 89, Issue:1

    Topics: Child; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunoglobulin G; Lupus Erythematos

2012
Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid.
    Modern rheumatology, 2013, Volume: 23, Issue:1

    Topics: Adult; Central Serous Chorioretinopathy; Dose-Response Relationship, Drug; Drug Therapy, Combination

2013
Invasive fungal infection in Chinese patients with systemic lupus erythematosus.
    Clinical rheumatology, 2012, Volume: 31, Issue:7

    Topics: Adult; Age Factors; Anti-Inflammatory Agents; Asian People; Aspergillosis; Aspergillus; Candida; Can

2012
Young male with systemic lupus erythematosus presenting with sensorineural deafness with immune suppression induced miliary tuberculosis.
    The Journal of the Association of Physicians of India, 2011, Volume: 59

    Topics: Adult; Antineoplastic Agents; Antitubercular Agents; Biopsy; Hearing Loss, Sensorineural; Humans; Im

2011
Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Immunos

2012
Methimazole-induced bullous systemic lupus erythematosus: a case report.
    Journal of Korean medical science, 2012, Volume: 27, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Antithyroid Agents; Blister; Drug Therapy, Co

2012
Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:7

    Topics: Adolescent; Antiphospholipid Syndrome; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydro

2012
Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders.
    The Journal of dermatology, 2012, Volume: 39, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents; Diagnosis, Differential; Epstein-Barr Virus Infections; Female

2012
Intestinal obstruction as the initial presentation of lupus mesenteric vasculitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:6

    Topics: Antirheumatic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans;

2012
[Case of acute limbic encephalitis associated with SLE accompanied with anti-glutamate receptor antibodies].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:8

    Topics: Acute Disease; Autoantibodies; Autoimmunity; Biomarkers; Female; Humans; Limbic Encephalitis; Lupus

2012
A case of systemic lupus erythematosus with bamboo joint-like corditis as an antecedent symptom.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:4

    Topics: Adult; Female; Glucocorticoids; Hoarseness; Humans; Laryngitis; Lupus Erythematosus, Systemic; Predn

2013
Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:6

    Topics: Absorptiometry, Photon; Adult; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Case

2013
[Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2012, Volume: 50, Issue:9

    Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Biomarkers; Child; Child, Prescho

2012
Three-pointed star sign of lupus enteritis.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:6

    Topics: Abdominal Pain; Diarrhea; Female; Glucocorticoids; Humans; Intestinal Diseases; Lupus Erythematosus,

2013
C4 deficiency state in antiphospholipid antibody-related recurrent preeclampsia evolving into systemic lupus erythematosus.
    Rheumatology international, 2002, Volume: 22, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Complement C4; Drug Therapy, Combination

2002
Idiopathic intracranial hypertension with elevated cerebrospinal fluid level of interleukin-6 in a patient with systemic lupus erythematosus.
    Clinical rheumatology, 2002, Volume: 21, Issue:3

    Topics: Adolescent; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Interleukin-6; Intracranial

2002
Systemic lupus erythematosus with haemophagocytosis and severe liver disorder.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination

2002
Bilateral optic neuritis as first manifestation of systemic lupus erythematosus.
    Korean journal of ophthalmology : KJO, 2002, Volume: 16, Issue:1

    Topics: Adult; Female; Fluorescein Angiography; Humans; Lupus Erythematosus, Systemic; Optic Neuritis; Predn

2002
Fulminant necrotising fasciitis developing during long term corticosteroid treatment of systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:9

    Topics: Fasciitis, Necrotizing; Fatal Outcome; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemi

2002
A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:9

    Topics: Adult; Animals; Anti-Infective Agents; Antibodies, Protozoan; Cerebral Cortex; Drug Combinations; Fe

2002
[Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus].
    Deutsche medizinische Wochenschrift (1946), 2002, Sep-13, Volume: 127, Issue:37

    Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflamma

2002
Pyloric stenosis in a patient with systemic lupus erythematosus.
    Endoscopy, 2002, Volume: 34, Issue:10

    Topics: Adult; Anti-Inflammatory Agents; Cystitis; Female; Gastroscopy; Humans; Lupus Erythematosus, Systemi

2002
Disseminated candidiasis following prednisolone therapy in systemic lupus erythematosus.
    Pediatrics international : official journal of the Japan Pediatric Society, 2002, Volume: 44, Issue:6

    Topics: Anti-Inflammatory Agents; Candidiasis; Child; Humans; Lupus Erythematosus, Systemic; Male; Multiple

2002
Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:11

    Topics: Adolescent; Adult; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immun

2002
Active idiopathic Systemic Lupus Erythematosus in a 94-year-old woman necessitating immunosuppressive therapy.
    Age and ageing, 2002, Volume: 31, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cyclophosphamide; Female; Humans; Immunoglobulins

2002
Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.
    Scandinavian journal of rheumatology, 2002, Volume: 31, Issue:5

    Topics: Adolescent; Adult; Aged; Asian People; Female; Glucocorticoids; Hong Kong; Humans; Immunocompromised

2002
Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus.
    Lupus, 2003, Volume: 12, Issue:1

    Topics: Adult; Anemia, Hemolytic; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathio

2003
[Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis].
    Nihon Jinzo Gakkai shi, 2002, Volume: 44, Issue:8

    Topics: Adult; Angiotensin Receptor Antagonists; Anticoagulants; Antigen-Antibody Complex; Antihypertensive

2002
A case of lymphocytic infundibuloneurohypophysitis associated with systemic lupus erythematosus.
    Endocrine journal, 2002, Volume: 49, Issue:6

    Topics: Adrenal Insufficiency; Adult; Diabetes Insipidus; Humans; Hypogonadism; Hypothalamic Diseases; Hypot

2002
Relationship between glucocorticoid-induced osteoporosis and vitamin D receptor genotypes.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2002, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Arthritis, Rheumatoid; Bone Density; Female; Genotype; Humans; Lupus Erythematosu

2002
A case of nodular cutaneous lupus mucinosis.
    The Journal of dermatology, 2003, Volume: 30, Issue:4

    Topics: Adult; Biopsy, Needle; Female; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Lupus E

2003
Cytomegalovirus colitis following immunosuppressive therapy for lupus peritonitis and lupus nephritis.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:4

    Topics: Adult; Colitis; Colonoscopy; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Imm

2003
[Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:5

    Topics: Anti-Inflammatory Agents; Antiviral Agents; Connective Tissue Diseases; Drug Therapy, Combination; F

2003
[Plasma homocysteine levels in systemic lupus erythematosus].
    Medicina clinica, 2003, May-17, Volume: 120, Issue:18

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Cholesterol; Creatinine;

2003
Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases.
    The British journal of dermatology, 2003, Volume: 148, Issue:5

    Topics: Antifungal Agents; Clobetasol; Diagnosis, Differential; Drug Eruptions; Female; Glucocorticoids; Hum

2003
[Systemic lupus erythematosus with multifocal posterior pigment epitheliopathy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, May-10, Volume: 92, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic; Pigment Epithelium o

2003
Bilateral retinal detachment in a young woman.
    Lancet (London, England), 2003, Jun-14, Volume: 361, Issue:9374

    Topics: Adult; Anti-Inflammatory Agents; Choroid; Choroid Diseases; Cyclophosphamide; Drug Therapy, Combinat

2003
Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:6

    Topics: Adult; Biopsy, Needle; Bone Marrow Cells; Drug Therapy, Combination; Female; gamma-Globulins; Humans

2003
Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients.
    Lupus, 2003, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Biomarkers; Dose-Response Relationsh

2003
Quantitative imaging of cerebral blood flow using SPECT with 123I-iodoamphetamine in neuropsychiatric systemic lupus erythematosus.
    The Journal of rheumatology, 2003, Volume: 30, Issue:9

    Topics: Adult; Cerebrovascular Circulation; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Iof

2003
Treatment of systemic lupus erythematosus with prednisone and prednisolone.
    Journal of the American Medical Association, 1955, Dec-17, Volume: 159, Issue:16

    Topics: Humans; Lupus Erythematosus, Systemic; Prednisolone; Prednisone; Steroids

1955
Prednisone and prednisolone in the treatment of systemic lupus erythematous.
    Journal of the American Medical Association, 1956, Jun-02, Volume: 161, Issue:5

    Topics: Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Prednisolone; Prednisone; Stero

1956
[Prednisone & prednisolone in the treatment of generalized lupus erythematosus].
    Revista medica de Chile, 1957, Volume: 85, Issue:9

    Topics: Humans; Lupus Erythematosus, Systemic; Prednisolone; Prednisone

1957
[A case of acute systemic lupus erythematosus; resistance of the lupus nephropathy to combined treatment with prednisone, nivaquine and nitrogranulogen].
    Polskie Archiwum Medycyny Wewnetrznej, 1958, Volume: 28, Issue:3

    Topics: Chloroquine; Humans; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Mechlorethamine; Nitrog

1958
Effect of medrol on disseminated lupus erythematosus and on electrolyte metabolism.
    Metabolism: clinical and experimental, 1958, Volume: 7, Issue:4 Pt 2

    Topics: Electrolytes; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone

1958
Evaluation of steroids in systemic lupus erythematosus with particular emphasis on triamcinolone and methylprednisolone.
    Metabolism: clinical and experimental, 1958, Volume: 7, Issue:4 Pt 2

    Topics: Fludrocortisone; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone; Steroids;

1958
Systemic lupus erythematosus; results of treatment with triamcinolone.
    California medicine, 1958, Volume: 89, Issue:3

    Topics: Anti-Inflammatory Agents; Female; Fludrocortisone; Humans; Lupus Erythematosus, Systemic; Prednisolo

1958
[Present status of treatment of systemic lupus erythematosus. II. Steroid drugs (cortisone, prednisone, prednisolone)].
    Polskie Archiwum Medycyny Wewnetrznej, 1958, Volume: 28, Issue:7

    Topics: Cortisone; Humans; Lupus Erythematosus, Systemic; Prednisolone; Prednisone

1958
Methylprednisolone (medrol) in the treatment of systemic lupus erythematosus; analysis of results in forty cases.
    Journal of the American Medical Association, 1959, Jul-25, Volume: 170, Issue:13

    Topics: Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone

1959
Treatment of disseminated lupus erythematosus and rheumatoid arthritis with methylprednisolone.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1959, Volume: 111, Issue:6

    Topics: Arthritis; Arthritis, Rheumatoid; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Prednis

1959
Current therapy of systemic lupus erythematosus. A comparative evaluation of corticosteroids and their side-effects with emphasis on fifty patients treated with dexamethasone.
    JAMA, 1960, Aug-13, Volume: 173

    Topics: Adrenal Cortex Hormones; Cardiovascular Agents; Dexamethasone; Glucocorticoids; Humans; Lupus Erythe

1960
[On the combined therapeutic use of a corticoid and an anabolic steroid].
    Minerva medica, 1962, Dec-19, Volume: 53

    Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Anemia; beta-Thalasse

1962
[TREATMENT OF COLLAGEN DISEASES].
    Prensa medica argentina, 1963, Mar-29, Volume: 50

    Topics: Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases; Chloroquine; Collagen Diseases; Dermatomyosit

1963
LUPUS ERYTHEMATOSUS PRESENTING AS HEMOLYTIC ANEMIA; REPORT OF A CASE AND REVIEW OF CLINICAL ASPECTS.
    Rocky Mountain medical journal, 1963, Volume: 60

    Topics: Adrenocorticotropic Hormone; Anemia; Anemia, Hemolytic; Autoimmune Diseases; Humans; Lupus Erythemat

1963
[GENERAL CORTICOTHERAPY IN DERMATOLOGY].
    Strasbourg medical, 1963, Volume: 14

    Topics: Adrenal Cortex Hormones; Cortisone; Dermatitis Herpetiformis; Dermatology; Dermatomyositis; Dexameth

1963
A LUPUS-LIKE SYNDROME FOLLOWING PROPYLTHIOURACIL ADMINISTRATION.
    The Journal of the Kentucky Medical Association, 1964, Volume: 62

    Topics: Adolescent; Antithyroid Agents; Black People; Drug Hypersensitivity; Humans; Hyperthyroidism; Lupus

1964
EPILEPSY AND LUPUS ERYTHEMATOSUS.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Acetazolamide; Amphetamine; Anticonvulsants; Child; Dexamethasone; Diagnosis; Epilepsy; Lupus Erythe

1964
ALLERGY TO ACTH OF ANIMAL AND HUMAN ORIGIN.
    Acta allergologica, 1963, Volume: 18

    Topics: Adrenocorticotropic Hormone; Anaphylaxis; Arthritis; Arthritis, Rheumatoid; Asthma; Cyanosis; Dermat

1963
[ON 2 PEDIATRIC CASES OF DISSEMINATED LUPUS ERYTHEMATOSUS (MALIGNANT DERMATO-VISCERITIS)].
    Archivio italiano di pediatria e puericoltura, 1963, Volume: 23

    Topics: Child; Chloroquine; Lupus Erythematosus, Systemic; Pathology; Prednisolone; Radiography, Thoracic

1963
PROLONGED HIGH DOSAGE CORTICOSTEROID THERAPY IN DISSEMINATED LUPUS ERYTHEMATOSUS.
    The Medical journal of Australia, 1964, Feb-22, Volume: 1

    Topics: Adrenal Cortex Hormones; Diabetes Mellitus; Humans; Lupus Erythematosus, Systemic; Peptic Ulcer; Pre

1964
THYMIC ABNORMALITY IN SYSTEMIC LUPUS ERYTHEMATOSUS.
    Australasian annals of medicine, 1964, Volume: 13

    Topics: Adolescent; Blood Chemical Analysis; Brain Diseases; Cerebral Hemorrhage; Hemorrhage; Humans; Kidney

1964
TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE.
    Lancet (London, England), 1964, Apr-25, Volume: 1, Issue:7339

    Topics: Adolescent; Anemia; Anemia, Pernicious; Antineoplastic Agents; Autoimmune Diseases; Azathioprine; Cl

1964
A TRIAL OF AMOPYROQUIN IN THE TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS.
    The British journal of dermatology, 1964, Volume: 76

    Topics: Aminoquinolines; Antimalarials; Aspartate Aminotransferases; Biomedical Research; Leukopenia; Lupus

1964
[TREATMENT OF LUPUS-NEPHROPATHIES WITH 6-MERCAPTOPURINE].
    Orvosi hetilap, 1964, Jan-19, Volume: 105

    Topics: Albuminuria; Chloroquine; Diuretics; Edema; Glomerulonephritis; Humans; Lupus Erythematosus, Discoid

1964
[MENTAL DISORDERS FOLLOWING STEROID HORMONE THERAPY WITH SPECIAL REFERENCE TO SYSTEMIC LUPUS ERYTHEMATOSUS].
    Ceskoslovenska psychiatrie, 1964, Volume: 60

    Topics: Adrenocorticotropic Hormone; Central Nervous System Diseases; Collagen Diseases; Dexamethasone; Epil

1964
[THE ELECTROLYTE COMPOSITION OF THE BLOOD SERUM AND ADRENOCORTICAL FUNCTION IN PATIENTS WITH COLLAGEN DISEASES].
    Terapevticheskii arkhiv, 1963, Volume: 35

    Topics: Arthritis; Blood Chemical Analysis; Collagen Diseases; Electrolytes; Humans; Lupus Erythematosus, Sy

1963
CORTISOL TOLERANCE IN RHEUMATIC DISEASES.
    Lancet (London, England), 1964, Jul-11, Volume: 2, Issue:7350

    Topics: 17-Ketosteroids; Aldosterone; Arthritis; Arthritis, Rheumatoid; Cortisone; Drug Tolerance; Humans; H

1964
REVERSAL OF SEROLOGIC REACTIONS BY HEPARIN: THERAPEUTIC IMPLICATIONS. I. SYSTEMIC LUPUS ERYTHEMATOSUS.
    Annals of allergy, 1964, Volume: 22

    Topics: Antibodies; Antigen-Antibody Reactions; Blood Coagulation; Complement System Proteins; DNA; Heparin;

1964
[GROUP OCCURRANCE OF HERPES ZOSTER IN PATIENTS TREATED WITH CORTICOSTEROIDS].
    Orvosi hetilap, 1964, Jul-05, Volume: 105

    Topics: Adrenal Cortex Hormones; Cross Infection; Drug Therapy; Fluorescent Antibody Technique; Geriatrics;

1964
[CASES OF HERPES ZOSTER DURING A PROLONGED STEROID THERAPY].
    Orvosi hetilap, 1964, Jul-05, Volume: 105

    Topics: Chloramphenicol; Dermatitis, Exfoliative; Drug Therapy; gamma-Globulins; Herpes Zoster; Humans; Lupu

1964
[PREDOMINANTLY RENAL AND ANEMIC SYMPTOMS IN THE COURSE OF LUPUS ERTHEMATOSUS DISSEMINATUS].
    Die Medizinische Welt, 1965, Feb-27, Volume: 82

    Topics: Anemia; Anemia, Hemolytic; Biopsy; Drug Therapy; Humans; Kidney; Lupus Erythematosus, Systemic; Neph

1965
OBSERVATIONS IN A SERIES OF 14 CASES OF SYSTEMIC LUPUS ERYTHEMATOSUS.
    Bulletin of the Calcutta School of Tropical Medicine, 1964, Volume: 12

    Topics: Clinical Laboratory Techniques; Humans; Laboratories; Lupus Erythematosus, Systemic; Prednisolone

1964
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    Annals of the rheumatic diseases, 1965, Volume: 24

    Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marr

1965
[Evaluation of methylprednisolone, triamcinolone and dexamethasone in the treatment of generalized lupus erythematosus].
    Revista medica de Chile, 1960, Volume: 88

    Topics: Dexamethasone; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone; Triamcinolon

1960
Discoid lupus erythematosus.
    Medical times, 1960, Volume: 88

    Topics: Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Prednisolone

1960
Autoimmune hepatitis in a patient with systemic lupus erythematosus.
    Clinical rheumatology, 2003, Volume: 22, Issue:3

    Topics: Biopsy, Needle; Blood Chemical Analysis; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Hum

2003
A case of lupus peritonitis and cystitis after ovulation induction therapy.
    American journal of obstetrics and gynecology, 2003, Volume: 189, Issue:3

    Topics: Adult; Cystitis; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Menotropins

2003
[Effects of therapies on childhood systemic lupus erythematosus].
    Ryumachi. [Rheumatism], 2003, Volume: 43, Issue:4

    Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Therapy, C

2003
[Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Ryumachi. [Rheumatism], 2003, Volume: 43, Issue:4

    Topics: alpha-Tocopherol; Antioxidants; Bezafibrate; Caloric Restriction; Diet, Reducing; Fatty Liver; Femal

2003
Bone mineral density in premenopausal women with systemic lupus erythematosus.
    The Journal of rheumatology, 2003, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Bone Density; Calcium; Cross-Sectional Studies; Dietary Supplements; Female; Gluc

2003
An overwhelming pulmonary fungus ball in a systemic lupus erythematosus patient.
    Zeitschrift fur Rheumatologie, 2003, Volume: 62, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Aspergillosis; Diagnosis, Differential; Female; Humans; Lung; Lupus

2003
Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Rheumatology (Oxford, England), 2004, Volume: 43, Issue:5

    Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Intercellular Adhesion Molecule

2004
CMV enteritis causing ileal perforation in underlying lupus enteritis.
    Clinical rheumatology, 2004, Volume: 23, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cytomegalovirus; Cytomegalovirus In

2004
Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus.
    Lupus, 2004, Volume: 13, Issue:2

    Topics: Adult; Cerebrovascular Disorders; Complement C4; Female; Humans; Lupus Erythematosus, Systemic; Lupu

2004
[Beneficial effect of glucocorticosteroids for esophageal varices due to idiopathic portal hypertension following systemic lupus erythematosus].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2004, Volume: 27, Issue:1

    Topics: Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Lupus Erythematosus, Systemic;

2004
Cyanotic change of colon mucosa in a patient with Raynaud's phenomenon.
    The American journal of medicine, 2004, Apr-15, Volume: 116, Issue:8

    Topics: Aged; Colon; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Prednisolone; Radiograp

2004
Autoimmune hepatitis accompanied by systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:3

    Topics: Adult; Antibodies, Antinuclear; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver; Lupus

2004
Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization.
    Lupus, 2004, Volume: 13, Issue:4

    Topics: Adult; Central Nervous System Diseases; Cohort Studies; Dose-Response Relationship, Drug; Female; Gl

2004
Neonatal lupus erythematosus with cholestatic hepatitis.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2004, Volume: 37, Issue:2

    Topics: Anemia; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Cholestasis; Hepatitis; Humans; Infan

2004
Pulmonary hemorrhage in systemic lupus erythematosus.
    Seminars in arthritis and rheumatism, 2004, Volume: 33, Issue:6

    Topics: Adult; Cyclophosphamide; Female; Glucocorticoids; Health Status Indicators; Hemorrhage; Humans; Immu

2004
Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.
    Neurology, 2004, Jul-27, Volume: 63, Issue:2

    Topics: Adult; Antiparkinson Agents; Basal Ganglia; Delirium; Epilepsy, Tonic-Clonic; Female; Hallucinations

2004
Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis.
    Clinical rheumatology, 2004, Volume: 23, Issue:4

    Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Edema; Enteritis; Female; Glucocorticoids; Human

2004
Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.
    Journal of clinical pharmacology, 2004, Volume: 44, Issue:9

    Topics: Adult; Anti-Inflammatory Agents; Cell Proliferation; Drug Interactions; Drug Therapy, Combination; F

2004
Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid.
    Rheumatology international, 2005, Volume: 25, Issue:5

    Topics: Administration, Oral; Danazol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen

2005
Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2005, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bone Density; Cross-Sectional Studies; Engl

2005
Disseminated tuberculosis of the skin detected on gallium-67 scintigraphy.
    The Israel Medical Association journal : IMAJ, 2004, Volume: 6, Issue:12

    Topics: Adult; Female; Gallium; Glucocorticoids; Humans; Immunocompromised Host; Lupus Erythematosus, System

2004
[Antiphospholipid syndrome and exogenic risk factors in thromboses].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:11

    Topics: Antiphospholipid Syndrome; Antirheumatic Agents; Cyclophosphamide; Female; Glucocorticoids; Humans;

2004
Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus.
    The Journal of dermatology, 2004, Volume: 31, Issue:10

    Topics: Adult; Autoantibodies; Biomarkers; Biopsy, Needle; Female; Fluorescent Antibody Technique, Indirect;

2004
Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    The Journal of rheumatology, 2005, Volume: 32, Issue:4

    Topics: Adult; Antibiotic Prophylaxis; Antitubercular Agents; Azathioprine; Endemic Diseases; Female; Glucoc

2005
[A case of systemic lupus erythematosus presenting with jaundice and lupus pneumonia].
    Arerugi = [Allergy], 2005, Volume: 54, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Female; Hepatitis, Autoimmune; Humans; Jaundice; Lupus Erythematosu

2005
Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.
    Lupus, 2005, Volume: 14, Issue:4

    Topics: Acute Kidney Injury; Adult; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythe

2005
Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus.
    Pediatric pulmonology, 2005, Volume: 40, Issue:3

    Topics: Adolescent; Cryptogenic Organizing Pneumonia; Female; Follow-Up Studies; Glucocorticoids; Humans; Lu

2005
Hypovolemic shock as an initial presentation of pediatric systemic lupus erythematosus.
    Pediatrics international : official journal of the Japan Pediatric Society, 2005, Volume: 47, Issue:3

    Topics: Adolescent; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Glomerulon

2005
Successful treatment of Type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.
    Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22, Issue:6

    Topics: Adult; Diabetes Complications; Female; Glucocorticoids; Humans; Hyperglycemia; Hypoglycemic Agents;

2005
Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana.
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:6

    Topics: Adult; Antifungal Agents; Ascomycota; Biopsy; Dermatomycoses; Female; Fluconazole; Glucocorticoids;

2005
Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI.
    Lupus, 2005, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Case-Control Studies; Cholesterol; Female; Femur Head; Glucocorticoids; Humans; L

2005
Lupus erythematosus and sarcoidosis.
    Clinical rheumatology, 2005, Volume: 24, Issue:3

    Topics: Adult; Biopsy; Diagnosis, Differential; Female; Follow-Up Studies; Glucocorticoids; Humans; Lung; Lu

2005
Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
    Annals of the rheumatic diseases, 2006, Volume: 65, Issue:1

    Topics: Adalimumab; Adrenocorticotropic Hormone; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Huma

2006
Kikuchi-Fujimoto disease: a case report.
    Rheumatology international, 2005, Volume: 26, Issue:2

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Biomarkers; Diagnosis, Differential; Female; Histio

2005
Symptomatic renal tubular acidosis (RTA) in patients with systemic lupus erythematosus: an analysis of six cases with new association of type 4 RTA.
    Rheumatology (Oxford, England), 2005, Volume: 44, Issue:9

    Topics: Acidosis, Renal Tubular; Adult; Bicarbonates; Female; Glucocorticoids; Humans; Lupus Erythematosus,

2005
Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
    Lupus, 2005, Volume: 14, Issue:6

    Topics: Anemia, Hemolytic, Autoimmune; Cyclosporine; Female; Glucocorticoids; Hemoglobins; Humans; Immunosup

2005
CAPD-related peritonitis due to Salmonella enteritidis in a patient with SLE.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:2

    Topics: Catheterization; Device Removal; Disease Susceptibility; Female; Humans; Immunocompromised Host; Imm

2005
Rufo v Hosking [2004] NSWCA 391.
    Journal of law and medicine, 2005, Volume: 13, Issue:1

    Topics: Dexamethasone; Humans; Lupus Erythematosus, Systemic; Malpractice; New South Wales; Osteoporosis; Pr

2005
Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12

    Topics: Administration, Oral; Adolescent; Age of Onset; Child; Cyclophosphamide; Female; Follow-Up Studies;

2005
Minimal change nephrotic syndrome associated with systemic lupus erythematosus.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:1

    Topics: Adult; Biopsy, Needle; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunohistoche

2006
SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody).
    Rheumatology international, 2006, Volume: 26, Issue:8

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, M

2006
Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:4

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Azathioprine; Diarrhea;

2006
A case of lupus cystitis diagnosed from urinary symptoms as the sole initial complaint.
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:10

    Topics: Adult; Anti-Inflammatory Agents; Cystitis, Interstitial; Female; Humans; Lupus Erythematosus, System

2005
Systemic lupus erythematosus (SLE) presenting with nephrotic syndrome and membranous glomerulopathy in a 10-year-old girl.
    Acta paediatrica (Oslo, Norway : 1992), 2005, Volume: 94, Issue:10

    Topics: Antibodies, Antinuclear; Biopsy, Needle; Child; Cyclophosphamide; Diagnosis, Differential; Drug Ther

2005
Serositis related to systemic lupus erythematosus: prevalence and outcome.
    Lupus, 2005, Volume: 14, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Glucocorticoids; Hong Kong; Humans; Lupus Er

2005
Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus.
    The Malaysian journal of pathology, 1994, Volume: 16, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Child; Early Diagnosis; Glucocorticoids; Humans; Lupus Erythematosus,

1994
Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:3

    Topics: Adult; Brain; Cyclosporine; Female; Glucocorticoids; Humans; Hypertensive Encephalopathy; Immunosupp

2005
A catastrophic-onset longitudinal myelitis accompanied by bilateral internuclear ophthalmoplegia in a patient with systemic lupus erythematosus.
    Journal of Korean medical science, 2005, Volume: 20, Issue:6

    Topics: Adult; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging;

2005
Fatal varicella infection in a girl with systemic lupus erythematosus after oral acyclovir prophylaxis.
    European journal of pediatrics, 2006, Volume: 165, Issue:4

    Topics: Acyclovir; Adolescent; Antiviral Agents; Aspergillosis; Azathioprine; Brain; Chickenpox; Disseminate

2006
Platelet satellitism in lupus erythematosus resolving after treatment.
    Acta haematologica, 2006, Volume: 115, Issue:1-2

    Topics: Adult; Anti-Inflammatory Agents; Blood Platelets; Female; Humans; Lupus Erythematosus, Systemic; Neu

2006
The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy.
    Lupus, 2005, Volume: 14, Issue:12

    Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Methyl

2005
Lupus and leg ulcers--a diagnostic quandary.
    Clinical rheumatology, 2007, Volume: 26, Issue:7

    Topics: Adult; Azathioprine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; L

2007
A case of systemic lupus erythematosus complicated by pure red cell aplasia and idiopathic portal hypertension after thymectomy.
    Modern rheumatology, 2006, Volume: 16, Issue:2

    Topics: Adult; Female; Humans; Hypertension, Portal; Lupus Erythematosus, Systemic; Myasthenia Gravis; Posto

2006
C1qRP (CD93) expression on peripheral blood monocytes in patients with systemic lupus erythematosus.
    Rheumatology international, 2006, Volume: 26, Issue:12

    Topics: Adult; Humans; Lupus Erythematosus, Systemic; Male; Membrane Glycoproteins; Middle Aged; Monocytes;

2006
Loss of chance: what loss?
    Australian family physician, 2006, Volume: 35, Issue:5

    Topics: Adolescent; Allergy and Immunology; Dexamethasone; Family Practice; Female; Glucocorticoids; Humans;

2006
Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis.
    Clinical and experimental nephrology, 2006, Volume: 10, Issue:2

    Topics: Adult; Antigen-Antibody Complex; Basement Membrane; Biopsy; Capillaries; Female; Humans; Kidney Tubu

2006
Lymphoma in a patient with systemic lupus erythematosus.
    Nature clinical practice. Rheumatology, 2006, Volume: 2, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Doxor

2006
Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus.
    Clinical rheumatology, 2007, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Central Nervous System Infections; China; Cohort Studies; Dose-Response Relations

2007
Benzodiazepines in catatonia associated with systemic lupus erythematosus.
    Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Catatonia; Diazepam; Electroencephalography; Female; GABA Modulator

2006
Outcome of pregnancy in patients with systemic lupus erythematosus.
    Taiwanese journal of obstetrics & gynecology, 2006, Volume: 45, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; Fertilization; Glucocorticoids; Humans; Lupus Eryth

2006
A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
    Lupus, 2007, Volume: 16, Issue:1

    Topics: Administration, Oral; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; Autoantigens; C

2007
[Rowell syndrome].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2007, Volume: 58, Issue:4

    Topics: Adult; Amphotericin B; Anti-Inflammatory Agents; Drug Combinations; Erythema Multiforme; Female; Flu

2007
Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases.
    Annals of the Academy of Medicine, Singapore, 2007, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Asian People; Co

2007
Mycobacterial spindle cell pseudotumor of the skin.
    Journal of cutaneous pathology, 2007, Volume: 34, Issue:4

    Topics: Anti-Inflammatory Agents; Diabetes Mellitus; Diagnosis, Differential; Female; Humans; Immunohistoche

2007
The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:7

    Topics: Acute Disease; Computer Simulation; Cost-Benefit Analysis; Cyclophosphamide; Day Care, Medical; Drug

2007
Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits.
    Pathology international, 2007, Volume: 57, Issue:6

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Fatty Liver; Female; Glucocorticoids; Humans; Liver;

2007
A case of a pregnant woman developing systemic lupus erythematosus during pregnancy.
    Clinical nephrology, 2007, Volume: 67, Issue:5

    Topics: Adult; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus,

2007
Extensive medium-vessel vasculitis with SLE: an unusual association.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2007, Volume: 13, Issue:3

    Topics: Adolescent; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Eryth

2007
[Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2007, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Azathioprine; Child; Chloroquine; Dose-Response Relat

2007
Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
    Lupus, 2007, Volume: 16, Issue:6

    Topics: Adolescent; Cardiac Tamponade; Drainage; Drug Administration Schedule; Echocardiography; Female; Glu

2007
Childhood-onset systemic lupus erythematosus.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:7

    Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Child; Cyclophosphamide; Female; Humans; Lupus E

2007
Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.
    The Journal of rheumatology, 2007, Volume: 34, Issue:9

    Topics: Adult; Aged; Antirheumatic Agents; Case-Control Studies; Dose-Response Relationship, Drug; Female; H

2007
Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Acta obstetricia et gynecologica Scandinavica, 2007, Volume: 86, Issue:9

    Topics: Antibodies, Antinuclear; Female; Glucocorticoids; Heart Block; Humans; Infant, Newborn; Lupus Erythe

2007
[A case of pulmonary nocardiosis cured by early sulfamethoxazole-trimethoprim therapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:8

    Topics: Anti-Infective Agents; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male;

2007
Familial childhood systemic lupus erythematosus: report of 2 cases.
    Journal of the Indian Medical Association, 2007, Volume: 105, Issue:3

    Topics: Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Humans; Immunosuppressive A

2007
[Growth hormone administration in the treatment of growth retardation in juvenile SLE--case history].
    Pediatric endocrinology, diabetes, and metabolism, 2007, Volume: 13, Issue:3

    Topics: Adolescent; Body Height; Body Mass Index; Child; Chronic Disease; Female; Glucocorticoids; Growth Di

2007
Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody.
    Lupus, 2007, Volume: 16, Issue:10

    Topics: Abdominal Pain; Adult; Antiphospholipid Syndrome; Autoantibodies; Case-Control Studies; Enteritis; F

2007
Laryngeal involvement in systemic lupus erythematosus: report of two cases.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2007, Volume: 13, Issue:5

    Topics: Adult; Antirheumatic Agents; Female; Hoarseness; Humans; Laryngeal Diseases; Lupus Erythematosus, Sy

2007
A case of very-late-onset systemic lupus erythematosus.
    Modern rheumatology, 2007, Volume: 17, Issue:5

    Topics: Age of Onset; Aged, 80 and over; Female; Humans; Lupus Erythematosus, Systemic; Pleurisy; Prednisolo

2007
Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared.
    Clinical rheumatology, 2008, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antitubercular Agents; Female; Humans; Lupus Eryt

2008
Neonatal lupus erythematosus complicated by mucocutaneous and visceral hemangiomas.
    Lupus, 2007, Volume: 16, Issue:11

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Female; Hemangioma, Capillary; Humans; Inf

2007
[Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2007, Volume: 30, Issue:5

    Topics: Adult; Brain Diseases; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Myelitis; Pr

2007
Elderly onset systemic lupus erythematosus (SLE) presenting with disseminated intravascular coagulation (DIC).
    Clinical rheumatology, 2008, Volume: 27 Suppl 1

    Topics: Aged, 80 and over; Antirheumatic Agents; Disseminated Intravascular Coagulation; Humans; Lupus Eryth

2008
[Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus].
    Nihon Jinzo Gakkai shi, 2007, Volume: 49, Issue:8

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lu

2007
Successful full-term pregnancies with assisted reproduction supported with prednisolone, acetylsalicylic acid and high progesterone doses in a lupus patient.
    Clinical and experimental obstetrics & gynecology, 2007, Volume: 34, Issue:4

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Inflammatory Agents; Aspirin; Female

2007
Oxcarbazepine and valproic acid-induced lupus in a 7-year-old boy.
    Acta paediatrica (Oslo, Norway : 1992), 2008, Volume: 97, Issue:8

    Topics: Anti-Inflammatory Agents; Anticonvulsants; Carbamazepine; Child; Diagnosis, Differential; Humans; Lu

2008
Systemic lupus erythematosus with lichen planus-like eruptions associated with pericarditis.
    The Journal of dermatology, 2008, Volume: 35, Issue:5

    Topics: Adult; Diagnosis, Differential; Female; Glucocorticoids; Humans; Lichen Planus; Lupus Erythematosus,

2008
A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies.
    Rheumatology international, 2008, Volume: 29, Issue:1

    Topics: Adult; Autoantibodies; Diagnosis, Differential; Female; Glucocorticoids; Humans; Hypoglycemia; Insul

2008
Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
    Clinical and experimental immunology, 2008, Volume: 153, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphoc

2008
[The use of dibazol in the complex therapy of lupus erythematosus].
    Vestnik dermatologii i venerologii, 1966, Volume: 40, Issue:7

    Topics: Adult; Antimalarials; Ascorbic Acid; Benzimidazoles; Female; Humans; Lupus Erythematosus, Discoid; L

1966
Aseptic bone necrosis in systemic lupus erythematosus. 1. Report of a case involving four joints. 2. The result of x-ray examination of 22 other cases of lupus erythematosus.
    Nihon Seikeigeka Gakkai zasshi, 1966, Volume: 39, Issue:13

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Male; Necrosis; Prednisolone; Radiography

1966
Disseminated lupus erythematosus profundus.
    The British journal of dermatology, 1967, Volume: 79, Issue:1

    Topics: Adult; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone

1967
Systemic lupus erythematosus (SLE) and aseptic bone necrosis. A discussion based on the presentation of one case treated with corticosteroids.
    Acta medica Scandinavica, 1967, Volume: 182, Issue:1

    Topics: Female; Femur Head; Hip Joint; Humans; Lupus Erythematosus, Systemic; Necrosis; Osteoporosis; Predni

1967
[Effect of prednisolone on changes in the fundus oculi in LED].
    Orvosi hetilap, 1967, Feb-26, Volume: 108, Issue:9

    Topics: Fundus Oculi; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Papilledema; Prednisolone; R

1967
Steroid treatment of lupus nephropathy: results of 60 cases.
    Acta medica Academiae Scientiarum Hungaricae, 1967, Volume: 23, Issue:3

    Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Glomerulonephritis; Humans; Lupus Erythematosus, Syste

1967
The effect of corticosteroid drugs on serum iron levels in systemic lupus erythematosus and rheumatoid arthritis.
    The Medical journal of Australia, 1967, Sep-30, Volume: 2, Issue:14

    Topics: Anemia, Hypochromic; Arthritis, Rheumatoid; Autoanalysis; Chronic Disease; Female; Humans; Hydrocort

1967
[Case of normocholesterolemic nephrotic syndrome (SLE)].
    Naika. Internal medicine, 1967, Volume: 19, Issue:1

    Topics: Adult; Cholesterol; Humans; Lupus Erythematosus, Systemic; Male; Nephrotic Syndrome; Prednisolone

1967
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases.
    Annals of the rheumatic diseases, 1982, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Connective Tissue Diseases; Dermatomyos

1982
Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange.
    Journal of neurology, 1982, Volume: 228, Issue:4

    Topics: Azathioprine; Biopsy; Diagnosis, Differential; Extremities; Female; Humans; Lupus Erythematosus, Sys

1982
[Corticoid myopathy in children].
    Acta paediatrica Academiae Scientiarum Hungaricae, 1981, Volume: 22, Issue:3

    Topics: Adolescent; Adrenocorticotropic Hormone; Arthritis, Juvenile; Child; Delayed-Action Preparations; De

1981
Steroids in renal disease.
    British journal of hospital medicine, 1982, Volume: 28, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Glomerulonephritis; Glomerulosclerosis, Focal

1982
Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients.
    The Quarterly journal of medicine, 1984,Spring, Volume: 53, Issue:210

    Topics: Adolescent; Adult; Child; Female; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Malaysi

1984
[Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Nihon Jinzo Gakkai shi, 1984, Volume: 26, Issue:4

    Topics: Biopsy; Complement C3; Complement C4; Glomerulonephritis; Humans; Kidney; Lupus Erythematosus, Syste

1984
Anaplastic myeloma in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1984, Volume: 43, Issue:4

    Topics: Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Multiple Myeloma; Prednisolone

1984
[Roentgenological features of disseminated tuberculosis following long-term corticosteroid therapy].
    Kekkaku : [Tuberculosis], 1984, Volume: 59, Issue:7

    Topics: Adult; Aged; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; Radiogr

1984
Persistent immunoglobulin deficiency after prednisolone and antiepileptic therapy in a C2 deficient patient with lupus-like syndrome.
    The Journal of rheumatology, 1984, Volume: 11, Issue:6

    Topics: Adult; Agammaglobulinemia; Anticonvulsants; Complement C2; Female; Humans; IgA Deficiency; Immunoglo

1984
[Case of "steroid" tuberculosis in a patient with systemic lupus erythematosus, simulating metastatic tumor].
    Problemy tuberkuleza, 1984, Issue:12

    Topics: Adult; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Lupus Erythematosus, Systemic; Predn

1984
[Double filtration plasma exchange in the treatment of lupus nephritis].
    Ryumachi. [Rheumatism], 1984, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Lupus Erythematosus

1984
Fatal pneumococcal epiglottitis in lupus overlap syndrome.
    Clinical rheumatology, 1984, Volume: 3, Issue:4

    Topics: Adult; Epiglottitis; Female; Humans; Laryngitis; Lupus Erythematosus, Systemic; Myositis; Pneumococc

1984
Amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus successfully treated by a high-dose prednisolone therapy.
    Japanese journal of medicine, 1984, Volume: 23, Issue:2

    Topics: Bone Marrow; Female; Humans; Lupus Erythematosus, Systemic; Megakaryocytes; Middle Aged; Prednisolon

1984
Severe thoracic systemic lupus erythematosus.
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:3

    Topics: Adult; Aged; Azathioprine; Female; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Middle Aged

1984
Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Journal of clinical & laboratory immunology, 1984, Volume: 13, Issue:1

    Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Counterimmunoelectrophoresis; Humans; Lupus Erythema

1984
[Actions of lymphocytes from patients with systemic lupus erythematosus on granulocyte-macrophage colony formation of human marrow cells and the reversal of these actions by prednisolone].
    Ryumachi. [Rheumatism], 1983, Volume: 23, Issue:2

    Topics: Adult; Bone Marrow Cells; Colony-Forming Units Assay; Female; Granulocytes; Hematopoietic Stem Cells

1983
Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    The Journal of rheumatology, 1983, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antibody-Dependent Cell Cytotoxicity; Child; Cytotoxicity, Immunologic; Dermatomy

1983
[Extracorporeal hemosorption in the complex treatment of systemic lupus erythematosus in children].
    Pediatriia, 1983, Issue:11

    Topics: Adolescent; Azathioprine; Combined Modality Therapy; Female; Hemoperfusion; Humans; Lupus Erythemato

1983
Chorea as an initial manifestation of systemic lupus erythematosus. A case report of a 10-year-old girl.
    Clinical pediatrics, 1984, Volume: 23, Issue:5

    Topics: Child; Chorea; Female; Haloperidol; Humans; Lupus Erythematosus, Systemic; Prednisolone

1984
Renal involvement in systemic lupus erythematosus.
    The Medical journal of Australia, 1984, Jun-23, Volume: 140, Issue:13

    Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Glome

1984
IgG therapy in systemic lupus erythematosus--two case reports.
    Blut, 1984, Volume: 48, Issue:6

    Topics: Azathioprine; Child; Cushing Syndrome; Female; Humans; Immunoglobulin G; Lupus Erythematosus, System

1984
[Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Kekkaku : [Tuberculosis], 1984, Volume: 59, Issue:4

    Topics: Enzyme Induction; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rifampin

1984
[Therapy of acute pulmonary hemorrhage in systemic lupus erythematosus].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-21, Volume: 122, Issue:12

    Topics: Azathioprine; Child; Hematuria; Hemorrhage; Humans; Lung; Lupus Erythematosus, Systemic; Male; Predn

1980
Phagocytosis-connected oxygen consumption by peripheral leukocytes from patients with systemic lupus erythematosus.
    Acta haematologica, 1982, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Complement C3; Female; Humans; Leukocytes; Lupus Erythematosus, Systemic; Male; M

1982
Protein-losing enteropathy in systemic lupus erythematosus.
    The American journal of gastroenterology, 1983, Volume: 78, Issue:3

    Topics: Adult; Edema; Female; Humans; Intestine, Small; Lupus Erythematosus, Systemic; Prednisolone; Protein

1983
Choreoathetosis and seizures associated with systemic lupus erythematosus--a case report.
    Singapore medical journal, 1983, Volume: 24, Issue:1

    Topics: Adolescent; Athetosis; Chorea; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Seizures

1983
[Use of the preparation essentiale in the therapy of lupus erythematosus].
    Vestnik dermatologii i venerologii, 1983, Issue:5

    Topics: Adolescent; Adult; Aged; Aspirin; Chloroquine; Chronic Disease; Drug Combinations; Drug Evaluation;

1983
Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
    Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology, 1983, Volume: 91, Issue:2

    Topics: Adolescent; Adult; Antigen-Antibody Complex; Blood Physiological Phenomena; Cell Movement; Chemotaxi

1983
[Therapy of lupus nephritis in childhood].
    Padiatrie und Grenzgebiete, 1983, Volume: 22, Issue:2-3

    Topics: Adolescent; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Humans; Immunosuppression Therapy;

1983
Plasma infusions in thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus--a successful outcome.
    Postgraduate medical journal, 1982, Volume: 58, Issue:683

    Topics: Adult; Blood Transfusion; Female; Humans; Lupus Erythematosus, Systemic; Plasma; Prednisolone; Purpu

1982
Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
    Arthritis and rheumatism, 1980, Volume: 23, Issue:11

    Topics: Adult; Animals; Antibodies; Antibodies, Antinuclear; Antigen-Antibody Complex; Antilymphocyte Serum;

1980
The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
    Clinical nephrology, 1980, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Azathioprine; B-Lymphocytes; Chronic Disease; Glomerulonephritis; Humans; Lupus E

1980
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Clinical and experimental immunology, 1982, Volume: 48, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antigen-Antibody Complex; Arthritis, Rheumatoid; Complement Activati

1982
[T cell subsets and the helper effect of T cells in rheumatoid arthritis and systemic lupus erythematosus, and the effects of antirheumatic agents (author's transl)].
    Ryumachi. [Rheumatism], 1982, Volume: 22, Issue:1

    Topics: Arthritis, Rheumatoid; Cyclophosphamide; Humans; Lupus Erythematosus, Systemic; Prednisolone; T-Lymp

1982
Elevated levels of chemotaxis inhibitory activity in sera of patients with systemic lupus erythematosus.
    The Journal of dermatology, 1980, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Chemotactic Factors; Humans; Lupus Erythematosus, Systemic; Prednisolone

1980
Anti-poly(G) . poly(C) antibodies in the serum of patients with systemic lupus erythematosus.
    Clinical immunology and immunopathology, 1982, Volume: 22, Issue:3

    Topics: Adult; Aged; Antibodies; Antibody Specificity; Arthritis, Rheumatoid; Binding Sites, Antibody; Chrom

1982
[Clinical and immunological studies on the exacerbation of systemic lupus erythematosus (author's transl)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1982, Apr-10, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pr

1982
[Pathogenesis of leukopenia in systemic lupus erythematosus (I). Effect of prednisolone on colony forming units in culture (CFU-C) growth in patients with systemic lupus erythematosus (SLE)].
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1982, Volume: 45, Issue:3

    Topics: Adult; Aged; Bone Marrow; Cells, Cultured; Colony-Forming Units Assay; Female; Humans; Leukopenia; L

1982
Effect of peripheral blood lymphocytes from systemic lupus erythematosus patients on human bone marrow granulocyte precursor cells (colony-forming units in culture).
    Stem cells, 1982, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Blood; Bone Marrow Cells; Colony-Forming Units Assay; Female; Granulocytes; Hemat

1982
[Possibilities of combined treatment of diffuse collagenous glomerulonephritis].
    Vutreshni bolesti, 1982, Volume: 21, Issue:5

    Topics: Acenocoumarol; Adolescent; Adult; Azathioprine; Drug Therapy, Combination; Female; Glomerulonephriti

1982
[Treatment of lupus nephropathy with large doses of steroids. Personal experience].
    Polskie Archiwum Medycyny Wewnetrznej, 1982, Volume: 68, Issue:5

    Topics: Administration, Oral; Glomerulonephritis; Humans; Infusions, Parenteral; Lupus Erythematosus, System

1982
Management plan of systemic lupus erythematosus -- a flow chart.
    Singapore medical journal, 1980, Volume: 21, Issue:4

    Topics: Aspirin; Cyclophosphamide; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Prednisolone

1980
Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression.
    Archives of internal medicine, 1981, Volume: 141, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Anemia, Aplastic; Cyclophosphamide; Female; Humans; Immunosuppressi

1981
Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus.
    Archives of internal medicine, 1981, Volume: 141, Issue:9

    Topics: Adolescent; Adult; Female; Humans; L-Lactate Dehydrogenase; Lupus Erythematosus, Systemic; Male; Mid

1981
Platelet-bound IgG in systemic lupus erythematosus with and without thrombocytopenia.
    Journal of immunological methods, 1981, Volume: 45, Issue:3

    Topics: Antigen-Antibody Complex; Azathioprine; Binding Sites, Antibody; Blood Platelets; Humans; Immunoglob

1981
Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
    Osaka city medical journal, 1980, Volume: 26, Issue:2

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Pneumonia; Prednisolone

1980
[Hemoperfusion through activated charcoal in the complex treatment of systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1981, Volume: 53, Issue:8

    Topics: Adolescent; Adult; Charcoal; Chlorambucil; Drug Therapy, Combination; Female; Humans; Lupus Erythema

1981
[Plasma exchange in rapidly progressive glomerulonephritis (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1981, Nov-27, Volume: 106, Issue:48

    Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antigen-Antibody Complex; Azathi

1981
Platelet kinetics in systemic lupus erythematosus (SLE), with special reference to corticosteroid and azathioprine therapy.
    Scandinavian journal of rheumatology, 1981, Volume: 10, Issue:4

    Topics: Adult; Aged; Azathioprine; Blood Platelets; Cell Survival; Female; Humans; Kinetics; Lupus Erythemat

1981
Steroid-induced benign intracranial hypertension.
    Postgraduate medical journal, 1981, Volume: 57, Issue:665

    Topics: Adult; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone; Pseudotumor Cerebri

1981
[Comparative effectiveness of different therapeutic regimens in lupus nephritis in children and adolescents].
    Pediatriia, 1980, Issue:4

    Topics: Adolescent; Azathioprine; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Evaluati

1980
Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Clinical and experimental immunology, 1980, Volume: 40, Issue:1

    Topics: Adult; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Humans; Killer Cells, Na

1980
A sensitive high-pressure liquid chromatographic method for the determination of prednisone, prednisolone and hydrocortisone in plasma.
    Research communications in chemical pathology and pharmacology, 1980, Volume: 28, Issue:1

    Topics: Adult; Chromatography, High Pressure Liquid; Dexamethasone; Female; Humans; Hydrocortisone; Lupus Er

1980
Transient retinopathy in uncomplicated case of systemic lupus erythematosus.
    East African medical journal, 1980, Volume: 57, Issue:7

    Topics: Child; Female; Humans; Kenya; Lupus Erythematosus, Systemic; Prednisolone; Retinal Diseases

1980
[Treatment of lupus nephritis].
    Terapevticheskii arkhiv, 1980, Volume: 52, Issue:4

    Topics: Azathioprine; Humans; Lupus Erythematosus, Systemic; Nephritis; Plasmapheresis; Prednisolone; Renal

1980
Systemic lupus erythematosus and habitual abortion. Case report.
    British journal of obstetrics and gynaecology, 1980, Volume: 87, Issue:8

    Topics: Abortion, Habitual; Adult; Female; Heart Block; Humans; Infant, Newborn; Lupus Erythematosus, System

1980
Malabsorption of prednisolone from enteric-coated tablets after ileostomy.
    British medical journal, 1980, Sep-27, Volume: 281, Issue:6244

    Topics: Adrenal Insufficiency; Adult; Biological Availability; Female; Humans; Ileostomy; Intestinal Absorpt

1980
Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
    American journal of nephrology, 1995, Volume: 15, Issue:5

    Topics: Adult; Biopsy; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Methylprednisolone; Nephrosis,

1995
Acute pancreatitis: an early manifestation of systemic lupus erythematosus.
    Pediatric emergency care, 1994, Volume: 10, Issue:5

    Topics: Abdominal Pain; Acute Disease; Adolescent; Amylases; Female; Humans; Lupus Erythematosus, Systemic;

1994
Systemic lupus erythematosus--not to be forgotten in the elderly.
    Singapore medical journal, 1995, Volume: 36, Issue:1

    Topics: Age of Onset; Aged; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone

1995
[Outcome of patients with chronic systemic lupus erythematosus].
    Ryumachi. [Rheumatism], 1995, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Bone Density; Child; Chronic Disease; Female; Fem

1995
[Suspected case of lupus cystitis with successful early treatment].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Apr-10, Volume: 84, Issue:4

    Topics: Cystitis; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone

1995
[The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
    Terapevticheskii arkhiv, 1995, Volume: 67, Issue:5

    Topics: Administration, Oral; Adult; Central Nervous System Diseases; Chronic Disease; Cyclophosphamide; Dru

1995
SLE and HIV infection, two systemic conditions that can be clinically indistinguishable.
    The Central African journal of medicine, 1995, Volume: 41, Issue:6

    Topics: Adult; Diagnosis, Differential; Female; HIV Infections; Humans; Lupus Erythematosus, Systemic; Predn

1995
Fatal salmonellosis in systemic lupus erythematosus.
    Clinical and experimental dermatology, 1995, Volume: 20, Issue:3

    Topics: Aged; Bacteremia; Fatal Outcome; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Pre

1995
Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
    Singapore medical journal, 1995, Volume: 36, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Factor VIII; Female; Gingival Hemorrhage; Humans; Lupus Erythematosu

1995
Sensorineural hearing loss of suspected autoimmune etiology: a report of three cases.
    Auris, nasus, larynx, 1995, Volume: 22, Issue:1

    Topics: Adult; Audiometry, Pure-Tone; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Dose-Response R

1995
Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
    British journal of obstetrics and gynaecology, 1993, Volume: 100, Issue:9

    Topics: Acenocoumarol; Bone and Bones; Developmental Disabilities; Drug Combinations; Female; Fetal Diseases

1993
[Three cases with systemic rheumatic diseases who developed pulmonary lesions suggestive of bronchiolitis obliterans organizing pneumonia].
    Ryumachi. [Rheumatism], 1995, Volume: 35, Issue:1

    Topics: Adult; Arthritis, Rheumatoid; Cryptogenic Organizing Pneumonia; Female; Humans; Lupus Erythematosus,

1995
Plasma thrombomodulin as an indicator of thromboembolic disease in systemic lupus erythematosus.
    International journal of cardiology, 1994, Volume: 47, Issue:1 Suppl

    Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Cyclophosphamide; Enzyme-Linked Immunosorben

1994
Subdural fluid collections: an unusual manifestation of CNS disease in a connective tissue disorder.
    Clinical rheumatology, 1995, Volume: 14, Issue:1

    Topics: Adult; Antibodies, Antinuclear; Central Nervous System Diseases; Connective Tissue Diseases; Female;

1995
A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
    Journal of reproductive immunology, 1995, Volume: 28, Issue:2

    Topics: Antibodies, Antiphospholipid; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Lupus Erythemato

1995
A case of Werner's syndrome associated with systemic lupus erythematosus.
    Clinical rheumatology, 1995, Volume: 14, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Biopsy; Female; Humans; Lupus Erythematosus, Systemic; Methylprednis

1995
Hemophagocytic syndrome in a patient with rheumatoid arthritis.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:10

    Topics: Arthritis, Rheumatoid; Diagnosis, Differential; Female; Herpesviridae Infections; Herpesvirus 4, Hum

1994
[A case report: cryptococcal meningitis and fluconazole therapy].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1994, Volume: 68, Issue:11

    Topics: Adolescent; Azathioprine; Female; Fluconazole; Humans; Immunocompromised Host; Lupus Erythematosus,

1994
Treatable dementia in an elderly woman.
    The Journal of the Association of Physicians of India, 1994, Volume: 42, Issue:6

    Topics: Dementia; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; F

1994
[Effects of pregnancy on the course of systemic lupus erythematosus].
    Klinicheskaia meditsina, 1994, Volume: 72, Issue:5

    Topics: Adult; Female; Glomerulonephritis; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Male; Nep

1994
Pregnancy and its outcome in systemic lupus erythematosus.
    QJM : monthly journal of the Association of Physicians, 1994, Volume: 87, Issue:12

    Topics: Abortion, Therapeutic; Adolescent; Adult; Antibodies, Antinuclear; Female; Fetal Death; France; Huma

1994
Abnormal expression of intercellular adhesion molecule-1 on peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Journal of clinical & laboratory immunology, 1993, Volume: 40, Issue:3

    Topics: Adolescent; Adult; B-Lymphocytes; Cell Fractionation; Cell Separation; Centrifugation, Density Gradi

1993
Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. A case report.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1994, Volume: 14, Issue:2

    Topics: Acute Disease; Child; Female; Humans; Lupus Erythematosus, Systemic; Optic Neuritis; Prednisolone; R

1994
[Case of SLE with fatal acute adrenal insufficiency caused by contagious cytomegalovirus infection].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Apr-10, Volume: 83, Issue:4

    Topics: Acute Disease; Adrenal Insufficiency; Aged; Cyclophosphamide; Cytomegalovirus Infections; Female; Hu

1994
Lipid profiles in patients with systemic lupus erythematosus.
    The Journal of rheumatology, 1994, Volume: 21, Issue:7

    Topics: Adult; Female; Humans; Hyperlipidemias; Kidney; Lipids; Lupus Erythematosus, Systemic; Male; Prednis

1994
Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids.
    Scandinavian journal of immunology, 1994, Volume: 40, Issue:2

    Topics: Adult; Aged; Betamethasone; Complement C1q; Female; Glucocorticoids; Humans; Immunoenzyme Techniques

1994
A case of bullous systemic lupus erythematosus.
    Dermatology (Basel, Switzerland), 1994, Volume: 189 Suppl 1

    Topics: Child; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Skin; Skin Diseases, Ve

1994
Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging.
    Clinical orthopaedics and related research, 1994, Issue:305

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Femur Head Necrosis; Humans; Lupus Eryt

1994
Post-infantile giant cell hepatitis in an elderly female patient with systemic lupus erythematosus.
    Journal of gastroenterology, 1994, Volume: 29, Issue:3

    Topics: Aged; Azathioprine; Cyclosporine; Female; Giant Cells; Hepatitis, Viral, Human; Humans; Liver; Lupus

1994
Bullous eruption of systemic lupus erythematosus.
    The Journal of dermatology, 1994, Volume: 21, Issue:6

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Skin; Skin Diseases, Vesiculobul

1994
Methotrexate for steroid-resistant systemic lupus erythematosus.
    Clinical rheumatology, 1994, Volume: 13, Issue:2

    Topics: Adult; Drug Resistance; Female; Humans; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisol

1994
Bullous systemic lupus erythematosus--a variable disease.
    Lupus, 1993, Volume: 2, Issue:6

    Topics: Adult; Autoantibodies; Collagen; Dapsone; Drug Therapy, Combination; Female; Humans; Lupus Erythemat

1993
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cerebral Infarction; Depressive Disorder; Dose-Response

1994
[Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
    Ryumachi. [Rheumatism], 1994, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Human

1994
[Bilateral kidney enlargement with kidney failure. Manifestation of primary extranodal B-cell lymphoma after long-term immunosuppression].
    Medizinische Klinik (Munich, Germany : 1983), 1994, Feb-15, Volume: 89, Issue:2

    Topics: Azathioprine; Female; Humans; Hypertrophy; Kidney; Kidney Failure, Chronic; Kidney Neoplasms; Lupus

1994
Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus.
    European heart journal, 1994, Volume: 15, Issue:1

    Topics: Adult; Echocardiography, Doppler; Female; Heart Valve Prosthesis; Humans; Lupus Erythematosus, Syste

1994
[Two cases of systemic lupus erythematosus associated with fatty liver and Basedow's disease].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1994, Volume: 85, Issue:3

    Topics: Adult; Fatty Liver; Female; Graves Disease; Humans; Lupus Erythematosus, Systemic; Methimazole; Midd

1994
[A case of systemic lupus erythematosus who developed nodular shadows in the lung in parallel with the disease activity].
    Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:4

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Pulmonary Fibrosis; Radiography,

1993
[Renal and cerebral infarctions in a patient with systemic lupus erythematosus without antiphospholipid antibodies].
    Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:4

    Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Cerebral Infarction; Female; Fibrinolytic Agent

1993
Fetal salvage in maternal systemic lupus erythematosus.
    Annals of the Academy of Medicine, Singapore, 1993, Volume: 22, Issue:4

    Topics: Abortion, Spontaneous; Adult; Azathioprine; Female; Fetal Death; Humans; Infant, Newborn; Kidney Fun

1993
Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.
    European journal of clinical pharmacology, 1993, Volume: 45, Issue:3

    Topics: Adult; Drug Interactions; Female; Half-Life; Humans; Lupus Erythematosus, Systemic; Male; Metabolic

1993
[A case of an elderly SLE patient associated with acute renal failure].
    Nihon Jinzo Gakkai shi, 1993, Volume: 35, Issue:10

    Topics: Acute Kidney Injury; Aged; Drug Administration Schedule; Humans; Lupus Erythematosus, Systemic; Lupu

1993
Protothecosis in a patient with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:7

    Topics: Abscess; Adult; Amphotericin B; Elbow Injuries; Female; Humans; Immunity, Cellular; Immunocompromise

1993
Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus.
    The Journal of rheumatology, 1993, Volume: 20, Issue:10

    Topics: Adult; Antibodies, Antiphospholipid; Biopsy; Female; Humans; Lupus Erythematosus, Systemic; Placenta

1993
[Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome)].
    Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:2

    Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Edema; Female; Humans; Lupus Erythematosus, Sy

1993
Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy.
    British journal of obstetrics and gynaecology, 1993, Volume: 100, Issue:6

    Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Gestational Age;

1993
[Reversible dementia and polyneuritis in an elderly woman: a case of late-onset disseminated lupus erythematosus].
    Acta neurologica Belgica, 1993, Volume: 93, Issue:3

    Topics: Aged; Dementia; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Polyneuropat

1993
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.
    The Journal of rheumatology, 1993, Volume: 20, Issue:6

    Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Lupus E

1993
Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases.
    Clinical rheumatology, 1993, Volume: 12, Issue:2

    Topics: Adult; Arthritis, Rheumatoid; Atrial Natriuretic Factor; Creatinine; Electrocardiography; Female; He

1993
Unusual neuroradiological findings in systemic lupus erythematosus.
    European neurology, 1993, Volume: 33, Issue:1

    Topics: Activities of Daily Living; Cerebral Arterial Diseases; Drug Administration Schedule; Female; Humans

1993
[Clinical significance of electroencephalograph in patients with systemic lupus erythematosus].
    Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Electroencephalography; Female; Humans; Lupus Erythematosus, S

1993
Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 56, Issue:4

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Middle Ag

1995
[Atypical optic neuritis in systemic lupus erythematosus (SLE)].
    Klinische Monatsblatter fur Augenheilkunde, 1995, Volume: 207, Issue:5

    Topics: Aged; Antibodies, Antinuclear; Dose-Response Relationship, Drug; Drug Administration Schedule; Femal

1995
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies.
    British journal of rheumatology, 1996, Volume: 35, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Female; Follo

1996
Trabecular and cortical bone loss in systemic lupus erythematosus.
    British journal of rheumatology, 1996, Volume: 35, Issue:3

    Topics: Adult; Bone and Bones; Bone Density; Female; Fractures, Bone; Glucocorticoids; Humans; Lupus Erythem

1996
Late onset systemic lupus erythematosus diagnosed in an elderly man with unusual skin eruptions and sudden death.
    The Journal of dermatology, 1995, Volume: 22, Issue:12

    Topics: Age of Onset; Anti-Inflammatory Agents; Death, Sudden; Diagnosis, Differential; Fluorescent Antibody

1995
[Open heart surgery in patients with systemic diseases requiring steroid treatment].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1996, Volume: 44, Issue:4

    Topics: Aortic Arch Syndromes; Aortic Valve Insufficiency; Arthritis, Rheumatoid; Cardiac Surgical Procedure

1996
Steroid pulse therapy in lupus cystitis.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:2

    Topics: Anti-Inflammatory Agents; Chemokine CCL2; Cystitis, Interstitial; Drug Therapy, Combination; Edema;

1996
[A case of SLE with the onset of pleuritis showing eosinophilia and elevation of serum IgE].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1996, Volume: 87, Issue:4

    Topics: Adult; Eosinophilia; Female; Humans; Hypergammaglobulinemia; Immunoglobulin E; Lupus Erythematosus,

1996
[Mixed warm and cold antibody type autoimmune hemolytic anemia associated with systemic lupus erythematosus].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Cold Temperature; Female; Glucocorticoids; Humans; Lu

1996
Obstructive uropathy due to interstitial cystitis in a patient with systemic lupus erythematosus.
    Clinical nephrology, 1996, Volume: 45, Issue:3

    Topics: Adult; Chronic Disease; Cyclophosphamide; Cystitis, Interstitial; Drug Therapy, Combination; Female;

1996
[A case of systemic lupus erythematosus with pleural effusion, ascites and pericardial effusion].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1996, Apr-10, Volume: 85, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Ascites; Female; Humans; Lupus Erythematosus, Systemic; Pericardial

1996
Danazol for thrombocytopenia in pregnancy with underlying systemic lupus erythematosus.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1996, Volume: 79, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Danazol; Estrogen Antagonists; Female; Humans; Lupus Erythematosus,

1996
[Acute pulmonary disease in systemic lupus erythematosus successfully treated with prednisolone pulse therapy].
    Nihon Kyobu Shikkan Gakkai zasshi, 1996, Volume: 34, Issue:1

    Topics: Acute Disease; Drug Administration Schedule; Humans; Lung Diseases, Interstitial; Lupus Erythematosu

1996
Femoral neck fracture following avascular necrosis of the femoral head.
    Acta medica Okayama, 1996, Volume: 50, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Bone Diseases; Female; Femoral Neck Fractures; Femur; Humans; Lupus

1996
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
    Prenatal diagnosis, 1995, Volume: 15, Issue:12

    Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases

1995
Hoarseness as the initial manifestation of systemic lupus erythematosus.
    The Journal of laryngology and otology, 1996, Volume: 110, Issue:5

    Topics: Female; Hoarseness; Humans; Laryngoscopy; Larynx; Lupus Erythematosus, Systemic; Middle Aged; Predni

1996
[Arterial hypertension and the antiphospholipid syndrome].
    Terapevticheskii arkhiv, 1996, Volume: 68, Issue:2

    Topics: Adult; Antiphospholipid Syndrome; Autoimmune Diseases; Chronic Disease; Female; Glucocorticoids; Hum

1996
Myelofibrosis secondary to SLE and its reversal on steroid therapy.
    Indian pediatrics, 1995, Volume: 32, Issue:11

    Topics: Biopsy, Needle; Bone Marrow; Child; Female; Follow-Up Studies; Glucocorticoids; Humans; Lupus Erythe

1995
False positive pleural biopsy and high CA125 levels in serum and pleural effusion in systemic lupus erythematosus.
    Clinical rheumatology, 1996, Volume: 15, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Biopsy, Needle; CA-125 Antigen; Exudates and Transudates; False Posi

1996
[A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment].
    Ryumachi. [Rheumatism], 1996, Volume: 36, Issue:3

    Topics: Adolescent; Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anticonvulsants; Chorea; Epilepsy; Fem

1996
[A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1996, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Anti-Inflammatory Agents; Endometrial Neoplasms; Female; Humans; Lupus Erythematosus

1996
Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:6

    Topics: Antigens, Viral; Antiviral Agents; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Fe

1996
SLE; should a rise in dsDNA antibody be treated?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:8

    Topics: Antibodies; DNA; Humans; Lupus Erythematosus, Systemic; Prednisolone

1996
Lupus cystitis improved with oral prednisolone therapy.
    The Journal of rheumatology, 1996, Volume: 23, Issue:9

    Topics: Administration, Oral; Adult; Cystitis; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone

1996
Soluble Fas molecule in the serum of patients with systemic lupus erythematosus.
    Journal of clinical immunology, 1996, Volume: 16, Issue:5

    Topics: CD4 Antigens; CD8 Antigens; Enzyme-Linked Immunosorbent Assay; fas Receptor; Humans; Lupus Erythemat

1996
Systemic lupus erythematosus with erythema multiforme-like lesions and histiocytic necrotizing lymphadenitis--a case report.
    Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:4

    Topics: Child; Erythema Multiforme; Female; Histiocytes; Humans; Lupus Erythematosus, Systemic; Lymphadeniti

1996
Predicting infection in hospitalized patients with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Cohort Studies; Creatinine; Female; Humans; Infections; Lupus Erythematosus, Syst

1996
Erysipelothrix rhusiopathiae septicemia in systemic lupus erythematosus.
    International journal of dermatology, 1996, Volume: 35, Issue:11

    Topics: Adult; Erysipelothrix Infections; Female; Glucocorticoids; Humans; Immunocompromised Host; Lupus Ery

1996
Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone.
    Rheumatology international, 1996, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Antirheumatic Agents; Azathioprine; Child; Drug Therapy, Combination; Female; Hum

1996
[A case of ASD with SLE treated with Carmeda BioActive surface circuit in cardiopulmonary bypass system].
    Kyobu geka. The Japanese journal of thoracic surgery, 1996, Volume: 49, Issue:5

    Topics: Anti-Inflammatory Agents; Cardiopulmonary Bypass; Complement System Proteins; Female; Heart Septal D

1996
[Toxicoderma caused by prednisone and prednisolone. Value of skin tests in the screening of cross sensitivity].
    Annales de dermatologie et de venereologie, 1996, Volume: 123, Issue:8

    Topics: Aged; Anti-Inflammatory Agents; Cross Reactions; Drug Eruptions; Female; Humans; Lupus Erythematosus

1996
Grand round--University Hospital of Wales. Focal myositis mimicking acute psoas abscess.
    BMJ (Clinical research ed.), 1997, Mar-15, Volume: 314, Issue:7083

    Topics: Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Myositis; Predn

1997
[Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Medizinische Klinik (Munich, Germany : 1983), 1996, Dec-15, Volume: 91, Issue:12

    Topics: Aged; Aspergillosis; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Fungemia; H

1996
[Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Terapevticheskii arkhiv, 1996, Volume: 68, Issue:5

    Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Drug Therapy, Combination;

1996
Pseudoxanthomatous lesions with membranocystic changes of collagen fibers in an SLE patient receiving long-term steroid treatment.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:2

    Topics: Anti-Inflammatory Agents; Arm; Collagen; Connective Tissue; Female; Glucocorticoids; Humans; Lipid M

1997
Hypereosinophilic syndrome associated with systemic lupus erythematosus.
    International journal of dermatology, 1997, Volume: 36, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Hypereosinophilic Syndrome

1997
Total knee arthroplasty for corticosteroid associated avascular necrosis of the knee.
    Clinical orthopaedics and related research, 1997, Issue:338

    Topics: Adult; Aged; Female; Femur; Glucocorticoids; Humans; Knee Prosthesis; Lupus Erythematosus, Systemic;

1997
[A surgical case of aortic valve stenosis associated with systemic lupus erythematosus].
    [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1997, Volume: 45, Issue:6

    Topics: Aortic Valve Stenosis; Female; Heart Valve Prosthesis; Humans; Lupus Erythematosus, Systemic; Middle

1997
Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE).
    Clinical and experimental immunology, 1997, Volume: 109, Issue:1

    Topics: Adult; Aniline Compounds; Anti-Inflammatory Agents; Female; Fluorescent Antibody Technique, Indirect

1997
Infective endocarditis caused by Erysipelothrix rhusiopathiae in a patient with systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 1996, Volume: 44, Issue:3

    Topics: Adult; Animals; Endocarditis, Bacterial; Erysipelothrix Infections; Female; Glucocorticoids; Humans;

1996
[Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1997, Volume: 72, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents; Apoptosis; Dexamethasone; Fas Ligand Protein; Female; Gene Ex

1997
Eruptive keratoacanthomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:3 Pt 1

    Topics: Adult; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratoacanthoma; Lupus E

1997
Serial single photon emission computed tomography imaging in patients with cerebral lupus during acute exacerbation and after treatment.
    Pediatric neurology, 1997, Volume: 17, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Brain; Brain Diseases; Cerebral Cortex; Child; Female; Follow-

1997
Follicular mucinosis and systemic lupus erythematosus.
    Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:2

    Topics: Adult; Biopsy, Needle; Fluorescent Antibody Technique; Follow-Up Studies; Glucocorticoids; Humans; L

1997
Cold haemagglutinin disease in systemic lupus erythematosus.
    Yonsei medical journal, 1997, Volume: 38, Issue:4

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies; Female; Humans; Lupus Erythematosus, Systemic; Pre

1997
Acute lupus peritonitis successfully treated with steroid pulse therapy.
    Journal of gastroenterology, 1997, Volume: 32, Issue:5

    Topics: Acute Disease; Adult; Dose-Response Relationship, Drug; Endoscopy, Digestive System; Follow-Up Studi

1997
[A case of lupus myocarditis and nephritis with transient foramen jugular syndrome].
    Ryumachi. [Rheumatism], 1997, Volume: 37, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cranial Nerve Diseases; Erythrop

1997
[Two cases with SLE and MCTD developed after a long period of chronic arthritis that was initially diagnosed as JRA].
    Ryumachi. [Rheumatism], 1997, Volume: 37, Issue:5

    Topics: Adolescent; Adult; Arthritis, Juvenile; Diagnosis, Differential; Female; Humans; Lupus Erythematosus

1997
[Case of myocarditis and congestive heart failure as main symptoms of systemic erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Dec-10, Volume: 86, Issue:12

    Topics: Adult; Anti-Inflammatory Agents; Heart Failure; Humans; Lupus Erythematosus, Systemic; Male; Myocard

1997
Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study.
    Lupus, 1998, Volume: 7, Issue:1

    Topics: Adult; Brain; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Lu

1998
Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.
    The Journal of rheumatology, 1998, Volume: 25, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Cyclophosphamide;

1998
Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Apoptosis; CD4 Antigens; CD8 Antigens; Cell Culture Techniques; Cell Survival; Dr

1998
[A case of systemic lupus erythematodes with hemosputum and pneumothorax probably resulting from pulmonary infarction and pulmonary angitis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 1998, Volume: 36, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Hemoptysis; Humans; Lupus Erythematosus, Systemic; Male; Methylpred

1998
Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 1998, Volume: 255, Issue:5

    Topics: Aging; Animals; Anti-Inflammatory Agents; Auditory Threshold; Autoimmune Diseases; Capillaries; Coch

1998
Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment.
    Scandinavian journal of rheumatology, 1998, Volume: 27, Issue:3

    Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Biomarkers; Bone and Bones; Bone Density; Bone Remo

1998
White, fibrous, papular lesions associated with systemic lupus erythematosus.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Biopsy, Needle; Female; Follow-Up Studies; Humans; Lupus Erythemato

1998
Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Diabetes care, 1998, Volume: 21, Issue:8

    Topics: Adipocytes; Animals; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Fema

1998
Pemphigus vulgaris associated with systemic lupus erythematosus.
    International journal of dermatology, 1998, Volume: 37, Issue:8

    Topics: Administration, Oral; Adolescent; Autoantibodies; Autoantigens; Basement Membrane; Desmosomes; Femal

1998
[Case of lupus cystitis diagnosed in the early stage].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Jul-10, Volume: 87, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Cystitis, Interstitial; Humans; Hydronephrosis; Lupus Erythematosus

1998
[Procainamide-induced lupus in a patient with bilateral pleural effusion].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 1998, Volume: 36, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Autoantibodies; Enzyme-Linked Immunosorbent

1998
[Case of systemic erythematodes on long-term care with repeated development of severe cytomegalovirus infection].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Aug-10, Volume: 87, Issue:8

    Topics: Azathioprine; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive

1998
[Successful surgical treatment of atrial septal defect with systemic lupus erythematosis in a 47-year-old female].
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 1998, Volume: 46, Issue:8

    Topics: Female; Glucocorticoids; Heart Septal Defects, Atrial; Humans; Lupus Erythematosus, Systemic; Middle

1998
[SLE with interstitial pneumonia during cyclophosphamide pulse therapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 1998, Volume: 36, Issue:7

    Topics: Cyclophosphamide; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lupus Erythematosus

1998
[A case developing tetraplegia due to systemic lupus erythematosus which was remitted by a steroid].
    Ryumachi. [Rheumatism], 1998, Volume: 38, Issue:5

    Topics: Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Peripheral Ner

1998
Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection.
    Lupus, 1998, Volume: 7, Issue:8

    Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA,

1998
[An interactive national symposium with mentometer voting. Experienced specialists learned more about SLE with renal involvement].
    Lakartidningen, 1998, Dec-09, Volume: 95, Issue:50

    Topics: Adult; Anti-Inflammatory Agents; Clinical Competence; Drug Therapy, Combination; Female; Humans; Kid

1998
Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    The Journal of rheumatology, 1999, Volume: 26, Issue:2

    Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Demineralization, Pathologic; Bone Density; Dem

1999
[Tuberculous meningitis developed during treatment for systemic lupus erythematosus (SLE)].
    Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:1

    Topics: Adenosine Deaminase; Anti-Inflammatory Agents; Female; Humans; Immunosorbent Techniques; Lupus Eryth

1999
A case of edematous striae distensae in lupus nephritis.
    The Journal of dermatology, 1999, Volume: 26, Issue:2

    Topics: Abdomen; Adolescent; Edema; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Predniso

1999
Successful pregnancy and delivery in a case of systemic lupus erythematosus treated with immunoadsorption therapy and cyclosporin A.
    Scandinavian journal of rheumatology, 1999, Volume: 28, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Cyclosporine; Delivery, Obstetric; Exanthe

1999
Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.
    Rheumatology (Oxford, England), 1999, Volume: 38, Issue:1

    Topics: Absorptiometry, Photon; Adult; Body Composition; Bone Density; Cross-Sectional Studies; Female; Foll

1999
Cardiac tamponade in SLE.
    Lupus, 1999, Volume: 8, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiac Tamponade; Humans; Lupus Erythematosus, Systemic; P

1999
Retroperitoneal fibrosis and systemic lupus erythematosus.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:5

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Female; Humans; Lupus Erythematosus, Systemic; Magnet

1999
Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.
    Scandinavian journal of rheumatology, 1999, Volume: 28, Issue:3

    Topics: Adult; CD4-CD8 Ratio; Colonic Diseases; Cyclosporine; Female; HLA-DR Antigens; Humans; Interphase; L

1999
[A case of systemic lupus erythematosus associated with severe acute pancreatitis].
    Ryumachi. [Rheumatism], 1999, Volume: 39, Issue:3

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cyclophosphamide; Female; Humans; Immunosuppressive

1999
Borderline tuberculoid leprosy coexisting with systemic lupus erythematosus.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 1999, Volume: 12, Issue:3

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Female; Foot Ulcer; Humans; Leprosy,

1999
Elevated serum interleukin-15 levels in systemic lupus erythematosus.
    Yonsei medical journal, 1999, Volume: 40, Issue:4

    Topics: Adolescent; Adult; Female; Glucocorticoids; Humans; Interleukin-15; Lupus Erythematosus, Systemic; M

1999
Patient with lichen planus and conjunctival immunopathologic features of lupus erythematosus.
    American journal of ophthalmology, 1999, Volume: 128, Issue:3

    Topics: Biopsy; Cicatrix; Complement C3; Conjunctivitis; Female; Fluorescent Antibody Technique; Humans; Imm

1999
Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus.
    American journal of reproductive immunology (New York, N.Y. : 1989), 1999, Volume: 42, Issue:3

    Topics: Adult; Complement System Proteins; Female; Fetal Growth Retardation; Humans; Infant; Infant, Newborn

1999
Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Acute Disease; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical

1999
Fever and leucopenia with steroids.
    Lancet (London, England), 2000, Jan-15, Volume: 355, Issue:9199

    Topics: Adult; Drug Hypersensitivity; Female; Fever; Glucocorticoids; Humans; Leukopenia; Lupus Erythematosu

2000
[Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) accompanied by hemophagocytosis and salivary gland swelling in a patient with systemic lupus erythematosus].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:1

    Topics: Adult; Female; Histiocytic Necrotizing Lymphadenitis; Histiocytosis, Non-Langerhans-Cell; Humans; Lu

2000
Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
    Lupus, 2000, Volume: 9, Issue:1

    Topics: Adult; Antigens, CD; Cyclophosphamide; Female; Glucocorticoids; HLA-DP Antigens; Humans; Immunosuppr

2000
Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus.
    Lupus, 2000, Volume: 9, Issue:1

    Topics: Adult; Apoptosis; Biopsy; Fas Ligand Protein; fas Receptor; Female; Glucocorticoids; Hepatitis; Huma

2000
Acute cerebellar ataxia of a patient with SLE.
    Clinical neurology and neurosurgery, 2000, Volume: 102, Issue:1

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Brain Edema; Brain Stem; Cerebellar Ataxia; Facial P

2000
Diminished expression of CD59 on activated CD8+ T cells undergoing apoptosis in systemic lupus erythematosus and Sjögren's syndrome.
    Scandinavian journal of immunology, 2000, Volume: 51, Issue:3

    Topics: Apoptosis; CD59 Antigens; CD8-Positive T-Lymphocytes; Cells, Cultured; Down-Regulation; Humans; Immu

2000
Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:4

    Topics: Administration, Oral; Angiography; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hyperten

2000
Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine.
    Rheumatology (Oxford, England), 2000, Volume: 39, Issue:4

    Topics: Adult; Bone Density; Female; Humans; Longitudinal Studies; Lumbar Vertebrae; Lupus Erythematosus, Sy

2000
Systemic lupus erythematosus presenting as mania.
    Acta psychiatrica Scandinavica, 2000, Volume: 101, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antipsychotic Agents; Bipolar Disorder; Ch

2000
[A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
    Ryumachi. [Rheumatism], 2000, Volume: 40, Issue:3

    Topics: Adult; Central Nervous System Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Humans;

2000
Multiple fish vertebra deformity in child with systemic lupus erythematosus: a case report.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2000, Volume: 67, Issue:4

    Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcitonin; Child; Female; Humans;

2000
Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus.
    Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:8-9

    Topics: Child; Cystitis, Interstitial; Female; Humans; Immunoglobulin G; Intestinal Obstruction; Lupus Eryth

2000
Periorbital heliotrope oedema as the only initial clinical manifestation of systemic lupus erythematosus in a primigravida.
    The British journal of dermatology, 2000, Volume: 143, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Edema; Eyelid Diseases; Female; Humans; Lupus Erythematosus, System

2000
Pure motor spastic quadriparesis in systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 1999, Volume: 47, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; M

1999
[Spontaneous infrapatellar tendon rupture in a patient with systemic lupus erythematosus].
    Ugeskrift for laeger, 2000, Sep-18, Volume: 162, Issue:38

    Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Humans;

2000
Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2000, Volume: 39, Issue:10

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Interleukin-12

2000
Excellent effect of steroid plus azathioprine in a young woman with pernicious anaemia and systemic lupus erythematosus.
    Clinical rheumatology, 2000, Volume: 19, Issue:6

    Topics: Adult; Anemia, Pernicious; Azathioprine; Bone Marrow Examination; Disease Progression; Drug Therapy,

2000
[A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1998, Volume: 21, Issue:5

    Topics: Aged; Antiphospholipid Syndrome; Female; Humans; Immunocompromised Host; Lupus Erythematosus, System

1998
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).
    Rheumatology (Oxford, England), 2001, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cardiovascular System; Central Nervous System; Child; C

2001
Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).
    Clinical and experimental immunology, 2001, Volume: 123, Issue:1

    Topics: Adult; Aged; Annexin A5; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Apoptosis;

2001
Development of severe longitudinal atrophy of thoracic spinal cord following lupus-related myelitis.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:4

    Topics: Adult; Atrophy; Azathioprine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Ery

2001
Protein-losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:5

    Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Female; Glucocorticoids; Humans; Lupus

2001
Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients.
    Lupus, 2001, Volume: 10, Issue:5

    Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Female; Glucocorti

2001
[A surgical treatment for ischemic heart disease associated with systemic lupus erythematodes: report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2001, Volume: 54, Issue:6

    Topics: Anti-Inflammatory Agents; Coronary Artery Bypass; Humans; Lupus Erythematosus, Systemic; Male; Middl

2001
Lupus flare associated with growth hormone.
    Lupus, 2001, Volume: 10, Issue:6

    Topics: Adult; Cyclophosphamide; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Immunosupp

2001
[A case of systemic lupus erythematosus presented with severe acute pancreatitis as an initial manifestation and improved by intensive care].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2001, Volume: 98, Issue:7

    Topics: Acute Disease; Adolescent; Female; Hemofiltration; Humans; Lupus Erythematosus, Systemic; Pancreatit

2001
[A case of SLE presenting the features of antiphospholipid antibody syndrome during a treatment for complicated cryptococcal meningitis].
    No to shinkei = Brain and nerve, 2001, Volume: 53, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Female; Flucytosine; Humans; Im

2001
[Systemic lupus erythematosus presenting as a brainstem infarction and hemorrhage during treating retroperitoneal abscess: a case report].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2001, Volume: 92, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Brain Stem Infarctions; Cerebral Hemorrhage; Drainage; Female; Huma

2001
Peripheral gangrene during infancy: a rare presentation of systemic lupus erythematosus.
    Archives of disease in childhood, 2001, Volume: 85, Issue:4

    Topics: Fingers; Gangrene; Glucocorticoids; Humans; Infant; Lupus Erythematosus, Systemic; Male; Prednisolon

2001
Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray.
    Arthritis and rheumatism, 2001, Volume: 45, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Hydroxychloroqui

2001
Multiple sterile abscesses in antiphospholipid antibody syndrome.
    Cutis, 2001, Volume: 68, Issue:4

    Topics: Abscess; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Extremities; Female;

2001
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biomarkers; C-Reactive

2002
Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus.
    Scandinavian journal of rheumatology, 2001, Volume: 30, Issue:6

    Topics: Adolescent; Antibodies, Viral; Blood Chemical Analysis; Cytomegalovirus; Cytomegalovirus Infections;

2001
Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Anticoagulants; Autoimmune Diseases; Calcium Channel Blockers; Disease Progression; Epoprostenol; Fa

2002
Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Adult; Agammaglobulinemia; Autoimmune Diseases; Colitis; Cyclophosphamide; Cytomegalovirus; Cytomega

2002
Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Adult; Autoimmune Diseases; Azathioprine; Brain; Cyclophosphamide; Drug Resistance; Facial Nerve Dis

2002
Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Anorexia; Antibodies, Antinuclear; Ascites; Autoimmune Diseases; Disseminated Intravascular Coagulat

2002
Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Autoimmune Diseases; Azathioprine; Colitis; Cyclophosphamide; Cytokines; Cytomegalovirus Infections;

2002
Late onset systemic lupus erythematosus with elevated CA125 and gastrointestinal ischaemia.
    Internal medicine journal, 2002, Volume: 32, Issue:3

    Topics: Age of Onset; Aged; Biomarkers, Tumor; CA-125 Antigen; Colonoscopy; Cyclophosphamide; Drug Therapy,

2002
Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.
    Pediatrics international : official journal of the Japan Pediatric Society, 2002, Volume: 44, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Hu

2002
Drug-induced lupus erythematosus by amiodarone.
    Archives of internal medicine, 2002, Apr-08, Volume: 162, Issue:7

    Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antibodies, Antinuclear; C-Reactive Pr

2002
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:5

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Antiphospholipid Syndrome; Child; Critical Care;

2002
Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lupus Erythematosus, Systemic; Predn

2002
Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:4

    Topics: Adolescent; Deamino Arginine Vasopressin; Female; Hemorrhage; Humans; Lupus Erythematosus, Systemic;

2002
Progressive multifocal leucoencephalopathy isolated to the posterior fossa in a patient with systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:7

    Topics: Adult; Azathioprine; Cranial Fossa, Posterior; Humans; Immunocompromised Host; Immunosuppressive Age

2002
Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.
    Clinical and experimental immunology, 2002, Volume: 129, Issue:1

    Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Autoimmunity; Female; Gene Expression Regulation;

2002
[Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1977, Oct-21, Volume: 119, Issue:42

    Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; Derm

1977
[Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1978, Jul-28, Volume: 103, Issue:30

    Topics: Adult; Colitis, Ulcerative; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic;

1978
[The coincidence of visceral lupus erythematosus and epilepsy].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1978, Sep-15, Volume: 33, Issue:18

    Topics: Adolescent; Carbamazepine; Epilepsy, Tonic-Clonic; Humans; Lupus Erythematosus, Systemic; Male; Phen

1978
Noninfectious canine arthritis: the inflammatory, nonerosive arthritides.
    Journal of the American Veterinary Medical Association, 1976, Aug-01, Volume: 169, Issue:3

    Topics: Animals; Arthritis; Arthritis, Infectious; Azathioprine; Cyclophosphamide; Dog Diseases; Dogs; Femal

1976
Maternal immunosuppression and cytomegalovirus infection of the fetus.
    Australian and New Zealand journal of medicine, 1979, Volume: 9, Issue:4

    Topics: Adult; Antibodies, Bacterial; Azathioprine; Brain Damage, Chronic; Cytomegalovirus Infections; Femal

1979
[Spinal cord lesion in systemic lupus erythematosus].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1979, Volume: 79, Issue:11

    Topics: Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Movement Disorders; Nervous System Disea

1979
Growth retardation in juvenile rheumatoid arthritis (JRA).
    Arthritis and rheumatism, 1977, Volume: 20, Issue:2 Suppl

    Topics: Arthritis, Juvenile; Child; Child, Preschool; Growth Disorders; Humans; Infant; Lupus Erythematosus,

1977
Mixed connective tissue disease in childhood. A clinical and serologic survey.
    The Journal of pediatrics, 1977, Volume: 90, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Antibodies, Antinuclear; Antigens, Viral; Child; C

1977
[Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1978, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Azathioprine; B-Lymphocytes; Glomerulonephritis; Humans; Leukocyte Count; Lupus E

1978
Avidity of anti-native DNA antibody and glomerular immune complex localization in lupus nephritis.
    Clinical nephrology, 1978, Volume: 10, Issue:4

    Topics: Adult; Antibodies, Antinuclear; Antigen-Antibody Complex; Binding Sites, Antibody; DNA; Female; Huma

1978
Levamisole in systemic lupus erythematosus.
    Annals of allergy, 1979, Volume: 43, Issue:3

    Topics: Adolescent; Antibodies; Antibodies, Antinuclear; Cyclophosphamide; DNA; Female; Herpes Simplex; Huma

1979
[Malignant lymphopathy in a patient suffering from acute disseminated lupus erythematosus (author's transl)].
    La Nouvelle presse medicale, 1977, Sep-24, Volume: 6, Issue:31

    Topics: Chlorambucil; Ganglia, Spinal; Humans; Lupus Erythematosus, Systemic; Lymphoma, Follicular; Male; Mi

1977
Immune deficiency states and immune imbalance in systemic lupus erythematosus and other autoimmune diseases.
    Clinical immunology and immunopathology, 1979, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Antibodies, Viral; Antibody Formation; Antitoxins; Autoimmune Diseases; Dinitroch

1979
[Steroid therapy for collagen diseases and allergic diseases--indications and methods of administration].
    Nihon rinsho. Japanese journal of clinical medicine, 1979, Jun-10, Volume: 37, Issue:6

    Topics: Adult; Arthritis, Rheumatoid; Asthma; Beclomethasone; Collagen Diseases; Female; Humans; Lupus Eryth

1979
[Steroid therapy for nephrotic syndrome--indications and methods of administration].
    Nihon rinsho. Japanese journal of clinical medicine, 1979, Jun-10, Volume: 37, Issue:6

    Topics: Humans; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Prednisolone

1979
[Comparative evaluation of the effectiveness of corticosteroids and cytostatics in hypertensive variants of systemic nephritis].
    Klinicheskaia meditsina, 1979, Volume: 57, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Azathioprine; Drug Evaluation; Dr

1979
Plasmapheresis in glomerulonephritis.
    Clinical nephrology, 1979, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System

1979
Clinical and radiological features of osteonecrosis in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1979, Volume: 38, Issue:5

    Topics: Adolescent; Adult; Female; Femur Head Necrosis; Humans; Knee Joint; Lupus Erythematosus, Systemic; O

1979
[Comparative evaluation of the effectiveness of cyclic polychemotherapy and continuous treatment of lupus nephritis with 2 immunodepressants].
    Terapevticheskii arkhiv, 1979, Volume: 51, Issue:1

    Topics: Adolescent; Adult; Cyclophosphamide; Dipyridamole; Female; Heparin; Humans; Lupus Erythematosus, Sys

1979
[Alternate-day corticosteroid regimens and "pulse" therapy in collagen diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 1977, Volume: 35, Issue:12

    Topics: Drug Administration Schedule; Humans; Lupus Erythematosus, Systemic; Nephritis; Prednisolone

1977
Pulmonary nocardiosis in a patient receiving immunosuppressive agent.
    The Southeast Asian journal of tropical medicine and public health, 1977, Volume: 8, Issue:3

    Topics: Adult; Chloramphenicol; Drug Resistance, Microbial; Female; Humans; Lung Diseases; Lupus Erythematos

1977
Disseminated nocardiosis after pulmonary collapse: a case report.
    The Southeast Asian journal of tropical medicine and public health, 1977, Volume: 8, Issue:4

    Topics: Abscess; Adult; Exophthalmos; Female; Humans; Lupus Erythematosus, Systemic; Nocardia Infections; Pr

1977
Triple therapy in children with lupus nephritis.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1978, Volume: 61 Suppl 1

    Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up

1978
Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
    The Journal of pediatrics, 1978, Volume: 93, Issue:2

    Topics: Administration, Oral; Adolescent; Adrenocortical Hyperfunction; Asthma; Biological Availability; Chi

1978
[The immunologic problems in chronic glomerulonephritis. Doubts of a clinical immunologist].
    Minerva medica, 1978, Jun-30, Volume: 69, Issue:32

    Topics: Antigen-Antibody Complex; Chronic Disease; Complement System Proteins; Cortisone; Dose-Response Rela

1978
[Change of long term prognosis of systemic lupus erythematosus (author's transl)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1978, Dec-10, Volume: 67, Issue:12

    Topics: Female; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone; Prognosis; Time Factors

1978
Lupus-scleroderma syndrome induced by ethosuximide.
    Archives of disease in childhood, 1975, Volume: 50, Issue:8

    Topics: Adolescent; Anemia; Epilepsy, Tonic-Clonic; Ethosuximide; Female; Humans; Lupus Erythematosus, Syste

1975
Systemic lupus erythematosus in a boy with a review of the Japanese literature.
    European journal of pediatrics, 1977, Apr-26, Volume: 125, Issue:1

    Topics: Age Factors; Child, Preschool; Female; Humans; Japan; Lupus Erythematosus, Systemic; Male; Prednisol

1977
[Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1977, Volume: 49, Issue:8

    Topics: Adolescent; Adult; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; T

1977
[Objective evaluation of remote results of treatment of systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1977, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Azathioprine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studi

1977
[Uric acid of plasma in patients with rheumatic heart disease, rheumatoid arthritis and systemic lupus erythematosus and its dynamics during treatment].
    Terapevticheskii arkhiv, 1976, Volume: 48, Issue:5

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cardiac Glycosides;

1976
[Disputable problems of immunosuppressive therapy with cytostatic drugs].
    Klinicheskaia meditsina, 1976, Volume: 54, Issue:6

    Topics: Antineoplastic Agents; Autoimmune Diseases; Drug Evaluation; Humans; Immunosuppressive Agents; Infla

1976
[Presocyl in the treatment of lupus erythematosus].
    Vestnik dermatologii i venerologii, 1976, Issue:7

    Topics: Adolescent; Adult; Aspirin; Chloroquine; Drug Combinations; Female; Humans; Lupus Erythematosus, Dis

1976
Epidermolysis bullosa dystorphica and systemic lupus erythematosus.
    Proceedings of the Royal Society of Medicine, 1976, Volume: 69, Issue:12

    Topics: Adolescent; Epidermolysis Bullosa; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Vita

1976
Canine systemic lupus erythematosus. The disease, clinical manifestations and treatment.
    Journal of the South African Veterinary Association, 1976, Volume: 47, Issue:4

    Topics: Animals; Dog Diseases; Dogs; Female; Lupus Erythematosus, Systemic; Male; Oxytetracycline; Prednisol

1976
Systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 1976, Volume: 24, Issue:9

    Topics: Adult; Brain Diseases; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Prednisolone

1976
[A case of systemic lupus erythematosus associated with persistent p-type hyperamylasemia during steroid therapy (author's transl)].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1976, Volume: 73, Issue:12

    Topics: Adult; Amylases; Female; Humans; Lupus Erythematosus, Systemic; Pancreas; Prednisolone

1976
Complete heart block and systemic lupus erythematosus.
    British heart journal, 1975, Volume: 37, Issue:9

    Topics: Adams-Stokes Syndrome; Adolescent; Chloroquine; Female; Heart Block; Humans; Lupus Erythematosus, Sy

1975
Radiographic and endoscopic features of colonic ulcers in systemic lupus erythematosus.
    The American journal of gastroenterology, 1975, Volume: 64, Issue:4

    Topics: Adult; Colitis, Ulcerative; Colonic Diseases; Diagnosis, Differential; Endoscopy; Female; Humans; Lu

1975
[Psychopathologic manifestations in systemic lupus erythematosus].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1975, Volume: 75, Issue:4

    Topics: Adult; Affective Symptoms; Dementia; Dexamethasone; Female; Hallucinations; Humans; Lupus Erythemato

1975
Psychiatric problems in systemic lupus erythematosus.
    The British journal of psychiatry : the journal of mental science, 1976, Volume: 128

    Topics: Adult; Aggression; Confusion; Delusions; Depression; Female; Hallucinations; Humans; Hypertension; L

1976
[Systemic lupus erythematosus in puerperium].
    Zentralblatt fur Gynakologie, 1992, Volume: 114, Issue:12

    Topics: Adult; Autoantibodies; Azathioprine; Blood Component Removal; Cyclophosphamide; Diagnosis, Different

1992
Canine systemic lupus erythematosus. I: A study of 75 cases.
    Lupus, 1992, Volume: 1, Issue:3

    Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Dog Diseases; Dogs; Female; Levamisole; Lupus Eryt

1992
[An analysis of the hormonal response during the performance of stress tests in patients with systemic lupus erythematosus and systemic scleroderma].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:5

    Topics: Adrenocorticotropic Hormone; Female; Hormones; Humans; Lupus Erythematosus, Systemic; Male; Predniso

1992
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.
    Clinical and experimental immunology, 1992, Volume: 89, Issue:3

    Topics: Adult; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Female; Humans; Immunoglobulin A; Imm

1992
[Severe hepatitis with encephalopathy induced by acetylsalicylic acid in a case of lupus erythematosus disseminatus].
    Gastroenterologie clinique et biologique, 1992, Volume: 16, Issue:4

    Topics: Aspirin; Chemical and Drug Induced Liver Injury; Female; Hepatic Encephalopathy; Humans; Lupus Eryth

1992
[A case of systemic lupus erythematosus associated with Sjögren's syndrome diagnosed by lung localization].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:4

    Topics: Adult; Female; Humans; Lung; Lupus Erythematosus, Systemic; Prednisolone; Pulmonary Fibrosis; Radiog

1992
Two UV-induced episodes of myelitis in a patient with systemic lupus erythematosus.
    Journal of internal medicine, 1992, Volume: 232, Issue:5

    Topics: Acute Disease; Adult; Cerebrospinal Fluid; Contraceptives, Oral, Hormonal; Female; Humans; Lupus Ery

1992
[A case of SLE occurring after pacemaker implantation].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Nov-10, Volume: 81, Issue:11

    Topics: Aged; Autoantibodies; Female; Foreign-Body Reaction; Humans; Lupus Erythematosus, Systemic; Pacemake

1992
Neuropsychiatric systemic lupus erythematosus in elderly people: a case series.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:12

    Topics: Aged; Aged, 80 and over; Azathioprine; Confusion; Dementia; Diagnosis, Differential; Drug Therapy, C

1992
Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:2

    Topics: Adult; Aged; Autoantibodies; Cardiolipins; Fasting; Female; Humans; Lipids; Lupus Erythematosus, Sys

1992
Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy.
    Clinical orthopaedics and related research, 1992, Issue:277

    Topics: Adult; Blood Chemical Analysis; Female; Femur Head Necrosis; Humans; Lupus Erythematosus, Systemic;

1992
Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Cardiolipins; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglob

1992
Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:3

    Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; DNA; Female; Humans; Lupus Coag

1992
Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide.
    The Journal of rheumatology, 1992, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Cyclophosphamide; Female; Humans; Injections, Intravenous; Lupus Erythematosus, S

1992
Use of a radioreceptor assay in the assessment of cushingoid features in patients with juvenile rheumatic diseases.
    Therapeutic drug monitoring, 1992, Volume: 14, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Cushing Syndrome; Dermatomyositis;

1992
[Studies on clinical subsets and severity of systemic lupus erythematosus based on a 1987 questionnaire conducted in Japan--clinical analysis of the outcome and treatments in clinical subsets].
    Ryumachi. [Rheumatism], 1992, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Child; Humans; Immunosuppressive Agents; Japan; Lupus Erythematosus, Systemic; Pl

1992
[Cryptococcal meningoencephalitis following immunosuppressive therapy].
    Zeitschrift fur arztliche Fortbildung, 1992, May-11, Volume: 86, Issue:9

    Topics: Adult; Azathioprine; Brain; Cryptococcus neoformans; Female; Humans; Immune Tolerance; Lupus Erythem

1992
[Systemic lupus erythematosus and pancreatitis. Apropos of a case].
    Anales espanoles de pediatria, 1992, Volume: 36, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Humans; Lupus Erythematosus, Systemic; Male; Pancreatitis; Parent

1992
[Physiopathology and therapy of systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Mar-10, Volume: 81, Issue:3

    Topics: Adult; Cyclophosphamide; Female; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Mal

1992
Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Blood Sedimentation; Cell Line; Cytotoxicity, Immunologic; Female; Humans; Killer

1992
Abnormal production of B cell growth factor in patients with systemic lupus erythematosus.
    Clinical and experimental immunology, 1992, Volume: 89, Issue:1

    Topics: Adolescent; Adult; Antigens, CD; Biological Assay; Cell Division; Cell Line; Dose-Response Relations

1992
Cerebral ischemia associated with anticardiolipin antibodies.
    Acta neurologica Scandinavica, 1992, Volume: 85, Issue:6

    Topics: Adult; Aged; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Brain Ischemia; Cardiolipins; Cereb

1992
[Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1991, Volume: 65, Issue:7

    Topics: Adult; Antibodies, Viral; Chi-Square Distribution; Female; Herpes Zoster; Herpesvirus 3, Human; Huma

1991
Cryptococcal meningitis in a child with systemic lupus erythematosus.
    Annals of tropical paediatrics, 1990, Volume: 10, Issue:3

    Topics: Amphotericin B; Azathioprine; Cerebrospinal Fluid; Child; Cryptococcosis; Diagnosis, Differential; F

1990
Serum level of interferon-gamma in autoimmune diseases.
    The Tohoku journal of experimental medicine, 1991, Volume: 164, Issue:4

    Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antigens, Surface; Arthritis, Rheumatoid; Autoim

1991
Lung cavities from Pneumocystis carinii in a patient with systemic lupus erythematosus.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1991, Volume: 74, Issue:7

    Topics: Adult; Biopsy; Female; Humans; Lupus Erythematosus, Systemic; Pneumonia, Pneumocystis; Prednisolone;

1991
Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.
    Annals of the rheumatic diseases, 1991, Volume: 50, Issue:12

    Topics: Administration, Oral; Bronchiolitis Obliterans; Cyclophosphamide; Drug Therapy, Combination; Female;

1991
Clinical features of patients with mild systemic lupus erythematosus.
    Scandinavian journal of rheumatology, 1991, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Autoantigens; Child; Complement C3; Complement C4; Complement Hemolytic Activity

1991
T-zone lymphoma in association with systemic lupus erythematosus.
    Journal of medicine, 1991, Volume: 22, Issue:4-5

    Topics: Humans; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Male; Microscopy, Electron; Middle Aged; Pr

1991
[The beta-glucuronidase activity in the blood cells and serum of patients with systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1991, Volume: 63, Issue:12

    Topics: Blood Donors; Glucuronidase; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Neutrop

1991
Pulse cyclophosphamide for severe neuropsychiatric lupus.
    The Quarterly journal of medicine, 1991, Volume: 81, Issue:296

    Topics: Adolescent; Adult; Central Nervous System Diseases; Cyclophosphamide; Drug Administration Schedule;

1991
Brown-Séquard and SLE.
    Neurology, 1991, Volume: 41, Issue:5

    Topics: Aged; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Spinal Cord Injurie

1991
Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
    The Journal of rheumatology, 1991, Volume: 18, Issue:3

    Topics: B-Lymphocytes; Cell Division; Cell Fractionation; Humans; Immunoglobulin G; Interferon-gamma; Interl

1991
[A case of systemic lupus erythematosus complicated with pulmonary hypertension and massive pericardial effusion].
    Ryumachi. [Rheumatism], 1991, Volume: 31, Issue:2

    Topics: Adult; Dysgammaglobulinemia; Female; Humans; Hypertension, Pulmonary; Immunoglobulin A; Lupus Erythe

1991
Osteonecrosis of femoral head in SLE patient after short period of corticosteroid therapy--a case report.
    JPMA. The Journal of the Pakistan Medical Association, 1991, Volume: 41, Issue:8

    Topics: Adolescent; Aspirin; Drug Combinations; Female; Femur Head Necrosis; Humans; Lupus Erythematosus, Sy

1991
Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1991, Volume: 6, Issue:8

    Topics: Adult; Aged; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Arteritis; Autoantibodies; Cyclopho

1991
Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer.
    Journal of clinical & laboratory immunology, 1990, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Autoimmune Diseas

1990
The pharmacokinetics of plasma total and free prednisolone during an alternate-day regimen.
    Nihon Naibunpi Gakkai zasshi, 1991, Jan-20, Volume: 67, Issue:1

    Topics: Adult; Drug Administration Schedule; Female; Half-Life; Humans; Longitudinal Studies; Lupus Erythema

1991
Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
    Clinical immunology and immunopathology, 1991, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antigens, Viral; B-Lymphocytes; Enzyme-Linked Immu

1991
[Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].
    Zeitschrift fur Erkrankungen der Atmungsorgane, 1991, Volume: 176, Issue:1

    Topics: Adult; Azathioprine; B-Lymphocyte Subsets; Bronchoalveolar Lavage Fluid; Female; Flow Cytometry; Hum

1991
[Effects of disease activities and corticosteroid therapy on the chemiluminescence of peripheral polymorphonuclear leukocytes in patients with systemic lupus erythematosus].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1991, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Aged; Female; Humans; Luminescent Measurements; Lupus Erythematosus, Systemic; Ma

1991
Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy.
    Scandinavian journal of immunology, 1990, Volume: 31, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; CD4 Antigens; CD8 Antigens;

1990
High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis.
    Annals of the rheumatic diseases, 1990, Volume: 49, Issue:8

    Topics: Adult; Aged; Antibodies, Viral; Antibody Formation; Female; Herpes Zoster; Herpesvirus 3, Human; Hum

1990
Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus.
    The Journal of rheumatology, 1990, Volume: 17, Issue:10

    Topics: Adult; Brain; Cerebrovascular Disorders; Female; Humans; Lupus Erythematosus, Systemic; Necrosis; Pr

1990
[Diagnosis and clinical symptoms of systemic lupus erythematosus and overlap syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Antibodies, Antinuclear; Captopril; Humans; Lupus Erythematosus, Systemic; Mixed Connective Tissue D

1990
[Classification and therapy of systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Blood Component Removal; Female; Humans; Immun

1990
[Important points in adrenal-corticosteroid therapy of systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Diet; Humans; Infusions, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolon

1990
[Clinical study and therapy of pulmonary hypertension in systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Female; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Ma

1990
[Clinical concept of lupus cystitis].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Adult; Antibodies, Antinuclear; Autoimmunity; Cystitis; Female; Humans; Lupus Erythematosus, Systemi

1990
[Clinical study and therapy of systemic lupus erythematosus and pregnancy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Antibodies, Antinuclear; Aspirin; Female; Heparin; Humans; Infant, Newborn; Kidney Function Tests; L

1990
[Countermeasure for adverse effects of therapeutic agents for systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10

    Topics: Diabetes Mellitus; Humans; Immunosuppressive Agents; Infections; Lupus Erythematosus, Systemic; Oste

1990
Renal transplantation in patients with systemic lupus erythematosus: increased risk of early graft loss.
    Scandinavian journal of urology and nephrology, 1990, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Azathioprine; Cyclosporins; Female; Follow-Up Studies; Graft Rejection; Graft Sur

1990
Persistent fetal sinus bradycardia associated with maternal anti-Ro antibodies. Case report.
    British journal of obstetrics and gynaecology, 1990, Volume: 97, Issue:12

    Topics: Adult; Antibodies, Antinuclear; Bradycardia; Female; Fetal Diseases; Fetal Monitoring; Humans; Infan

1990
[Fatal infection in patients with systemic lupus erythematosus and incidence, types, predisposing factors, and prevention--comparative study of patients with rheumatoid arthritis and primary nephrotic syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:10

    Topics: Adult; Arthritis, Rheumatoid; Bacterial Infections; Female; Humans; Incidence; Japan; Lupus Erythema

1990
The 'shrinking lungs syndrome'--an infrequently recognised feature of systemic lupus erythematosus.
    Australian and New Zealand journal of medicine, 1990, Volume: 20, Issue:1

    Topics: Breath Tests; Humans; Lung Diseases; Lung Volume Measurements; Lupus Erythematosus, Systemic; Male;

1990
[Evaluation of disease activity in patients with systemic lupus erythematosus and administration of adrenal cortex steroids].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Mar-10, Volume: 79, Issue:3

    Topics: Antigen-Antibody Complex; Blood Sedimentation; C-Reactive Protein; Complement System Proteins; Human

1990
[The functional morphology of the thymus in systemic lupus erythematosus and its characteristics during immunodepressive and immunostimulating therapies].
    Arkhiv patologii, 1990, Volume: 52, Issue:2

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Autoimmune Diseases; Child; Dose-Response Relationship, I

1990
[Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:3

    Topics: Dermatomyositis; Humans; Lupus Erythematosus, Systemic; Prednisolone; Prognosis; Pulmonary Fibrosis;

1990
[A case of systemic lupus erythematosus complicated by polycythemia vera and acquired ichthyosis in an aged male].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Feb-10, Volume: 79, Issue:2

    Topics: Age Factors; Aged; Humans; Ichthyosis; Lupus Erythematosus, Systemic; Male; Polycythemia Vera; Predn

1990
[Systemic lupus erythematosus accompanied by cutaneous vasculitis. Comparison of molecular size of circulating immune complexes].
    Arerugi = [Allergy], 1990, Volume: 39, Issue:3

    Topics: Adolescent; Antigen-Antibody Complex; Enzyme-Linked Immunosorbent Assay; Humans; Lupus Erythematosus

1990
[A case of systemic lupus erythematosus associated with cryptococcal meningitis which was successfully cured by the administration of massive dose of amphotericin B].
    Nihon Jinzo Gakkai shi, 1990, Volume: 32, Issue:4

    Topics: Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infusions, In

1990
Systemic manifestations of systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:5

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone

1990
Cardiac rupture following acute myocardial infarction in systemic lupus erythematosus: case report.
    Angiology, 1990, Volume: 41, Issue:8

    Topics: Adult; Female; Heart Rupture; Heart Rupture, Post-Infarction; Humans; Lupus Erythematosus, Systemic;

1990
Fetal-pericardial effusion in association with congenital heart block and maternal systemic lupus erythematosus. Case report.
    British journal of obstetrics and gynaecology, 1990, Volume: 97, Issue:7

    Topics: Adult; Antibodies, Antinuclear; Echocardiography; Electrocardiography; Female; Heart Block; Humans;

1990
Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry.
    Annals of the rheumatic diseases, 1990, Volume: 49, Issue:8

    Topics: Administration, Oral; Adult; Bone and Bones; Bone Density; Densitometry; Female; Humans; Lupus Eryth

1990
[Hemosorption in the complex treatment of rheumatic diseases].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:8

    Topics: Adult; Aortitis; Combined Modality Therapy; Connective Tissue Diseases; Dextrans; Female; Follow-Up

1985
[Therapy of rheumatic diseases with inosiplex].
    Immunitat und Infektion, 1986, Volume: 14, Issue:3

    Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Collagen Diseases; Complement System Prot

1986
[Hyperamylasemia in systemic lupus erythematosus (SLE)].
    Ryumachi. [Rheumatism], 1988, Volume: 28, Issue:1

    Topics: Amylases; Humans; Isoenzymes; Lupus Erythematosus, Systemic; Paramethasone; Prednisolone; Triglyceri

1988
[A case of systemic lupus erythematosus (SLE) associated with anti-thyrotropin (TSH) autoantibodies].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:4

    Topics: Adolescent; Autoantibodies; Female; gamma-Globulins; Humans; Lupus Erythematosus, Systemic; Predniso

1989
[A case of systemic lupus erythematosus associated with lateral medullary syndrome and unilateral internuclear ophthalmoplegia].
    Rinsho shinkeigaku = Clinical neurology, 1989, Volume: 29, Issue:1

    Topics: Adolescent; Blood Coagulation Factors; Brain Diseases; Female; Humans; Immunoglobulin G; Lupus Coagu

1989
Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.
    Annals of the rheumatic diseases, 1989, Volume: 48, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Blood Coagulation Factors; Child; Female; Hemostasis; Hu

1989
Intraplatelet and urinary serotonin concentrations in systemic lupus erythematosus with reference to its clinical manifestations.
    Journal of medicine, 1989, Volume: 20, Issue:5-6

    Topics: Adolescent; Adult; beta-Thromboglobulin; Blood Platelets; Chromatography, High Pressure Liquid; Fema

1989
Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1989, Volume: 48, Issue:10

    Topics: Aged; Annexins; Arthritis, Rheumatoid; Autoantibodies; Calcium-Binding Proteins; Enzyme-Linked Immun

1989
[Low T3 syndrome and chronic inflammatory rheumatism].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1989, Sep-01, Volume: 44, Issue:17

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Eut

1989
[Porphyria cutanea tarda and lupus erythematosus].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1989, Sep-01, Volume: 44, Issue:17

    Topics: Adult; Biopsy; Chloroquine; Cyclophosphamide; Humans; Kidney; Liver; Liver Function Tests; Lupus Ery

1989
[Systemic lupus erythematosus in three sisters].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:9

    Topics: Adult; Antibodies, Antinuclear; Female; HLA Antigens; Humans; Lupus Erythematosus, Systemic; Middle

1989
An unusual case of painful ophthalmoplegia in a patient with rheumatoid arthritis.
    Annals of ophthalmology, 1989, Volume: 21, Issue:11

    Topics: Adult; Arthritis, Rheumatoid; Diplopia; Eye Movements; Female; Humans; Lupus Erythematosus, Systemic

1989
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.
    Annals of the rheumatic diseases, 1989, Volume: 48, Issue:12

    Topics: Adolescent; Adult; Aged; Autoantibodies; Cardiolipins; Female; Humans; Lupus Erythematosus, Systemic

1989
Systemic lupus erythematosus in a young male.
    Journal of the Indian Medical Association, 1989, Volume: 87, Issue:9

    Topics: Adult; Humans; India; Lupus Erythematosus, Systemic; Male; Neurocognitive Disorders; Prednisolone; P

1989
[A case of acute dissecting aneurysm of the aorta in systemic lupus erythematosus].
    Nihon Jinzo Gakkai shi, 1989, Volume: 31, Issue:11

    Topics: Adult; Aortic Aneurysm; Aortic Dissection; Arteriosclerosis; Female; Humans; Hypercholesterolemia; H

1989
[Systemic lupus erythematosis presenting a peculiar clinical course: report of a case].
    Journal of cardiology. Supplement, 1989, Volume: 22

    Topics: Adult; Female; Heart Failure; Humans; Lupus Erythematosus, Systemic; Mitral Valve Insufficiency; Pre

1989
[Results of prednisolone pulse therapy of children with systemic lupus erythematosus].
    Pediatriia, 1989, Issue:2

    Topics: Administration, Oral; Adolescent; Child; Dose-Response Relationship, Drug; Drug Administration Sched

1989
Systemic lupus erythematosus and acute intermittent porphyria.
    British journal of rheumatology, 1989, Volume: 28, Issue:3

    Topics: Acute Disease; Antibodies; Cardiolipins; Female; Humans; Lupus Erythematosus, Systemic; Methylpredni

1989
[A case of lupus cystitis].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:4

    Topics: Adult; Cystitis; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone

1989
A 47-year-old woman presenting with a 20-year history of SLE.
    British journal of rheumatology, 1989, Volume: 28, Issue:4

    Topics: Estrogens; Female; Humans; Lupus Erythematosus, Systemic; Menopause; Middle Aged; Osteoporosis; Pred

1989
[A case of systemic lupus erythematosus complicated with dissecting aortic aneurysm].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:4

    Topics: Adult; Aortic Aneurysm; Aortic Dissection; Female; Humans; Lupus Erythematosus, Systemic; Prednisolo

1989
[A case of systemic lupus erythematosus associated with meningitis, myelitis, and bilateral optic neuritis].
    Ryumachi. [Rheumatism], 1989, Volume: 29, Issue:2

    Topics: Adolescent; Female; Humans; Lupus Erythematosus, Systemic; Meningitis; Myelitis; Optic Neuritis; Pre

1989
Steroid induced exophthalmos. A case report.
    Australasian radiology, 1989, Volume: 33, Issue:2

    Topics: Adult; Exophthalmos; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone

1989
Root canal calcification associated with prednisone therapy: a case report.
    Journal of the American Dental Association (1939), 1989, Volume: 119, Issue:4

    Topics: Adult; Dental Pulp Calcification; Dentinogenesis; Female; Follow-Up Studies; Humans; Lupus Erythemat

1989
Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.
    Journal of hypertension, 1989, Volume: 7, Issue:2

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Glomerulonephritis; Heart Rate; Hu

1989
Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
    The Journal of rheumatology, 1986, Volume: 13, Issue:4

    Topics: Adolescent; Adult; B-Lymphocytes; Central Nervous System Diseases; Female; Humans; Immunoglobulin ka

1986
Systemic lupus erythematosus in child with autoimmune thrombocytopenic purpura and circulating lupus anticoagulant.
    Journal of the Royal Society of Medicine, 1987, Volume: 80, Issue:3

    Topics: Adolescent; Autoimmune Diseases; Blood Coagulation Factors; Female; Humans; Lupus Coagulation Inhibi

1987
Arterial thrombotic manifestations in young women associated with the lupus anticoagulant.
    Clinical rheumatology, 1988, Volume: 7, Issue:1

    Topics: Adult; Angiography; Arterial Occlusive Diseases; Blood Coagulation Factors; Cerebrovascular Disorder

1988
Release of leukotriene C4 from human monocytes: defects in patients with systemic lupus erythematosus.
    Arerugi = [Allergy], 1988, Volume: 37, Issue:5

    Topics: Adult; Calcimycin; Female; Humans; Lupus Erythematosus, Systemic; Male; Monocytes; Prednisolone; SRS

1988
Cerebellar ataxia in systemic lupus erythematosus: three case reports.
    Annals of the rheumatic diseases, 1988, Volume: 47, Issue:11

    Topics: Adolescent; Adult; Blood Coagulation Factors; Cerebellar Ataxia; Female; Humans; Lupus Coagulation I

1988
Myelofibrosis and pancytopenia in systemic lupus erythematosus.
    Acta haematologica, 1988, Volume: 80, Issue:4

    Topics: Adolescent; Female; Humans; Lupus Erythematosus, Systemic; Pancytopenia; Prednisolone; Primary Myelo

1988
Relation between the level of IgG subclasses and infections in patients with systemic lupus erythematosus.
    International archives of allergy and applied immunology, 1988, Volume: 87, Issue:1

    Topics: Adult; Communicable Diseases; Female; Humans; Immunoglobulin G; Immunoglobulin Isotypes; Lupus Eryth

1988
Pregnancy and lupus: prognostic indicators and response to treatment.
    The Quarterly journal of medicine, 1988, Volume: 66, Issue:250

    Topics: Adult; Autoantibodies; Cardiolipins; Female; Fetal Death; Humans; Infant, Newborn; Lupus Erythematos

1988
Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis.
    Annals of the rheumatic diseases, 1988, Volume: 47, Issue:12

    Topics: Adult; Drug Resistance; Female; Humans; Lupus Erythematosus, Systemic; Pleural Effusion; Prednisolon

1988
[Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus].
    Vutreshni bolesti, 1988, Volume: 27, Issue:5

    Topics: Acute Disease; Administration, Oral; Drug Evaluation; Humans; Infusions, Intravenous; Lupus Erythema

1988
[Systemic lupus erythematosus associated with autoimmune hemolytic anemia and diversified symptoms responsive to methylprednisolone pulse therapy: a case report].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1988, Volume: 77, Issue:5

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Female; Humans; Injections, Intravenous; Lupus Erythematosus,

1988
[A case of thrombotic thrombocytopenic purpura (TTP) complicated with systemic lupus erythematosus (SLE)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1988, Volume: 77, Issue:6

    Topics: Adult; Blood Transfusion; Female; Humans; Immunologic Tests; Lupus Erythematosus, Systemic; Predniso

1988
Endometrial carcinoma following chronic anovulation in a premenopausal woman with systemic lupus erythematosus.
    Acta obstetricia et gynecologica Scandinavica, 1988, Volume: 67, Issue:6

    Topics: Adenocarcinoma; Adult; Anovulation; Azathioprine; Endometrium; Female; Humans; Hyperplasia; Lupus Er

1988
2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
    The Journal of rheumatology, 1988, Volume: 15, Issue:6

    Topics: Adult; Antibodies; Antigens, Differentiation, T-Lymphocyte; Cell Membrane; Flow Cytometry; HLA-D Ant

1988
Rejection and recurrence of SLE nephritis in cyclosporine-treated kidney transplant recipients.
    Transplantation proceedings, 1987, Volume: 19, Issue:1 Pt 2

    Topics: Adult; Cyclosporins; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy;

1987
Systemic lupus erythematosis in a Papua New Guinean highlander.
    Papua and New Guinea medical journal, 1988, Volume: 31, Issue:1

    Topics: Adolescent; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Papua New Guinea

1988
Altered circadian blood pressure rhythm in patients with Cushing's syndrome.
    Hypertension (Dallas, Tex. : 1979), 1988, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Blood Pressure; Circadian Rhythm; Cushing Syndrome; Female; Glomerulonephritis; H

1988
A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis.
    The Journal of rheumatology, 1988, Volume: 15, Issue:4

    Topics: Adult; Brain Diseases; Cyclophosphamide; Female; Humans; Immunoglobulins; Lupus Erythematosus, Syste

1988
Giant cell arteritis and systemic lupus erythematosus.
    The British journal of dermatology, 1988, Volume: 119, Issue:1

    Topics: Female; Giant Cell Arteritis; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone

1988
Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus.
    Mutation research, 1987, Volume: 177, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Cells, Cultured; Chloroquine; DNA

1987
[Modification of in vitro immune mechanisms by various glucocorticosteroid preparations--studies of lymphocytes in healthy probands and autoimmune patients].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1987, Mar-15, Volume: 42, Issue:6

    Topics: Adult; Autoimmune Diseases; Dexamethasone; Female; Glucocorticoids; Humans; Hydrocortisone; Lupus Er

1987
[Production of interleukin 1 and interleukin 2 in systemic lupus erythematosus].
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1987, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Animals; Antibodies, Antinuclear; Child; Female; Humans; Interleukin-1; Interleuk

1987
[Primary malignant lymphoma of the brain following immunosuppressive therapy of systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:5

    Topics: Brain Neoplasms; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Sy

1987
[Complete recovery from severe organic brain damage in a patient with systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:11

    Topics: Adolescent; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Mutism; Neurocognitive

1987
[Follow-up of immunological parameters and therapy of systemic lupus erythematosus].
    Immunitat und Infektion, 1986, Volume: 14, Issue:2

    Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; B-Lymphocytes; Cyclophosphamide; DNA; Female; Fluo

1986
[Systemic lupus erythematosus with spinal cord involvement].
    Ryumachi. [Rheumatism], 1986, Volume: 26, Issue:5

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Paralysis; Prednisolone; Spinal Cord Diseases;

1986
Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
    Annals of internal medicine, 1987, Volume: 107, Issue:3

    Topics: Administration, Oral; Adult; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedu

1987
[A case report of angiosarcoma of the breast].
    Gan no rinsho. Japan journal of cancer clinics, 1987, Volume: 33, Issue:9

    Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Hemangiosarcoma; Humans; L

1987
Multiple thromboses in systemic lupus erythematosus.
    Archives of disease in childhood, 1987, Volume: 62, Issue:7

    Topics: Anemia, Hemolytic, Autoimmune; Child, Preschool; Female; Humans; Lupus Erythematosus, Systemic; Pred

1987
Lupus catatonia: a case report.
    Pharmatherapeutica, 1987, Volume: 5, Issue:2

    Topics: Adult; Azathioprine; Catatonia; Electroencephalography; Female; Humans; Lupus Erythematosus, Systemi

1987
[Prednisolone sensitivity of peripheral blood mononuclear cells of patients with systemic lupus erythematosus clinically resistant to glucocorticoids and the effects of carbon hemoperfusion].
    Terapevticheskii arkhiv, 1987, Volume: 59, Issue:8

    Topics: Adolescent; Adult; Blood Cells; Carbon; Cells, Cultured; Drug Resistance; Female; Glucocorticoids; H

1987
The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
    Agents and actions, 1987, Volume: 21, Issue:3-4

    Topics: Animals; Cyclophosphamide; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Graft vs Ho

1987
Two cases of systemic lupus erythematosus associated with hyperthyroidism.
    Japanese journal of medicine, 1987, Volume: 26, Issue:3

    Topics: Adult; Betamethasone; Female; Humans; Hyperthyroidism; Lupus Erythematosus, Systemic; Methimazole; P

1987
Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression.
    Clinical nephrology, 1986, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Biopsy; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Kidney; Lupus

1986
[Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment].
    Nihon Naibunpi Gakkai zasshi, 1986, Jun-20, Volume: 62, Issue:6

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Biological Availability; Female; Humans; Inj

1986
In vivo evidence of regulation by pituitary-adrenal axis of urinary epinephrine excretion in men.
    Endocrinologia japonica, 1986, Volume: 33, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Arthritis, Rheumatoid; Dopamine; Epinephrine; Femal

1986
Rupture of Achilles tendon in a case of systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:8

    Topics: Achilles Tendon; Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Rupture

1986
[Studies on the glucocorticoid receptor in human peripheral lymphocytes. II. Regulation by glucocorticoid].
    Nihon Naibunpi Gakkai zasshi, 1986, Nov-20, Volume: 62, Issue:11

    Topics: Adult; Cells, Cultured; Collagen Diseases; Cycloheximide; Dermatomyositis; Dexamethasone; Female; Gl

1986
[Studies on the glucocorticoid receptor in human peripheral lymphocytes. III. Correlation between receptor number and clinical response to glucocorticoid].
    Nihon Naibunpi Gakkai zasshi, 1986, Nov-20, Volume: 62, Issue:11

    Topics: Adolescent; Adult; Calcium; Cholesterol; Dermatomyositis; Dose-Response Relationship, Drug; Female;

1986
[Ascites disclosing systemic lupus erythematosus].
    Gastroenterologie clinique et biologique, 1986, Volume: 10, Issue:12

    Topics: Adult; Ascites; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone

1986
Myelopathy as the main presenting feature of systemic lupus erythematosus.
    European neurology, 1985, Volume: 24, Issue:2

    Topics: Adult; Antibodies, Antinuclear; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, System

1985
Impaired B cell proliferation by Staphylococcus aureus Cowan 1 in patients with systemic lupus erythematosus.
    Arthritis and rheumatism, 1985, Volume: 28, Issue:9

    Topics: B-Lymphocytes; Humans; Indomethacin; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mitogens;

1985
Development of chronic lymphocytic leukaemia in a case of Sjögren's syndrome with systemic lupus erythematosus.
    Scandinavian journal of haematology, 1985, Volume: 35, Issue:2

    Topics: Aged; B-Lymphocytes; Cephalosporins; Female; Gentamicins; Humans; Leukemia, Lymphoid; Lupus Erythema

1985
Erythrocyte insulin receptor and glucose tolerance test in children treated with prednisolone.
    Endocrinologia japonica, 1985, Volume: 32, Issue:3

    Topics: Adolescent; Arthritis, Juvenile; Child; Erythrocytes; Female; Glucose Tolerance Test; Humans; Insuli

1985
Widespread cutaneous necrosis associated with the lupus anticoagulant.
    Clinical and experimental dermatology, 1985, Volume: 10, Issue:6

    Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Female; Humans; Lupus Coagulation Inh

1985
Plasmapheresis in a pregnancy complicated by acute systemic lupus erythematosis. Case report.
    British journal of obstetrics and gynaecology, 1985, Volume: 92, Issue:5

    Topics: Acute Disease; Adult; Female; Humans; Lupus Erythematosus, Systemic; Plasmapheresis; Prednisolone; P

1985
Prednisolone pulse therapy for childhood systemic lupus erythematosus with prominent dermatomyositis. A case report.
    Dermatologica, 1985, Volume: 171, Issue:1

    Topics: Child; Dermatomyositis; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone

1985
[Risk factors in the development of steroid-induced hypertension in patients with nephritis].
    Klinicheskaia meditsina, 1985, Volume: 63, Issue:6

    Topics: Adolescent; Adult; Age Factors; Blood Volume; Female; Humans; Hypernatremia; Hypertension; Lupus Ery

1985
Adult respiratory distress syndrome caused by acute systemic lupus erythematosus.
    European journal of respiratory diseases, 1985, Volume: 67, Issue:2

    Topics: Acute Disease; Adult; Antigen-Antibody Complex; Glomerulonephritis; Humans; Lupus Erythematosus, Sys

1985
[An autopsy case of acute pancreatitis in systemic lupus erythematosus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1985, Volume: 74, Issue:7

    Topics: Acute Disease; Adult; Female; Humans; Lupus Erythematosus, Systemic; Pancreatitis; Prednisolone

1985
[Use of high doses of glucocorticoids in patients with rheumatic diseases].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:8

    Topics: Acute Disease; Adult; Arthritis, Rheumatoid; Dermatomyositis; Drug Therapy, Combination; Female; Fol

1985
[Circulating immune complexes, immunoglobulins and phagocytic activity of neutrophils in the evaluation of the activity and effectiveness of treatment of systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:8

    Topics: Antigen-Antibody Complex; Azathioprine; Cyclophosphamide; Dipyridamole; Follow-Up Studies; Heparin;

1985
Treatment of lupus nephritis with cyclophosphamide.
    Lancet (London, England), 1970, Oct-24, Volume: 2, Issue:7678

    Topics: Adolescent; Adult; Age Factors; Azathioprine; Biopsy; Chlorambucil; Cortisone; Cyclophosphamide; Fem

1970
Systemic lupus erythematosus with fibrosing alveolitis.
    Proceedings of the Royal Society of Medicine, 1971, Volume: 64, Issue:1

    Topics: Azathioprine; Humans; Lupus Erythematosus, Systemic; Male; Neutrophils; Prednisolone; Pulmonary Fibr

1971
Systemic lupus erythematosus induced by psychotropic drugs.
    Acta rheumatologica Scandinavica, 1971, Volume: 17, Issue:2

    Topics: Adult; Blood Cell Count; Chlorpromazine; Chlorprothixene; Female; Humans; Lupus Erythematosus, Syste

1971
Lupus erythematosus panniculitis.
    The British journal of dermatology, 1971, Volume: 85, Issue:3

    Topics: Adipose Tissue; Antibodies, Antinuclear; Biopsy; Buttocks; Female; Humans; Hyperbaric Oxygenation; I

1971
Treatment of lupus nephritis.
    Lancet (London, England), 1971, Oct-30, Volume: 2, Issue:7731

    Topics: Autoantibodies; Complement System Proteins; Cyclophosphamide; DNA; Glomerular Filtration Rate; Human

1971
[Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Monatsschrift fur Kinderheilkunde, 1972, Volume: 120, Issue:6

    Topics: Adrenocorticotropic Hormone; Antibodies, Antinuclear; Arthritis, Juvenile; Azathioprine; Bone Marrow

1972
Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Perspectives in nephrology and hypertension, 1973, Volume: 1 Pt 2, Issue:0

    Topics: Antibodies, Antinuclear; Biopsy; Female; gamma-Globulins; Humans; Kidney; Lupus Erythematosus, Syste

1973
Systemic lupus erythematosus syndrome induced by practolol.
    British medical journal, 1973, May-26, Volume: 2, Issue:5864

    Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amino Alcohols; Angina Pectoris; Electrocardiograph

1973
Bacterial L-forms in relapsing urinary-tract infection.
    Lancet (London, England), 1967, Mar-04, Volume: 1, Issue:7488

    Topics: Ampicillin; Bacteria; Child; Erythromycin; Female; Humans; L Forms; Lupus Erythematosus, Systemic; P

1967
Steroid therapy and hyperosmolar non-ketotic coma.
    Lancet (London, England), 1968, Mar-16, Volume: 1, Issue:7542

    Topics: Adult; Diabetic Coma; Female; Glucocorticoids; Humans; Hydrocortisone; Lupus Erythematosus, Systemic

1968
Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone.
    The Quarterly journal of medicine, 1968, Volume: 37, Issue:147

    Topics: Adolescent; Adult; Autoimmune Diseases; Azathioprine; Female; gamma-Globulins; Hepatitis; Humans; Im

1968
Generalized cytomegalovirus infection in a patient with lupoid hepatitis.
    Australasian annals of medicine, 1969, Volume: 18, Issue:2

    Topics: Adult; Autoantibodies; Azathioprine; Cytomegalovirus Infections; Edema; Esophagus; Female; Hemorrhag

1969
Active chronic hepatitis with positive L.E. cell test and lupus nephritis.
    Australasian annals of medicine, 1969, Volume: 18, Issue:3

    Topics: Child; Chronic Disease; Cyclophosphamide; Female; Hepatitis; Humans; Kidney; Liver; Lupus Erythemato

1969
Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus.
    Scandinavian journal of haematology, 1969, Volume: 6, Issue:5

    Topics: Adult; Aged; Antibodies, Antinuclear; Arthritis, Rheumatoid; Blood Sedimentation; Complement System

1969
Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.
    Australasian annals of medicine, 1970, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Biopsy; Blood Pressure; Blood Sedimentation; Complement

1970
Plasma C3 and C4 concentrations in management of glomerulonephritis.
    British medical journal, 1973, Sep-29, Volume: 3, Issue:5882

    Topics: Antibodies, Antinuclear; Azathioprine; Biopsy; Complement System Proteins; Glomerulonephritis; Human

1973
[Treatment of certain dermatoses with corticosteroid preparations].
    Vestnik dermatologii i venerologii, 1970, Volume: 44, Issue:7

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Dermatitis, Exfoliative; Dexamethasone; Fe

1970
Glucocorticoid-induced pancreatitis in children.
    Pediatrics, 1968, Volume: 41, Issue:2

    Topics: Acute Disease; Adolescent; Adrenocorticotropic Hormone; Child; Child, Preschool; Cortisone; Female;

1968
Systemic lupus erythematosus complicated by coccidioidomycosis.
    JAMA, 1968, Oct-28, Volume: 206, Issue:5

    Topics: Adrenocorticotropic Hormone; Adult; Amphotericin B; Chloroquine; Coccidioidomycosis; Cortisone; Fema

1968
Preliminary results of azathioprine treatment in severe rheumatic disease.
    Annals of physical medicine, 1969, Volume: 10, Issue:3

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Arthritis; Arthritis, Rheumatoid; Azathioprine; Blood Cell

1969
Single daily dose corticosteroid treatment. Effect on adrenal function and therapeutic efficacy in various diseases.
    Annals of the rheumatic diseases, 1971, Volume: 30, Issue:2

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Arteritis; Arthritis, Reactive; Arthritis,

1971
Anti-inflammatory drugs in rheumatic diseases.
    The Practitioner, 1974, Volume: 213, Issue:1276 SPEC

    Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Aspirin

1974
Posterior subcapsular cataract in nephrotic children receiving steroid therapy.
    American journal of diseases of children (1960), 1974, Volume: 128, Issue:5

    Topics: Adolescent; Cataract; Child; Child, Preschool; Cyclophosphamide; Dexamethasone; Dose-Response Relati

1974
Long-term effect of corticosteroids on cardiac function.
    Japanese heart journal, 1974, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Arthritis, Rheumatoid; Collagen Diseases; Cushing Syndrome; Electrocardiography;

1974
Norwegian scabies in acute SLE patient treated with high dose corticosteroid.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1974, Volume: 57, Issue:10

    Topics: Acute Disease; Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Pregnancy; Pregna

1974
Acute serum sickness induced immunologic injury of the choroid plexus; with particular reference to the effect of prednisolone and the nature of the interstitial cell.
    Yonsei medical journal, 1974, Volume: 15, Issue:2

    Topics: Acute Disease; Animals; Choroid Plexus; Lupus Erythematosus, Systemic; Prednisolone; Rabbits; Serum

1974
The treatment of connective tissue diseases with a new plurichronocorticoid.
    Chronobiologia, 1974, Volume: 1 Suppl 1

    Topics: Arthritis, Rheumatoid; Connective Tissue; Cortisone; Drug Combinations; Drug Evaluation; Female; Hum

1974
Systemic lupus erythematosus in a Chinese woman presenting with gangrene of the fingers.
    Australian and New Zealand journal of medicine, 1973, Volume: 3, Issue:2

    Topics: Adult; Female; Fingers; Gangrene; Humans; Lupus Erythematosus, Systemic; Prednisolone

1973
A sequential trial comparing cyclophosphamide and azathioprine as adjuncts in the treatment of systemic lupus erythematosus.
    Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:2

    Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Hospitalization; Humans; Lupus Er

1974
Pattern recognition in medicine--a place for the use of principal component analysis and factor analysis.
    Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:5

    Topics: Azathioprine; Body Height; Body Weight; Child; Computers; Cyclophosphamide; Diagnosis, Differential;

1974
Which drugs for which rheumatic disorder?
    British medical journal, 1972, Apr-01, Volume: 2, Issue:5804

    Topics: Analgesics; Arthritis, Rheumatoid; Aspirin; Gold; Gout; Humans; Indomethacin; Lupus Erythematosus, S

1972
[Study of rosette-forming lymphocytes in peripheral blood of patients with systemic lupus erythematosus].
    Terapevticheskii arkhiv, 1974, Volume: 46, Issue:11

    Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; B-Lymphocytes; Female; Humans; Immune Adherence Re

1974
[Lupus erythematosus].
    Fortschritte der Medizin, 1972, Dec-07, Volume: 90, Issue:34

    Topics: Adult; Age Factors; Antibodies, Antinuclear; Autoimmune Diseases; Chronic Disease; Female; Fluoresce

1972
B- and T-lymphocytes in rheumatoid synovitis and the effect of cyclophosphamide.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:6 Pt 2

    Topics: Arthritis, Rheumatoid; B-Lymphocytes; Cyclophosphamide; Humans; Immunoglobulin A; Immunoglobulin G;

1974
[Immunodepressants in the treatment of the major collagenoses].
    Vrachebnoe delo, 1972, Volume: 11

    Topics: Adolescent; Adult; Arthritis, Rheumatoid; Chlorambucil; Chloroquine; Female; Humans; Immunosuppressi

1972
Pathways of complement activation in glomerulonephritis.
    Kidney international, 1972, Volume: 1, Issue:2

    Topics: Antibodies; Antigen-Antibody Complex; Calcium; Complement Inactivator Proteins; Complement System Pr

1972
Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome.
    The American journal of medicine, 1973, Volume: 54, Issue:1

    Topics: Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Hydralazine; Lupus Erythematosus, Sy

1973
Cyclophosphamide in treatment of systemic lupus erythematosus: 7 years' experience.
    British medical journal, 1973, May-26, Volume: 2, Issue:5864

    Topics: Administration, Oral; Adolescent; Adult; Amenorrhea; Blood Cell Count; Cyclophosphamide; Female; Hem

1973
Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
    The Journal of laboratory and clinical medicine, 1973, Volume: 82, Issue:3

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Histocytochemistry; Humans; Hydroxychloroquine; In V

1973
Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematosus.
    Scandinavian journal of haematology, 1973, Volume: 10, Issue:1

    Topics: Adult; Autoimmune Diseases; Azathioprine; Blood Cell Count; Female; Humans; Immunity, Cellular; Immu

1973
Mortality in systemic lupus erythematosus: a 10-year review.
    British medical journal, 1973, Dec-29, Volume: 4, Issue:5895

    Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cerebrospinal Fluid Proteins; Child; Chlorides; Coma; Cyc

1973
[Wissler's allergic subsepsis in the adult age].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1973, Oct-15, Volume: 28, Issue:20

    Topics: Age Factors; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Sy

1973
[Case of pregnancy and labor in systemic lupus erythematosus].
    Pediatriia, 1973, Issue:3

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Obstetric Labor Complications; Prednisolone; P

1973
[Aseptic bone necrosis in systemic lupus erythematosus].
    Sovetskaia meditsina, 1973, Volume: 36, Issue:11

    Topics: Adult; Female; Femur Head Necrosis; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone; Sex F

1973
The course of lupus nephritis: a clinical-pathological correlation of fifty patients.
    Perspectives in nephrology and hypertension, 1973, Volume: 1 Pt 2, Issue:0

    Topics: Adolescent; Adult; Azathioprine; Basement Membrane; Biopsy; Chloroquine; Cyclophosphamide; Female; F

1973
Lupus nephritis: clinical course in relation to treatment.
    Perspectives in nephrology and hypertension, 1973, Volume: 1 Pt 2, Issue:0

    Topics: Adolescent; Adult; Aged; Azathioprine; Child; Creatinine; Cyclophosphamide; Female; Follow-Up Studie

1973
Lupus nephropathy.
    The British journal of clinical practice, 1974, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Female; Humans; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Mid

1974
[Epilepsy as an early symptom of lupus erythematosus].
    Dermatologische Wochenschrift, 1965, Nov-06, Volume: 151, Issue:45

    Topics: Adult; Epilepsy, Tonic-Clonic; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone

1965
[Treatment of chronic connective tissue diseases with cytostatics].
    Minerva medica, 1970, Jul-11, Volume: 61, Issue:55

    Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen

1970
Mixed monoclonal-polyclonal gammopathy.
    Guy's Hospital reports, 1969, Volume: 118, Issue:4

    Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Blood Protein Electrophoresis; Female; Hepatiti

1969
Nephrotic syndrome: a clinico-pathological study.
    Singapore medical journal, 1972, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Amyloidosis; Child; Diabetes Complications; Female; Glomerulonephritis; Hum

1972
Malignant lymphoma and acute SLE.
    British medical journal, 1972, Jul-29, Volume: 3, Issue:5821

    Topics: Aged; Female; Hodgkin Disease; Humans; Lupus Erythematosus, Systemic; Prednisolone

1972
[Discontinuous corticosteroid treatment of systemic lupus erythematosus].
    Klinicheskaia meditsina, 1972, Volume: 50, Issue:6

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Time Factors

1972
An unusual cutaneous manifestation of systemic lupus erythematosus.
    Archives of dermatology, 1971, Volume: 103, Issue:4

    Topics: Adolescent; Humans; Lupus Erythematosus, Systemic; Male; Prednisolone; Skin Manifestations

1971
[Systemic lupus erythematosus].
    Naika. Internal medicine, 1971, Volume: 27, Issue:6

    Topics: Adult; Betamethasone; Female; Humans; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Prednisolon

1971
Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years.
    Acta medica Academiae Scientiarum Hungaricae, 1971, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Aged; Antimalarials; Autoimmune Diseases; Azathioprine; Chlorambucil; Cyclophosph

1971
[Complications of corticosteeroid therapy in children].
    Voprosy okhrany materinstva i detstva, 1971, Volume: 16, Issue:5

    Topics: Adrenal Glands; Adrenocortical Hyperfunction; Arthritis, Infectious; Arthritis, Rheumatoid; Child; G

1971
Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.
    The Journal of clinical investigation, 1971, Volume: 50, Issue:12

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Chemotaxis; Child; Complement System Proteins; Femal

1971
Results of thymectomy in systemic lupus erythematosus: observations on clinical course and serological reactions.
    Clinical and experimental immunology, 1966, Volume: 1, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Complement System Proteins; Coombs

1966
[Complications of steroid ulcers of the stomach].
    Klinicheskaia meditsina, 1969, Volume: 47, Issue:1

    Topics: Adult; Female; Gastrointestinal Hemorrhage; Humans; Lupus Erythematosus, Systemic; Peptic Ulcer Perf

1969
[Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Naika. Internal medicine, 1970, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Child; Complement Fixation Tests; Complement System Prot

1970
[Erythematodes provocation by gold therapy in primary chronic polyarthritis].
    Deutsche medizinische Wochenschrift (1946), 1969, Oct-03, Volume: 94, Issue:40

    Topics: Arthritis, Rheumatoid; Female; Gold; Humans; Injections, Intramuscular; Lupus Erythematosus, Systemi

1969
[Case of systemic lupus erythematosis with massive pericardial effusion].
    Naika. Internal medicine, 1969, Volume: 24, Issue:4

    Topics: Adult; Electrocardiography; Female; Humans; Lupus Erythematosus, Systemic; Pericardial Effusion; Pre

1969
[Treatment of patients with discoid lupus erythematosus by injections of 10 per cent Quingamine].
    Vestnik dermatologii i venerologii, 1969, Volume: 45, Issue:12

    Topics: Chloroquine; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Nicotinic Acids; P

1969
[Physical and sexual development of girls in systemic lupus erythematosus (under massive corticosteroid therapy)].
    Voprosy okhrany materinstva i detstva, 1969, Volume: 14, Issue:10

    Topics: Adolescent; Child; Female; Growth; Humans; Lupus Erythematosus, Systemic; Prednisolone; Puberty

1969
Systemic lupus erythematosus. Report of a case.
    Indian journal of pediatrics, 1969, Volume: 36, Issue:263

    Topics: Autoantibodies; Child; Female; Humans; India; Lupus Erythematosus, Systemic; Prednisolone

1969
[Clinico-theoretical bases of steroid therapy of collagen diseases].
    Vestnik Akademii meditsinskikh nauk SSSR, 1969, Volume: 24, Issue:7

    Topics: Arthritis, Rheumatoid; Collagen Diseases; Humans; Lupus Erythematosus, Systemic; Prednisolone; Pyraz

1969
[Treatment of chronic collagen diseases using cytostatics].
    Munchener medizinische Wochenschrift (1950), 1970, Mar-20, Volume: 112, Issue:12

    Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Chronic Disease; Collagen Diseases; Humans; Immunosupp

1970
[A case of monosymptomatic lupus erythematosus in childhood].
    Kinderarztliche Praxis, 1970, Volume: 38, Issue:5

    Topics: Child; Humans; Lupus Erythematosus, Systemic; Male; Nephritis; Prednisolone

1970
[Immunological indices in diffuse glomerulonephritis during immunodepressive therapy].
    Sovetskaia meditsina, 1970, Volume: 33, Issue:7

    Topics: Adolescent; Adult; Antistreptolysin; Autoantibodies; Autoimmune Diseases; Azathioprine; Child; Chlor

1970
[Cytochemical changes in peripheral blood neutrophils in collagen diseases and nephropathies].
    Vestnik Akademii meditsinskikh nauk SSSR, 1970, Volume: 25, Issue:9

    Topics: Acid Phosphatase; Alkaline Phosphatase; Arthritis, Rheumatoid; Collagen Diseases; Dermatomyositis; H

1970
[Role of proteolytic and treatment of nephritis].
    Vestnik Akademii meditsinskikh nauk SSSR, 1970, Volume: 25, Issue:9

    Topics: Adult; Amyloidosis; Antimetabolites; Chymotrypsin; Female; Glomerulonephritis; Humans; Kidney Diseas

1970
Cyclophosphamide in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 1970, Volume: 29, Issue:6

    Topics: Adult; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Male; Pre

1970
[Change in the amino acid spectrum of the blood serum in patients with lupus erythematosus under the effect of therapy].
    Vestnik dermatologii i venerologii, 1970, Volume: 44, Issue:7

    Topics: Adolescent; Adult; Aged; Amino Acids; Antimalarials; Child; Child, Preschool; Humans; Lupus Erythema

1970
Coincidence of autoimmune diseases and polycythemia vera.
    Haematologia, 1970, Volume: 4, Issue:3

    Topics: Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Bone Marrow Examination; Female; Hand; Humans; Lup

1970
[Serum complement levels in nephritis].
    Arerugi = [Allergy], 1967, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Animals; Complement System Proteins; Female; Guinea Pigs; Humans; In Vitro Techni

1967
[Erythematodes familiaris].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1968, Aug-01, Volume: 43, Issue:15

    Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Chloroquine; Chronic Disease;

1968
[3 cases of systemic lupus erythmatosus].
    Naika hokan. Japanese archives of internal medicine, 1968, Volume: 15, Issue:1

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone

1968
Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
    American journal of diseases of children (1960), 1968, Volume: 116, Issue:6

    Topics: Adolescent; Arthritis, Juvenile; Cataract; Child; Child, Preschool; Chloroquine; Colitis, Ulcerative

1968
[Autopsy case of systemic lupus erythematosus accompanied by diffuse cryptococcosis].
    Saishin igaku. Modern medicine, 1968, Volume: 23, Issue:7

    Topics: Adolescent; Animals; Betamethasone; Cryptococcosis; Factor XI Deficiency; Female; Humans; Lupus Eryt

1968
[Systemic erythematosus--the blood].
    Nihon rinsho. Japanese journal of clinical medicine, 1968, Volume: 26, Issue:12

    Topics: Adult; Aged; Blood Coagulation Disorders; Female; Humans; Lupus Erythematosus, Systemic; Male; Middl

1968
[Lupus nephropathies and their treatment].
    Semaine therapeutique, 1968, Volume: 44, Issue:4

    Topics: Chlorambucil; Glomerulonephritis; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Prednisolo

1968
Recurrent Osler's nodes in systemic lupus erythematosus.
    Angiology, 1969, Volume: 20, Issue:1

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Prednisone; Skin Manifestations

1969
[Lupus erythematosus disseminatus: pregnancy and birth].
    Deutsche medizinische Wochenschrift (1946), 1969, Feb-07, Volume: 94, Issue:6

    Topics: Adult; Chloroquine; Female; Humans; Lupus Erythematosus, Systemic; Obstetric Labor, Premature; Penic

1969
Thymic size in systemic lupus erythematosus. Roentgenological assessment.
    Archives of internal medicine, 1969, Volume: 124, Issue:1

    Topics: Adolescent; Adult; Age Factors; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Male; M

1969
[Collagen diseases. On clinical aspects and theapy of disseminated lupus erythematosus, progressive scleroderma and dermatomyositis].
    Hippokrates, 1969, Aug-31, Volume: 40, Issue:16

    Topics: Collagen Diseases; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic;

1969
Systemic lupus erythematosus and pregnancy.
    British medical journal, 1965, Nov-20, Volume: 2, Issue:5472

    Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Pregnancy; Pregnancy Complicatio

1965
Albumin turnover in pleural effusions.
    Clinical science, 1965, Volume: 29, Issue:2

    Topics: Administration, Topical; Anti-Inflammatory Agents; Breast Neoplasms; Capillary Permeability; Heart F

1965
Corticosteroids in heart disease.
    British medical journal, 1966, Sep-24, Volume: 2, Issue:5516

    Topics: Adrenal Cortex Hormones; Female; Heart Block; Heart Diseases; Heart Failure; Heart Injuries; Humans;

1966
Steroid arthropathy.
    Radiology, 1966, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Joint Diseases; Lupus Erythematosus,

1966
[Modification of systemic lupus erythematosus in connection with steroid hormone therapy (clinico-morphological parallels)].
    Sovetskaia meditsina, 1966, Volume: 29, Issue:8

    Topics: Adult; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone

1966